| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Feb―10 |
Correction: Ensuring tight control in patients with rheumatoid arthritis treated with targeted therapies during the COVID-19 pandemic using a telehealth strategy |
|
| 2 |
[GO] |
2024―Aug―01 |
POS1313 CANCER-ASSOCIATED MYOSITIS BEFORE AND AFTER THE COVID-19 PANDEMIC ONSET - A CHANGING TREND |
F. Costa, B. Correia, M. Bandeira, E. Dourado, A.T. Melo, F.M. Diamantino Saraiva, J.E. Fonseca, S.C. Barreira, R. Campanilho-Marques |
| 3 |
[GO] |
2024―Aug―01 |
POS1273 NO DISPROPORTIONATE INCREASE IN MORTALITY DIRECTLY ATTRIBUTED TO DERMATOPOLYMYOSITIS DURING THE COVID-19 PANDEMIC: A POPULATION-BASED STUDY |
E. Matz, S. Rajkumar, R. Singh |
| 4 |
[GO] |
2024―Jun―10 |
AB0062 COVID-19: THE RISE OF RHEUMATOID ARTHRITIS |
C. Baimukhamedov |
| 5 |
[GO] |
2024―Jun―10 |
AB0088 OSTEOARTICULAR REACTIONS POST ANTI COVID-19 VACCINATION |
N. EL Ouardi, H. Zouaki, E.A. Houda, L. Taoubane, H. Elhani, K. El Marbouh, A. Majjad, H. Toufik, A. Bezza |
| 6 |
[GO] |
2024―Jun―10 |
AB0070 DURABILITY OF CELLULAR AND HUMORAL IMMUNITY FOLLOWING A FIFTH SARS-CoV-2 VACCINE IN PATIENTS WITH INFLAMMATORY JOINT DISEASES ON IMMUNOSUPPRESSIVE THERAPIES |
H.S. Ørbo, I. Jyssum, A.T. Tveter, A. Lind, V.P. Dimova-Svetoslavova, I.E. Christensen, J. Sexton, K.H. Bjørlykke, T.K. Kvien, E.A. Haavardsholm, K.K. Jørgensen, S. Aarrestad Provan, S.W. Syversen, G.L. Goll |
| 7 |
[GO] |
2024―Jun―10 |
AB1353 SAFETY OF UPDATED XBB.1.5 SARS-CoV-2 VACCINE BOOSTERS IN PATIENTS WITH INFLAMMATORY JOINT DISEASES ON IMMUNOSUPPRESSIVE THERAPIES |
H.S. Ørbo, I. Jyssum, A.T. Tveter, I.E. Christensen, J. Sexton, K.H. Bjørlykke, T.K. Kvien, E.A. Haavardsholm, K.K. Jørgensen, S. Aarrestad Provan, S.W. Syversen, G.L. Goll |
| 8 |
[GO] |
2024―Jun―10 |
POS0111 BENEFICIAL EFFECT OF TEMPORARY METHOTREXATE WITHDRAWAL ON B AND T CELL RESPONSES UPON SARS-CoV-2 VACCINATION IN PATIENTS WITH RHEUMATOID ARTHRITIS OR PSORIATIC ARTHRITIS |
S. Castañeda, E. Vicente-Rabaneda, P. Martínez-Fleta, A. Triguero-Martinez, M. Uriarte-Ecenarro, F. Gutiérrez-Rodríguez, P. Quiroga Colina, A. Romero, N. García Castañeda, J.A. García-Vadillo, C. Valero, I. Llorente, A. Ortiz, E. Tomero Muriel, M.A. Alfranca, R. Garcia-Vicuña, F. Sánchez-Madrid, I. González-Álvaro |
| 9 |
[GO] |
2024―Jun―10 |
AB0227 FLARES AFTER SARS-CoV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY ARTHRITIS: RESULTS OF A SINGLE CENTER |
G. Vukatana, L.B. Boling, A. Carbone, M. Reta |
| 10 |
[GO] |
2024―Jun―10 |
AB1732 PROFILE OF MULTISYSTEM INFLAMMATORY SYNDROME (MIS-C) IN INFANTS DURING THE SECOND WAVE OF SARS-CoV-2 PANDEMIC: AN OBSERVATIONAL CROSS-SECTIONAL STUDY |
R. Gupta, A. Maheshwari, D. Mahto, S. Basu, S. Sehgal, A. Kumar |
| 11 |
[GO] |
2024―Jun―10 |
POS0174 VACCINE UPTAKE AGAINST INFLUENZA AND PNEUMOCOCCAL INFECTIONS DURING THE SARS-CoV-2 PANDEMIC IN PATIENTS WITH AND WITHOUT CHRONIC INFLAMMATORY RHEUMATIC DISEASES (CIRD) |
I. Andreica, I. Roman, X. Baraliakos, U. Kiltz, J. Braun |
| 12 |
[GO] |
2024―Jun―10 |
AB0068 LONG-TERM FOLLOW-UP OF PATIENTS WITH RHEUMATIC DISEASES AND SARS-CoV-2 INFECTION: DATA FROM THE SAR-COVID REGISTRY |
C.A. Isnardi, M.A. Alfaro, B.M. Virasoro, G. Gómez, M.E. D´angelo, V. Saurit, I.E. Petkovic, R. Quintana, Y. Tissera, C. Pisoni, G. Berbotto, M. Haye Salinas, S. Ornella, M. Pera, A.A. Reyes, R. Baez, D.A. Pereira, G. Alle, V.V. Castro Coello, P. Alba, A.K. Cogo, C.G. Alonso, C. Gobbi, J. Gallino Yanzi, G. Pons-Estel |
| 13 |
[GO] |
2024―Jun―10 |
AB0023 A SINGLE CENTER STUDY ON THE EFFECTS OF SARS-CoV-2 INFECTION AND VACCINATION IN PATIENTS WITH ADULT-ONSET STILL’S DISEASE |
L.B. Boling, G. Vukatana, D. Pilastro, S. Orsinetti, M. Mirizio, R. Mulè, M. Reta |
| 14 |
[GO] |
2024―Jun―10 |
AB0079 NO FLARE AFTER PRE-EXPOSURE PROPHYLAXIS WITH MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 IN 82 PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES: A SINGLE CENTER EXPERIENCE |
M. Fernanda Zacarin, R. Suwa Marques, R. Da Rocha Jorge, V. De Castro Grotti, C.W. Menuzzo, D.P. De Souza, T.J. Trevisan, L.T. Hirata, M. Paula Souza Dos Santos, J.G. Borghi, A.P. Del Rio, L. Tereza Lavras Costallat, Z. Sachetto, M.B. Bertolo, A. Pugliesi |
| 15 |
[GO] |
2024―Jun―10 |
AB0074 VACCINATION RATE, ADVERSE REACTIONS, AND REASONS FOR NONVACCINATION OF COVID-19 VACCINE UP TO FIFTH DOSE IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A JAPANESE REAL-WORLD CLINICAL PRACTICE |
Y. Hirano, Y. Saito |
| 16 |
[GO] |
2024―Jun―10 |
AB0066 UNRAVELING KEY FACTORS IN COVID-19 VACCINATION AMONG RHEUMATOID ARTHRITIS PATIENTS: A LANDMARK MONOCENTRIC INVESTIGATION |
H. Elhani, H. Toufik, L. Taoubane, N. EL Ouardi, A. Majjad, A. Bezza |
| 17 |
[GO] |
2024―Jun―10 |
AB0859 A SINGLE-CENTRE EXPERIENCE WITH SJÖGREN’S DISEASE AND SARS-CoV-2 |
K. Perdan-Pirkmajer, L. Furjanič, M. Tomšič, A. Hocevar, S. Praprotnik, S. Pirkmajer |
| 18 |
[GO] |
2024―Jun―10 |
POS0764 IMMUNOGENICITY AND SAFETY OF COVID-19 VACCINES IN PATIENTS WITH JUVENILE AUTOIMMUNE DISEASES: DATA FROM SAFER STUDY |
C. Strauss Estevez Gadelha, Y. Oliveira Gondim Moraes, M.T. Terreri, A. Coelho Moreira Da Fraga, D. Borges Ferreira, A.P. Neves Burian, K. Lysie Libardi Lira Machado, S. Lúcia Euzébio Ribeiro, C. Maria Paiva França Telles, R. Poubel Vieira de Rezende, K. Lino Baptista, V. Schinzel, G.A. Ferreira, R. Machado Xavier, O.A. Monticielo, E. Torres Dos Reis Neto, E.I. Sato, V. Angelina de Souza, G. Clemente, G. Salviato Pileggi, V. Valim |
| 19 |
[GO] |
2024―Jun―10 |
AB0581 BIVALENT MRNA COVID-19 VACCINE BOOSTER DOES NOT INCREASE THE RISK OF FLARE IN RHEUMATOID ARTHRITIS PATIENTS UNDER REAL LIFE SETTING - DATA FROM SAFER STUDY |
V. Cruz, C. Guimarães, J. Rêgo, K. Lysie Libardi Lira Machado, S.T. Miyamoto, A.P. Neves Burian, L.H. Dias, K. Rosemarie Lallemand Tapia, D. Cristina Filgueira Alves Batista, J. Geraldo Mill, Y. Gurtler Pinheiro de Oliveira, C. Strauss Estevez Gadelha, M. Gomes Gouveia, A.C. Simões Moulin, B. Oliveira Souza, L. Gonçalves Rodrigues Aguiar, G. Smith Sobral Vieira, L. Lorenzoni Grillo, M. Deorce de Lima, L. Pizzol Pasti, H. Filipe Surlo, F. Faé, I. Ribeiro Moulaz, M. De Oliveira Macabú, P. Dias Cardoso Ribeiro, V. De Oliveira Magalhães, M. Freitas de Aguiar, E. Biegelmeyer, F.M. Matos Melo Campos Peixoto, C. Kayser, A. Wagner Silva de Souza, C. Heldan de Moura Castro, S. Lúcia Euzébio Ribeiro, C. Maria Paiva França Telles, J. Buhring, R. Lima, S.H. Dos Santos, S. Elias Basualto Dias, N. Seixas de Melo, R. Holanda Da Silva Sanches, A. Luiz Boechat, N. Sartori, V. Hax, L. Denardi Dória, R. Poubel Vieira de Rezende, K. Lino Baptista, N. Rodrigues Querido Fortes, A.K. Melo, T. Santos Melo, R. Maria Rodrigues Vieira, A. Sophia Rodrigues Vieira, A.M. Kakehasi, A.C. Faria Moreira Gomes Tavares, A. Teixeira de Landa, P. Costa, V.F. Azevedo, O. Assis Martins-Filho, V. Peruhype-Magalhães, M. Pinheiro, O.A. Monticielo, E. Torres Dos Reis Neto, G.A. Ferreira, V. Angelina de Souza, A. Teixeira-Carvalho, R. Machado Xavier, E.I. Sato, V. Valim, G. Salviato Pileggi |
| 20 |
[GO] |
2024―Jun―10 |
AB0093 RATE AND CAUSES OF HESITANCY IN COVID-19 VACCINATION IN KOREAN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: A SURVEY STUDY |
B. Song |
| 21 |
[GO] |
2024―Jun―10 |
AB0075 CAPILLAROSCOPY IN COVID-19 SURVIVORS AND COPD AFFECTED PATIENTS: A PILOT STUDY |
B. Ruaro, A. Romallo, F. Salton, P. Confalonieri, L. Mondini, M. Confalonieri |
| 22 |
[GO] |
2024―Jun―10 |
AB0067 COVID-19 REINFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS |
Y.G. Kim, Y.E. Kim, W.J. Seo, S.M. Ahn, J.S. Oh, S. Hong, C.K. Lee, B. Yoo |
| 23 |
[GO] |
2024―Jun―10 |
AB0086 COMBINATION THERAPY OF HIGH-DOSE INTRAVENOUS ANAKINRA AND BARICITINIB IN PATIENTS WITH CRITICAL COVID-19: PROMISING RESULTS FROM RETROSPECTIVE OBSERVATIONAL STUDY |
M. Bektaş |
| 24 |
[GO] |
2024―Jun―10 |
AB0087 INTRAVENOUS HIGH-DOSE ANAKINRA DROPS VENOUS THROMBOSIS AND MYOCARDIAL INFARCTION IN SEVERE AND CRITICAL COVID-19 PATIENTS: A PROPENSITY SCORE MATCHED STUDY |
M. Bektaş, M. Ay, M. Uyar, M.İ. Kiliç |
| 25 |
[GO] |
2024―Jun―10 |
AB0071 PROGNOSTIC FACTORS IN ICU PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES AND COVID-19: INSIGHTS FROM A RETROSPECTIVE COHORT STUDY |
E. Wiebe, F. Münch, N. Léprêtre, J. Klotsche, J.H.B. Hardenberg, K. Rubarth, M. Mittermaier, F. Balzer, R. Biesen, G. Krönke, K.U. Eckardt |
| 26 |
[GO] |
2024―Jun―10 |
POS0864 NEWLY DIAGNOSE ANCA-ASSOCIATED VASCULITIS, IS THERE REALLY AN INCREASE IN CASES RELATED TO COVID-19 PANDEMIC? STUDY IN A SINGLE UNIVERSITY HOSPITAL |
L. Gabrie, F. Benavides-Villanueva, H.M. Ulloa Alvarado, M. Renuncio-García, D. Prieto-Peña, V. Calvo-Río, R. Blanco |
| 27 |
[GO] |
2024―Jun―10 |
AB0085 PRE-EXPOSURE PROPHYLAXIS OF SARS-COV-2 INFECTION AND SEVERE COVID-19 WITH TIXAGEVIMAB AND CILGAVIMAB (EVUSHELD) IN RHEUMATOLOGIC PATIENTS TREATED WITH RITUXIMAB AT RISK OF SEVERE COVID-19: EFFICACY AND SAFETY ANALYSIS OF AN ITALIAN MONOCENTRIC COHORT |
M. Sette, M. Manara, L. Giudice, M. Biggioggero, N. Del Papa, E.G. Favalli, M. Gerosa, F. Ingegnoli, R.F. Caporali |
| 28 |
[GO] |
2024―Jun―10 |
POS0106 MICROVASCULAR STATUS IN COVID-19 SURVIVORS: A NAILFOLD VIDEO CAPILLAROSCOPY ANALYSIS |
R. Campitiello, A. Sulli, E. Gotelli, E. Hysa, C. Pizzorni, S. Paolino, A. Pinelli, P. Vittoriano Clini, F. Lalli, T. Vojinovic, C. Schenone |
| 29 |
[GO] |
2024―Jun―10 |
AB1461 ASSOCIATION OF FLARES OF CONNECTIVE TISSUE DISEASE AND SYSTEMIC LUPUS ERYTHEMATOSUS WITH DRUG USE FOLLOWING COVID-19 MRNA VACCINATION: RESULTS FROM THE CORONAVIRUS NATIONAL VACCINE REGISTRY FOR IMMUNE DISEASES SINGAPORE (CONVIN-SING) |
P. Dhanasekaran, A. Mak, M. MA, Y.H. Chan, A. Santosa, P. Cheung, W. Fong, S. Angkodjojo, C. Xu, K.O. Kong, T. Arkachaisri, K.F. Phang, T.C. Tan, M. Sriranganathan, S.H. Tay, M. Lahiri |
| 30 |
[GO] |
2024―Jun―10 |
POS0575 COVID-19 IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB: A RETROSPECTIVE CLINICAL STUDY |
Y. Liu, D. Huang |
| 31 |
[GO] |
2024―Jun―10 |
AB0084 EFFECT OF SOCIOECONOMIC CHARACTERISTICS ON MORTALITY DUE TO COVID-19 IN PATIENTS WITH RHEUMATIC IMMUNE-MEDIATED INFLAMMATORY DISEASES IN THREE COUNTRIES OF LATIN AMERICA |
M. Martínez-Martínez, D. Alpizar-Rodriguez, C.A. Isnardi, G. Pons-Estel, M.A. Alfaro, B.M. Virasoro, I.E. Petkovic, R. Quintana, G. Berbotto, M. Haye Salinas, S. Ornella, M. Pera, I.J. Colunga-Pedraza, F. Irazoque-Palazuelos, G. Reyes-Cordero, T.S. Rodriguez-Reyna, J.A. Veloz Aranda, C.M. Skinner-Taylor, I.M. Juarez Mora, L. Silveira, R. Machado Xavier, A.M. Kakehasi, A.P. Gomides, E. Torres, G. Salviato Pileggi, G.A. Ferreira, L. Mota, M. Pinheiro, C. Marques, D. Calderaro |
| 32 |
[GO] |
2024―Jun―10 |
POS0576 OUTCOMES OF COVID-19 INFECTION IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES COMPARED TO THE GENERAL POPULATION: A NATIONWIDE POPULATION-BASED RETROSPECTIVE STUDY USING THE KOREAN HEALTH INSURANCE REVIEW AND ASSESSMENT SERVICE (HIRA) DATABASE |
E.J. Park, H. Jeong, E.J. Joo |
| 33 |
[GO] |
2024―Jun―10 |
AB0051 THE ASSOCIATION BETWEEN COVID-19 INFECTION AND DISEASE FLARES IN PATIENTS WITH BEHÇET’S SYNDROME |
W. Zheng, Y. Liu, Z. Wang, X. Yu, J. Liu |
| 34 |
[GO] |
2024―Jun―10 |
AB0076 LONG-TERM SAFETY OF VACCINATION FOR COVID-19 IN PATIENTS WITH RHEUMATIC DISEASES AND PSORIASIS: DATA FROM THE SAR-CoVAC REGISTRY |
C.A. Isnardi, B.M. Virasoro, M.E. D´angelo, D.A. Pereira, I.E. Petkovic, Y. Tissera, M.D.L.A. Correa, C. Pisoni, G.F. Rodriguez Gil, R. Quintana, A.K. Cogo, J. Kreimer, C.G. Alonso, N. Kogan, A.L. Toledo, M.A. Alfaro, M. Cosatti, R. Nieto, L. Garcia, A. Rollano Perasso, Z. Troyano, E. Debernardi, G. Pons-Estel, E.E. Schneeberger |
| 35 |
[GO] |
2024―Jun―10 |
AB0091 DID COVID-19 PANDEMIC AFFECT THERAPEUTIC DECISION MAKING OF RHEUMATOLOGISTS? ASSESSMENT OF CHANGES OVER TIME USING JAPANESE NINJA REGISTRY |
A. Ihata, A. Sekiguchi, Y. Sato, E. Ohno, E. Hashimoto, T. Matsui, S. Tohma |
| 36 |
[GO] |
2024―Jun―10 |
AB0063 PREVALENCE AND CLINICAL SEVERITY RELATED TO POSITIVE TEST OF CRYOFIBRINOGEN IN PRECOVID-19 ERA AND COVID-19 ERA |
C. Lasa-Teja, A. Sánchez López, M.E. Peiró Callizo, M. Renuncio García, A. Martín-Gutiérrez, C. Secada-Gómez, J. Irure-Ventura, M. López Hoyos, R. Blanco |
| 37 |
[GO] |
2024―Jun―10 |
AB1413 LONG TERM FOLLOW-UP OF PATIENTS WITH POSITIVE CRIOFIBRINOGEN TEST DURING COVID-19 ERA |
C. Lasa-Teja, A. Sánchez López, M.E. Peiró Callizo, M. Renuncio García, A. Martín-Gutiérrez, C. Secada-Gómez, J. Irure-Ventura, M. López Hoyos, R. Blanco |
| 38 |
[GO] |
2024―Jun―10 |
AB0073 ANTIBODY RESPONSE AND COVID-19 DISEASE AFTER SARS-CoV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES RECEIVING BIOLOGICAL TREATMENT |
E.K. Raussi, M. Eisen, K. Palk, M. Kütt |
| 39 |
[GO] |
2024―Jun―10 |
AB1645-PARE DISEASE FLARES IN PATIENTS WITH RHEUMATOID ARTHRITIS FOLLOWING COVID-19 BREAKTHROUGH INFECTION: RESULT FROM COVAD E-SURVEY STUDY |
C. Sieiro Santos, J.P. Chen, E. Nikiphorou, C.W. Tseng, C.E. Toro-Gutierrez, A.L. Tan, A. Nune, E. Kadam, M. Kuwana, J. Day, S. Saha, T. Velikova, J.B. Lilleker, C. Vinicio Caballero, P. Sen, H. Chinoy, R. Aggarwal, V. Agarwal, L. Gupta, Y.M. Chen |
| 40 |
[GO] |
2024―Jun―10 |
POS0071 IMMUNOMODULATORY TREATMENT AND IMMUNE RESPONSES TO COVID-19 BOOSTER SHOTS IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: RESULTS FROM THE COVID-19 VACCINE RESPONSE IN RHEUMATOLOGY PATIENTS (COVER) STUDY |
J.R. Curtis, A. Mudano, G. Cutter, T. Mikuls, G. Thiele, E. Holladay, K.L. Winthrop, M. Law, B. Hamilton, M. Bastidas, M. Zikry, K. Chun, M. George |
| 41 |
[GO] |
2024―Jun―10 |
AB0089 SUPERIOR SARS-CoV-2 ANTIBODY RESPONSE ACHIEVED IN RITUXIMAB-TREATED PATIENTS WHEN VACCINATED AGAINST COVID-19 BEFORE COMPARED TO AFTER RITUXIMAB INITIATION - GUIDANCE FOR FUTURE VACCINATION STRATEGIES |
C. Ammitzbøll, M.K. Thomsen, L.E. Bartels, C.B. Hansen, M.L.F. Hermansen, M. Hänel, R. Klose-Jensen, M.C.L. Larsen, C.E. Mistegaard, M.O. Lauritzen, S. Mikkelsen, J.B.M. Olesen, E. Naeser, M.A. Nielsen, C. Erikstrup, P. Garred, E.M. Hauge, A. Troldborg |
| 42 |
[GO] |
2024―Jun―10 |
AB0276 PECULIARITIES OF THE COURSE OF COVID-19 AND ALLELIC POLYMORPHISM RS4646994 OF THE ACE1 GENE IN JUVENILE IDIOPATHIC ARTHRITIS |
O. Mukvich, N. Diachenko |
| 43 |
[GO] |
2024―Jun―10 |
AB0090 PRESENTATION RISK FACTORS ASSOCIATED WITH PROGRESSION TO CRITICAL ILLNESS IN COVID-19 PATIENTS UNDERGOING INDEX HOSPITALIZATION WITH RHEUMATIC DISEASE |
K. Cai Zhen, G. Garcia, P. Kotlarz, B. Long, G. Ramos, I. Vargas, M. Rosario, K. Hamad, W. Wiese-Rometsch |
| 44 |
[GO] |
2024―Jun―10 |
AB0158 PSYCHOEMOTIONAL STATE AND INFLAMMATION AS PREDICTORS FOR MUSCULOSKELETAL PAIN IN PATIENTS WITH INFLAMMATORY ARTHRITIS AND COVID-19 |
S. Bogdanova-Petrova, T. Shivacheva, S. Dimitrov, R. Moraliyska, G. Gerganov, S. Hristova, Z. Dimova, M. Markov, T. Georgiev |
| 45 |
[GO] |
2024―Jun―10 |
AB0061 PATHOGENIC VARIANTS OF SCAVENGER RECEPTOR CD36 LEAD TO DECREASED EFFEROCYTOSIS AND PREDISPOSE TO MYOCARDITIS FOLLOWING VACCINATION WITH PFIZER-BioNTech BNT162b2 AGAINST CORONAVIRUS INFECTION (COVID-19) |
D. Mevorach |
| 46 |
[GO] |
2024―Jun―10 |
AB1045 LONG COVID SYMPTOMS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE-CONTROL STUDY |
K.L. Chan, C.C. Mok, C.L. Cheung |
| 47 |
[GO] |
2024―Jun―10 |
POS0574 POPULATION-BASED ANALYSIS OF THE ASSOCIATION BETWEEN SARS-CoV-2 INFECTION AND INCIDENT AUTOIMMUNE DISEASES |
J.A. Aviña-Zubieta, S. Marozoff, N. Lu, J.M. Loree, H. Xie, D. Lacaille, J. Esdaile, B. Corradetti, P. Malone, C.L. Koehn, P. Mennell, A. Hoens |
| 48 |
[GO] |
2024―Jun―10 |
AB0082 RITUXIMAB THERAPY AND SARS-CoV-2 INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS |
D. Ramachandran, M.T. Ghaffar, D. Makkuni |
| 49 |
[GO] |
2024―Jun―10 |
AB0083 THE IMPACT OF COVID-19 AND ‘LONG COVID’ ON SELF-REPORTED DISEASE ACTIVITY, DISABILITY, AND QUALITY OF LIFE IN PEOPLE WITH INFLAMMATORY ARTHRITIS |
Z.S. Wallace, M. Lin, X. Wang, N. Patel, Y. Kawano, A. Schiff, A. King, J. Hanberg, S. Srivatsan, E. Kowalski, C. Johnson, K. Vanni, Z. Williams, G. Qian, C. Bolden, K. Mueller, K. Bade, A. Saavedra, R. Venkat, J.A. Sparks |
| 50 |
[GO] |
2024―Jun―10 |
AB0080 EXAMINING THE DYNAMICS OF RHEUMATOLOGY CONSULTATION OF THE INTENSIVE CARE UNIT PATIENTS BEFORE AND AFTER THE COVID-19 PANDEMIC AT A FOURTH-LEVEL CLINIC IN COLOMBIA |
M. Muñoz-Urbano, Y.M. Chamorro-Melo, D.C. Quintero-González, M.C. Guerrero Oviedo, M.E. Tello-Cajiao, Á. Arbeláez-Cortés |
| 51 |
[GO] |
2024―Jun―10 |
AB1332 TEMPORAL TREND IN VACCINATION WITH 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) AMONG PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES: REAL-WORLD DATA FROM ISRAEL PRIOR TO AND AT THE START OF THE COVID-19 PANDEMIC (2017-2020) |
V. Furer, C. Weil, S. Gazit, G. Chodik, S.A. Slav, S. Nafterlberg Blonder, O. Elkayam |
| 52 |
[GO] |
2024―Jun―10 |
AB0064 BIOINFORMATICS AND SYSTEMS-BIOLOGY APPROACH TO IDENTIFY COMMON PATHOGENIC MECHANISMS FOR COVID-19 AND SYSTEMIC LUPUS ERYTHEMATOSUS |
Y. Wu, Y. LI, X. Bai, Y. Liu |
| 53 |
[GO] |
2024―Jun―10 |
AB0092 COVID-19 MRNA VACCINES BASED ON THE ANCESTRAL WUHAN STRAIN GENERATE ANTI-SARSCOV2 ANTIBODIES WITH LOW VIRAL INHIBITION LEVELS TO OMICRON VARIANTS IN PEOPLE WITH IMMUNE MEDIATED INFLAMMATORY DISEASES |
C.A. Hitchon, J. Ahmed, P. Adams, S. Kiazyk, C.N. Bernstein, R. Marrie, J. Kim, S. Bernatsky, C. Card |
| 54 |
[GO] |
2024―Jun―10 |
POS0571 THE NEW OCCURENCE OF ANTIPHOSPOLIPID SYNDROME IN PATIENTS WITH THE MOST SEVERE FORMS OF COVID-19 |
M. Zlatkovic-Svenda, M. Ovuka, M. Zdravković, A. Ravdivcev, M. Ogrič, S. Čučnik, P. Zigon, G. Radunovic |
| 55 |
[GO] |
2024―Jun―10 |
AB0065 A LONGITUDINAL STUDY OF SARS-CoV-2 INDUCED HUMORAL AND CELLULAR IMMUNE RESPONSE IN IMMUNOCOMPROMISED PATIENTS AND HEALTHY CONTROLS |
D. Nemeth, H. Vago, L. Tothfalusi, Z. Ulakcsai, D. Becker, Z. Szabo, B. Rojkovich, L. Gunkl-Toth, B. Merkely, G. Nagy |
| 56 |
[GO] |
2024―Jun―10 |
POS0090 CELLULAR AND HUMORAL RESPONSES RESTORED BY UPDATED SARS-CoV-2 VACCINES AND HYBRID IMMUNITY IN PATIENTS ON TNF INHIBITORS: A PROSPECTIVE COHORT STUDY |
H.S. Ørbo, A.S. Wolf, T.M. Kasahara, K.H. Bjørlykke, I. Jyssum, J. Sexton, A.T. Tveter, G. Solum, I. Fadum Kjønstad, I.E. Christensen, T.K. Kvien, G.B. Kro, J. Jahnsen, E.A. Haavardsholm, L.A. Munthe, S. Aarrestad Provan, J.T. Vaage, K.K. Jørgensen, G. Grødeland, S. Mjaaland, S.W. Syversen, G.L. Goll |
| 57 |
[GO] |
2024―Jun―10 |
AB0078 PREDICTORS OF HOSPITALIZATION DUE TO BREAKTHROUGH COVID-19 INFECTION IN PATIENTS WITH IMMUNE-MEDIATED RHEUMATIC DISEASES: DATA FROM SAFER STUDY |
D. Calderaro, K. Lysie Libardi Lira Machado, E. Torres Dos Reis Neto, S. Lúcia Euzébio Ribeiro, M. Gomes Gouveia, L.H. Dias, D. Veghini, R. Casian Tuão, K. Rosemarie Lallemand Tapia, M. Barbosa Beloni Lirio, M. Deorce de Lima, F. Faé, L. Fiorotti Albertino, J. Ribeiro de Oliveira, H. Corona, I. Ribeiro Moulaz, L. Gonçalves Rodrigues Aguiar, P. Dias Cardoso Ribeiro, V. De Oliveira Magalhães, M. Freitas de Aguiar, E. Biegelmeyer, F.M. Matos Melo Campos Peixoto, C. Kayser, A. Wagner Silva de Souza, C. Heldan de Moura Castro, C. Maria Paiva França Telles, J. Buhring, R. Lima, R. Holanda Da Silva Sanches, N. Seixas de Melo, C. Ruas Yasuda, N. Sartori, V. Hax, R. Cavalheiro Do Espírito Santo, R. Poubel Vieira de Rezende, K. Lino Baptista, N. Rodrigues Querido Fortes, A.K. Melo, T. Santos Melo, V. Cruz, J. Rêgo, R. Maria Rodrigues Vieira, A. Sophia Rodrigues Vieira, A.M. Kakehasi, A.C. Faria Moreira Gomes Tavares, A. Teixeira de Landa, P. Costa, V.F. Azevedo, O. Assis Martins-Filho, V. Peruhype-Magalhães, M. Pinheiro, E.I. Sato, O.A. Monticielo, R. Machado Xavier, A. Teixeira-Carvalho, V. Angelina de Souza, G. Ferreira, V. Valim, G. Salviato Pileggi |
| 58 |
[GO] |
2024―Jun―10 |
AB0094 RISK OF SEVERE COVID-19 IN PATIENTS WITH RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF COHORT STUDIES |
P. Paramiraksa, M. Boonsiri, P. Patthamalai, A. Tansawet |
| 59 |
[GO] |
2024―Jun―10 |
POS0763 MUSCULOSKELETAL MANIFESTATIONS INDUCED BY SARS-CoV-2 IN PEDIATRIC POPULATION - A PORTUGUESE MULTICENTRIC STUDY |
A.J. Serra Gaspar Silva, B. Correia, H. Sousa, J. Silva-Dinis, M.E. Santos, V. Fraga, A.F. Mourão, S. Sousa, F. Oliveira-Ramos, M. Bernardo, P. Costa Reis, R. Campanilho-Marques |
| 60 |
[GO] |
2024―Jun―10 |
POS0573 NEUTRALISING ANTIBODY RESPONSES TO BIVALENT SARS-CoV-2 VACCINES AND HYBRID IMMUNITY IN PATIENTS ON TNF INHIBITORS: A PROSPECTIVE COHORT STUDY |
H.S. Ørbo, T.M. Kasahara, A.S. Wolf, K.H. Bjørlykke, J. Sexton, I. Jyssum, A.T. Tveter, G. Solum, I. Fadum Kjønstad, A. Lind, V.P. Dimova-Svetoslavova, T.K. Kvien, J. Jahnsen, E.A. Haavardsholm, L.A. Munthe, S. Aarrestad Provan, J.T. Vaage, S. Mjaaland, K.K. Jørgensen, G. Grødeland, S.W. Syversen, G.L. Goll |
| 61 |
[GO] |
2024―Jun―10 |
AB1348 RESPONSE TO SARS-CoV2 VACCINATION IN RHEUMATIC AND NEUROLOGICAL PATIENTS TREATED WITH DIFFERENT IMMUNOSUPPRESSIVE THERAPIES |
C. Calomarde-Gómez, R. Ugena-García, J. Valera, M. Mena, M. Esteve, I. Casas, J.A. Dominguez, L. Carabias, I. Nuño, C. Ramo, J. Santesmases, L. Mateo-Soria, M. Martinez-Morillo |
| 62 |
[GO] |
2024―Jun―10 |
POS0093 COMPARISON OF, CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A STUDY OF CASES WITH COVID-19 AND CONTROLS WITHOUT COVID-19 |
G.E. Acelas-Gonzalez, J. Arias-Aponte, R. Parra-Medina, M.L. Monsalve-Córdoba, A. Rojas-Villarraga, P.D. Nieto-Zambrano, M.C. Cortés-Osma, H.F. Restrepo-Guerrero, L. Villarreal, A. Gómez-López, P. Santos-Moreno |
| 63 |
[GO] |
2024―Jun―10 |
POS0081 ASSOCIATIONS OF CIRCULATING INFLAMMATORY CYTOKINES WITH LONG COVID AMONG PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES |
J.A. Sparks, X. Wang, P.Y. Lee, K. Brodeur, M. Lin, N. Patel, Y. Kawano, A. Schiff, A. King, J. Hanberg, S. Srivatsan, E. Kowalski, C. Johnson, K. Vanni, Z. Williams, G. Qian, C. Bolden, K. Mueller, K. Bade, A. Saavedra, R. Venkat, Z.S. Wallace |
| 64 |
[GO] |
2024―Jun―10 |
AB0736 DEVELOPMENT AND APPLICATION OF EPITOPESCAN, A PYTHON3 TOOLSET FOR MUTATION TRACKING IN SARS-CoV-2 IMMUNOGENIC EPITOPES RESTRICTED BY THE RHEUMATOID ARTHRITIS SUSCEPTIBILITY ALLELE HLA-DRB1*04:01 |
A. Kovalenko, S. Viatte |
| 65 |
[GO] |
2024―Jun―10 |
AB1247 VASCULITIS ASSOCIATED WITH SARS-CoV2: A SYSTEMATIC REVIEW |
D. Santos-Álvarez, N. Cabaleiro-Raña, D. López-Clemente, L. Romar, E.C. Cervantes Pérez, J.R. Maneiro, M. Caeiro-Aguado, A. Souto-Vilas, S. Fernández, C. Álvarez-Reguera, S. Romero-Yuste |
| 66 |
[GO] |
2024―Mai―30 |
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry |
Bayram Farisogullari, Saskia Lawson-Tovey, Kimme L Hyrich, Laure Gossec, Loreto Carmona, Anja Strangfeld, Elsa F Mateus, Martin Schäfer, Ana Rodrigues, Eric Hachulla, Jose A Gomez-Puerta, Marta Mosca, Patrick Durez, Ludovic Trefond, Tiphaine Goulenok, Martina Cornalba, Emoke Stenova, Inita Bulina, Eva Strakova, Julija Zepa, Nicolas Roux, Olivier Brocq, Eric Veillard, Bernd Raffeiner, Gerd R Burmester, Xavier Mariette, Pedro M Machado |
| 67 |
[GO] |
2024―Apr―04 |
Development and evaluation of a text analytics algorithm for automated application of national COVID-19 shielding criteria in rheumatology patients |
Meghna Jani, Ghada Alfattni, Maksim Belousov, Lynn Laidlaw, Yuanyuan Zhang, Michael Cheng, Karim Webb, Robyn Hamilton, Andrew S Kanter, William G Dixon, Goran Nenadic |
| 68 |
[GO] |
2024―Feb―23 |
Acute rheumatic fever in the province of Manitoba, Canada, before and after the coronavirus (COVID-19) pandemic |
Kayla Edison, Dion Pepelassis, Reeni Soni, Daryl Schantz, Ilan Buffo |
| 69 |
[GO] |
2024―Jan―10 |
Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study |
Abigail E Schiff, Xiaosong Wang, Naomi J Patel, Yumeko Kawano, Jennifer L Hanberg, Emily N Kowalski, Claire E Cook, Kathleen MM Vanni, Grace Qian, Katarina J Bade, Alene A Saavedra, Shruthi Srivatsan, Zachary K Williams, Rathnam K Venkat, Zachary S Wallace, Jeffrey A Sparks |
| 70 |
[GO] |
2023―Nov―21 |
Improving the nosology of Long COVID: it is not so simple |
Leonard H Calabrese, Philip J Mease |
| 71 |
[GO] |
2023―Nov―03 |
Long COVID: a new word for naming fibromyalgia? |
Xavier Mariette |
| 72 |
[GO] |
2023―Jul―20 |
AB1291 COVID-19 AND CRYOGLOBULINEMIC VASCULITIS.LONG-TERM SURVEY STUDY ON THE IMPACT OF PANDEMIC AND VACCINATION ON A LARGE PATIENT’S POPULATION |
L. Gragnani, M. Visentini, S. Lorini, S. Santini, G. Lauletta, C. Mazzaro, T. Urraro, Q. Luca, F. Cacciapaglia, P. Ruscitti, A. Tavoni, S. Marri, G. Cusano, L. Petraccia, C. Naclerio, E. Treppo, G. Del Frate, I. Di Cola, V. Raimondo, D. Scorpiniti, M. Monti, L. Puccetti, G. Elia, P. Fallahi, S. Basili, S. Scarpato, F. Iannone, M. Casato, A. Antonelli, A. L. Zignego, C. Ferri |
| 73 |
[GO] |
2023―Jul―20 |
AB1287 FACTORS ASSOCIATED WITH ADHERENCE TO ANTI TNF-Α THERAPY DURING THE COVID-19 PANDEMIC IN PATIENTS WITH RHEUMATOID ARTHRITIS |
W. G. Rojas Zuleta, M. Barbosa, O. J. Felipe Díaz, A. E. Pantoja Marquez, J. Canizales, C. Becerra-Arias, J. H. Donado Gómez, N. Duque Zapata |
| 74 |
[GO] |
2023―Jul―20 |
AB1290 IMPACT OF THE COVID-19 PANDEMIC ON SEPTIC ARTHRITIS MANAGEMENT |
S. Zemrani, B. Amine, I. EL Binoune, S. Rostom, R. Bahiri |
| 75 |
[GO] |
2023―Jul―20 |
AB1292 EFFECTS OF DMARD TREATMENT ON SARS-CoV-2 mRNA VACCINATION IN PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASE: A MATCHED, PROSPECTIVE COHORT STUDY |
E. Simader, T. Deimel, F. Kartnig, S. Tobudic, H. Haslacher, T. M. Karonitsch, D. Mrak, T. Nothnagl, T. Perkmann, H. Lechner-Radner, J. Sautner, F. Winkler, H. Burgmann, D. Aletaha, S. Winkler, S. Blüml, P. Mandl |
| 76 |
[GO] |
2023―Jul―20 |
AB1286 HUMORAL AND CELLULAR IMMUNOGENICITY INDUCED BY THIRD BOOSTER OF SARS-CoV-2 VACCINES IN PATIENTS WITH RHEUMATIC MUSCULOSKELETAL DISEASES |
Y. Kondo, M. Takeshita, S. Saito, J. Kikuchi, H. Hanaoka, K. Suzuki, Y. Kaneko |
| 77 |
[GO] |
2023―Jul―06 |
Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study |
Annemarie Lyng Lyng Svensson, Hanne-Dorthe Emborg, Lars Erik Bartels, Torkell Ellingsen, Thomas Adelsten, René Cordtz, Lene Dreyer, Niels Obel |
| 78 |
[GO] |
2023―Jun―07 |
POS1219 INCIDENCE, FEATURES AND OUTCOME OF DISEASE RELAPSE AFTER COVID-19 VACCINATION IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES |
T. G. Béldi, M. Nagy-Vincze, K. Szabó, A. Vincze, B. Miltényi-Szabó, Z. Varga, J. Varga, Z. Griger |
| 79 |
[GO] |
2023―Jun―07 |
POS1215 FLARES AFTER COVID-19 INFECTION IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: RESULTS FROM THE COVAD STUDY |
S. S. Ali, N. Ravichandran, P. Sen, J. Day, M. Joshi, S. Saha, R. Aggarwal, V. Agarwal, H. Chinoy, O. Distler, C. Vinicio Caballero, C. E. Toro Gutierrez, D. Dzifa, A. Makol, A. L. Tan, S. Katsuyuki Shinjo, V. Agarwal, L. Gupta |
| 80 |
[GO] |
2023―Jun―07 |
POS0999-HPR THE IMPACT OF THE COVID-19 PANDEMIC ON REFERRALS TO MUSCULOSKELETAL SERVICES FROM PRIMARY CARE AND SUBSEQUENT INCIDENCE OF INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISEASE: AN OBSERVATIONAL STUDY |
R. Bajpai, C. Burton, K. Mason, J. Bailey, M. Frisher, K. Jordan, C. Mallen, V. Welsh |
| 81 |
[GO] |
2023―Jun―07 |
POS0781-PARE RETROSPECTIVE STUDY OF VITAMIN D DEFICIENCY IN RHEUMATOLOGIC PATIENTS DURING THE COVID-19 PANDEMIC IN POLAND |
B. Nieradko-Iwanicka |
| 82 |
[GO] |
2023―Jun―07 |
POS0570 IMPACT OF CLINICIAN-RELATED FACTORS ON PHONE CONSULTATIONS IN RHEUMATOLOGY - ANALYSIS OF MEDICAL VS NON-MEDICAL CLINICIANS’ OUTCOMES FROM A COVID-19 INITIATIVE |
M. Hannides, S. Wig, S. Vasireddy |
| 83 |
[GO] |
2023―Jun―07 |
POS0559 ACCELERATED WANING OF HUMORAL IMMUNE RESPONSE TO A THIRD COVID-19 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES |
D. Mrak, F. Kartnig, D. Sieghart, E. Simader, H. Radner, P. Mandl, L. Göschl, P. Hofer, T. Deimel, I. Gessl, R. Kain, S. Winkler, J. S. Smolen, T. Perkmann, H. Haslacher, D. Aletaha, L. Heinz, M. Bonelli |
| 84 |
[GO] |
2023―Jun―07 |
POS0558 FLARES OF AUTOIMMUNE RHEUMATIC DISEASE FOLLOWING COVID-19 INFECTION: OBSERVATIONS FROM THE COVAD STUDY |
N. Ravichandran, N. Sandhu, A. Nune, J. Day, P. Sen, E. Nikiphorou, A. L. Tan, M. Joshi, S. Saha, S. Katsuyuki Shinjo, K. Jagtap, V. Agarwal, N. Ziade, T. Velikova, M. Milchert, M. Kuwana, A. Makol, H. Chinoy, V. Agarwal, R. Aggarwal, L. Gupta |
| 85 |
[GO] |
2023―Jun―07 |
POS0557 COVID-19 OUTCOMES IN KOREAN PATIENTS WITH GOUT |
M. J. Kim, B. Ryu, S. Yi, J. W. Park, Y. Jang, K. Shin |
| 86 |
[GO] |
2023―Jun―07 |
POS0555 HIGH DOSE INTRAVENOUS ANAKINRA TREATMENT IS SAFE AND EFFECTIVE IN SEVERE AND CRITICAL COVID-19 PATIENTS: A PROPENSITY SCORE MATCHED STUDY IN A SINGLE CENTER |
M. Bektaş, S. Yüce, M. Ay, M. Uyar, M. Önder, M. İ. Kiliç |
| 87 |
[GO] |
2023―Jun―07 |
POS0554 ANTIPHOSPHOLIPID ANTIBODIES AND VASCULAR THROMBOSIS IN PATIENTS WITH THE MOST SEVERE FORMS OF COVID-19 |
M. Zlatkovic-Svenda, M. Zdravković, M. Ovuka, M. Ogrič, S. Čučnik, P. Zigon |
| 88 |
[GO] |
2023―Jun―07 |
POS0552 NEUTROPHIL EXTRACELLULAR TRAPS AND B-CELL ACTIVATING FACTOR AS MARKERS TO PREDICT AND MONITOR ADVERSE EFFECTS AFTER COVID-19 VACCINES |
Y. M. Kuo, Z. Y. Lai, C. C. Hsu, C. J. Jung |
| 89 |
[GO] |
2023―Jun―07 |
POS0551 SARS-COV-2 BREAKTHROUGH INFECTION IN COVID-19-VACCINATED ADOLESCENTS AND YOUNG ADULTS WITH CHILDHOOD-ONSET RHEUMATIC DISEASES |
T. Arkachaisri, K. L. Teh, Y. X. Book, S. F. Hoh, X. Gao, L. Das, J. G. Yeo |
| 90 |
[GO] |
2023―Jun―07 |
POS0549 BREAKTHROUGH SARS-COV-2 INFECTION IN FULLY VACCINATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASE (COVAD) STUDY |
E. Kihlgren Olsson, N. Ravichandran, E. Nikiphorou, J. Lindblom, S. Saha, S. S. Shaharir, W. Katchamart, P. A. Goo, L. Traboco, Y. M. Chen, K. Jagtap, J. B. Lilleker, A. Nune, J. Pauling, C. Wincup, V. Agarwal, D. Dzifa, C. E. Toro Gutierrez, C. Vinicio Caballero, H. Chinoy, V. Agarwal, R. Aggarwal, L. Gupta, I. Parodis |
| 91 |
[GO] |
2023―Jun―07 |
POS0546 REVACCINATION OF PATIENTS WITH SLE OR RA WITHOUT AN INITIAL COVID-19 VACCINE RESPONSE ELICITS SEROCONVERSION IN HALF OF THE PATIENTS |
C. Ammitzbøll, M. K. Thomsen, J. B. Andersen, J. M. B. Jensen, R. Bayarri-Olmos, P. Garred, M. L. F. Hermansen, A. D. Johannesen, M. C. L. Larsen, C. E. Mistegaard, S. Mikkelsen, L. Nielsen, R. Olesen, L. Pérez-Alós, S. R. Vils, F. Szabados, O. Søgaard, M. Tolstrup, C. Erikstrup, E. M. Hauge, A. Troldborg |
| 92 |
[GO] |
2023―Jun―07 |
POS0545 PRE-EXPOSURE PROPHYLAXIS OF COVID-19 WITH TIXAGEVIMAB AND CILGAVIMAB IN RHEUMATOLOGIC PATIENTS TREATED WITH RITUXIMAB: DATA FROM A SINGLE-CENTRE COHORT |
M. Manara, M. Sette, L. Giudice, M. Biggioggero, N. Del Papa, E. G. Favalli, M. Gerosa, F. Ingegnoli, R. Caporali |
| 93 |
[GO] |
2023―Jun―07 |
POS0544 THE CONTRIBUTION OF THE 3RD AND 4TH BOOSTER BNT162B2 MRNA VACCINES TO PREVENT SEVERE COVID-19 AMONG AUTOIMMUNE INFLAMMATORY RHEUMATOID DISEASES (AIRD) PATIENTS DURING THE OMICRON OUTBREAKS |
Y. Braun-Moscovici, M. Kaplan, M. Braun, R. Dr, D. Markovits, S. Giryes, V. Shataylo, R. Erlich, K. Toledano, F. Hasan, K. Dolnikov, Y. Tavor, A. Balbir-Gurman |
| 94 |
[GO] |
2023―Jun―07 |
POS0542 LYMPHOCYTES POPULATIONS AND AUTOANTIBODIES, IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS: A LONG-TERM STUDY OF COVID-19 CASES AND NON-COVID-19 CONTROLS |
J. Arias-Aponte, A. Gómez-López, P. D. Nieto-Zambrano, M. C. Cortés-Osma, H. F. Restrepo-Guerrero, M. L. Monsalve-Córdoba, E. Garavito-Rodríguez, R. Parra-Medina, L. Villarreal, A. Rojas-Villarraga, P. Santos-Moreno |
| 95 |
[GO] |
2023―Jun―07 |
POS0541 INFLAMMATORY RHEUMATIC DISEASES (IRD) WITH ONSET AFTER SARS-COV-2 INFECTION OR COVID-19 VACCINATION: A COHORT STUDY FROM THE COVID-19 & ASD COLLABORATIVE STUDY GROUP |
F. Ursini, P. Ruscitti, O. Addimanda, R. Foti, V. Raimondo, G. Murdaca, V. Caira, E. Pigatto, G. Cuomo, A. Lo Gullo, I. Cavazzana, C. Campochiaro, C. Naclerio, R. De Angelis, J. Ciaffi, L. Mancarella, V. Brusi, E. Marchetti, F. Motta, M. Visentini, S. Lorusso, M. De Santis, G. De Luca, L. Massaro, D. Olivo, R. Pellegrini, J. M. E. Luppino, I. DI Cola, R. Foti, G. Varcasia, F. Caso, M. Reta, L. Dagna, C. Selmi, A. Iagnocco, R. Giacomelli, F. Iannone, C. Ferri |
| 96 |
[GO] |
2023―Jun―07 |
POS0538 THE IMPACT OF IMMUNOMODULATING TREATMENT ON THE SEROLOGICAL IMMUNOGENICITY FOLLOWING THREE DOSES OF COVID-19 VACCINE AND PERSISTENCE OF IMMUNOGENICITY OF TWO VACCINE DOSES IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES - A SWEDISH STUDY (COVID19-REUMA) |
M. Frodlund, P. Nived, K. Chatzidionysiou, A. Södergren, E. Klingberg, M. Hansson, E. Pin, L. Klareskog, M. C. Kapetanovic |
| 97 |
[GO] |
2023―Jun―07 |
POS0371 DEVELOPMENT AND EVALUATION OF A TEXT-ANALYTICS ALGORITHM FOR AUTOMATED APPLICATION OF NATIONAL COVID-19 SHIELDING CRITERIA IN RHEUMATOLOGY PATIENTS |
M. Jani, G. Alfattni, M. Belousov, Y. Zhang, M. Cheng, K. Webb, L. Laidlaw, A. Kanter, W. Dixon, G. Nenadic |
| 98 |
[GO] |
2023―Jun―07 |
POS0547 RISK OF SARS-COV-2 INFECTION FOLLOWING THREE DOSES OF BNT162B2 OR MRNA-1273 IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES |
C. E. Raptis, C. Polysopoulos, C. Berger, A. Ciurea, D. O. Andrey, P. Lescuyer, T. Maletic, M. Riek, A. Scherer, I. Von Loga, J. Safford, K. Lauper, B. Moeller, N. Vuilleumier, A. Finckh, A. Rubbert-Roth |
| 99 |
[GO] |
2023―Jun―07 |
POS0537 SAFETY OF BIVALENT SARS-COV-2 VACCINES AS A SECOND BOOSTER DOSE IN ARTHRITIS PATIENTS ON IMMUNOSUPPRESSIVE THERAPIES |
H. Ørbo, I. Jyssum, A. T. Tveter, I. E. Christensen, J. Sexton, K. H. Bjørlykke, G. B. Kro, T. K. Kvien, L. A. Munthe, G. Grodeland, S. Mjaaland, J. T. Vaage, E. A. Haavardsholm, K. K. Jørgensen, S. Aarrestad Provan, S. W. Syversen, G. L. Goll |
| 100 |
[GO] |
2023―Jun―07 |
POS0539 CELLULAR AND HUMORAL IMMUNOGENICITY OF THE NEOANTIGEN S1 FROM SARS-COV-2 VACCINES IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES |
M. P. Álvarez Hernandez, I. Pérez - Sancristóbal, K. Mohamed Mohamed, M. Rodríguez Laguna, C. Martinez Prada, D. Freites, M. E. Toledano Martinez, B. Fernandez, M. Rodero, C. Bravo, A. Rodriguez de la Peña, S. Sanchez - Ramon, G. Mato Chaín, G. Candelas |
| 101 |
[GO] |
2023―Jun―07 |
POS0540 PERFORMANCE OF COMMERCIAL SARS-COV-2 WILD-TYPE AND OMICRON BA.1 ANTIBODY ASSAYS COMPARED WITH PSEUDOVIRUS NEUTRALIZATION TESTS |
E. Habermann, L. M. Frommert, K. Ghannam, L. Nguyen My, L. Gieselmann, P. Tober-Lau, J. Klotsche, A. N. Arumahandi de Silva, A. Ten Hagen, J. Zernicke, F. Kurth, L. Sander, F. Klein, G. R. Burmester, R. Biesen, F. Albach |
| 102 |
[GO] |
2023―Jun―07 |
POS0550 IMMUNE RESPONSE AFTER VACCINATION AGAINST SARS-COV2 IN PATIENTS WITH IMMUNOMEDIATED DISEASES (RIM-COV PROJECT) |
A. Boteanu, V. Garcia Garcia, N. Villarrubia Migallón, A. Corral Bote, A. M. Ruiz Bejerano, J. Arroyo Palomo, P. Garcia Casado, R. Rodríguez Ramos, L. M. Villar, M. J. Rodríguez Dominguez, A. Muriel García, C. Guillén-Astete, M. Á. Blázquez, J. Bachiller-Corral, M. Vázquez Díaz |
| 103 |
[GO] |
2023―Jun―07 |
POS0562 FREQUENCY OF IN-PERSON AND VIRTUAL VISITS FOR RHEUMATOID ARTHRITIS: ANALYSIS OF THREE YEARS OF VISIT DATA BEFORE AND AFTER THE COVID PANDEMIC |
D. Solomon, M. Jiang, L. Santacroce, R. Rudin |
| 104 |
[GO] |
2023―Jun―07 |
POS0584-HPR PROS AND DISEASE ACTIVITY IN YEAR PRIOR TO COVID PREDICT TRAJECTORIES OF DEPRESSION IN ADULTS WITH RA IN FIRST 2 YEARS OF PANDEMIC: DATA FROM THE CANADIAN EARLY ARTHRITIS COHORT |
S. J. Bartlett, O. Schieir, M. F. Valois, J. Pope, L. Bessette, G. Boire, C. Hitchon, E. Keystone, C. Thorne, D. Tin, G. Hazlewood, V. Bykerk |
| 105 |
[GO] |
2023―Jun―07 |
AB1852 DERMATO-NEURO SYNDROME PRECIPITATED BY COVID-19 INFECTION IN THE SETTING OF SCLEROMYXEDEMA |
C. G. Hobayan, J. Lin |
| 106 |
[GO] |
2023―Jun―07 |
AB1830-HPR MUSCULOSKELETAL DISORDERS DURING COVID-19 INFECTION: A SURVEY OF HEALTHCARE WORKERS |
H. Ziedi, D. Brahim, I. Youssef, M. Mersni, Z. Athimni, N. Mechergui, G. Bahri, H. Ben Said, N. Ladhari |
| 107 |
[GO] |
2023―Jun―07 |
AB1790-HPR COVID-19: AFTER TWO YEARS OF IATROGENIC AND BIOLOGIC IMMUNIZATION/ VACCINATION DO WE ACTUALLY NEED FURTHER BOOSTER IMMUNIZATION/ VACCINATION? |
C. Pohl |
| 108 |
[GO] |
2023―Jun―07 |
AB1752-PARE THE RATE OF COVID-19 VACCINATION IN PATIENTS WITH RHEUMATOID ARTHRITIS. SINGLE-CENTER CROSS-SECTIONAL PILOT STUDY |
H. Elhani, L. Taoubane, N. EL Ouardi, H. Taoufik, A. Majjad, A. Bezza |
| 109 |
[GO] |
2023―Jun―07 |
AB1751-PARE MUSCULOSKELETAL DISORDERS IN THE ERA OF THE COVID-19 PANDEMIC |
L. Ben Afia, D. Brahim, I. Youssef, Z. Athimni, M. Mersni, N. Mechergui, H. Ben Said, G. Bahri, N. Ladhari |
| 110 |
[GO] |
2023―Jun―07 |
AB1744-PARE TREATMENT ADHERENCE IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) DURING THE COVID-19 PANDEMIC |
L. L. Holguín Arias, V. V. Castro Coello, C. Soliz, G. Gómez, L. Sorrentino, A. Hamaui, D. Dubinsky |
| 111 |
[GO] |
2023―Jun―07 |
AB1739-PARE COVID-19 PANDEMIC: THE IMPACT ON PSORIATIC DISEASE PATIENTS’ LIFE |
U. Viora, G. Mascarino, D. Rava, D. Romagnolo, M. T. Mascarino |
| 112 |
[GO] |
2023―Jun―07 |
AB1736-PARE CHALLENGES FOR PATIENTS WITH RMD’S IN BULGARIA DURING THE COVID-19 PANDEMIC |
A. Marinkov, Z. Batalov, R. Karalilova, A. Batalov, B. Boteva |
| 113 |
[GO] |
2023―Jun―07 |
AB1699 COVID-19 IMPACT ON SECOND YEAR MEDICAL STUDENTS EXPERIENCE WITH INTERACTIVE PATIENT ENCOUNTERS AS A SUPPLEMENT TO TEACHING THE SKIN AND RHEUMATOLOGY COURSE |
E. Littman, S. Beg |
| 114 |
[GO] |
2023―Jun―07 |
AB1679 VASCULITIS DISEASE ACTIVITY SCORES BEFORE AND DURING THE COVID-19 PANDEMIC: A COMPARISON OF FACE-TO-FACE CLINICIAN SCORING AND PROMS COLLECTED USING REMOTE MONITORING IN A SINGLE-CENTRE COHORT |
D. Kurzeja, K. Song, M. Mirza, M. Ashraf, R. Luqmani |
| 115 |
[GO] |
2023―Jun―07 |
AB1364 VACCINATION AGAINST COVID-19 IN PARAGUAYAN PATIENTS WITH RHEUMATOID ARTHRITIS |
S. Cabrera-Villalba, G. Avila, A. Amarilla, M. Zarza, E. Leiva, P. Pusineri, L. Roman, V. Valinotti, P. DE Abreu Trigueros |
| 116 |
[GO] |
2023―Jun―07 |
AB1363 FIRST PRESENTATION OF AUTOIMMUNE RHEUMATIC DISEASES AFTER COVID-19 VACCINATION: A SYSTEMATIC REVIEW |
C. Soto, A. Peña, F. Gonzalez, P. Flores, A. C. Medina-Garcia, A. Bernal, O. L. Vera Lastra, C. Pineda, L. J. Jara |
| 117 |
[GO] |
2023―Jun―07 |
AB1361 COVID-19 IN PATIENTS WITH INFLAMMATORY ARTHRITIS IN THE VINSCHGAU VALLEY IN SOUTH TYROL |
P. Matzneller, A. Mulrenin, M. Wierer, C. Duftner, C. Dejaco |
| 118 |
[GO] |
2023―Jun―07 |
AB1362 STUDY OF ADVERSE REACTIONS TO COVID-19 VACCINATION IN PATIENTS WITH RHEUMATIC DISEASES |
Y. Akiyama, M. Matsuda |
| 119 |
[GO] |
2023―Jun―07 |
AB1358 BIOLOGIC TREATMENT SUSPENSION AND ASSOCIATED FACTORS IN PATIENTS WITH RHEUMATIC DISEASES DURING THE COVID-19 PANDEMIC: DATA FROM MEXICAN ADVERSE REGISTRY (BIOBADAMEX) |
V. Rivera Teran, D. X. Xibille Friedmann, D. Vega-Morales, S. Sicsik, A. Castillo Ortiz, F. Irazoque-Palazuelos, D. Miranda, I. J. Colunga-Pedraza, J. C. Casasola, O. E. Muñoz-Monroy, S. Carrilo, A. Peña, S. Duran Barragan, L. F. Valdés Corona, E. Torres Valdéz, A. Ramos, A. Paz, E. A. Zamora-Tehozol, D. Alpizar-Rodriguez |
| 120 |
[GO] |
2023―Jun―07 |
AB1360 AUTOANTIBODIES RELATED TO RHEUMATIC DISEASES AFTER COVID-19 INFECTION |
X. Zheng, X. Wu, Y. Jiang, Y. Liang, S. Zhong, J. Gu, Z. Liao |
| 121 |
[GO] |
2023―Jun―07 |
AB1359 CLINICAL FEATURES OF COVID-19 IN PATIENTS WITH CONNECTIVE TISSUE DISEASES DURING THE RECENT PANDEMIC IN GUANGZHOU, CHINA |
Y. Jiang, X. Zheng, X. Wu, S. Zhong, Y. Liang, Q. Wei, J. Gu, Y. Pan |
| 122 |
[GO] |
2023―Jun―07 |
AB1357 RISK OF APS AND aPLs POSITIVE PATIENTS FOR THROMBOSIS WITH COVID-19 |
F. Berianu, R. Butendieck, B. Wang |
| 123 |
[GO] |
2023―Jun―07 |
AB1356 COVID-19 VACCINE PERCEPTION AND HESITANCY AMONG PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASE (AIRD) IN MALAYSIA |
S. S. Shaharir, L. Kamaruzaman, T. N. Mariamutu, M. S. Mohamed Said, A. Mohammed Nawi, W. S. Wan Ghazali, M. Mohd Noh |
| 124 |
[GO] |
2023―Jun―07 |
AB1355 EFFECT OF COVID-19 VACCINES ON ACTIVITY OF AUTOIMMUNE RHEUMATIC DISEASES |
M. A. Mahmoud Besar, A. Abd El Salam |
| 125 |
[GO] |
2023―Jun―07 |
AB1353 RHEUMATOLOGICAL PAIN CONDITIONS ARE NOT RISK FACTORS FOR THE DEVELOPMENT OF WIDESPREAD POST-COVID PAIN IN COVID-19 SURVIVORS |
L. Arendt-Nielsen, B. D. Ebbesen, R. Giordano, J. A. Valera-Calero, C. Fernández-de-Las-Peñas |
| 126 |
[GO] |
2023―Jun―07 |
AB1350 THE KINETICS OF HUMORAL AND CELLULAR RESPONSES AFTER THE BOOSTER DOSE OF COVID-19 VACCINE IN INFLAMMATORY ARTHRITIS PATIENTS |
J. Wroński, B. Jaszczyk, L. Roszkowski, A. Felis-Giemza, K. Bonek, A. Kornatka, M. Plebanczyk, T. Burakowski, B. Lisowska, B. Kwiatkowska, W. Maśliński, M. Wisłowska, M. Massalska, E. Kuca-Warnawin, M. Ciechomska |
| 127 |
[GO] |
2023―Jun―07 |
AB1341 COVID-19 IN PATIENTS WITH RHEUMATIC IMMUNE-MEDIATED INFLAMMATORY DISEASES IN AMERICA: DIFFERENCES AND SIMILARITIES BETWEEN MEXICO AND ARGENTINA |
C. A. Isnardi, D. Alpizar-Rodriguez, M. U. Martínez-Martínez, R. Quintana, I. E. Petkovic, S. Ornella, V. V. Castro Coello, E. Velozo, D. Zelaya, M. Severina, A. K. Cogo, R. Nieto, D. A. Pereira, I. J. Colunga-Pedraza, F. Irazoque-Palazuelos, G. C. Reyes Cordero, T. S. Rodriguez-Reyne, J. A. Veloz Aranda, C. M. Skinner Taylor, I. M. Juarez Mora, B. E. Zazueta Montiel, A. Martínez, C. F. Pacheco Tena, G. Pons-Estel |
| 128 |
[GO] |
2023―Jun―07 |
AB1340 CRYOFIBRINOGENEMIA IN PRECOVID-19 AND COVID-19 ERA: A COMPARATIVE STUDY IN A SINGLE UNIVERSITY HOSPITAL |
C. Lasa, M. E. Peiró Callizo, J. Irure-Ventura, M. Lopez-Hoyos, M. Renuncio García, A. Martínez Gutiérrez, C. Secada-Gómez, A. Sanchez-López, R. Blanco |
| 129 |
[GO] |
2023―Jun―07 |
AB1348 PERICARDITIS AFTER COVID-19 VACCINATION: A CASE SERIES |
F. Casarin, C. Carollo, R. Mascolo, A. Pedroli, G. Faraci, E. Bizzi, M. Pancrazi, L. Trotta, C. Lorentino, A. M. Pisacreta, A. Brucato |
| 130 |
[GO] |
2023―Jun―07 |
AB1346 ASSOCIATION OF URIC ACID LEVELS WITH COVID-19 SEVERITY DURING 2020 AND 2021 YEARS |
A. Sydorova, O. Iaremenko |
| 131 |
[GO] |
2023―Jun―07 |
AB1345 COVID-19 AND ADVERSE MENTAL HEALTH OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS |
M. Ghali, M. Ardhaoui, J. Mahbouba, S. Zrour, I. Bejia, M. Touzi, N. Bergaoui |
| 132 |
[GO] |
2023―Jun―07 |
AB1337 COVID-19 AND JAKI: ANALYSIS AFTER THREE-YEAR PANDEMIC AT A SPANISH TERTIARY CARE HOSPITAL |
P. Muñoz Martinez, L. Mas Sanchez, E. Grau García, A. M. Torrat Noves, D. Ramos Castro, C. Riesco Barcena, A. V. Huaylla Quispe, S. Leal Rodriguez, I. Cánovas Olmos, H. Charia, L. Gonzalez Puig, J. Ivorra Cortés, I. Martínez Cordellat, C. Nájera Herranz, R. Negueroles Albuixech, J. E. Oller Rodríguez, F. Ortiz-Sanjuán, E. Tovar-Sugrañes, E. Vicens Bernabeu, J. A. Román Ivorra |
| 133 |
[GO] |
2023―Jun―07 |
AB1342 THE EMERGENCE OF FIBROMYALGIA FOLLOWING ACUTE COVID-19 INFECTION |
E. Savin, A. M Tsur, G. Rosenn, O. Gendelman, D. Buskila, G. Halpert, D. Amital, H. Amital |
| 134 |
[GO] |
2023―Jun―07 |
AB1333 THE IMPACT OF IMMUNOCOMPROMISE ON OUTCOMES OF COVID-19 IN CHILDREN AND YOUNG PEOPLE - A SYSTEMATIC REVIEW AND META-ANALYSIS |
C. Ciurtin, J. Greenan- Barett, S. Aston, C. Deakin |
| 135 |
[GO] |
2023―Jun―07 |
AB1332 CLINICAL OUTCOMES AND RISK FACTORS OF COVID-19 IN AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES: A LARGE REAL-WORLD SURVEY IN CHINA |
Y. Geng, Y. Fan, Z. Zhang |
| 136 |
[GO] |
2023―Jun―07 |
AB1330 FREQUENCY OF DISEASE FLARE AND ITS RISK FACTORS FOLLOWING TWO-DOSE OF COVID-19 VACCINATION IN PATIENTS WITH RHEUMATOID ARTHRITIS |
S. Kojima, Y. Kondo, Y. Sakai, S. Kasai, J. Kikuchi, Y. Kaneko |
| 137 |
[GO] |
2023―Jun―07 |
AB1327 COVID-19 CUTANEOUS AND SYSTEMIC MANIFESTATIONS AMONG DIFFERENT RACIAL GROUPS: A META-ANALYSIS |
A. El-Said, A. Ahmad, M. Valenti, N. Shah, S. Soto, S. Beg |
| 138 |
[GO] |
2023―Jun―07 |
AB1324 COVID-19 CHALLENGE IN THE ANTIPHOSPHOLIPID SYNDROME - AN OBSERVATIONAL STUDY OF A SERBIAN COHORT |
A. Djokovic, L. Stojanovich, N. Stanisavljevic, S. Djokic, D. Colic, D. Škrijelj, I. Soldatovic, P. Matic |
| 139 |
[GO] |
2023―Jun―07 |
AB1323 ANALYSIS OF ADVERSE EFFECTS AFTER VACCINATION AGAINST COVID-19 IN PATIENTS WITH IMMUNO-MEDIATED RHEUMATIC DISEASES IN MANAUS - AMAZONAS |
M. M. Sousa Dias, N. Seixas de Melo, S. E. B. Dias, C. Pinheiro Martins, V. Miki Pang Takatani, R. Beatriz Nazareth Alagia, B. Guimarães Dutra, G. Bacellar Marques, D. Queiroz Rego, D. Buzaglo Gonçalves, C. Telles, S. Ribeiro |
| 140 |
[GO] |
2023―Jun―07 |
AB1322 COVID-19 PANDEMIC AND SYSTEMIC INFLAMMATORY RHEUMATIC DISEASES: OUR EXPERIENCE IN DAKAR, SENEGAL (SUB-SAHARAN AFRICA) |
B. S. Kane, M. Dieng, B. Fall, M. Sow, A. T. Lemrabott, M. A. Ndour, A. C. Ndao, S. Ndongo, A. Pouye |
| 141 |
[GO] |
2023―Jun―07 |
AB1320 COVID-19 OUTCOME IN AN ITALIAN RHEUMATOID ARTHRITIS COHORT |
E. Molteni, C. Castellani, G. Sciarra, L. Di Sanzo, G. Bevignani, M. Di Franco, V. Riccieri, C. Alessandri, R. Priori, F. Conti, R. Scrivo |
| 142 |
[GO] |
2023―Jun―07 |
AB1317 EFFICACY AND SAFETY OF COVID-19 VACCINES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH DIFFERENT ANTI-RHEUMATIC THERAPIES |
Q. Y. Su, J. Luo, Y. Zhang, B. R. Zhao, Y. Cao, Q. Yu, P. F. He, X. Li, S. X. Zhang |
| 143 |
[GO] |
2023―Jun―07 |
AB1315 EFFECTS OF COVID-19 IN RHEUMATOLOGICAL PAIN CONDITIONS SIX MONTHS AFTER INFECTION |
B. D. Ebbesen, C. Fernández-de-Las-Peñas, J. A. Valera-Calero, R. Giordano, L. Arendt-Nielsen |
| 144 |
[GO] |
2023―Jun―07 |
AB1313 EFFICACY AND SAFETY OF COVID-19-SPECIFIC TREATMENTS IN SLE: A MULTICENTRE CASE-CONTROL STUDY |
G. A. Ramirez, M. Gerosa, D. Arroyo-Sánchez, C. Asperti, L. M. Argolini, G. Gallina, C. Bellocchi, M. Cornalba, I. Scotti, I. Suardi, L. Beretta, L. Moroni, E. Bozzolo, R. Caporali, L. Dagna |
| 145 |
[GO] |
2023―Jun―07 |
AB1312 MYOSITIS PATIENTS WITHOUT AUTOIMMUNE MULTIMORBIDITY AT LOWER RISK OF DELAYED ONSET COVID-19 VACCINE ADVERSE EVENTS THAN OTHER AUTOIMMUNE DISEASES: RESULTS FROM THE COVAD STUDY |
S. S. Shaharir, B. Doskaliuk, N. Ravichandran, J. Day, P. Sen, S. Katsuyuki Shinjo, M. Joshi, N. Ziade, T. Velikova, M. Milchert, S. Saha, J. Knitza, A. Makol, K. Jagtap, V. Agarwal, D. Dey, C. E. Toro Gutierrez, C. Vinicio Caballero, V. Agarwal, R. Aggarwal, L. Gupta |
| 146 |
[GO] |
2023―Jun―07 |
AB1306 HOW DOES COVID-19 VACCINATION AFFECT DISEASE ACTIVITY AND SAFETY IN SECUKINUMAB TREATED PATIENTS WITH AXIAL SPONDYLOARTHRITIS? REAL WORLD DATA FROM THE GERMAN AQUILA STUDY |
J. Brandt-Juergens, K. Gente, P. Kästner, D. Peterlik, U. Kiltz |
| 147 |
[GO] |
2023―Jun―07 |
AB1305 RHEUMATOID ARTHRITIS FLARE FOLLOWING COVID-19 VACCINATION IN MALAYSIAN POPULATION AND ITS ASSOCIATED RISK FACTORS |
N. A. Zakaria, L. Mohd Isa, L. Mohamednor, B. H. Ng, T. Chou Luan, F. N. Sulaiman, S. Ramasamy, W. R. Wan Musa, N. S. Shahril |
| 148 |
[GO] |
2023―Jun―07 |
AB1304 CHRONIC CHILBLAIN-LIKE LESIONS ASSOCIATED WITH THE COVID-19 PANDEMIC |
J. Nathan, A. Rastogi, P. Kiely |
| 149 |
[GO] |
2023―Jun―07 |
AB1302 IMPACT OF THE COVID-19 PANDEMIC ON TREATMENT ADHERENCE AND THE ACTIVITY OF RHEUMATOID ARTHRITIS |
M. Ghali, M. Ardhaoui, J. Mahbouba, S. Zrour, I. Bejia, M. Touzi, N. Bergaoui |
| 150 |
[GO] |
2023―Jun―07 |
AB1296 EQUATED HOSPITALIZATION RATE OF PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES AS COMPARED TO GENERAL POPULATION - DATA FROM THE SECOND WAVE OF THE COVID-19 PANDEMIC |
G. Dallagiacoma, C. Weichenberger, B. Raffeiner, S. Zandonella Callegher, P. Matzneller, A. Maier, L. Karadar, A. Masl, I. Kuppelwieser, E. Hantikainen, C. Dejaco |
| 151 |
[GO] |
2023―Jun―07 |
AB1294 SAFETY OF COVID-19 VACCINES AND HEALTH CARE UTILIZATION FOLLOWING VACCINATION AMONG ADULTS WITH RHEUMATOID ARTHRITIS - A POPULATION-BASED SELF-CONTROLLED CASE SERIES ANALYSIS |
J. Lee, S. Bernatsky, J. Kwong, Q. Li, T. Kwok, J. Widdifield |
| 152 |
[GO] |
2023―Jun―07 |
AB1289 IS THERE HIGHER RISK OF FATIGUE, DEPRESSION, ANXIETY AND STRESS AFTER COVID-19 IN PATIENTS WITH IMMUNE-MEDIATED RHEUMATIC DISEASES? DATA FROM THE REUMACOV BRASIL COHORT |
C. Marques, M. Pinheiro, S. Ribeiro, R. Barros DE Souza, L. D. D. A. Valadares, A. Ranzolin, R. Cavalheiro Do Espírito Santo, N. Sartori, N. Araújo, C. Martins Vieira, K. L. Libardi Machado, H. De Leon de Lima, F. Sina, L. Mota, A. P. Gomides, A. Kakehasi, E. Reis Neto, G. Salviato Pileggi, G. Ferreira, R. Xavier |
| 153 |
[GO] |
2023―Jun―07 |
AB1285 MODELING OF ANTIBODY RESPONSE TO COVID-19 VACCINATIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS |
Y. K. Kim, Y. Choi, J. I. Jung, J. Y. Kim, M. H. Kim, J. Curtis, E. B. Lee |
| 154 |
[GO] |
2023―Jun―07 |
AB1284 COMPARISON OF THE EFFECTS OF COVID-19 AND INFLUENZA VACCINATION ON RHEUMATIC DISEASES: ANALYSES OF PATIENT SURVEY DATA AFTER VACCINATION |
J. W. Kim, H. A. Kim, J. Y. Jung, C. H. Suh |
| 155 |
[GO] |
2023―Jun―07 |
AB1283 COVID-19 WAS NOT TRIGGER FOR RHEUMATIC DISEASE ACTIVITY AFTER 6 MONTHS FOLLOW-UP: RESULTS FROM REUMACOV BRASIL REGISTER |
C. Marques, R. Xavier, S. Ribeiro, J. Scrignoli, L. D. D. A. Valadares, R. Cavalheiro Do Espírito Santo, N. Sartori, C. Z. Costa, P. Nacácio e Silva, V. De Souza, F. Machado Ribeiro, F. Omura, G. Resende, S. Katsuyuki Shinjo, V. Barbosa, M. Peixoto Gu e Silva de Souza, M. Carvalho, M. Alexandre Yazbek, V. Valim, L. Rocha, A. S. Martins, A. B. Bacchiega, A. K. Melo, S. Carneiro, A. Marinho, A. Kakehasi, G. Ferreira, G. Salviato Pileggi, E. Reis Neto, L. Mota, A. P. Gomides, M. Pinheiro |
| 156 |
[GO] |
2023―Jun―07 |
AB1086 COVID-19-RELATED ADVERSE EVENTS IN THE PHASE 3 POETYK TRIALS OF THE ALLOSTERIC TYROSINE KINASE 2 INHIBITOR, DEUCRAVACITINIB, IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS |
D. Thaçi, K. B. Gordon, M. Gooderham, A. Alexis, V. Lalchandani, J. Scotto, L. Hippeli, M. J. Colombo, S. Banerjee, T. Lezhava, M. Lebwohl |
| 157 |
[GO] |
2023―Jun―07 |
AB0768 NEW INSIGHTS ON EPIDEMIOLOGICAL DATA AND IMPACT OF THE COVID-19 PANDEMIC ON IGA VASCULITIS IN CHILDREN AND ADULTS IN FRANCE: A NATIONWIDE COHORT |
V. Maisons, Y. Ramdani, C. Messaien, A. S. Jannot, B. Sautenet, J. M. Halimi, F. Maillot, E. Pillebout, A. Audemard |
| 158 |
[GO] |
2023―Jun―07 |
AB0697 COMPARISON OF COVID-19 VACCINATION WITH INFLUENZA VACCINATION IN KOREAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: PERCEPTION, ADVERSE EVENTS, AND FLARES FROM THE CIVIL STUDY |
S. C. Shim, J. Lee, Y. H. Lee, S. K. Kwok, Y. G. Kim, Y. Park, S. H. Park, S. C. Bae, C. H. Suh, Y. K. Sung, S. S. Lee, C. K. Lee, H. S. Lee, S. M. Jung, H. S. Cha, S. H. Park |
| 159 |
[GO] |
2023―Jun―07 |
AB0614 EFFECT OF COVID-19 INFECTION ON DISEASE FLARES AND HERPES ZOSTER REACTIVATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE-CONTROL STUDY |
C. L. Cheung, C. H. To, L. Y. Ho, K. L. Chan, S. M. Tse, C. C. Mok |
| 160 |
[GO] |
2023―Jun―07 |
AB0591 COVID-19 VACCINE SAFETY DURING PREGNANCY IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
N. Giannopoulou, L. Gupta, L. Andreoli, D. Lini, E. Nikiphorou, R. Aggarwal, V. Agarwal, I. Parodis |
| 161 |
[GO] |
2023―Jun―07 |
AB1349 D-DIMER AND FIBRINOGEN TRENDS IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES INFECTED WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2: A RETROSPECTIVE COMPARATIVE STUDY |
O. Alsaed, S. Al Emadi, K. Becetti, R. Saleh, H. Ashour, E. Elsayed, M. Hamed, F. Alam, Y. A. Y. Alrimawi, M. A. Al Kahlout, B. Awadh, M. Hammoudeh |
| 162 |
[GO] |
2023―Jun―07 |
AB1319 DYNAMIC IMMUNE FEATURES REVEALED BY SINGLE-CELL RNA AND SINGLE-CELL TCR/BCR SEQUENCING IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING SARS-CoV-2 BOOSTER VACCINATION |
Y. Fan, Y. Geng, J. Zhao, H. Huang, J. Zhang, Y. Wang, Z. Zhang |
| 163 |
[GO] |
2023―Jun―07 |
AB1352 IMPACT OF SYSTEMIC THERAPIES ON THE SEROPREVALENCE OF SARS-CoV-2 IN PATIENTS WITH IMMUNE-MEDIATED DISEASES |
M. L. C. Romero Bogado, M. Steiner, T. Cobo-Ibáñez, A. Gómez, B. Paredes Romero, I. Thuissard Vasallo, C. Andreu Vazquez, A. V. Esteban Vazquez, M. A. Matias de la Mano, L. Cebrián Méndez, C. Garcia Yubero, M. D. M. Esteban-Ortega, N. Maceñido Marcos, R. Pajares Villarroya, M. D. R. Arribas Lopez, C. Esteban Alba, A. Martinez Hernandez, R. Guillen Santos, I. Garcia, M. T. Navio Marco, S. Muñoz-Fernández |
| 164 |
[GO] |
2023―Jun―07 |
AB1316 SAFETY AND IMMUNOGENICITY OF TWO HETEROLOGOUS VACCINE SCHEDULES AGAINST SARS-CoV-2 IN PATIENTS WITH RHEUMATOID ARTHRITIS: BRAZILIAN MULTICENTER STUDY |
V. Cruz, K. Lysie Libardi Lira Machado, V. Gonçalves Da Silva, K. Rosemarie Lallemand Tapia, L. Baptista Ferreira, A. P. Neves Burian, L. H. Dias, C. Strauss Estevez Gadelha, Y. Gurtler Pinheiro de Oliveira, M. Deorce de Lima, L. Pizzol Pasti, J. Ribeiro de Oliveira, L. Fiorotti Albertino, M. De Oliveira Macabú, P. Zava Lorencini, V. Oliveira Magalhães, M. Freitas de Aguiar, E. Biegelmeyer, P. Dias Cardoso Ribeiro, F. M. Matos Melo Campos Peixoto, C. Kayser, A. Wagner Silva de Souza, C. H. D. M. Castro, S. Ribeiro, R. Holanda Da Silva Sanches, A. Luiz Boechat, V. Miki Pang Takatani, C. Ruas Yasuda, D. Queiroz Rego, R. Beatriz Nazareth Alagia, R. Teixeira Rebello, J. Buhring, N. Sartori, N. Pamplona Bueno de Andrade, M. L. Gasparini Vieira, R. Poubel Vieira de Rezende, K. Lino Baptista, L. Rodrigues Campos, A. K. Melo, T. Santos Melo, J. Rêgo, R. M. R. Vieira, A. Sophia Rodrigues Vieira, A. Kakehasi, A. C. Faria Moreira Gomes Tavares, A. Teixeira de Landa, M. C. Dias Corrêa, V. F. Azevedo, O. Assis Martins-Filho, V. Peruhype-Magalhães, M. Pinheiro, O. Monticielo, E. Torres Dos Reis Neto, G. Ferreira, V. De Souza, A. Teixeira-Carvalho, R. Xavier, E. Sato, V. Valim, G. Salviato Pileggi, N. Da Silva |
| 165 |
[GO] |
2023―Jun―07 |
AB1321 CLINICAL CHARACTERISTICS AND DISEASE COURSE BEFORE AND AFTER SARS-CoV-2 INFECTION IN A LARGE COHORT OF SYSTEMIC SCLEROSIS PATIENTS |
A. Avanoglu Guler, B. Ozcimen, M. Aydogdu, A. Sari, N. Aliyeva, N. Tuzun, S. Colak, H. Karadeniz, I. Vasi, H. Küçük, Y. Yalçinkaya, M. A. Ozturk, B. Goker, S. Yilmaz, O. Küçükşahin, S. S. Koca, M. Inanc, A. Akdoğan, A. Tufan |
| 166 |
[GO] |
2023―Jun―07 |
AB0767 OUTCOMES OF SARS-COV-2 INFECTION IN PATIENTS WITH ASSOCIATED ANCA VASCULITIS. DATA FROM THE NATIONAL SAR-COVID REGISTRY |
J. A. Brigante, C. A. Isnardi, D. Emili, V. Saurit, Y. Tissera, M. E. D’Angelo, I. Petkovic, C. Pisoni, R. Quintana, R. Baez, S. Ornella, V. V. Castro Coello, M. Pera, M. Haye, D. A. Pereira, G. Berbotto, C. G. Alonso, C. Gobbi, A. A. Reyes, P. Alba, E. Velozo, M. J. Gamba, R. Tanten, M. Severina, D. Zelaya, G. Alle, A. K. Cogo, R. Nieto, C. Asnal, J. A. Albiero, M. Cosatti, J. Villafañe, F. Maldonado, G. Pons-Estel |
| 167 |
[GO] |
2023―Jun―07 |
AB1343 PERSISTENCE OF SYMPTOMS AFTER SARS-CoV-2 INFECTION IN PATIENTS WITH INFLAMMATORY ARTHRITIS: A RETROSPECTIVE STUDY |
C. Castellani, E. Molteni, G. Sciarra, L. Di Sanzo, G. Bevignani, M. Di Franco, V. Riccieri, C. Alessandri, A. Sili Scavalli, R. Priori, R. Scrivo, F. Conti |
| 168 |
[GO] |
2023―Jun―07 |
AB1329 CLINICAL CHARACTERISTICS OF SARS-CoV-2 INFECTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN ARGENTINA: DATA FROM THE SAR-COVID NATIONAL REGISTRY |
C. A. Isnardi, K. Roberts, Y. Tissera, I. Petkovic, G. Berbotto, C. Gobbi, R. Tanten, A. K. Cogo, C. Asnal, A. R. Baños, F. Vivero, M. Schmid, M. A. Lazaro, N. German, L. Takashima, J. Scafati, M. L. Werner, L. Casalla, S. S. De la Vega Fernandez, D. Castrillon Bustamante, F. Rodriguez, S. Moyano, M. L. Martin, V. Cosentino, N. Herscovich, E. R. Tralice, T. Barbich, D. L. Vasquez, E. Buschiazzo, P. Maid, C. Ledesma, V. Yohena, G. Gómez, R. Quintana, G. Pons-Estel |
| 169 |
[GO] |
2023―Jun―07 |
AB1309 CLINICAL CHARACTERISTICS OF NEW-ONSET IDIOPATHIC INFLAMMATORY MYOPATHIES FOLLOWING SARS-CoV-2 INFECTION OR VACCINATION - ANALYSIS OF A CASE SERIES |
A. Marian, M. M. Tamas, L. Muntean, O. M. Resteu, D. A. Vaida-Voevod, I. Felea, L. Damian, I. Filipescu, C. Pamfil, I. Szabo, S. P. Simon, S. Rednic |
| 170 |
[GO] |
2023―Jun―07 |
AB1297 EFFECT OF ABO AND RH BLOOD TYPE ON SARS-CoV-2 INFECTION SEVERITY IN PATIENTS WITH RHEUMATIC DISEASES: DATA FROM THE NATIONAL SAR-COVID REGISTRY |
F. Valdez Donelli, V. Carrizo Abarza, C. A. Isnardi, E. E. Schneeberger, G. Citera, M. E. D’Angelo, S. Ornella, M. Haye, C. G. Alonso, M. Severina, G. Alle, M. Cosatti, J. Gallino Yanzi, M. A. Medina, R. Perez Alamino, N. Lloves Schenone, M. D. L. A. Correa, M. De la Vega, L. Carlevaris, N. Cucchiaro, A. Bertoli, M. E. Calvo, M. C. Córdoba, V. Martire, S. Petruzzelli, B. Kisluk, L. Muñoz, G. Gomez, M. P. Diaz, A. B. Gómez Vara, S. Soares de Souza, J. L. Velasco Zamora, M. S. Castaño, N. S. Morales, M. L. Mamani Ortega, G. Gómez, K. Roberts, R. Quintana, G. Pons-Estel |
| 171 |
[GO] |
2023―Jun―07 |
AB1318 CLINICAL CHARACTERISTICS & OUTCOMES AMONG PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES AND SARS-CoV-2 INFECTION: 2-YEAR DATA FROM A TERTIARY RHEUMATOLOGY CENTRE IN GREECE |
N. Gerolymatou, N. Koletsos, T. Zoi, T. E. Memi, A. Drosos, P. Voulgari |
| 172 |
[GO] |
2023―Jun―07 |
AB1335 INTAKE OF ACETAMINOPHEN SUPPRESSES ANTIVIRAL HUMORAL IMMUNE RESPONSES IN PATIENTS WITH RA FOLLOWING VACCINATION WITH ANTI SARS-CoV-2 mRNA BASED VACCINES |
K. Schmiedeberg, J. Beyer, I. Abela, N. Vuilleumier, M. Schwarzmueller, S. Pagano, J. Von Kempis, A. Rubbert-Roth |
| 173 |
[GO] |
2023―Jun―07 |
AB1298 PATIENTS WITH AXIAL SPONDYLOARTHRITIS HAVE BETTER SARS-CoV-2 OUTCOMES COMPARED WITH PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE NATIONAL SAR-COVID REGISTRY |
A. Bravo, T. Barbich, C. Isnardi, G. Citera, E. E. Schneeberger, R. Quintana, C. Pisoni, M. Pera, E. Velozo, D. A. Pereira, P. Alba, J. A. Albiero, J. Villafañe, H. Maldonado Ficco, V. Savio, S. E. Aguero, R. Rojas Tessel, M. I. Quaglia, M. S. Gálvez Elkin, G. P. Pendon, C. Aeschlimann, G. F. Rodriguez Gil, M. Viola, C. Romeo, C. Maldini, S. M. Conti, R. Gallo, L. Ibañez Zurlo, M. N. Tamborenea, S. I. Pineda Vidal, D. Guaglianone, J. M. Mareco, C. Goizueta, E. Novatti, F. Guzzanti, G. Gómez, K. Roberts, G. Pons-Estel |
| 174 |
[GO] |
2023―Jun―07 |
AB1326 DIFFERENCES IN ADVERSE EVENTS EXPERIENCED BY INDIVIDUALS WITH INFLAMMATORY RHEUMATIC DISEASES AND HEALTHY INDIVIDUALS AFTER SARS-CoV-2 VACCINATION |
L. Huppke, C. Gebhardt, L. Grümme, J. Lichtnekert, D. Singh, F. Ullrich, S. Wolfrum, A. Skapenko, H. Schulze-Koops |
| 175 |
[GO] |
2023―Jun―07 |
AB1365 COMPARISON OF HOMOLOGOUS AND HETEROLOGOUS BOOSTER SARS-CoV-2 VACCINATION IN AUTOIMMUNE RHEUMATIC AND MUSCULOSKELETAL PATIENTS |
D. Honfi, G. Szebeni, A. Balog |
| 176 |
[GO] |
2023―Jun―07 |
AB1336 EVALUATION OF THE IMMUNOGENICITY AND EFFICACY OF THE SARS-CoV-2 VACCINE IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES TREATED WITH BIOLOGICAL THERAPY |
J. Calvo Gutierrez, M. C. Ábalos-Aguilera, D. Ruíz-Vilchez, E. Iglesias, R. Ortega Castro, A. Escudero Contreras, C. López-Medina |
| 177 |
[GO] |
2023―Jun―07 |
AB1339 EFFICACY AND SAFETY OF THE SARS-CoV-2 VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS |
E. F. Vicente-Rabaneda, M. Torres, M. Uriarte, P. Quiroga Colino, F. Gutiérrez-Rodríguez, A. Triguero-Martinez, A. Gutiérrez, N. García Castañeda, A. Romero, L. Cardeñoso, S. Castañeda |
| 178 |
[GO] |
2023―Jun―07 |
AB1374 ADVERSE EVENTS AFTER VACCINATION FOR SARS-CoV2 IN A CASE SERIES OF FIBROMYALGIA PATIENTS VERSUS HEALTHY CONTROLS |
M. L. Aprile, L. Cutore, D. Sambataro, G. Sambataro, M. Colaci |
| 179 |
[GO] |
2023―Jun―07 |
AB1344 DO PATIENTS ON SUPPRESSIVE THERAPY HAVE A DECREASED HUMORAL RESPONSE TO SARS-CoV2 VACCINATION? |
R. Bourguiba, K. Dridi, M. Ayari, M. Boudokhane, I. Abdelaali, T. Jomni, S. Bellakhal, M. H. Douggui |
| 180 |
[GO] |
2023―Jun―07 |
AB1301 CYCLOPHOSPHAMIDE THERAPY DURING THE COVID19 PANDEMIC |
B. Bitik, C. S. Oygur, A. Yalçintaş Kanbur, A. E. Yucel |
| 181 |
[GO] |
2023―Jun―07 |
AB0669 CUTANEOUS LUPUS ERYTHEMATOSUS OVER THE COVID MAJOR PANDEMIC PERIOD, INCIDENCE AND CLINICAL CHARACTERISTICS |
M. Ferraioli, P. Conigliaro, C. Bonini, S. Ferrigno, M. Teoli, C. Paganini, V. Maffei, M. Galluzzo, M. Talamonti, A. Bergamini, M. S. Chimenti |
| 182 |
[GO] |
2023―Jun―07 |
POS1259 SYSTEMIC SCLEROSIS AND COVID-19 VACCINE-ASSOCIATED DELAYED ADVERSE EVENTS: INSIGHTS FROM THE COVAD-2 STUDY |
B. Doskaliuk, P. Sen, M. Joshi, N. Ravichandran, A. L. Tan, S. Katsuyuki Shinjo, S. Saha, N. Ziade, T. Chatterjee, M. Kuwana, J. Knitza, O. Distler, R. Aggarwal, A. Makol, L. Gupta, V. Agarwal |
| 183 |
[GO] |
2023―Jun―07 |
AB0127 ANTIGENIC ASSESSMENT FOR THE Β2GPIOX-PF4 COMPLEX IN A MONOCENTRIC COHORT OF PATIENTS WITH APS, THROMBOSIS DURING SARS-COV-2 INFECTION AND VITT |
F. M. Ucci, F. Villani, A. Capozzi, M. De Michele, S. Truglia, S. Mancuso, L. Rapino, G. Tripodi, V. Manganelli, G. Riitano, R. Misasi, M. Sorice, F. Conti, C. Alessandri |
| 184 |
[GO] |
2023―Jun―07 |
POS1477 DISEASE FLARES AFTER SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS ARE ASSOCIATED WITH DISEASE ACTIVITY BEFORE VACCINATION |
J. Kikuchi, Y. Kondo, S. Kojima, S. Kasai, Y. Sakai, M. Takeshita, K. Hiramoto, S. Saito, H. Fukui, K. Suzuki, Y. Kaneko |
| 185 |
[GO] |
2023―Jun―07 |
AB0113 CHRONIC STIMULATION WITH SARS-COV-2 SPIKE PROTEIN DOES NOT TRIGGER AUTOIMMUNITY |
M. Scherlinger, J. Sibilia, G. Tsokos, J. E. Gottenberg |
| 186 |
[GO] |
2023―Jun―07 |
POS0556 LONG COVID IN RHEUMATOID ARTHRITIS AND IN PSORIATIC ARTHRITIS: CLINICAL PATTERN AND GENDER-BASED DIFFERENCES FROM A SINGLE-CENTRE CASE-CONTROL STUDY |
M. Ferraioli, L. De Marco, L. Fiannacca, M. Iacovantuono, B. Monosi, P. Triggianese, P. Conigliaro, A. Bergamini, M. S. Chimenti |
| 187 |
[GO] |
2023―Jun―06 |
POS0284 COVID-19 SYMPTOMS AND DISEASE COURSE IN GERMAN PEDIATRIC RHEUMATOLOGY PATIENTS REPORTED TO BIKER |
A. Klein, T. Hospach, F. Dressler, D. Windschall, M. Hufnagel, W. Emminger, S. Mrusek, P. Ruehmer, A. Kühn, P. Bismarck, M. Haller, G. Horneff |
| 188 |
[GO] |
2023―Jun―06 |
POS0273 POST COVID-19 SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: RESULTS FROM THE COVAD STUDY |
P. Sen, N. Ravichandran, M. Joshi, S. Saha, K. Jagtap, V. Agarwal, O. Distler, E. Nikiphorou, A. L. Tan, S. Katsuyuki Shinjo, N. Ziade, T. Velikova, M. Milchert, I. Parodis, A. E. Gracia-Ramos, L. Cavagna, M. Kuwana, J. Knitza, A. Makol, A. Patel, J. Pauling, C. Wincup, B. Barman, E. A. Zamora-Tehozol, J. Rojas-Serrano, I. Garcia-De La Torre, I. J. Colunga-Pedraza, J. Merayo-Chalico, W. Katchamart, P. A. Goo, Y. M. Chen, L. S. Hoff, L. Kibbi, H. Halabi, B. Vaidya, S. S. Shaharir, R. Shumnalieva, A. T. M. T. Hasan, D. Dzifa, C. E. Toro Gutierrez, C. Vinicio Caballero, J. B. Lilleker, B. Salim, T. A. Gheita, T. Chatterjee, A. Nune, M. A. Saavedra, J. Day, H. Chinoy, V. Agarwal, R. Aggarwal, L. Gupta |
| 189 |
[GO] |
2023―Jun―06 |
POS0272 IMPACT OF THE COVID-19 PANDEMIC ON ADHERENCE TO DISEASE MODIFYING DRUGS AMONG PATIENTS WITH RHEUMATIC DISEASES: A POPULATION-BASED, INTERRUPTED TIME SERIES ANALYSIS |
N. Rebić, E. C. Sayre, M. Law, M. De Vera |
| 190 |
[GO] |
2023―Jun―06 |
POS0271 HETEROLOGOUS COVID-19 BOOSTER VACCINATION PRODUCED GREATER ANTIBODY TITERS IN AUTOIMMUNE DISEASE PATIENTS: DATA FROM MULTICENTRIC PROSPECTIVE PHASE IV SAFER STUDY |
K. Lysie Libardi Lira Machado, S. T. Miyamoto, A. P. Neves Burian, L. H. Dias, F. Z. Pretti, D. Cristina Filgueira Alves Batista, J. Geraldo Mill, Y. Gurtler Pinheiro de Oliveira, C. Strauss Estevez Gadelha, M. Gomes Gouveia, A. C. Simões Moulin, L. Gonçalves Rodrigues Aguiar, B. Oliveira Souza, G. Smith Sobral Vieira, L. Lorenzoni Grillo, M. Deorce de Lima, H. Filipe Surlo, L. Pizzol Pasti, F. Faé, I. Ribeiro Moulaz, M. De Oliveira Macabú, P. Dias Cardoso Ribeiro, V. Oliveira Magalhães, M. Freitas de Aguiar, E. Biegelmeyer, F. M. Matos Melo Campos Peixoto, C. Kayser, A. Wagner Silva de Souza, C. H. D. M. Castro, S. Ribeiro, C. Telles, J. Buhring, R. Lima, S. H. Dos Santos, S. E. B. Dias, N. Seixas de Melo, R. Holanda Da Silva Sanches, A. Luiz Boechat, N. Sartori, V. Hax, L. Denardi Dória, R. Poubel Vieira de Rezende, K. Lino Baptista, N. Rodrigues Querido Fortes, A. K. Melo, T. Santos Melo, V. Cruz, J. Rêgo, R. M. R. Vieira, A. Sophia Rodrigues Vieira, A. Kakehasi, A. C. Faria Moreira Gomes Tavares, A. Teixeira de Landa, P. Costa, V. F. Azevedo, O. Assis Martins-Filho, V. Peruhype-Magalhães, M. Pinheiro, O. Monticielo, E. Torres Dos Reis Neto, G. Ferreira, V. De Souza, A. Teixeira-Carvalho, R. Xavier, E. Sato, G. Salviato Pileggi, V. Valim |
| 191 |
[GO] |
2023―Jun―06 |
POS0270 BURDEN OF COVID-19 IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: INSIGHTS FROM A SWISS APP-BASED SURVEY |
C. Blapp, S. Yaghmaei, A. Ciurea, A. Scherer, M. Kuster, K. Lauper |
| 192 |
[GO] |
2023―Jun―06 |
POS0275 COVID-19 INFECTION IN PATIENTS WITH RHEUMATIC DISEASE DURING OMICRON OUTBREAK IN SOUTH KOREA: A SINGLE-CENTER PROSPECTIVE STUDY |
Y. K. Kim, J. I. Jung, J. K. Park, E. Y. Lee, E. B. Lee, J. W. Park |
| 193 |
[GO] |
2023―Jun―06 |
POS0268 PRE-EXPOSURE PROPHYLAXIS WITH TIXAGEVIMAB/CILGAVIMAB IS EFFECTIVE IN LIMITING THE RISK AND THE SEVERITY OF COVID-19 IN PATIENTS WITH AUTOIMMUNE OR INFLAMMATORY DISEASES AT INCREASED RISK OF SEVERE COVID-19 WHO ARE POOR RESPONDERS TO VACCINATION |
M. Thomas, M. Masson, S. Bitoun, R. Seror, H. Dupuy, E. Lazaro, C. Richez, Y. Allanore, J. Avouac |
| 194 |
[GO] |
2023―Jun―06 |
POS0269 COVID-19 SEVERITY AND VACCINE BREAKTHROUGH INFECTIONS IN SJÖGREN’S SYNDROME: RESULTS FROM THE COVAD STUDY |
A. Alunno, F. Carubbi, J. Day, J. Knitza, S. Katsuyuki Shinjo, S. Saha, M. Milchert, O. Distler, A. Makol, T. Chatterjee, V. Agarwal, R. Aggarwal, L. Gupta |
| 195 |
[GO] |
2023―Jun―06 |
POS0267 MORTALITY OUTCOME OF ACUTE MYOCARDIAL INFRACTION AND ACUTE HEART FAILURE HOSPITALIZATION IN RHEUMATIC DISEASES PATIENTS PRE-COVID-19 VS. COVID-19 PANDEMIC FROM 2016-2020 NATIONAL INPATIENT SAMPLE (NIS) DATABASE |
Z. Y. LI, S. Huang, S. Gokcebel, A. M. Reginato |
| 196 |
[GO] |
2023―Jun―06 |
POS0266 CELLULAR IMMUNE RESPONSE PERSISTENCE AFTER COVID-19 MRNA VACCINES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS UNDER RITUXIMAB |
J. Marin, P. Bourgoin, N. Saverna, C. Cartagena García, P. Lafforgue, J. Roudier, J. M. Busnel, N. Balandraud |
| 197 |
[GO] |
2023―Jun―06 |
POS0131 RELATION BETWEEN COVID-19 AND ANCA VASCULITIS. STUDY IN A SINGLE UNIVERSITY HOSPITAL |
F. Benavides-Villanueva, V. Calvo-Río, J. Loricera, J. Irure-Ventura, M. Lopez-Hoyos, R. Blanco |
| 198 |
[GO] |
2023―Jun―06 |
LB0006 COVID-19 severity, breakthrough infections and anti-SARS-CoV-2 vaccine safety in young people with rheumatic and non-rheumatic autoimmune diseases: results from the COVAD1 and COVAD2 projects |
A. Alunno, F. Carubbi, A. L. Tan, P. Sen, L. Cavagna, M. Joshi, J. Day, K. Jagtap, S. Saha, C. E. Toro Gutierrez, C. Vinicio Caballero, O. Distler, H. Chinoy, R. Aggarwal, V. Agarwal, L. Gupta |
| 199 |
[GO] |
2023―Jun―06 |
OP0085 LONGITUDINAL T CELL RESPONSES TO A SERIES OF FOUR SARS-COV-2 VACCINE DOSES OR COVID-19 IN PATIENTS ON TNF INHIBITORS |
H. Ørbo, A. S. F. M. Wolf, K. H. Bjørlykke, S. Josefsson, G. Solum, I. Fadum Kjønstad, I. Jyssum, I. E. Christensen, A. T. Tveter, J. Sexton, G. B. Kro, G. Grodeland, T. K. Kvien, J. Jahnsen, J. T. Vaage, E. A. Haavardsholm, S. Aarrestad Provan, H. Kared, L. A. Munthe, K. K. Jørgensen, S. W. Syversen, S. Mjaaland, G. L. Goll |
| 200 |
[GO] |
2023―Jun―06 |
OP0081 PREVALENCE, CHARACTERISTICS, AND PREDICTORS OF BREAKTHROUGH COVID-19 INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASE (COVAD) STUDY |
N. Ravichandran, I. Parodis, L. Gupta, S. Katsuyuki Shinjo, N. Ziade, M. Milchert, L. Cavagna, A. L. Tan, J. B. Lilleker, A. Nune, J. Pauling, C. Wincup, W. Katchamart, P. A. Goo, C. Study, H. Chinoy, R. Aggarwal, V. Agarwal, E. Nikiphorou |
| 201 |
[GO] |
2023―Jun―06 |
OP0082 COVID-19 VACCINE SAFETY DURING PREGNANCY AND BREASTFEEDING IN WOMEN WITH AUTOIMMUNE DISEASES: RESULTS FROM THE COVAD STUDY |
L. Andreoli, D. Lini, K. Schreiber, P. Sen, N. Ravichandran, I. Parodis, C. E. Toro Gutierrez, W. Katchamart, P. A. Goo, R. Shumnalieva, O. C. Chibuzo, T. Velikova, J. Day, M. Joshi, S. Katsuyuki Shinjo, A. E. Gracia-Ramos, L. Cavagna, M. Kuwana, J. Knitza, A. Makol, Y. M. Chen, C. Study, H. Chinoy, V. Agarwal, R. Aggarwal, L. Gupta |
| 202 |
[GO] |
2023―Jun―06 |
OP0080 INCIDENCE AND CLINICAL OUTCOME OF COVID-19 RELATED TO POST-VACCINATION ANTIBODY LEVELS IN PATIENTS ON IMMUNOSUPPRESSIVE THERAPY: A PROSPECTIVE STUDY IN THE OMICRON ERA |
H. Ørbo, K. H. Bjørlykke, J. Sexton, A. T. Tveter, I. Jyssum, I. E. Christensen, G. B. Kro, T. K. Kvien, L. A. Munthe, E. A. Haavardsholm, G. Grodeland, S. Mjaaland, J. T. Vaage, K. K. Jørgensen, S. Aarrestad Provan, S. W. Syversen, G. L. Goll |
| 203 |
[GO] |
2023―Jun―06 |
OP0079 OMICRON VARIANT INFECTION IN INFLAMMATORY RHEUMATOLOGICAL CONDITIONS - OUTCOMES FROM A COVID-19 NAIVE POPULATION IN AOTEAROA NEW ZEALAND |
J. Brooks, A. Montgomery, N. Dalbeth, M. Sapsford, A. Cooper, R. Ngan Kee, V. Quincey, J. Liew, S. Bhana, M. Gore-Massy, J. Hausmann, P. Machado, P. Sufka, E. Sirotich, P. Robinson, Z. Wallace, J. Yazdany, R. Grainger |
| 204 |
[GO] |
2023―Jun―06 |
OP0084 POSSIBLE ROLE OF PEPTIDE EPITOPES OF COVID-19 BNT-162B2 MRNA VACCINE IN FOMENTING AUTOIMMUNITY: AN IN SILICO ANALYSIS |
R. Talotta |
| 205 |
[GO] |
2023―Jun―06 |
OP0042 VACCINATION RATE, ADVERSE REACTIONS, AND REASONS FOR NONVACCINATION OF COVID-19 VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A JAPANESE REAL-WORLD CLINICAL PRACTICE |
Y. Hirano, Y. Saito |
| 206 |
[GO] |
2023―Jun―06 |
POS0274 PROSPECTIVE EVALUATION OF THE EFFECT OF THE VACCINE AGAINST SARS-COV-2 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM SAFER STUDY |
N. Sartori, F. M. Matos Melo Campos Peixoto, P. Dias Cardoso Ribeiro, K. Lysie Libardi Lira Machado, J. Geraldo Mill, F. Z. Pretti, M. Gomes Gouveia, Y. Gurtler Pinheiro de Oliveira, S. T. Miyamoto, V. Gonçalves Da Silva, A. P. Neves Burian, K. Rosemarie Lallemand Tapia, D. Veghini, M. Deorce de Lima, P. Athayde, A. C. Simões Moulin, L. Lorenzoni Grillo, H. Corona, L. Fiorotti Albertino, L. Pizzol Pasti, S. Ramos, H. Filipe Surlo, L. Gonçalves Rodrigues Aguiar, P. Zava Lorencini, M. Pinheiro, V. Oliveira Magalhães, M. Freitas de Aguiar, E. Biegelmeyer, C. Kayser, A. Wagner Silva de Souza, C. H. D. M. Castro, A. A. Gasparin, V. Hax, R. Poubel Vieira de Rezende, K. Lino Baptista, R. C. Gaudio, J. Buhring, S. Ribeiro, S. H. Dos Santos, C. Pinheiro Martins, J. Rodrigues, M. M. Sousa Dias, B. Guimarães Dutra, C. Telles, S. E. B. Dias, V. Cruz, J. Rêgo, R. M. R. Vieira, A. Sophia Rodrigues Vieira, A. Kakehasi, A. C. Faria Moreira Gomes Tavares, V. Dornelas, R. Azevedo, V. F. Azevedo, V. Valim, A. Teixeira-Carvalho, O. Assis Martins-Filho, R. Xavier, V. De Souza, G. Ferreira, G. Salviato Pileggi, E. Sato, E. Torres Dos Reis Neto, O. Monticielo |
| 207 |
[GO] |
2023―Jun―06 |
POS0276 SARS-COV-2 INFECTION OUTCOMES IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES -A DANISH NATIONWIDE COHORT STUDY |
A. Svensson, H. D. Emborg, L. E. Bartels, C. Ammitzbøll, T. Ellingsen, T. Adelsten, R. L. Cordtz, L. Dreyer, N. Obel |
| 208 |
[GO] |
2023―Jun―06 |
OP0083 ANAKINRA PLUS STANDARD OF CARE FOR THE REDUCTION OF HYPERINFLAMMATION AND RESPIRATORY DISTRESS IN PATIENTS WITH SARS-COV-2 INFECTION: A MULTICENTRE, RANDOMISED, OPEN-LABEL PHASE 2/3 TRIAL (ANA-COVID-GEAS STUDY) |
P. Fanlo, B. Gracia Tello, E. Fonseca, J. Álvarez Troncoso, A. González, S. Prieto-González, M. Freire, A. Argibay, L. Pallares Ferreres, J. A. Todoli, M. Perez Conesa, S. Bujan Rivas, B. Ibañez |
| 209 |
[GO] |
2023―Jun―06 |
OP0265 WORK PARTICIPATION AND THE COVID19 PANDEMIC: A DUTCH PROSPECTIVE COHORT STUDY IN PEOPLE WITH INFLAMMATORY RHEUMATIC DISEASES AND HEALTHY CONTROLS |
M. Butink, L. Boekel, A. Boonen, A. De Rijk, G. Wolbink, C. Webers |
| 210 |
[GO] |
2023―Mai―25 |
Rheumatology and Long COVID: lessons from the study of fibromyalgia |
Daniel J Clauw, Leonard Calabrese |
| 211 |
[GO] |
2023―Mrz―08 |
COVID-19 infection after autologous stem cell transplantation for systemic sclerosis |
Joerg Christoph Henes, Ioana Martac, Wichard Vogel, Claudia Lengerke, Reinhild Klein, Luca Hensen, Ann-Christin Pecher |
| 212 |
[GO] |
2023―Feb―14 |
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries |
Pedro M Machado, Martin Schäfer, Satveer K Mahil, Jean Liew, Laure Gossec, Nick Dand, Alexander Pfeil, Anja Strangfeld, Anne Constanze Regierer, Bruno Fautrel, Carla Gimena Alonso, Carla G S Saad, Christopher E M Griffiths, Claudia Lomater, Corinne Miceli-Richard, Daniel Wendling, Deshire Alpizar Rodriguez, Dieter Wiek, Elsa F Mateus, Emily Sirotich, Enrique R Soriano, Francinne Machado Ribeiro, Felipe Omura, Frederico Rajão Martins, Helena Santos, Jonathan Dau, Jonathan N Barker, Jonathan Hausmann, Kimme L Hyrich, Lianne Gensler, Ligia Silva, Lindsay Jacobsohn, Loreto Carmona, Marcelo M Pinheiro, Marcos David Zelaya, María de los Ángeles Severina, Mark Yates, Maureen Dubreuil, Monique Gore-Massy, Nicoletta Romeo, Nigil Haroon, Paul Sufka, Rebecca Grainger, Rebecca Hasseli, Saskia Lawson-Tovey, Suleman Bhana, Thao Pham, Tor Olofsson, Wilson Bautista-Molano, Zachary S Wallace, Zenas Z N Yiu, Jinoos Yazdany, Philip C Robinson, Catherine H Smith |
| 213 |
[GO] |
2022―Okt―19 |
Database of synovial T cell repertoire of rheumatoid arthritis patients identifies cross-reactive potential against pathogens including unencountered SARS-CoV-2 |
Zihan Zheng, Ling Chang, Jie Mu, Qingshan Ni, Zhong Bing, Qing-Hua Zou, Ying Wan, Yuzhang Wu, Jingyi Li, Liyun Zou |
| 214 |
[GO] |
2022―Sep―15 |
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls |
Felix Kartnig, Daniel Mrak, Elisabeth Simader, Selma Tobudic, Helga Radner, Peter Mandl, Lisa Göschl, Nikolaus Hommer, Margareta Mayer, Philipp Hofer, Thomas Hummel, Thomas Deimel, Irina Geßl, Antonia Puchner, Andreas Kerschbaumer, Renate Thalhammer, Alessandra Handisurya, Renate Kain, Stefan Winkler, Josef S Smolen, Karin Stiasny, Thomas Perkmann, Helmuth Haslacher, Judith H Aberle, Daniel Aletaha, Leonhard X Heinz, Daniela Sieghart, Michael Bonelli |
| 215 |
[GO] |
2022―Sep―05 |
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases |
Eileen W Stalman, Luuk Wieske, Koos P J van Dam, Laura Y Kummer, Zoé L E van Kempen, Joep Killestein, Adriaan G Volkers, Sander W Tas, Laura Boekel, Gertjan J Wolbink, Anneke J Van der Kooi, Joost Raaphorst, Mark Löwenberg, R Bart Takkenberg, Geert R A M D’Haens, Phyllis I Spuls, Marcel W Bekkenk, Annelie H Musters, Nicoline F Post, Angela L Bosma, Marc L Hilhorst, Yosta Vegting, Frederique J Bemelman, Alexandre E Voskuyl, Bo Broens, Agner Parra Sanchez, Cécile A C M van Els, Jelle De Wit, Abraham Rutgers, Karina de Leeuw, Barbara Horváth, Jan J G M Verschuuren, Annabel M Ruiter, Lotte van Ouwerkerk, Diane van der Woude, C F Allaart, Onno Y K Teng, Pieter van Paassen, Matthias H Busch, Papay B P Jallah, Esther Brusse, Pieter A van Doorn, Adája Elisabeth Baars, Dirk Jan Hijnen, Corine R G Schreurs, W Ludo Van der Pol, H Stephan Goedee, Maurice Steenhuis, Sofie Keijzer, Jim B D Keijser, Arend Boogaard, Olvi Cristianawati, Anja ten Brinke, Niels J M Verstegen, Koos A H Zwinderman, Theo Rispens, S Marieke van Ham, Taco W Kuijpers, Filip Eftimov |
| 216 |
[GO] |
2022―Aug―17 |
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study |
Daniel Mrak, Elisabeth Simader, Daniela Sieghart, Peter Mandl, Helga Radner, Thomas Perkmann, Helmuth Haslacher, Margareta Mayer, Maximilian Koblischke, Philipp Hofer, Lisa Göschl, Felix Kartnig, Thomas Deimel, Andreas Kerschbaumer, Thomas Hummel, Barbara Kornek, Renate Thalhammer, Karin Stiasny, Stefan Winkler, Josef S Smolen, Judith H Aberle, Daniel Aletaha, Leonhard X Heinz, Michael Bonelli |
| 217 |
[GO] |
2022―Aug―16 |
Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α |
Alexis Mathian, Paul Breillat, Karim Dorgham, Paul Bastard, Caroline Charre, Raphael Lhote, Paul Quentric, Quentin Moyon, Alice-Andrée Mariaggi, Suzanne Mouries-Martin, Clara Mellot, François Anna, Julien Haroche, Fleur Cohen-Aubart, Delphine Sterlin, Noël Zahr, Adrian Gervais, Tom Le Voyer, Lucy Bizien, Quentin Amiot, Micheline Pha, Miguel Hié, Francois Chasset, Hans Yssel, Makoto Miyara, Pierre Charneau, Pascale Ghillani-Dalbin, Jean-Laurent Casanova, Flore Rozenberg, Zahir Amoura, Guy Gorochov |
| 218 |
[GO] |
2022―Aug―11 |
POS0195 PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS HAVE AN INCREASED RISK OF MORTALITY, MECHANICAL VENTILATION, AND HOSPITALIZATION FROM COVID-19 |
S. Bruera, X. Lei, H. Zhao, J. Yazdany, M. Chavez-Macgregor, S. Giordano, M. Suarez-Almazor |
| 219 |
[GO] |
2022―Aug―11 |
POS0197 SARS-CoV-2 INFECTION CAUSED THROMBOSIS IN THE LUPUS MODEL WITH ANTIPHOSPHOLIPID ANTIBODY, WHEREAS COVID-19 ASSOCIATED THROMBOSIS WAS IRRELEVANT IN PATIENTS WITH POSITIVE ANTIPHOSPHOLIPID ANTIBODY |
S. Oba, T. Hosoya, D. Kawata, W. Lee, M. Kamiya, Y. Komiya, H. Iwai, Y. Nukui, S. Tohda, S. Yasuda |
| 220 |
[GO] |
2022―Aug―11 |
POS0204 RETROSPECTIVE STUDY OF THE COVID-19 COURSE IN CHILDREN WITH RHEUMATIC DISEASES: SINGLE CENTER EXPERIENCE |
Z. Kolkhidova, I. Nikishina, V. Matkava, A. Shapovalenko, S. Arsenyeva, M. Kaleda, S. Salugina, E. Fedorov, T. Pachkoria |
| 221 |
[GO] |
2022―Aug―11 |
POS0202 CONTROL OF RHEUMATIC DISEASE AND COVID-19: RESULTS FROM THE INTERNATIONAL COVID-19 EUROPEAN PATIENT REGISTRY |
S. Shoop-Worrall, S. Verstappen, W. Costello, S. Angevare, Y. Uziel, C. Wouters, N. Wulffraat, R. Beesley |
| 222 |
[GO] |
2022―Aug―11 |
POS0194 MORBIDITY AND MORTALITY OF BREAKTHROUGH COVID-19 IN PATIENTS WITH IMMUNE MEDIATED CONDITIONS ON B CELL DEPLETING THERAPIES AND THE EFFECTS OF MONOCLONAL ANTIBODY TREATMENT |
C. Calabrese, E. Kirchner, M. E. Husni, B. Moss, A. Fernandez, Y. Jin, L. Calabrese |
| 223 |
[GO] |
2022―Aug―11 |
POS0203 PREDICTIVE SEVERITY FACTORS OF COVID-19 IN PATIENTS WITH RHEUMATIC IMMUNE MEDIATED DISEASES |
D. Martínez-López, I. Ferraz-Amaro, D. Prieto-Peña, F. Benavides-Villanueva, C. Corrales-Selaya, L. Sanchez-Bilbao, A. Herrero-Morant, C. Álvarez-Reguera, M. Trigueros-Vazquez, M. A. González-Gay, R. Blanco |
| 224 |
[GO] |
2022―Aug―11 |
POS0170 EXPERIENCES WITH COVID-19 INFECTIONS IN GERMAN PEDIATRIC RHEUMATOLOGY CENTERS |
G. Horneff, F. Dressler, D. Windschall, S. Mrusek, T. Hospach, A. Kühn, M. Haller, P. Von Bismarck, W. Emminger, P. Ruehmer, M. Hufnagel, A. Klein |
| 225 |
[GO] |
2022―Aug―11 |
POS0263 RE-VACCINATION COMPARED TO BOOSTER COVID-19 mRNA VACCINATION SIGNIFICANTLY INCREASES THE SEROLOGICAL RESPONSE IN RITUXIMAB-TREATED PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES WITHOUT A PRIMARY DETECTABLE SEROLOGICAL COVID-19 VACCINE RESPONSE |
C. Ammitzbøll, M. K. Thomsen, M. L. F. Hermansen, S. R. Vils, J. B. Andersen, A. D. Johannesen, F. Szabados, C. M. Jørgensen, M. C. L. Larsen, C. Erikstrup, E. M. Hauge, A. Troldborg |
| 226 |
[GO] |
2022―Aug―11 |
POS0261 TIME SINCE LAST RITUXIMAB TREATMENT IS ESSENTIAL FOR DEVELOPING A HUMORAL RESPONSE TO THE COVID-19 MRNA VACCINE IN PATIENTS WITH RHEUMATIC DISEASES. |
A. Troldborg, M. K. Thomsen, L. E. Bartels, J. B. Andersen, S. R. Vils, C. M. Jørgensen, A. D. Johannesen, M. L. F. Hermansen, S. Mikkelsen, C. Erikstrup, E. M. Hauge, C. Ammitzbøll |
| 227 |
[GO] |
2022―Aug―11 |
POS0198 COVID-19 OUTCOMES IN PATIENTS WITH DERMATOMYOSITIS: A REGISTRY-BASED COHORT ANALYSIS |
L. Gupta, H. Pakhchanian, H. Khan, R. Raiker, M. Abbasi, C. Deyoung, S. Kardes, S. Ahmed, C. Kavadichanda, P. Sen, R. Aggarwal |
| 228 |
[GO] |
2022―Aug―11 |
POS0088-PARE CHANGES IN PATIENT-REPORTED OUTCOME SCORES DURING COVID-19 PANDEMIC: DATA FROM THE ArthritisPower REGISTRY |
K. Gavigan, E. Rivera, J. R. Curtis, S. Venkatachalam, L. Stradford, D. Curtis, W. B. Nowell |
| 229 |
[GO] |
2022―Aug―11 |
OP0308-HPR MORE THAN HALF OF RA PATIENTS WITH A LIFETIME HISTORY OF MOOD DISORDERS WERE ANXIOUS AND DEPRESSED DURING THE COVID-19 PANDEMIC: RESULTS FROM THE CANADIAN EARLY COHORT (CATCH) STUDY |
S. J. Bartlett, O. Schieir, M. F. Valois, G. Boire, G. Hazlewood, C. Thorne, D. Tin, C. Hitchon, J. Pope, E. Keystone, L. Bessette, V. Bykerk |
| 230 |
[GO] |
2022―Aug―11 |
POS0201 COVID-19 SEVERITY AND VACCINE BREAKTHROUGH INFECTIONS IN IDIOPATHIC INFLAMMATORY MYOPATHIES, OTHER SYSTEMIC AUTOIMMUNE AND INFLAMMATORY DISEASES, AND HEALTHY INDIVIDUALS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASES (COVAD) STUDY. |
L. Gupta, L. S. Hoff, N. R, P. Sen, S. Katsuyuki Shinjo, J. Day, J. B. Lilleker, V. Agarwal, S. Kardes, M. Kim, A. Makol, M. Milchert, T. A. Gheita, B. Salim, T. Velikova, A. E. Gracia-Ramos, I. Parodis, A. Selva-O’callaghan, E. Nikiphorou, T. Chatterjee, A. L. Tan, A. Nune, L. Cavagna, M. A. Saavedra, N. Ziade, J. Knitza, M. Kuwana, O. Distler, H. Chinoy, V. Agarwal, R. Aggarwal |
| 231 |
[GO] |
2022―Aug―11 |
POS0258 SAFETY AND IMMUNOGENICITY OF BNT162b2 mRNA COVID-19 VACCINE AMONG ADOLESCENTS WITH RHEUMATIC DISEASES TREATED WITH IMMUNOMODULATORY MEDICATIONS |
M. Heshin-Bekenstein, A. Ziv, N. Toplak, D. Hagin, D. Kadishevich, Y. Butbul, E. Saiag, G. Shefer, O. Sharon, S. Pel, O. Elkayam, Y. Uziel |
| 232 |
[GO] |
2022―Aug―11 |
POS0255 PREDICTORS OF ANTIBODY RESPONSE TO COVID-19 VACCINE IN RITUXIMAB TREATED PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES. A SWEDISH NATIONWIDE STUDY (COVID19-REUMA) |
M. Frodlund, K. Chatzidionysiou, A. Södergren, E. Klingberg, M. Hansson, E. Pin, S. Olsson, A. Bengtsson, L. Klareskog, M. C. Kapetanovic |
| 233 |
[GO] |
2022―Aug―11 |
OP0303-PARE HEALTH DEMOCRACY IN THE TIME OF COVID-19: A COLLABORATIVE INITIATIVE BETWEEN PATIENT ORGANIZATIONS AND HEALTHCARE PROFESSIONALS TO SUPPORT PEOPLE LIVING WITH RHEUMATOID ARTHRITIS |
S. Tropé, R. M. Flipo |
| 234 |
[GO] |
2022―Aug―11 |
POS0200 POST-mRNA VACCINE FLARES IN AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES: INTERIM RESULTS FROM THE CORONAVIRUS NATIONAL VACCINE REGISTRY FOR IMMUNE DISEASES SINGAPORE (CONVIN-SING) |
M. Ma, A. Santosa, K. O. Kong, C. Xu, J. T. G. Xiang, G. G. Teng, A. Mak, S. H. Tay, V. W. W. Ng, J. Z. E. Koh, W. Fong, L. C. Chew, A. Low, A. Law, Y. J. Poh, S. I. Yeo, Y. Y. Leung, W. R. Goh, C. T. Yu, N. E. Roslan, S. Angkodjojo, K. F. Phang, T. Arkachaisri, M. Sriranganathan, T. C. Tan, P. Cheung, M. Lahiri |
| 235 |
[GO] |
2022―Aug―11 |
POS0254 IMMUNE RESPONSE TO SARS-CoV-2 INFECTION IN PATIENTS WITH RHEUMATIC MUSCULOSKELETAL DISEASES: THE MAINSTREAM STUDY |
E. G. Favalli, A. Favalli, G. Andrea, G. Maioli, E. Zagato, M. Bombaci, E. Pesce, L. Donnici, P. Gruarin, M. Biggioggero, S. Curti, L. Manganaro, E. Marchisio, V. Bevilacqua, M. Martinovic, T. Fabbris, M. L. Sarnicola, M. Crosti, L. Marongiu, F. Granucci, S. Notabartolo, A. Bandera, A. Gori, R. De Francesco, S. Abrignani, R. Caporali, R. Grifantini |
| 236 |
[GO] |
2022―Aug―11 |
POS0275 SEROLOGICAL RESPONSE FOLLOWING THREE DOSES OF SARS-CoV-2 mRNA VACCINE IN PATIENTS WITH GIANT CELL ARTERITIS: EXPERIENCE OF A SINGLE-CENTRE COHORT |
A. Bartoletti, G. Franchi, C. Fornara, P. Delvino, F. Baldanti, D. Lilleri, C. Montecucco, S. Monti |
| 237 |
[GO] |
2022―Aug―11 |
POS0264 CHARACTERIZATION OF THE IMMUNE RESPONSE IN PATIENTS WITH INFLAMMATORY IMMUNE-MEDIATED DISEASES ON IMMUNOSUPPRESSIVE TREATMENT AFTER ONE MONTH OF SARS-CoV-2 VACCINATION |
A. Martínez-Feito, P. Nozal, M. Novella-Navarro, E. Fernández-Fernández, L. Del Pino Molina, M. Casas Temprano, I. Akatbach Bousaid, M. D. Martin Arranz, A. Balsa, C. Plasencia |
| 238 |
[GO] |
2022―Aug―11 |
POS0050 B CELL CHARACTERISTICS AT BASELINE PREDICT HUMORAL RESPONSE UPON SARS-CoV-2 VACCINATION AMONG PATIENTS TREATED WITH RITUXIMAB |
A. L. Stefanski, H. Rincon-Arevalo, E. Schrezenmeier, K. Karberg, F. Szelinski, J. Ritter, B. Jahresdoerfer, H. Schrezenmeier, C. Ludwig, Y. Chen, A. Claußnitzer, A. Lino, T. Dörner |
| 239 |
[GO] |
2022―Aug―11 |
POS0256 CLINICAL PREDICTORS OF ATTENUATED ANTIBODY RESPONSE TO PRIMARY SARS-CoV-2 VACCINATION IN A LARGE PROSPECTIVE STUDY OF PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES |
C. Connolly, T. P. Y. Chiang, M. Teles, S. Frey, J. Alejo, A. Massie, L. Christopher Stine, W. Werbel, D. Segev, J. Paik |
| 240 |
[GO] |
2022―Aug―11 |
POS0260 LONG-TERM HUMORAL RESPONSE TO SARS-CoV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASE |
K. Tascilar, D. Simon, A. Kleyer, F. Fagni, G. Krönke, C. Meder, P. Dietrich, T. Orlemann, T. Kliem, J. Mößner, A. M. Liphardt, V. Schönau, D. Bohr, L. Schuster, F. Hartmann, J. Taubmann, M. Leppkes, A. Ramming, M. Pachowsky, F. Schuch, M. Ronneberger, S. Kleinert, A. Hueber, K. Manger, B. Manger, R. Atreya, C. Berking, M. Sticherling, M. F. Neurath, G. Schett |
| 241 |
[GO] |
2022―Aug―11 |
POS0259 A RANDOMIZED CLINICAL TRIAL OF 2-WEEK METHOTREXATE DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS VACCINATED WITH INACTIVATED SARS-COV-2 VACCINE |
C. Scognamiglio Renner Araujo, A. C. Medeiros Ribeiro, C. Saad, K. Bonfiglioli, D. S. Domiciano, A. Yukie Shimabuco, M. Rodrigues Silva, E. Neves, S. Pasoto, T. Pedrosa, L. Kanda Kupa, G. Zou, R. M. Pereira, C. A. Silva, N. Aikawa, E. Bonfa |
| 242 |
[GO] |
2022―Aug―11 |
POS0257 COMPARISON OF SARS-CoV-2 VACCINE RESPONSE IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASE; mRNA-1273 VACCINE INDUCES HIGHER HUMORAL IMMUNOGENICITY THAN BNT162b2 |
Y. Kondo, M. Takeshita, Y. Uwamino, H. Namkoong, S. Saito, J. Kikuchi, H. Hanaoka, K. Suzuki, N. Hasegawa, M. Murata, Y. Kaneko |
| 243 |
[GO] |
2022―Aug―11 |
POS0262 HUMORAL AND CELLULAR SARS-CoV-2 VACCINE RESPONSES IN PATIENTS WITH GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA |
Y. Van Sleen, K. Van der Geest, R. Reitsema, I. Esen, J. H. Terpstra, E. Raveling-Eelsing, M. Van der Heiden, J. Jansen, A. Buisman, D. Van Baarle, M. Sandovici, E. Brouwer |
| 244 |
[GO] |
2022―Aug―11 |
POS0196 NINE PERCENT OF PATIENTS PRESENT WITH MUSCULOSKELETAL SYMPTOMS AFTER A SEVERE SARS-CoV2 INFECTION: A DESCRIPTIVE ANALYSIS OF THE ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS CLINICAL DATA WAREHOUSE. |
A. Moltó, P. Pinson, N. Beeker, C. Roux |
| 245 |
[GO] |
2022―Aug―11 |
OP0304-PARE “THE CORONA PANDEMIC - AND HOW WE REACTED TO PATIENTS’ NEEDS” |
C. Elling-Audersch |
| 246 |
[GO] |
2022―Aug―11 |
LB0003 WITHDRAWING METHOTREXATE AFTER BOTH VERSUS ONLY SECOND DOSE OF THE ChAdOx1 nCoV-19 VACCINE IN PATIENTS WITH AUTOIMMUNE INFLAMMATORY ARTHRITIS: TWO INDEPENDENT RANDOMIZED CONTROLLED TRIALS (MIVAC I AND II) |
A. Sreekanth, T. Skaria, S. Joseph, R. Umesh, M. Mohanan, A. Paul, S. Ahmed, P. Mehta, S. Oomen, J. Benny, J. George, A. Paulose, K Narayanan, S. Joseph, A. Vijayan, K. Nalianda, P. Shenoy |
| 247 |
[GO] |
2022―Aug―09 |
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave |
Yumeko Kawano, Naomi J Patel, Xiaosong Wang, Claire E Cook, Kathleen MM Vanni, Emily N Kowalski, Emily P Banasiak, Grace Qian, Michael DiIorio, Tiffany Y-T Hsu, Michael E Weinblatt, Derrick J Todd, Zachary S Wallace, Jeffrey A Sparks |
| 248 |
[GO] |
2022―Aug―03 |
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination |
Giuseppe A Ramirez, Lorenza Maria Argolini, Tommaso Schioppo, Savino Sciascia, Luca Moroni, Gabriella Moroni, Renato Alberto Sinico, Grazia Bonelli, Federico Alberici, Federica Mescia, Francesco Tamborini, Paolo Miraglia, Chiara Bellocchi, Lorenzo Beretta, Dario Roccatello, Enrica Paola Bozzolo, Roberto Caporali, Maria Gerosa, Lorenzo Dagna |
| 249 |
[GO] |
2022―Jul―25 |
SARS-CoV-2 Omicron escapes mRNA vaccine booster-induced antibody neutralisation in patients with autoimmune rheumatic diseases: an observational cohort study |
Woo-Joong Kim, Seong-Ho Choi, Ji Young Park, Jung Soo Song, Jin-Won Chung, Sang Tae Choi |
| 250 |
[GO] |
2022―Jul―11 |
Correspondence on “Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry” by Machado et al |
Rim Bourguiba, Marion Delplanque, Léa Savey, Veronique Hentgen, Gilles Grateau, Sophie Georgin-lavialle |
| 251 |
[GO] |
2022―Jun―30 |
Serum urate outcomes of treat-to-target urate lowering treatment: results of a nationwide cohort study from 1997 to the COVID-19 pandemic using data from the Clinical Practice Research Datalink |
Abhishek Abhishek, Edoardo Cipolletta, Georgina Nakafero, Anthony J Avery, Mamas Mamas, Laila J Tata |
| 252 |
[GO] |
2022―Jun―28 |
AB1128 MAINTENANCE THERAPY FOR PATIENTS WITH RHEUMATIC DISEASES DURING THE COVID-19 |
D. Ben Nessib, M. Yasmine, H. Ferjani, W. Triki, K. Maatallah, D. Kaffel, W. Hamdi |
| 253 |
[GO] |
2022―Jun―28 |
AB1143 MUSCULOSKELETAL PAIN AS A PART OF THE RHEUMATIC SPECTRUM IN COVID-19 |
S. Bogdanova-Petrova, T. Georgiev, S. Dimitrov, S. Hristova, T. Shivacheva |
| 254 |
[GO] |
2022―Jun―28 |
AB1182 SPECIALIZED PRO-RESOLVING MEDIATORS (SPMS) AND INFLAMMATORY NETWORKS IN PATIENTS AFFECTED BY ADULT ONSET STILL’S DISEASE (AOSD) AND COVID-19 |
L. Navarini, M. Vomero, O. Berardiucrti, D. Currado, A. Marino, A. Biaggi, S. DI Donato, F. Ursini, P. Ruscitti, R. Meliconi, P. Cipriani, A. Iagnocco, A. Afeltra, R. Giacomelli |
| 255 |
[GO] |
2022―Jun―28 |
AB1098 DEVELOPMENT OF INFLAMMATORY MYOPATHY AFTER COVID-19 |
I. Menshikova, A. Shilina, N. Nikolaeva |
| 256 |
[GO] |
2022―Jun―28 |
AB1097 FEATURES OF THE COURSE AND CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF PATIENTS WITH RHEUMATOID ARTHRITIS WHO UNDERWENT COVID-19 |
E. Aronova, G. Gridneva, B. Belov |
| 257 |
[GO] |
2022―Jun―28 |
AB1083 MUSCULOSKELETAL MANIFESTATIONS AND POSTCOVID SYNDROME IN HOSPITALIZED PATIENTS INFECTED WITH COVID-19 |
Ö. Küçülmez, G. Gençtoy |
| 258 |
[GO] |
2022―Jun―28 |
AB0981 DYNAMICS OF PAIN ACCORDING TO THE VAS SCALE, FUNCTIONAL ACTIVITY ACCORDING TO THE WOMAC INDEX AND QUALITY OF LIFE ACCORDING TO THE EQ-5D QUESTIONNAIRE IN ELDERLY AND SENILE PATIENTS WITH KNEE JOINT OSTEOARTHRITIS AFTER COVID-19 |
M. Letaeva, M. Koroleva, O. Malyshenko, J. Averkieva, T. Raskina |
| 259 |
[GO] |
2022―Jun―28 |
AB0812 EFFECT OF PRO-INFLAMMATORY CYTOKINE- INTERLEUKIN 6 ON THE COURSE OF ANKYLOSING SPONDYLITIS IN PATIENTS AFTER COVID-19 |
N. Abdurakhmanova, K. Akhmedov |
| 260 |
[GO] |
2022―Jun―28 |
POS1261 CLINICAL RESPONSE PREDICTORS OF TOCILIZUMAB THERAPY IN PATIENTS WITH SEVERE COVID-19 |
W. Schmidt, K. Pawlak-Bus, P. Leszczynski |
| 261 |
[GO] |
2022―Jun―28 |
POS1203 INCREASED PROTEASE-ACTIVATED RECEPTOR 1 AUTOANTIBODIES ARE ASSOCIATED WITH SEVERE COVID-19 |
F. Tran, A. Scharmacher, H. Grasshoff, S. Schinke, N. Kaeding, J. Bernades, J. Y. Humrich, O. Cabral-Marques, K. Gaede, C. Lange, J. Rupp, P. Rosenstiel, B. F. Hoyer, K. Schulze-Forster, H. Heidecke, G. Halpert, H. Amital, Y. Shoenfeld, S. Schreiber, G. Riemekasten |
| 262 |
[GO] |
2022―Jun―28 |
POS1195 CAN PRE-TREATMENT INFLAMMATORY BIOMARKER LEVELS GUIDE TO DETERMINE APPROPRIATE TIME OF TOCILIZUMAB THERAPY IN COVID-19 |
D. Tecer, M. Çinar, M. N. Kaya, F. Bicakci, S. Colak, E. Tekgoz, S. Yilmaz |
| 263 |
[GO] |
2022―Jun―28 |
POS1234 DMARD DISRUPTION, INCREASED DISEASE ACTIVITY, AND PROLONGED SYMPTOM DURATION AFTER ACUTE COVID-19 AMONG PATIENTS WITH RHEUMATIC DISEASE: A PROSPECTIVE STUDY |
M. DI Iorio, C. Cook, K. Vanni, N. Patel, K. D’silva, X. Fu, J. Wang, L. Prisco, E. Kowalski, A. Zaccardelli, L. Martin, G. Qian, T. Hsu, Z. Wallace, J. Sparks |
| 264 |
[GO] |
2022―Jun―28 |
AB1173 INCIDENT CASES OF COVID-19 AND VACCINATION ADHERENCE IN A MULTICENTRIC COHORT OF INFLAMMATORY ARTHRITIS IN BRAZIL |
S. M M de Souza, A. C. Medeiros-Ribeiro, M. Bredemeier, A. Duarte, M. Pinheiro, B. Stadler, J. C. Macieira, R. Ranza, J. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, R. Botelho, C. Brenol, H. M. Da Silveira DE Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L. Rocha, H. De Leon de Lima, I. Pereira, M. Ohira Gazzeta, A. Kakehasi, P. Louzada, A. L. S. Hayata, F. Pina, M. Alves Ferreira, L. Balarini, I. G. Silveira, S. Kowalski, D. Titton, R. Mendonça Da Silva Chakr, A. Ranzolin, I. Laurindo, R. Xavier |
| 265 |
[GO] |
2022―Jun―28 |
POS1202 B-CELL RECONSTITUTION IS STRONGLY ASSOCIATED WITH A POSITIVE SEROLOGIC RESPONSE TO THE COVID-19 BOOSTER VACCINE IN PREVIOUSLY SEROLOGICALLY UNRESPONSIVE RITUXIMAB TREATED RHEUMATIC DISEASE PATIENTS |
K. Schultz, D. Jannat-Khah, R. Spiera |
| 266 |
[GO] |
2022―Jun―28 |
AB1466 CORRELATION BETWEEN SALES OF CERTAIN BEVERAGES AND GOUT ATTACKS DURING THE COVID-19 CURFEW IN CAMEROON: A HOSPITAL-BASED STUDY |
F. Kemta Lekpa, K. Frank Forex, H. Mbatchou, A. Jerome, H. Namme Luma, S. P. Choukem |
| 267 |
[GO] |
2022―Jun―28 |
POS1222 FOLIC ACID AND METHOTREXATE USE AND THEIR ASSOCIATION WITH COVID-19 DIAGNOSIS AND MORTALITY: AN ANALYSIS FROM THE UK BIOBANK |
R. Topless, R. Green, S. Morgan, P. Robinson, T. Merriman, A. Gaffo |
| 268 |
[GO] |
2022―Jun―28 |
AB1175 EFFECTS OF THE COVID-19 DISEASE ON AXIAL SPONDYLOARTHRITIS DISEASE FLARE |
B. Armagan, E. Atalar, B. Özdemir, Ö. Karakaş, E. Kayacan Erdogan, S. C. Güven, I. Dogan, O. Küçükşahin, A. Erden |
| 269 |
[GO] |
2022―Jun―28 |
POS1567-PARE ASSESSMENT OF ADHERENCE AMONG GREEK PATIENTS WITH RHEUMATIC DISEASES DURING THE COVID-19 ERA |
K. Koutsogianni, E. Repa, K. Spanidou, I. Papadakis, I. Chatzikrystallis, P. Pratsidou-Gertsi, F. Asimakopoulou |
| 270 |
[GO] |
2022―Jun―28 |
AB1492 COMPARISON OF TELEREHABILITATION METHODS FOR SYSTEMIC SCLEROSIS PATIENTS IN THE COVID-19 ERA: A RANDOMIZED CONTROLLED STUDY |
T. Civi Karaaslan, E. Tarakci, O. Keles, Y. Aslan Keles, S. Ugurlu |
| 271 |
[GO] |
2022―Jun―28 |
AB1392 COVID-19 HAD AN ADVERSE IMPACT ON DENOSUMAB TREATMENT PROVISION - COMPARISON WITH PRE-PANDEMIC WAITING TIMES AT A UK-BASED RHEUMATOLOGY DEPARTMENT |
S. Ling, L. Bromilow, S. Vasireddy |
| 272 |
[GO] |
2022―Jun―28 |
AB1180 COVID-19 HAD DISPROPORTIONATE IMPACTS ON RA SYMPTOMS AND FUNCTION BY SEX AND AGE: RESULTS FROM THE CANADIAN EARLY ARTHRITIS COHORT (CATCH) |
S. J. Bartlett, O. Schieir, M. F. Valois, D. Tin, E. Keystone, L. Bessette, J. Pope, G. Boire, G. Hazlewood, C. Hitchon, C. Thorne, V. Bykerk |
| 273 |
[GO] |
2022―Jun―28 |
POS1213 SAFETY AND EFFICACY ASSESSMENT OF COVID-19 IMMUNIZATIONS / VACCINATIONS IN PATIENTS OF A GERMAN GENERAL RHEUMATOLOGICAL PRACTICE |
C. Pohl |
| 274 |
[GO] |
2022―Jun―28 |
POS1253 THE COURSE OF COVID-19 IN A COHORT OF SPONDYLOARTHRITIS PATIENTS: A CASE-CONTROL PROSPECTIVE STUDY |
C. Castellani, R. Terribili, L. DI Sanzo, E. Molteni, G. Sciarra, G. Bevignani, M. DI Franco, V. Riccieri, C. Alessandri, R. Scrivo, F. Conti |
| 275 |
[GO] |
2022―Jun―28 |
AB0858 Clinical characteristics of patients with spondyloarthritis with COVID-19 in anamnesis in the Republic of Tatarstan |
V. Mukhamadieva, S. Lapshina, N. Shamsutdinova, A. Sagitova, A. Zakirova, L. Krasnova, R. Abdrakipov, D. Abdulganieva |
| 276 |
[GO] |
2022―Jun―28 |
AB1132 FEATURES OF THE COURSE OF COVID-19 IN ELDERLY PATIENTS WITH IMMUNO-INFLAMMATORY RHEUMATIC DISEASES (PRELIMINARY DATA). |
N. Muravyeva, B. Belov, A. Kulikov |
| 277 |
[GO] |
2022―Jun―28 |
AB1176 DOES VACCINATION AND VARIANTS AFFECT THE COURSE OF THE COVID-19 IN INFLAMMATORY RHEUMATIC DISEASE? |
S. Çelik, M. E. Kutu, B. Karadeniz, M. Soy |
| 278 |
[GO] |
2022―Jun―28 |
AB1161 COVID-19 IN MY RA CLINIC: DATA FROM QUESTIONNAIRE, VACCINATION, INFECTION AND FLARES FROM THE RA LOUVAIN BRUSSELS COHORT |
V. Pirson, T. Sokolova, X. Theunssens, L. Bricman, E. Sapart, S. DE Montjoye, S. Dierckx, A. Avramovska, P. Durez |
| 279 |
[GO] |
2022―Jun―28 |
AB1087 COVID-19 IN PATIENTS WITH ANCA ASSOCIATED VASCULITIS |
A. Hočevar, B. Burja, M. Tomsic, Z. Rotar |
| 280 |
[GO] |
2022―Jun―28 |
POS1265 DISTURBED CELLULAR IMMUNITY FOLLOWING mRNA VACCINATION AGAINST COVID-19 IN PATIENTS WITH B-CELL DEPLETING THERAPY |
C. Sallegger, I. Hodl, B. Dreo, V. L. Ihm, J. Thiel, M. Stradner, J. Fessler, C. Consortium |
| 281 |
[GO] |
2022―Jun―28 |
POS1279 FAVOURABLE COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER USING BIOLOGIC AGENTS |
N. Aliyeva, S. Sari, S. Amikishiyev, B. Ç. Yalçin Dulundu, V. Suleymanova, P. Telli, Y. Yalçinkaya, B. Artim-Esen, M. Inanc, A. Gül |
| 282 |
[GO] |
2022―Jun―28 |
POS1193 COVID-19 IN PATIENTS WITH GIANT CELL ARTERITIS |
J. Kramarič, R. Jese, M. Tomsic, Z. Rotar, A. Hočevar |
| 283 |
[GO] |
2022―Jun―28 |
POS1283 THE COURSE OF NOVEL CORONAVIRUS DISEASE 2019 (COVID-19) IN PATIENTS WITH IgG4-RELATED DISEASE TREATED WITH RITUXIMAB |
E. Sokol, A. Torgashina |
| 284 |
[GO] |
2022―Jun―28 |
POS1194 COVID-19 IN PATIENTS WITH INFLAMMATORY MYOPATHY |
A. Hočevar, B. Radič, M. Krosel, M. Tomsic, Z. Rotar |
| 285 |
[GO] |
2022―Jun―28 |
POS1205 COVID-19 IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES - DATA FROM THE ROMANIAN REGISTRY OF RHEUMATIC DISEASES |
D. Minca, A. Minca, C. E. Ionescu, O. G. Dinache, C. Popescu, M. Agache, L. Enache, C. Mogosan, C. Codreanu |
| 286 |
[GO] |
2022―Jun―28 |
AB1139 SARS-CoV2- INFECTION AFTER VACCINATION AGAINST COVID-19 IN PATIENTS WITH RHEUMATIC DISORDERS IN A REAL LIFE SETTING OF A RHEUMATOLOGICAL OUTPATIENT CENTER |
S. G. Werner, L. Moll, A. Uhlenberg-Moll, S. Mettler, H. E. Langer |
| 287 |
[GO] |
2022―Jun―28 |
POS1286 SEVERITY OF COVID-19 IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING BIOLOGICAL DMARDs |
R. Samigullina, A. Dadalova, E. Vasilenko, V. Mazurov |
| 288 |
[GO] |
2022―Jun―28 |
AB1129 SAFETY OF VACCINES AGAINST COVID-19 IN PATIENTS WITH SPONDYLOARTHRITIS (PRELIMINARY DATA). |
A. Kulikov, N. Muravyeva, B. Belov |
| 289 |
[GO] |
2022―Jun―28 |
AB1126 CHARACTERISTICS AND OUTCOMES OF COVID-19 IN PATIENTS WITH SYSTEMIC RHEUMATIC DISEASES: EXPERIENCE FROM A TERTIARY RHEUMATOLOGY CENTER IN MALAYSIA |
S. Selvananda, S. L. Kan |
| 290 |
[GO] |
2022―Jun―28 |
POS1271 THE COURSE AND OUTCOMES OF COVID-19 IN PATIENTS WITH TAKAYASU ARTERITIS: CASE SERIES OF 15 PATIENTS FROM A TERTIARY SINGLE CENTER |
G. Sevik, S. Kutluğ Ağaçkiran, K. Abacar, A. Aliyeva, H. Direskeneli, F. Alibaz-Oner |
| 291 |
[GO] |
2022―Jun―28 |
AB1082 FREQUENCY AND SEVERITY OF COVID-19 IN PATIENTS WITH VARIOUS RHEUMATIC DISEASES TREATED REGULARLY WITH COLCHICINE OR HYDROXYCHLOROQUINE |
M. Oztas, M. Bektaş, I. Karacan, N. Aliyeva, A. Dag, S. Aghamuradov, S. B. Cevirgen, S. Sari, M. Bolayirli, G. Can, G. Hatemi, E. Seyahi, H. Ozdogan, A. Gul, S. Ugurlu |
| 292 |
[GO] |
2022―Jun―28 |
POS1192 INCIDENCE AND RISK FACTORS OF COVID-19 IN PATIENTS WITH VASCULITIS: A DANISH NATIONWIDE COHORT STUDY |
S. Kristensen, R. L. Cordtz, K. Duch, J. Lindhardsen, C. Torp-Pedersen, L. Dreyer |
| 293 |
[GO] |
2022―Jun―28 |
AB1171 PERSISTENT POST-DISCHARGE SYMPTOMS AFTER COVID-19 IN RHEUMATIC AND MUSCULOSKELETAL DISEASES |
I. Perez-Sancristobal, L. León, M. P. Álvarez Hernandez, A. Madrid García, L. Lopez Pedraza, J. I. Colomer, S. Lerma Lara, P. Lois, A. Mucientes, L. Rodriguez Rodriguez, B. Fernandez, L. Abasolo |
| 294 |
[GO] |
2022―Jun―28 |
POS1246 COVID-19 IN RITUXIMAB TREATED PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES |
R. Hasseli, B. F. Hoyer, H. M. Lorenz, A. Pfeil, A. Regierer, J. Richter, T. Schmeiser, A. Strangfeld, R. Voll, H. Schulze-Koops, A. Krause, C. Specker, U. Müller-Ladner |
| 295 |
[GO] |
2022―Jun―28 |
AB1136 PREVALENCE OF COVID-19 IN SYSTEMIC LUPUS ERYTHEMATOSUS: A META-ANALYSIS |
J. Wang, S. X. Zhang, X. Y. Yin, B. R. Zhao, Y. R. Shi, J. Y. Meng, Q. Y. Su, X. F. LI, C. Wang |
| 296 |
[GO] |
2022―Jun―28 |
AB1179 CLINICAL CHARACTERISTICS OF PATIENTS WITH RHEUMATOID ARTHRITIS WHO UNDERWENT COVID-19 IN THE REPUBLIC OF TATARSTAN |
N. Shamsutdinova, S. Lapshina, V. Mukhamadieva, A. Sagitova, A. Zakirova, L. Krasnova, D. Abdulganieva, R. Abdrakipov, E. Sukhorukova |
| 297 |
[GO] |
2022―Jun―28 |
AB1157 CLINICAL CHARACTERISTICS OF PATIENTS WITH RHEUMATIC DISEASES AFTER COVID-19 IN THE REPUBLIC OF TATARSTAN |
S. Lapshina, N. Shamsutdinova, V. Mukhamadieva, R. Abdrakipov, E. Sukhorukova, A. Sagitova, A. Zakirova, L. Krasnova, D. Abdulganieva |
| 298 |
[GO] |
2022―Jun―28 |
AB1133 MUSCULOSKELETAL MANIFESTATIONS AMONG PATIENTS WITH COVID-19 INFECTION |
S. Tharwat, N. M. Shabana, M. K. Nassar |
| 299 |
[GO] |
2022―Jun―28 |
POS1467 SEPTAL PANNICULITIS AS A MANIFESTATION OF COVID-19 INFECTION |
O. Egorova, G. Tarasova, A. Datsina |
| 300 |
[GO] |
2022―Jun―28 |
POS1264 LONGITUDINAL FOLLOW-UP OF HUMORAL RESPONSE AGAINST SARS-CoV-2 AND VIRAL PERSISTENCE IN 96 DMARDs-TREATED PATIENTS WITH PREVIOUS COVID-19 INFECTION |
O. Fogel, M. Beretta, C. Planchais, T. Bruneau, P. Goncalves, J. Avouac, F. Berenbaum, J. Sellam, C. Deprouw, B. Fautrel, J. Morel, B. Parfait, J. DI Santo, S. Behillil, S. Van Der Werf, H. Péré, H. Mouquet, C. Miceli Richard |
| 301 |
[GO] |
2022―Jun―28 |
POS1230 INCREASED ANTIBODY RESPONSE AFTER SARS-CoV-2 mRNA-BASED VACCINATION IN RITUXIMAB-TREATED PATIENTS WITH PREVIOUS COVID-19 INFECTION |
J. Avouac, R. Ghossan, O. Al Tabaa, A. Combier, A. Steelandt, M. Thomas, O. Fogel, A. A. Mariaggi, J. F. Meritet, F. Rozenberg, A. Moltó, C. Miceli Richard, Y. Allanore |
| 302 |
[GO] |
2022―Jun―28 |
POS1254 RISK FACTORS FOR SEVERE COVID-19 INFECTION AMONG PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES (AIRD) AND THE IMPACT OF VACCINATIONS - AN ISRAELI, MULTI-CENTER EXPERIENCE |
F. Kharouf, T. Eviatar, M. Braun, E. Pokroy-Shapira, M. Brodavka, N. Agmon-Levin, K. Toledano, S. Oren, M. Lidar, M. Amit Vazina, F. Sabbah, Y. Tavor, G. Breuer, D. Zisman, D. Markovits, A. Dagan, R. Bishara Garzuzi, O. Shifman, S. Giryes, M. Elias, J. Feld, T. Reitblat, T. Gazit, A. Hadad, O. Elkayam, D. Paran, D. Mevorach, A. Balbir-Gurman, Y. Braun-Moscovici |
| 303 |
[GO] |
2022―Jun―28 |
POS0757 COVID-19 INFECTION AND RECOVERY AMONGST PATIENTS WITH MODERATE-TO-SEVERE LUPUS DURING THE PANDEMIC: RESULTS FROM THE BILAG-BIOLOGICS REGISTER (BILAG-BR) |
S. Dyball, M. Rodziewicz, E. Sutton, B. Parker, I. N. Bruce |
| 304 |
[GO] |
2022―Jun―28 |
AB1518 CASE REPORT OF A HARD TO TREAT DERMATOMYOSITIS AFTER A COVID-19 INFECTION AND SUBSEQUENT VACCINATION |
P. Peteva, L. Marinchev |
| 305 |
[GO] |
2022―Jun―28 |
AB1131 IDENTIFICATION OF FACTORS ASSOCIATED WITH THE OCCURRENCE OF SEVERE FORMS OF COVID-19 INFECTION IN PATIENTS WITH AUTOIMMUNE/INFLAMMATORY RHEUMATIC DISEASES |
K. Chevalier, M. Genin, T. Petit Jean, J. Avouac, R. M. Flipo, S. Georgin-Lavialle, S. El Mahou, E. Pertuiset, T. Pham, A. Servettaz, H. Marotte, F. Domont, P. Chazerain, M. Devaux, A. Mekinian, J. Sellam, B. Fautrel, D. Rouzaud, E. Ebstein, N. Costedoat-Chalumeau, C. Richez, E. Hachulla, X. Mariette, R. Seror |
| 306 |
[GO] |
2022―Jun―28 |
AB1193 THE COURSE OF COVID-19 INFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING VARIOUS BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS |
R. Samigullina, A. Dadalova, E. Vasilenko, V. Mazurov |
| 307 |
[GO] |
2022―Jun―28 |
POS1269 CLINICAL COURSE AND OUTCOMES OF COVID-19 INFECTION IN PATIENTS WITH SJOGREN’S SYNDROME TREATED WITH RITUXIMAB. |
A. Torgashina, E. Sokol, B. Chalcev, J. Khvan, O. Golovina, S. Glukhova |
| 308 |
[GO] |
2022―Jun―28 |
AB1107 COVID-19 INFECTION MAY BE TRIGGER FOR DEVELOPMENT OF IMMUNE-MEDIATED DISEASES (IMDs) |
N. Manukyan, V. Vardanyan, K. Ginosyan, A. Sargsyan, S. Mardoyan |
| 309 |
[GO] |
2022―Jun―28 |
AB1122 HAVE TREATMENTS FOR AUTOIMMUNE DISEASES WORSENED THE PROGNOSIS OF COVID-19 INFECTION? |
A. I. Rebollo Giménez, M. González Peñas, J. Seoane Romero, L. Martín de la Sierra López, L. Jiménez Rodríguez, D. Castro-Corredor, J. Anino-Fernández, D. Bellido Pastrana, J. L. Cuadra Díaz |
| 310 |
[GO] |
2022―Jun―28 |
POS1495-HPR COVID-19, INFLUENZA AND PNEUMOCOCCUS VACCINATION UPTAKE IN PATIENTS WITH RHEUMATIC DISEASE: A PROSPECTIVE AUDIT |
R. Mazumder, R. Yamin, M. Roberts, K. Afridi, E. Ntatsaki |
| 311 |
[GO] |
2022―Jun―28 |
AB1420 CLINICIAN-RELATED FACTORS MAY INFLUENCE REMOTE CONSULTATIONS IN RHEUMATOLOGY - ANALYSIS OF SENIOR VS TRAINEE CLINICIANS’ OUTCOMES FROM A COVID-19 INITIATIVE |
M. Hannides, S. Wig, S. Vasireddy |
| 312 |
[GO] |
2022―Jun―28 |
POS1491-HPR THE USEFULNESS OF THE PATIENT ACTIVITY SCORE-PASS-II TO ASSESS DISEASE ACTIVITY DURING THE COVID-19 LOCKDOWN IN PATIENTS WITH RHEUMATOID ARTHRITIS |
F. Rodriguez, D. Buitrago-Garcia, G. Sánchez, P. Santos-Moreno |
| 313 |
[GO] |
2022―Jun―28 |
AB0900 A temporary antirheumatic drugs withdrawal does not cause an excess of disease flares in patients with psoriatic arthritis undergoing Covid-19 mRNA vaccination |
R. Bixio, A. Milanesi, O. Viapiana, C. Montecucco, S. Bugatti, M. Rossini |
| 314 |
[GO] |
2022―Jun―28 |
AB1152 COVID-19 mRNA VACCINE BOOSTER IN PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES |
C. Cardelli, T. Caruso, C. Tani, F. Pratesi, R. Talarico, F. DI Cianni, N. Italiano, E. Laurino, M. Moretti, G. Cascarano, M. Diomedi, L. Gualtieri, R. D’urzo, P. Migliorini, M. Mosca |
| 315 |
[GO] |
2022―Jun―28 |
AB1251 LATE ONSET PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN AN INDIAN ADOLESCENT BOY DURING A PEAK OF POST COVID-19 MULTISYSTEM INFLAMMATORY SYNDROME |
D. B. Pandya |
| 316 |
[GO] |
2022―Jun―28 |
AB1140 IMPACT OF COVID-19 NEWS SOURCES ON RHEUMATOID ARTHRITIS PATIENTS’ LIFESTYLE AND THEIR DISEASE ACTIVITY FROM NINJA 2020 COHORT STUDY |
A. Ihata, T. Matsui, S. Tohma |
| 317 |
[GO] |
2022―Jun―28 |
POS1221 EFFECT OF COVID-19 ON CHILDREN WITH RHEUMATIC DISEASE |
T. Limon, G. Kaya Aksoy, S. Akman, M. Koyun, G. Öngüt, D. Mutlu, E. Çomak, T. Tural Kara, Ö. Koyuncu Özyurt |
| 318 |
[GO] |
2022―Jun―28 |
AB1118 INVESTIGATION OF THE EFFECT OF THE HISTORY OF COVID-19 ON COGNITIVE LEVEL, PAIN CATASTROPHIZATION, AND PHYSICAL ACTIVITY LEVEL IN INDIVIDUALS WITH CHRONIC LOW BACK AND NECK PAIN |
A. Asliyüce, O. Ulger |
| 319 |
[GO] |
2022―Jun―28 |
POS1229 THE IMPACT OF COVID-19 ON MEDICATION NON-ADHERENCE IN A RHEUMATOID AND PSORIATIC ARTHRITIS UK COHORT |
P. Curry, H. Chinoy, M. Jani, D. Plant, K. Hyrich, A. Morgan, A. G. Wilson, J. Isaacs, A. Morris, A. Barton, J. Bluett |
| 320 |
[GO] |
2022―Jun―28 |
AB1124 IMPACT OF COVID-19 ON PATIENTS WITH RHEUMATIC DISEASES IN A SECOND LEVEL HOSPITAL |
S. García-Díaz, D. Roig-Vilaseca, M. Vacas-Moreira, D. Cerda, P. Estrada Alarcón, V. A. Navarro Angeles, O. A. Camacho, S. Heredia, D. Reina |
| 321 |
[GO] |
2022―Jun―28 |
POS1267 LONG-TERM SURVEY STUDY OF THE IMPACT OF COVID-19 ON SYSTEMIC AUTOIMMUNE DISEASES. LOW DEATH RATE DESPITE THE INCREASED PREVALENCE OF SYMPTOMATIC INFECTION. ROLE OF PRE-EXISTING INTERSTITIAL LUNG DISEASE AND ONGOING TREATMENTS. |
C. Ferri, V. Raimondo, L. Gragnani, D. Giuggioli, L. Dagna, A. Tavoni, F. Ursini, M. L’andolina, F. Caso, P. Ruscitti, M. Caminiti, R. Foti, V. Riccieri, S. Guiducci, R. Pellegrini, E. Zanatta, G. Varcasia, D. Olivo, P. Gigliotti, G. Cuomo, G. Murdaca, R. Cecchetti, R. De Angelis, N. Romeo, F. Ingegnoli, F. Cozzi, V. Codullo, I. Cavazzana, M. Colaci, G. Abignano, M. De Santis, E. Lubrano, E. Fusaro, A. Spinella, F. Lumetti, G. De Luca, S. Bellando Randone, E. Visalli, Y. Dal Bosco, G. Amato, D. Giannini, S. Bilia, F. Masini, G. Pellegrino, E. Pigatto, E. Generali, G. Pagano Mariano, G. Pettiti, G. Zanframundo, R. Brittelli, V. Aiello, R. Caminiti, D. Scorpiniti, T. Ferrari, C. Campochiaro, V. Brusi, M. Fredi, L. Moschetti, F. Cacciapaglia, S. M. Ferrari, I. DI Cola, M. Vadacca, S. Lorusso, M. Monti, S. Lorini, S. R. Paparo, F. Ragusa, G. Elia, V. Mazzi, M. L. Aprile, M. Tasso, M. Miccoli, S. L. Bosello, S. D’angelo, A. Doria, F. Franceschini, R. Meliconi, M. Matucci-Cerinic, F. Iannone, R. Giacomelli, C. Salvarani, A. L. Zignego, P. Fallahi, A. Antonelli |
| 322 |
[GO] |
2022―Jun―28 |
POS1175 IMPACT OF COVID-19 ON THE CLINICAL COURSE OF GOUT AND THE OVERALL USAGE OF MEDICATION IN PATIENTS WITH GOUT |
S. Smiyan, O. Makhovska |
| 323 |
[GO] |
2022―Jun―28 |
POS1228 IMPACT OF COVID-19 ON THE PRESCRIPTION OF BIOLOGIC DMARDs: A POPULATION-LEVEL STUDY IN ENGLAND |
M. Russell, S. Balachandran, S. Norton, E. Alveyn, D. Nagra, M. Adas, J. Galloway |
| 324 |
[GO] |
2022―Jun―28 |
AB1125 SAFETY OF BIOLOGIC-DMARDs DURING COVID-19 OUTBREAK: FOLLOW-UP STUDY IN 1051 RHEUMATIC PATIENTS OVER THE FIRST TWO WAVES. |
A. Sonaglia, R. Comoretto, E. Pasut, G. Del Frate, D. Colatutto, A. Zabotti, S. De Vita, L. Quartuccio |
| 325 |
[GO] |
2022―Jun―28 |
POS0372 USE OF TELEMEDICINE FOR FOLLOW-UP OF LUPUS NEPHRITIS IN THE COVID-19 OUTBREAK: ONE-YEAR, PRAGMATIC RANDOMISED CONTROLLED TRIAL |
H. So, E. Chow, I. T. Cheng, S. L. Lau, T. K. LI, C. C. Szeto, L. S. Tam |
| 326 |
[GO] |
2022―Jun―28 |
AB1167 THE USE OF ORAL AMINO-BISPHOSPHONATES AND CORONAVIRUS DISEASE 2019 (COVID-19) OUTCOMES |
F. Pistillo, M. Rossini, A. Fassio, C. Benini, D. Gatti, G. Adami |
| 327 |
[GO] |
2022―Jun―28 |
AB1142 EFFECTS OF SULFASALAZINE USED IN AXIAL SPONDYLOARTHRITIS ON COVID-19 OUTCOMES: REAL-LIFE DATA FROM A SINGLE CENTER |
B. Armagan, E. Atalar, S. C. Güven, B. Özdemir, H. E. Konak, P. Akyüz Dağli, A. Erden, K. Gok, Y. Maraş, I. Dogan, O. Küçükşahin, S. Erten, A. Omma |
| 328 |
[GO] |
2022―Jun―28 |
AB1187 AUTOIMMUNITY PROFILE AND LUNG INVOLVEMENT IN ITALIAN PATIENTS WITH DERMATOMYOSITIS DURING COVID-19 PANDEMIA |
P. Triggianese, A. D’antonio, E. Cela, B. Kroegler, S. Modica, M. Ferraioli, P. Conigliaro, E. Greco, A. Bergamini, M. S. Chimenti |
| 329 |
[GO] |
2022―Jun―28 |
AB1533-HPR ASSOCIATED FACTORS OF FALL OR FRACTURE REPORTED BY RHEUMATOID ARTHRITIS PATIENTS IN ELECTRONIC MDHAQ DURING COVID-19 PANDEMIC |
I. Lineburger, C. V. Brenol, V. Naomi Hirakata |
| 330 |
[GO] |
2022―Jun―28 |
AB1498 THE BIOPSYCHOSOCIAL-BASED EXERCISE MODEL VIA TELEREHABILITATION IN PATIENTS WITH INFLAMMATORY AND NON-INFLAMMATORY RHEUMATIC DISEASES: A PROSPECTIVE COHORT STUDY DURING THE COVID-19 PANDEMIC |
N. E. Nacar, N. B. Karaca, L. Kiliç, S. Kiraz, E. Ünal |
| 331 |
[GO] |
2022―Jun―28 |
AB1412 IMPORTANCE OF TELEMEDICINE IN THE SYSTEMIC SCLEROSIS DURING COVID-19 PANDEMIC |
G. Cuomo, C. Di Vico, F. Masini, C. Iandoli, D. Perretta, R. Irace |
| 332 |
[GO] |
2022―Jun―28 |
AB1398 CORRELATES OF CANCELLED HEALTHCARE APPOINTMENTS IN PATIENTS WITH SYSTEMIC SCLEROSIS DURING THE COVID-19 PANDEMIC |
N. Dorr, P. Fennell, L. Shapiro |
| 333 |
[GO] |
2022―Jun―28 |
AB1177 SEXUALITY, FAMILY PLANNING AND MENTAL HEALTH AMONG REPRODUCTIVE-AGE WOMEN WITH RHEUMATIC DISEASE DURING THE COVID-19 PANDEMIC |
A. Puchner, N. Rosenberg, N. Valenta, V. Ritschl, T. Stamm, P. Mandl, D. Aletaha, K. Rosta |
| 334 |
[GO] |
2022―Jun―28 |
AB1159 HYDROXYCHLOROQUINE SHORTAGE AND ITS RELATION TO ANXIETY LEVEL AND DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS DURING COVID-19 PANDEMIC |
M. H. Abu-Zaid, H. Eitta, A. Moshrif, D. Abdeldaim, N. EL Ghobashy |
| 335 |
[GO] |
2022―Jun―28 |
AB0698 IMPACT OF ILOPROST WITHDRAWAL IN SCLERODERMA PATIENTS DUE TO COVID-19 PANDEMIC |
L. Verardi, E. de Lorenzis, G. Natalello, L. Gigante, P. G. Cerasuolo, M. A. D’Agostino, S. L. Bosello |
| 336 |
[GO] |
2022―Jun―28 |
POS1493-HPR FACTORS ASSOCIATED WITH THE OCCURRENCE OF MENTAL DISORDERS IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES DURING THE COVID-19 PANDEMIC. |
R. V. Gamboa Cárdenas, J. Huarcaya-Victoria, M. F. Ugarte-Gil, C. Reategui Sokolova, V. Pimentel-Quiroz, F. Zevallos Miranda, M. Medina, Z. Rodriguez Bellido, R. Perich Campos, C. Pastor Asurza, G. S. Alarcon |
| 337 |
[GO] |
2022―Jun―28 |
POS1547-HPR CREATION OF A MULTI-DISCIPLINARY TEAM (MDT) RHEUMATOLOGY CLINIC AT UNIVERSITY COLLEGE LONDON HOSPITAL (UCLH) TO TACKLE THE BACKLOG OF PATIENTS WAITING FOR TREATMENT AS A RESULT OF THE COVID-19 PANDEMIC. |
D. Ludwig, F. Higgs, N. Allotey, S. Begum, J. Burton |
| 338 |
[GO] |
2022―Jun―28 |
POS1317 HOW CAN WE ASSESS CARDIOVASCULAR RISK IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS? PRELIMINARY RESULTS REGARDING MEASUREMENTS OF CAROTID INTIMA-MEDIA THICKNESS DURING THE COVID-19 PANDEMIC. |
M. Gruca, K. Orczyk, J. Zamojska, K. Niewiadomska-Jarosik, J. Stanczyk, E. Smolewska |
| 339 |
[GO] |
2022―Jun―28 |
POS1257 READING THE WAVES: IDENTIFYING DISTINCT PHENOTYPES OF MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN IN A SINGLE CANADIAN CENTER DURING THE 2020-2021 COVID-19 PANDEMIC |
T. Renson, P. Miettunen, S. Parsons, M. Dhalla, N. Johnson, N. Luca, H. Schmeling, R. Stevenson, M. Twilt, L. Hamiwka, S. Benseler |
| 340 |
[GO] |
2022―Jun―28 |
POS1206 UNDERSTANDING THE LANDSCAPE OF RHEUMATOID ARTHRITIS (RA) PATIENTS TREATED WITH IL-6 INHIBITORS DURING THE COVID-19 PANDEMIC |
D. Baldock, E. Baynton, A. Kamaruddin |
| 341 |
[GO] |
2022―Jun―28 |
POS0609 STRESS-ASSOCIATED INCREASES IN RHEUMATOID ARTHRITIS DISEASE ACTIVITY AND FLARES DURING THE COVID-19 PANDEMIC |
D. Furst, N. T. Morris, A. Q. Pham, T. Woodworth, D. Elashoff, J. Brook, V. Ranganath |
| 342 |
[GO] |
2022―Jun―28 |
POS0375 EVALUATION OF PATIENTS WITH RHEUMATOID ARTHRITIS IN TELECONSULTATION DURING THE FIRST WAVE OF THE COVID-19 PANDEMIC |
J. Avouac, A. Moltó, C. Frantz, S. Wanono, E. Descamps, O. Fogel, A. Combier, L. Poiroux, C. Miceli Richard, Y. Allanore |
| 343 |
[GO] |
2022―Jun―28 |
AB1106 HOW HAS THE COVID-19 PANDEMIC AFFECTED OUR RHEUMATOLOGY PATIENTS USING BIOLOGICAL/TARGETED DMARDS? |
S. Gulle, Y. Erez, A. Karakas, T. Yüce İnel, S. B. Kocaer, T. Demirci Yildirim, G. Can, İ. Sari, M. Birlik, F. Onen |
| 344 |
[GO] |
2022―Jun―28 |
AB1096 THE INFLUENCE OF THE BEHAVIORAL RESTRICTION OF COVID-19 PANDEMIC FOR THE FRAILTY OF PATIENTS WITH RHEUMATOID ARTHRITIS |
M. Tada, Y. Yamada, K. Mandai, Y. Matsumoto, N. Hidaka |
| 345 |
[GO] |
2022―Jun―28 |
POS1226 CLINICAL FACTORS ASSOCIATED WITH A POSITIVE SARS-CoV-19 TEST AND WITH FREQUENT TESTING DURING THE COVID-19 PANDEMIC IN >10.000 PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES. RESULTS FROM A NATIONWIDE SURVEY FROM THE DANISH DANBIO REGISTRY |
B. Glintborg, D. V. Jensen, L. Terslev, O. Hendricks, M. Østergaard, S. H. Rasmussen, M. Pfeiffer-Jensen, T. Adelsten, A. Colic, K. Danebod, M. Kildemand, A. G. Loft, H. L. Munk, J. K. Pedersen, R. Østgård, C. M. Sørensen, N. Steen Krogh, J. Nørgaard Agerbo, C. Ziegler, M. L. Hetland |
| 346 |
[GO] |
2022―Jun―28 |
POS1572-PARE HELPER’S WAY OF WORKING IN ORS BRANCH - NIS DURING THE COVID-19 PANDEMIC IN 2021 |
D. Jankovic, V. Filipovic |
| 347 |
[GO] |
2022―Jun―28 |
AB1103 THE EFFECT OF COVID-19 PANDEMIC IN A LARGE SERIES OF PATIENTS WITH TAKAYASU ARTERITIS |
A. Karakas, T. Yuce Inel, F. Onen, İ. Sari |
| 348 |
[GO] |
2022―Jun―28 |
POS1235 WORKING FROM HOME IN PATIENTS WITH RMDs DURING THE COVID-19 PANDEMIC IN EUROPE. RESULTS FROM THE REUMAVID STUDY (PHASE 1 AND 2) |
M. Garrido-Cumbrera, V. Navarro-Compán, L. Christen, J. Correa-Fernández, H. Marzo-Ortega |
| 349 |
[GO] |
2022―Jun―28 |
AB1443 INCIDENCE OF RHEUMATIC DISEASES DURING THE COVID-19 PANDEMIC IN KOREA: A NATIONWIDE CLAIMS STUDY |
S. M. Ahn, S. Hong, C. K. Lee, B. Yoo, J. S. Oh, Y. G. Kim |
| 350 |
[GO] |
2022―Jun―28 |
AB1091 THE IMPACT OF COVID-19 PANDEMIC ON DISEASE MONITORING AND MONITORING FOR ADVERSE CLINICAL OUTCOMES IN THOSE ON BIOLOGIC THERAPY. |
B. Preece, E. Thomas |
| 351 |
[GO] |
2022―Jun―28 |
AB1089 PSYCHOSOCIAL IMPACTS OF THE COVID-19 PANDEMIC ON ETHIOPIAN AND CANADIAN RHEUMATOLOGY PATIENTS |
C. Hitchon, D. Dacosta, B. Abdissa Adugna, S. Bernatsky, I. Colmegna, B. Demelash, P. Fortin, M. Meltzer, A. Mendel, R. Scuccimarri, A. Melkie |
| 352 |
[GO] |
2022―Jun―28 |
AB1117 THE IMPACT OF THE COVID-19 PANDEMIC ON HEALTH AND LIFESTYLE IN INDIVIDUALS WITH KNEE PAIN, A HALLOA STUDY |
E. Sunesson, C. Sylwander, E. Haglund, M. Andersson, I. Larsson |
| 353 |
[GO] |
2022―Jun―28 |
AB1410 IMPACT OF COVID-19 PANDEMIC ON HEALTHCARE RESOURCE USE AND CLINICAL OUTCOMES IN A COHORT OF PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES- AN INTERIM ANALYSIS FROM THE PER-MAS PROJECT. |
F. Trentin, G. Fulvio, G. Andreozzi, C. Cigolini, M. Da Rio, V. Dell’Oste, E. Elefante, F. Fattorini, S. Fonzetti, V. Lorenzoni, M. Maffi, I. C. Navarro García, I. Palla, V. Pedrinelli, L. Scagnellato, D. Schilirò, A. Valevich, A. Gaglioti, C. Carmassi, C. Tani, L. Dell’osso, G. Turchetti, M. Mosca |
| 354 |
[GO] |
2022―Jun―28 |
AB1401 IMPACT OF THE COVID-19 PANDEMIC ON HEALTHCARE UTILIZATIONS OF RMD PATIENTS IN EUROPE. RESULTS FROM THE REUMAVID STUDY (PHASE 1 AND 2) |
M. Garrido-Cumbrera, H. Marzo-Ortega, J. Correa-Fernández, L. Christen, V. Navarro-Compán |
| 355 |
[GO] |
2022―Jun―28 |
POS0920 THE EFFECT OF COVID-19 PANDEMIC ON IDIOPATHIC INFLAMMATORY MYOSITIS PATIENTS - A SINGLE CENTRE’S EXPERIENCES |
T. G. Béldi, A. Vincze, B. Miltényi-Szabó, Z. Varga, M. Nagy-Vincze, Z. Griger |
| 356 |
[GO] |
2022―Jun―28 |
AB0681 The 2-year impact of COVID-19 pandemic on muscle strength and physical performance in patients with systemic sclerosis: a cohort study |
L. Denardi Dória, R. Cavalheiro do Espírito Santo, L. Santos, D. Nóbrega de Moraes, É. Pena, J. Katarina Schoer Portes, A. A. Gasparin, N. Pamplona Bueno de Andrade, V. Hax, R. Xavier, R. Mendonça da Silva Chakr |
| 357 |
[GO] |
2022―Jun―28 |
POS1190 IMPACT OF COVID-19 PANDEMIC ON PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES: DISRUPTIONS IN CARE AND SELF-REPORTED OUTCOMES |
A. M. Fouad, S. F. Elotla, E. Nourhan Elameen, A. E. Mohamed |
| 358 |
[GO] |
2022―Jun―28 |
POS1209 THE IMPACT OF THE COVID-19 PANDEMIC ON WORK PRODUCTIVITY IN PATIENTS WITH SPONDYLOARTHRITIS: RESULTS FROM THE DUTCH SpA-Net REGISTRY |
C. Webers, A. Van Tubergen, H. Vonkeman, A. Boonen |
| 359 |
[GO] |
2022―Jun―28 |
POS0378 EVALUATION OF THE USE OF VIDEO CONSULTATION IN GERMAN RHEUMATOLOGY CARE BEFORE AND DURING THE COVID-19 PANDEMIC WAVES |
J. Reiter, G. Chehab, P. Aries, F. Muehlensiepen, M. Welcker, A. Voormann, M. Schneider, C. Specker, J. G. Richter |
| 360 |
[GO] |
2022―Jun―28 |
AB0691 SYSTEMIC SCLEROSIS AT THE TIME OF COVID-19 PANDEMIC: A BIBLIOMETRIC STUDY |
B. Doskaliuk, R. Yatsyshyn, I. Stoika, K. Fedorovych, O. Hotsaniuk, O. Drogomeretska |
| 361 |
[GO] |
2022―Jun―28 |
AB1185 PATIENT-REPORTED EXPERIENCE IN IMMUNE MEDIATED INFLAMMATORY DISEASES (IMID) IN THECONTEXT OF THE COVID-19 PANDEMIC: ACCESSIBILITY AND CONTINUITY OF CARE. |
J. P. Baldivieso, E. Ramirez, M. Uriarte-Ecenarro, C. Valero, E. Velasco, I. Llorente, A. Morell, O. Solas, R. Garcia-Vicuna |
| 362 |
[GO] |
2022―Jun―28 |
AB1116 RESULTS OF PRESCRIBING BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS AND JANUS KINASE INHIBITORS FOR RHEUMATOID ARTHRITIS DURING THE COVID-19 PANDEMIC: DATA FROM A TELEPHONE SURVEY OF 254 PATIENTS. |
A. Potapova, A. Karateev, E. Pogozheva, E. Matianova, A. Bobkova, A. Semashko, E. Filatova, V. Amirdzhanova, E. Zotkin, A. Lila |
| 363 |
[GO] |
2022―Jun―28 |
POS1499-HPR ANKYLOSING SPONDYLITIS AND TELE-YOGA DURING COVID-19 PANDEMIC: PRELİMİNARY RESULTS OF A RANDOMIZED CONTROLLED TRIAL |
Y. Acar, N. Ilcin, İ. Sari |
| 364 |
[GO] |
2022―Jun―28 |
POS1197 REMOTE AND PHYSICAL CONSULTATIONS DURING THE FIRST 15 MONTHS OF THE COVID-19 PANDEMIC: USE AND PATIENT-SATISFACTION IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES FOLLOWED IN THE DANBIO REGISTRY |
B. Glintborg, D. V. Jensen, L. Terslev, O. Hendricks, M. Østergaard, S. H. Rasmussen, M. Pfeiffer-Jensen, T. Adelsten, A. Colic, K. Danebod, M. Kildemand, A. G. Loft, H. L. Munk, J. K. Pedersen, R. Østgård, C. M. Sørensen, N. Steen Krogh, J. Nørgaard Agerbo, C. Ziegler, M. L. Hetland |
| 365 |
[GO] |
2022―Jun―28 |
AB1121 HOW FEARS AND HOPES HAVE EVOLVED IN PATIENTS WITH RMDs THROUGHOUT THE COVID-19 PANDEMIC? RESULTS FROM THE REUMAVID STUDY (PHASE 1 AND 2) |
M. Garrido-Cumbrera, H. Marzo-Ortega, L. Christen, J. Correa-Fernández, E. Mateus, L. Grange, D. Webb, C. Jacklin, S. Irwin, S. Mingolla, K. Antonopoulou, S. Makri, V. Navarro-Compán |
| 366 |
[GO] |
2022―Jun―28 |
AB1162 THE LINK BETWEEN INFLAMMATION AND THROMBOSIS: CLINICAL AND IMMUNOHISTOCHEMICAL CHARACTERIZATION OF PULMONARY ARTERIAL THROMBOSIS IN COVID-19 PATIENTS |
L. Quartuccio, A. Sonaglia, L. Casarotto, D. Mcgonagle, C. DI Loreto, E. Pegolo |
| 367 |
[GO] |
2022―Jun―28 |
AB1134 BIBLIOMETRIC NETWORK ANALYSIS ON TOCILIZUMAB TREATMENT FOR COVID-19 PATIENTS |
L. Cascella, F. Monaco, D. Nocerino, A. Infernuso, V. Cascella, F. Del Prato, S. Cascella, M. Cascella |
| 368 |
[GO] |
2022―Jun―28 |
AB0020 COMPARATIVE DESCRIPTION OF CYTOKINES AND MATRIX METALLOPROTEINASES IN A GROUP OF PATIENTS WITH RHEUMATOID ARTHRITIS AND OSTEOARTHROSIS UNDER A STRICT FOLLOW-UP COMPARED WITH COVID-19 PATIENTS |
S. Navarrete, L. D. Gutiérrez-Castañeda, P. K. Bautista-Niño, J. A. Rubio-Rubio, G. S. Rodríguez-Vargas, P. Santos-Moreno, D. Echeverri, L. Saenz, L. Torres Tobar, A. Aparicio, A. Rojas-Villarraga, F. Sierra-Matamoros |
| 369 |
[GO] |
2022―Jun―28 |
POS1240 HIGH PREVALENCE OF SERUM AUTOANTIBODIES IN SEVERELY ILL COVID-19 PATIENTS HOSPITALIZED IN THE INTENSIVE CARE UNIT. |
K. Bitzogli, E. Jahaj, A. D. Bakasis, E. Kapsogeorgou, A. Goules, I. Stergiou, V. Pezoulas, P. Skendros, K. Ritis, D. I. Fotiadis, A. Kotanidou, A. Tzioufas, P. Vlachoyiannopoulos |
| 370 |
[GO] |
2022―Jun―28 |
POS1231 PREDICTORS OF MORTALITY IN SEVERE AND CRITICAL COVID-19 PATIENTS WHO RECEIVED ANAKINRA |
M. Bektaş, M. İ. Kiliç |
| 371 |
[GO] |
2022―Jun―28 |
AB1178 THE COMPARISON OF EXECUTIVE FUNCTIONS OF RECOVERED COVID-19 PATIENTS WITH HEALTHY CONTROLS |
C. Cakir, Y. Ulus, A. Bilgici |
| 372 |
[GO] |
2022―Jun―28 |
POS1216 POTENTIAL PREDICTORS OF OUTCOME FOR ANAKINRA TREATMENT IN COVID-19 PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME |
S. Amikishiyev, R. Deniz, M. G. Gunver, S. Aghamuradov, N. Koca, B. Ince, M. Bektas, A. Yilmaz, Y. Canturk, G. Durak, M. Kose, M. Erelel, A. A. Çağatay, S. K. Besisik, F. Esen, A. Gül |
| 373 |
[GO] |
2022―Jun―28 |
POS1268 PHASE II TRIAL OF ENPATORAN IN PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA |
J. E. Mckinnon, J. Santiaguel, C. Murta, D. Yu, M. Khursheed, F. Moreau, L. Klopp-Schulze, J. Shaw, S. Roy, A. Kao |
| 374 |
[GO] |
2022―Jun―28 |
POS1242 BARICITINIB AND PULSE STEROIDS COMBINED TREATMENT IN SEVERE COVID-19 PNEUMONIA: PRELIMINARY DATA FROM A RHEUMATOLOGIC EXPERIENCE IN INTENSIVE CARE UNIT |
F. Ferro, E. Elefante, N. Italiano, M. Moretti, G. La Rocca, R. Mozzo, L. De Simone, C. Baldini, M. Mosca |
| 375 |
[GO] |
2022―Jun―28 |
AB0513 COVID-19 PREVENTION IN PATIENTS WITH MODERATE-TO-SEVERE LUPUS DURING THE PANDEMIC: RESULTS FROM THE BILAG-BIOLOGICS REGISTER (BILAG-BR) |
S. Dyball, M. Rodziewicz, E. Sutton, B. Parker, I. N. Bruce |
| 376 |
[GO] |
2022―Jun―28 |
AB1141 THE PATTERN OF POST COVID-19 REACTIVE ARTHRITIS |
N. Varghese, V. Salaru, V. Sadovici-Bobeica |
| 377 |
[GO] |
2022―Jun―28 |
AB1148 POST COVID-19 RHEUMATIC AND MUSCULOSKELETAL DISEASES |
N. Varghese, N. Loghin-Oprea, V. Sadovici-Bobeica |
| 378 |
[GO] |
2022―Jun―28 |
AB1127 ANTIOSTEOPOROTIC TREATMENT AND COVID-19 RISK: IS THERE AN ASSOCIATION? |
N. Grygorieva, M. Bystrytska, N. Zaverukha, A. Musiienko |
| 379 |
[GO] |
2022―Jun―28 |
POS1198 VACCINATION AGAINST COVID-19 SHOULD BE ENCOURAGED IN PATIENTS WITH RHEUMATIC DISEASE, AS MOST PATIENTS DEVELOP A SEROLOGICAL RESPONSE AGAINST THE VACCINE AND VACCINATION REDUCES SELF-IMPOSED ISOLATION AND SHIELDING BEHAVIOR |
C. Ammitzbøll, M. K. Thomsen, J. B. Andersen, L. E. Bartels, M. L. F. Hermansen, A. D. Johannesen, C. M. Jørgensen, S. Mikkelsen, S. R. Vils, C. Erikstrup, E. M. Hauge, A. Troldborg |
| 380 |
[GO] |
2022―Jun―28 |
AB1160 IMPACT OF COVID-19 TREATMENTS ON PERIPHERAL CAPILLARY DENSITY EVALUATED BY NAILFOLD VIDEOCAPILLAROSCOPY |
E. Gotelli, A. Sulli, P. F. Bica, I. Schiavetti, T. Aloe’, M. Grosso, E. Barisione, C. Pizzorni, S. Paolino, V. Smith, M. Cutolo |
| 381 |
[GO] |
2022―Jun―28 |
POS0410 THE ROLE OF IL-6 IN ENDOTHELIAL DYSFUNCTION: RHEUMATOID ARTHRITIS AND COVID-19, TWO PATHOGENIC MODELS IN COMPARISON |
A. I. Celia, C. Barbati, T. Colasanti, M. Speziali, G. Pellegrino, F. Natalucci, F. M. Ucci, E. Balbinot, C. Ciancarella, G. Tripodi, G. Buoncuore, F. Ceccarelli, F. Conti, C. Alessandri |
| 382 |
[GO] |
2022―Jun―28 |
AB1516 A CASE OF SEVERE ANCA ASSOCIATED VASCULITIS AFTER COVID-19 VACCINATION |
I. Qaisar, K. Sunmboye |
| 383 |
[GO] |
2022―Jun―28 |
POS1281 DIFFERENT HUMORAL BUT SIMILAR CELLULAR RESPONSES OF PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES UNDER DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS AFTER COVID-19 VACCINATION |
I. Andreica, A. Blazquez-Navarro, J. Sokolar, M. Anft, U. Kiltz, S. Pfaender, E. Vidal Blanco, T. Westhoff, N. Babel, U. Stervbo, X. Baraliakos |
| 384 |
[GO] |
2022―Jun―28 |
AB1386 A SURVEY ON ACCEPTANCE OF COVID-19 VACCINATION AMONG PATIENTS WITH RHEUMATIC DISEASES -A SINGLE CENTER EXPERIENCE IN MALAYSIA |
C. R. Ng, W. S. Wong |
| 385 |
[GO] |
2022―Jun―28 |
AB1100 COVID-19 VACCINATION IN A REAL-LIFE SETTING OF A RHEUMATOLOGICAL OUTPATIENT CENTER |
S. G. Werner, L. Moll, A. Uhlenberg-Moll, S. Mettler, H. E. Langer |
| 386 |
[GO] |
2022―Jun―28 |
POS1260 COVID-19 VACCINATION-RELATED ADVERSE EVENTS AMONG AUTOIMMUNE DISEASE PATIENTS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASES (COVAD) STUDY |
P. Sen, N. R, A. Nune, J. B. Lilleker, V. Agarwal, S. Kardes, M. Kim, J. Day, M. Milchert, T. A. Gheita, B. Salim, T. Velikova, A. E. Gracia-Ramos, I. Parodis, A. Selva-O’callaghan, E. Nikiphorou, T. Chatterjee, A. L. Tan, L. Cavagna, M. A. Saavedra, S. Katsuyuki Shinjo, N. Ziade, J. Knitza, M. Kuwana, O. Distler, H. Chinoy, V. Agarwal, R. Aggarwal, L. Gupta |
| 387 |
[GO] |
2022―Jun―28 |
POS1250 EVALUATION AFTER COVID-19 VACCINATION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME: A RETROSPECTIVE COHORT STUDY. |
Ö. Karakaş, A. Erden, B. Armagan, S. C. Güven, E. Atalar, B. Polat, A. Omma, O. Küçükşahin |
| 388 |
[GO] |
2022―Jun―28 |
POS0738 IMMUNOGENICITY AND SAFETY OF COVID-19 VACCINATION IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME |
G. M. Verstappen, L. De Wolff, S. Arends, H. M. Heiermann, Y. Van Sleen, A. Visser, J. H. Terpstra, D. Diavatopoulos, M. Van der Heiden, A. Vissink, D. Van Baarle, F. G. M. Kroese, H. Bootsma |
| 389 |
[GO] |
2022―Jun―28 |
POS1232 LONG-TERM OUTCOMES OF COVID-19 VACCINATION IN PATIENTS WITH RARE AND COMPLEX CONNECTIVE TISSUE DISEASES: AN AD-INTERIM ANALYSIS OF ERN-ReCONNET VACCINATE STUDY |
F. Di Cianni, C. Cardelli, N. Italiano, E. Laurino, M. Moretti, R. Depascale, A. Gamba, L. Iaccarino, A. Doria, M. J. Sousa Bandeira, S. P. Dinis, V. C Romão, E. Alessandri, E. Gotelli, S. Paolino, N. DI Giosaffatte, P. Grammatico, A. Ferraris, L. Cavagna, C. Montecucco, V. Longo, L. Beretta, I. Cavazzana, M. Fredi, A. Tincani, R. D’urzo, S. Bombardieri, G. R. Burmester, M. Cutolo, J. E. Fonseca, C. H. Frank, I. Galetti, E. Hachulla, F. Houssiau, D. Marinello, U. Müller-Ladner, M. Schneider, V. Smith, R. Talarico, J. M. Van Laar, A. Vieira, C. Tani, M. Mosca |
| 390 |
[GO] |
2022―Jun―28 |
AB1155 PAUSING METHOTREXATE IMPROVES IMMUNOGENICITY OF COVID-19 VACCINATION IN PATIENTS WITH RHEUMATIC DISEASES |
A. N. Arumahandi de Silva, L. M. Frommert, F. Albach, J. Klotsche, V. Scholz, A. Ten Hagen, L. M. Jeworowski, T. Schwarz, J. Zernicke, V. M. Corman, C. Drosten, G. R. Burmester, R. Biesen |
| 391 |
[GO] |
2022―Jun―28 |
POS1262 COVID-19 VACCINATION IN PATIENTS WITH RHEUMATIC DISEASES -RESULTS OF 2,134 CASES ANALYSIS |
I. Gaydukova, V. Mazurov, O. Inamova, E. Gaydukova |
| 392 |
[GO] |
2022―Jun―28 |
POS1247 THE EFFECT OF IMMUNOSUPPRESSIVE AGENTS ON ANTIBODY FORMATION AFTER COVID-19 VACCINATION IN RHEUMATOID ARTHRITIS PATIENTS |
E. Kang, Y. G. Kim, J. S. Oh, S. Hong, C. K. Lee, B. Yoo, S. M. Ahn |
| 393 |
[GO] |
2022―Jun―28 |
POS1207 SEROCONVERSION AFTER A THIRD COVID-19 VACCINATION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH (ULTRA-)LOW DOSE RITUXIMAB WITH A PREVIOUS INSUFFICIENT HUMORAL RESPONSE IS DEPENDENT ON RITUXIMAB DOSAGE |
C. Van der Togt, D. Ten Cate, B. Van den Bemt, J. Rahamat-Langendoen, N. Den Broeder, A. Den Broeder |
| 394 |
[GO] |
2022―Jun―28 |
AB1085 COVID-19 VACCINATION INTENTION AMONG TUNISIAN HEALTH CARE WORKERS |
O. Hamdi, M. Boudokhane, Z. Teyeb, I. Abdelaali, T. Jomni, S. Belakhal, M. H. Dogui |
| 395 |
[GO] |
2022―Jun―28 |
AB0930 Psoriatic arthritis disease flares: is Covid-19 vaccination just an innocent bystander? |
R. Bixio, I. Gavioli, D. Bertelle, F. Pistillo, D. Rotta, E. Bertoldo, E. Fracassi, M. Rossini, O. Viapiana |
| 396 |
[GO] |
2022―Jun―28 |
AB1088 COVID-19 VACCINATION OF SPONDYLOARTHRITIS PATIENTS RECEIVING BIOLOGICAL THERAPY: REAL-LIFE DATA |
T. Demirci Yildirim, C. Akleylek, H. Cinakli, D. Yildirim, S. Hakbilen, B. N. Coşkun, B. Okyar, O. Ozdemir Isik, R. Piskin Sagir, H. Apaydin, S. Gulle, Y. Erez, T. Yuce Inel, N. Yilmaz, S. Akar, A. Tufan, S. Yilmaz, Y. Pehlivan, G. Yildirim Cetin, A. Cefle, S. S. Koca, S. Erten, A. Yazici, E. Dalkiliç, G. Can, İ. Sari, M. Birlik, F. Onen |
| 397 |
[GO] |
2022―Jun―28 |
POS1214 COVID-19 VACCINATION RATE AND SAFETY PROFILE IN PATIENTS AFFECTED BY MIXED CRYOGLOBULINEMIC VASCULITIS. |
C. Vacchi, S. Testoni, M. Visentini, R. Zani, G. Lauletta, L. Gragnani, D. A. Filippini, C. Mazzaro, P. Fraticelli, L. Quartuccio, R. Padoan, L. Castelnovo, A. L. Zignego, C. Ferri, A. Hoxha, C. Salvarani, G. Monti, M. Galli, M. Sebastiani |
| 398 |
[GO] |
2022―Jun―28 |
POS1208 EQUITY CONSIDERATIONS IN COVID-19 VACCINATION STUDIES OF INDIVIDUALS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES |
H. Wang, O. Dewidar, S. Whittle, E. Ghogomu, G. Hazlewood, L. Mbuagbaw, J. Pardo Pardo, P. Robinson, R. Buchbinder, V. Welch |
| 399 |
[GO] |
2022―Jun―28 |
POS1278 EXCELLENT PROGNOSIS OF RHEUMATIC MANIFESTATIONS FOLLOWING COVID-19 VACCINATION: 7 MONTHS FOLLOW-UP DATA |
M. Gasparotto, S. Bindoli, R. Padoan, E. Zanatta, P. Sfriso, A. Doria, L. Iaccarino |
| 400 |
[GO] |
2022―Jun―28 |
AB1095 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AFTER COVID-19 VACCINATION: A CASE REPORT |
D. Abdel Mohsen, R. A. Elziaty, A. A. Abdalkader |
| 401 |
[GO] |
2022―Jun―28 |
AB1511 SLE ONSET POST COVID-19 VACCINATION: COINCIDENTAL OR ASSOCIATION? |
C. R. Ng, C. E. Goh |
| 402 |
[GO] |
2022―Jun―28 |
AB1102 A RARE CASE OF ACUTE INFLAMMATORY DEMYELINATING POLYRADICULOPATHY FOLLOWING THE SECOND DOSE OF PFIZER COVID-19 VACCINE |
V. Courant, M. Silva, S. Grewal |
| 403 |
[GO] |
2022―Jun―28 |
POS1224 RHEUMATOID ARTHRITIS DISEASE ACTIVITY ASSESSED BY PATIENT-REPORTED OUTCOMES AND FLOW CYTOMETRY BEFORE AND AFTER AN ADDITIONAL DOSE OF COVID-19 VACCINE |
S. Tedeschi, J. Stratton, J. Ellrodt, M. G. Whelan, K. Hayashi, K. Yoshida, L. Chen, I. Adejoorin, K. E. Marks, A. H. Jonsson, D. Rao, D. Solomon |
| 404 |
[GO] |
2022―Jun―28 |
POS1245 REVERSAL OF DECLINE IN HUMORAL RESPONSE TO BNT162b2 mRNA COVID-19 VACCINE AFTER BOOSTER ADMINISTRATION IN AUTOIMMUNE INFLAMMATORY RHEUMATOID DISEASES (AIRD) PATIENTS |
Y. Braun-Moscovici, M. Kaplan, M. Braun, R. Daood, D. Markovits, S. Giryes, A. Mashiah Avshalom, V. Shataylo, K. Toledano, Y. Tavor, F. Hasan, K. Dolnikov, R. Erlich, A. Rozin, H. Jiries, A. Balbir-Gurman |
| 405 |
[GO] |
2022―Jun―28 |
POS1274 A SINGLE CENTER COVID-19 VACCINE EXPERIENCE IN FAMILIAL MEDITERRANEAN FEVER PATIENTS |
S. C. Güven, Ö. Karakaş, E. Atalar, H. E. Konak, P. Akyüz Dağli, E. Kayacan Erdogan, B. Armagan, K. Gok, I. Dogan, Y. Maraş, A. Erden, S. Erten, O. Küçükşahin, A. Omma |
| 406 |
[GO] |
2022―Jun―28 |
AB1115 COVID-19 VACCINE HESITANCY AMONG RHEUMATOID ARTHRITIS PATIENTS ON BIOLOGICS |
E. Hannech, S. Boussaid, S. Rekik, S. Jemmali, S. Rahmouni, H. Ajlani, H. Sahli, M. Elleuch |
| 407 |
[GO] |
2022―Jun―28 |
POS1227 TIME BETWEEN SECOND AND THIRD DOSES INFLUENCES RESPONSE TO COVID-19 VACCINE IN AUTO-IMMUNE DISEASE PATIENTS TREATED WITH RITUXIMAB WITHOUT RESPONSE TO TWO DOSES. |
S. Bitoun, J. Avouac, J. Henry, R. Ghossan, O. Al Tabaa, R. Belkhir, G. Nocturne, C. Vauloup-Fellous, X. Mariette, R. Seror |
| 408 |
[GO] |
2022―Jun―28 |
POS1220 HUMORAL IMMUNE RESPONSE AGAINST BNT162b2 mRNA COVID-19 VACCINE IN JAPANESE RHEUMATIC DISEASE PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY: A MONOCENTRIC STUDY |
K. Sugihara, R. Wakiya, H. Shimada, T. Kameda, S. Nakashima, M. Kato, T. Miyagi, M. Mizusaki, R. Mino, H. Dobashi |
| 409 |
[GO] |
2022―Jun―28 |
POS1285 IMMUNOGENICITY AND SAFETY OF THE CHADOX 1 COVID-19 VACCINE IN PATIENTS WITH AUTOIMMUNE DISEASES AND HEALTHY CONTROLS: DATA FROM SAFER STUDY |
K. Lysie Libardi Lira Machado, O. A. Martins Filho, E. Reis Neto, S. T. Miyamoto, I. Ribeiro Moulaz, L. Lorenzoni Grillo, L. Pizzol Pasti, A. C. Simões Moulin, B. Oliveira Souza, F. Faé, G. Smith Sobral Vieira, H. Filipe Surlo, M. De Oliveira Macabú, H. Da Silva Corona, P. Zava Lorencini, P. Athayde, L. Gonçalves Rodrigues Aguiar, L. Fiorotti Albertino, M. Deorce de Lima, A. P. Neves Burian, V. Cruz, A. Kakehasi, C. Gomes, V. F. Azevedo, A. K. Melo, R. Poubel Vieira DE Rezende, S. Ribeiro, R. M. R. Vieira, R. Casian Tuão, M. Barbosa Beloni Lirio, T. De Moraes Ribeiro Espirito Santo, F. Z. Pretti, D. Cristina Filgueira Alves Batista, O. Monticielo, V. De Souza, M. Pinheiro, G. Ferreira, E. Sato, A. Teixeira-Carvalho, R. Xavier, G. Salviato Pileggi, V. Valim |
| 410 |
[GO] |
2022―Jun―28 |
AB1150 IMMUNOGENICITY AND SAFETY OF THE CORONOVAC AND BNT162b2 COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES AND HEALTHY ADULTS: COMPARISON OF DIFFERENT VACCINES |
S. Batibay, R. Koçak Ulucaköy, Z. Günendi, I. Fidan, G. Bozdayi, F. N. Göğüş |
| 411 |
[GO] |
2022―Jun―28 |
AB0629 Glomerulonephritis associated with ANCA after COVID-19 vaccine: a systematic review |
A. Laskova, B. Mohammed, F. Ali, B. Syritsa |
| 412 |
[GO] |
2022―Jun―28 |
AB1183 COVID-19 VACCINE: HESITANCY, ACCEPTANCE AND TOLERANCE AMONG PATIENTS WITH RHEUMATOID ARTHRITIS |
M. Ghali, F. Fhima, M. Ardhaoui, N. Ben Chekaya, J. Mahbouba, S. Zrour, I. Bejia, M. Touzi, N. Bergaoui |
| 413 |
[GO] |
2022―Jun―28 |
POS1273 EVALUATION OF THE SAFETY PROFILE OF COVID-19 VACCINES IN CHILD PATIENTS USING BIOLOGICAL THERAPY |
B. Sözeri, R. E. Yigit |
| 414 |
[GO] |
2022―Jun―28 |
AB1086 VACCINE HESITANCY AGAINST COVID-19 VACCINES IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES AND EFFECT OF SPECIALIST COUNSELLING ON VACCINE HESITANT PATIENTS WILLINGNESS TO TAKE VACCINE |
K. Kunalchandwar@gmail.Com, K. Kishor, J. Dixit, P. Dogga, D. Ekbote, P. Kumar, U. Dhakad |
| 415 |
[GO] |
2022―Jun―28 |
POS1210 SAFETY AND IMMUNOGENICITY OF COVID-19 VACCINES IN PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASE |
C. Hitchon, R. Marrie, C. N. Bernstein, J. Kim, S. Obrien |
| 416 |
[GO] |
2022―Jun―28 |
AB1111 NO INCREASED RISK OF ADVERSE EVENTS OF THE WHO-VALIDATED COVID-19 VACCINES IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH BIOLOGICS |
M. Yasmine, W. Triki, H. Ferjani, D. Ben Nessib, K. Maatallah, D. Kaffel, W. Hamdi |
| 417 |
[GO] |
2022―Jun―28 |
AB1093 SAFETY OF COVID-19 VACCINES IN PATIENTS WITH RHEUMATOID ARTHRITIS (PRELIMINARY DATA). |
A. Kulikov, N. Muravyeva, B. Belov |
| 418 |
[GO] |
2022―Jun―28 |
POS0776 IMMUNOGENICITY AND SAFETY OF INACTIVATED AND mRNA COVID-19 VACCINES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
H. So, T. K. Li, V. Chan, L. S. Tam, P. K. Chan |
| 419 |
[GO] |
2022―Jun―28 |
POS1248 URIC ACID AND COVID-19: PATTERN OF CHANGES AND ASSOCIATION WITH PROGNOSIS |
A. Sydorova, O. Iaremenko |
| 420 |
[GO] |
2022―Jun―28 |
AB1120 PSYCHOLOGICAL ASSESSMENT IN PATIENTS WITH CHRONIC RHEUMATIC, SYSTEMIC AUTOIMMUNE, OR AUTOINFLAMMATORY DISEASES PRESENTED WITH COVID-19: THE MentCOVRMD STUDY. |
M. M. Farhat, M. Horn, G. Vaiva, E. Drumez, R. Seror, V. Gaud-Listrat, N. Costedoat-Chalumeau, N. Tieulie, N. Ait Abdallah, V. Devauchelle-Pensec, S. Guillaume-Czitrom, N. Hamamouche, S. Morell-Dubois, E. Hachulla |
| 421 |
[GO] |
2022―Jun―28 |
AB1099 CORONAVIRUS INFECTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (CASE SERIES). |
I. Menshikova, A. Shilina, Y. Pak, I. Kolosova |
| 422 |
[GO] |
2022―Jun―28 |
AB1081 FLARES OF RHEUMATOID ARTHRITIS FOLLOWING CORONAVIRUS VACCINATION |
R. Hayward, Z. Farah |
| 423 |
[GO] |
2022―Jun―28 |
POS0391 TRENDS IN THE DIAGNOSIS OF MYOSITIS AND ASSOCIATION WITH THE CORONAVIRUS-19 PANDEMIC AND VACCINES: DATA FROM THE VENETO RARE DISEASE REGISTRY, 2014-2021 |
A. Giollo, M. Zen, M. Gatto, E. Zanatta, L. Iaccarino, A. Doria |
| 424 |
[GO] |
2022―Jun―28 |
AB1172 POSTER: SARS-COV 2 INFECTION AND ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS PATIENTS |
D. Anghel, O. G. Petrache, C. Jurcut, A. Mihai, M. M. Negru, A. Ghiațău |
| 425 |
[GO] |
2022―Jun―28 |
AB1403 IMPACT OF THE SARS-COV 2 PANDEMIC AND RELATED EPIDEMIOLOGICAL RESTRICTIONS ON THE CARE OF PATIENTS WITH OSTEOPOROSIS - EXPERIENCES OF A HUNGARIAN CENTRE |
Z. Kardos |
| 426 |
[GO] |
2022―Jun―28 |
POS1233 DIFFICULTIES AND MENTAL IMPACT OF THE SARS-CoV- 2 PANDEMIC IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A NATIONWIDE PATIENT ASSOCIATION STUDY |
M. Scherlinger, N. Zein, J. E. Gottenberg, M. Riviere, J. F. Kleinmann, J. Sibilia, L. Arnaud |
| 427 |
[GO] |
2022―Jun―28 |
AB1154 HUMORAL AND CELLULAR RESPONSE TO A THIRD BOOSTER DOSE SARS-CoV- 2 VACCINATION IN PATIENTS WITH AUTOIMMUNE DISEASE: A CASE SERIES |
T. Dimitroulas, A. Tychala, K. Defteraiou, E. Katsimpourlia, E. Sidiropoulou, M. Papachristou, A. Fylaktou, L. Skoura |
| 428 |
[GO] |
2022―Jun―28 |
AB1501 EFFECT OF SARS-COV-19 PANDEMIC ON RHEUMATOLOGY TRAINING IN INDIA |
K. Kunalchandwar@gmail.com, K. Kishor, P. Dogga, D. Ekbote, J. Dixit, P. Kumar, U. Dhakad |
| 429 |
[GO] |
2022―Jun―28 |
AB1168 CLINICAL AND SEROLOGICAL EVOLUTION OF RHEUMATIC PATIENTS INFECTED BY SARS-COV-2 |
M. De la Rubia Navarro, J. Ivorra Cortés, E. Grau García, L. Gonzalez Puig, R. Negueroles Albuixech, I. Martínez Cordellat, F. Ortiz-Sanjuán, J. J. Fragío Gil, J. E. Oller Rodríguez, E. Vicens Bernabeu, C. Pávez Perales, S. Leal Rodriguez, L. Mas Sanchez, P. Muñoz, C. Riesco Barcena, A. V. Huaylla Quispe, I. Cánovas Olmos, C. Nájera Herranz, J. A. Román Ivorra |
| 430 |
[GO] |
2022―Jun―28 |
POS1316 PERFORMANCE OF THE KOBAYASHI SCORE AND MODIFIED KOBAYASHI SCORE IN PREDICTING RESISTANCE TO INTRAVENOUS IMMUNOGLOBULIN IN PATIENTS WITH PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME ASSOCIATED WITH SARS-CoV-2. |
N. Cybulska, K. Jozkow, K. Orczyk, A. Stasiak, E. Smolewska |
| 431 |
[GO] |
2022―Jun―28 |
POS1282 PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME TEMPORALLY-ASSOCIATED WITH SARS-CoV-2 - A PORTUGUESE SINGLE CENTRE CASE SERIES |
B. Santos, I. Cardoso, S. Miranda, F. Aguiar, M. Rodrigues, I. Brito |
| 432 |
[GO] |
2022―Jun―28 |
POS1219 SARS-COV-2 COURSE AND OUTCOME IN PATIENTS WITH SYSTEMIC AUTOINFLAMMATORY DISEASES (SAID) TREATED WITH IL-1 INHIBITORS AND COLCHICINE |
S. Bindoli, S. Della Mora, A. Doria, P. Sfriso |
| 433 |
[GO] |
2022―Jun―28 |
POS1296 T-CELL RESPONSE MEASURED BY INTERFERON-γ RELEASE ASSAY AS A NOVEL TOOL FOR BETTER UNDERSTANDING OF SARS-CoV-2 IMMUNITY: THE PRELIMINARY RESULTS OF A PROSPECTIVE STUDY IN PEDIATRIC PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS. |
K. Kapten, K. Orczyk, E. Smolewska |
| 434 |
[GO] |
2022―Jun―28 |
AB1094 SAFETY AND EFFICACY OF VACCINES FOR SARS-CoV-2 IN PATIENTS WITH RHEUMATIC AND IMMUNE-MEDIATED INFLAMMATORY DISEASES: DATA FROM THE ARGENTINEAN REGISTRY SAR-CoVAC |
C. A. Isnardi, K. Roberts, R. Quintana, J. Kreimer, C. Echeverria, P. C. Luna, B. M. Virasoro, I. E. Exeni, N. Kogan, M. D. L. A. Correa, D. A. Pereira, D. Zelaya, Y. Tissera, C. Pisoni, M. S. Gálvez Elkin, C. G. Alonso, A. K. Cogo, M. Cosatti, L. Garcia, C. Retamozo, M. Severina, R. Nieto, M. Rosemffet, E. D. Mussano, A. Bertoli, M. Delavega, V. Savio, V. Cosentino, B. Roldan, H. Maldonado Ficco, P. Maid, C. Calle Montoro, L. Fernandez, M. L. Leguizamón, A. B. Gómez Vara, M. A. Alfaro, M. Landi, N. Herscovich, C. Maldini, S. S. De la Vega Fernandez, E. Velozo, P. Giorgis, M. E. Sattler, C. Reyes Gómez, L. Perrotat, C. Reimundes, R. A. Ezquer, V. Saurit, J. Flores Trejo, O. L. Cerda, M. G. Crespo Rocha, V. Carrizo Abarza, I. Strusberg, R. Rojas Tessel, G. Verna, J. M. Bande, P. Farfan, G. Berbotto, G. Pons-Estel, E. E. Schneeberger |
| 435 |
[GO] |
2022―Jun―28 |
AB1144 COGNITIVE AND PSYCHOSOCIAL OUTCOME IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME FOLLOWING SARS-CoV-2 INFECTION |
D. Gosar, M. Zajc Avramovič, N. Emersic, M. Šušterič, M. M. Šömen, D. Osredkar, T. Avcin |
| 436 |
[GO] |
2022―Jun―28 |
POS1204 SARS-CoV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH RHEUMATIC DISEASES FROM ARGENTINA |
M. Cosatti, M. E. D´ Angelo, I. E. Petkovic, M. D. L. A. Correa, D. Zelaya, M. S. Gálvez Elkin, A. K. Cogo, C. Retamozo, R. Nieto, E. D. Mussano, E. M. Cavillon, V. Savio, B. Roldan, P. Maid, L. Fernandez, L. Muñoz, M. L. Leguizamón, N. Herscovich, M. A. Alfaro, C. Maldini, P. Giorgis, C. Reyes Gómez, C. Reimundes, V. Saurit, O. L. Cerda, M. G. Crespo Rocha, I. Strusberg, G. Verna, M. I. Quaglia, E. Picco, S. Catalan Pellet, M. Galan, Z. Troyano, M. Perandones, J. Kreimer, P. C. Luna, C. Echeverria, B. M. Virasoro, K. Roberts, C. A. Isnardi, E. E. Schneeberger, G. Pons-Estel, C. Pisoni |
| 437 |
[GO] |
2022―Jun―28 |
AB1112 SARS-COV-2 INFECTION AND IT VACCINATION IN AUTOINMUNE DISEASE-ASSOCIATED INTERSTICIAL LUNG DISEASE |
A. Garcia Studer, M. Rojas-Giménez, M. Velloso Feijoo, C. M. Romero-Barco, F. Godoy-Navarrete, N. Mena-Vázquez |
| 438 |
[GO] |
2022―Jun―28 |
POS1200 DIFFERENCES BETWEEN THE FIRST AND THE SECOND WAVE OF SARS-COV-2 INFECTION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES IN ARGENTINA: DATA FROM THE SAR-COVID REGISTRY |
A. Bertoli, L. Muñoz, M. J. López Pérez, L. Sanchez Freytes, M. S. Castaño, V. Saurit, G. Berbotto, G. Alle, M. Severina, R. Nieto, F. Maldonado, M. Pera, A. K. Cogo, A. R. Baños, F. Vivero, D. A. Pereira, M. Cosatti, V. Savio, R. Perez Alamino, M. A. Medina, M. Schmid, F. Risueño, M. I. Quaglia, G. P. Pendon, L. Casalla, M. Delavega, M. A. Lazaro, P. Finucci, J. Morbiducci, C. Romeo, N. Cucchiaro, S. Moyano, T. Barbich, S. M. Conti, C. Goizueta, E. R. Tralice, C. Maldini, J. Rebak, R. Gallo, P. Maid, J. L. Velasco Zamora, N. Lloves Schenone, S. Porta, N. S. Morales, M. P. Diaz, M. Viola, E. Buschiazzo, G. Gómez, K. Roberts, R. Quintana, C. A. Isnardi, G. Pons-Estel, C. E. Matellan |
| 439 |
[GO] |
2022―Jun―28 |
POS1238 GLUCOCORTICOIDS, RITUXIMAB AND THE PRESENCE OF INTERSTITIAL LUNG DISEASE ARE ASSOCIATED WITH POOR OUTCOMES OF THE SARS-COV-2 INFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE NATIONAL REGISTRY SAR-COVID. |
A. B. Gómez Vara, T. Barbich, C. A. Isnardi, E. E. Schneeberger, G. Citera, V. V. Castro Coello, R. Baez, M. Haye, A. A. Reyes, J. A. Albiero, R. Tanten, E. Velozo, P. Alba, M. J. Gamba, C. G. Alonso, H. Maldonado Ficco, J. Gallino Yanzi, V. Savio, C. Asnal, C. Matellan, L. Takashima, L. Carlevaris, M. S. Gálvez Elkin, J. Scafati, M. García, N. German, M. L. Werner, C. Aeschlimann, S. E. Aguero, M. E. Calvo, L. Gonzalez Lucero, G. F. Rodriguez Gil, M. Mauri, S. Petruzzelli, D. Castrillon Bustamante, L. Ibañez Zurlo, D. Alonso, J. L. Tomas, D. L. Vasquez, S. Soares de Souza, N. Herscovich, L. Raiti, J. M. Mareco, D. Guaglianone, C. Ledesma, M. P. Diaz, M. E. Bedoya, B. Kisluk, G. Gómez, K. Roberts, R. Quintana, G. Pons-Estel |
| 440 |
[GO] |
2022―Jun―28 |
POS1251 INCIDENCE AND OUTCOMES OF SARS-CoV-2 INFECTION IN PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES: A POPULATION-BASED STUDY OF MORE THAN FOUR MILLION INHABITANTS IN THE LAZIO ITALIAN REGION |
E. De Lorenzis, P. Parente, G. Natalello, S. Soldati, S. L. Bosello, A. Barbara, C. Sorge, S. Axelrod, L. Verardi, P. G. Cerasuolo, G. Peluso, A. Gemma, M. Davoli, D. Biliotti, V. Bruzzese, M. Goletti, M. DI Martino, M. A. D’agostino |
| 441 |
[GO] |
2022―Jun―28 |
AB1113 THE IMPACT OF SARS-COV-2 INFECTION ON DISEASE ACTIVITY AND CLINICAL RESPONSE TO BIOLOGICAL DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS |
B. Samões, A. Martins, D. Santos Oliveira, F. R. Martins, R. Nicolau, M. Rato, F. Oliveira Pinheiro, M. Bernardes, L. Costa |
| 442 |
[GO] |
2022―Jun―28 |
AB0107 IMPACT OF SARS-CoV-2 INFECTION ON THE DISEASE ACTIVITY OF PATIENTS WITH PSORIATIC ARTHRITIS UNDER bDMARDs: REAL LIFE DATA |
R. Nicolau, A. Martins, D. Santos Oliveira, B. Samões, F. R. Martins, M. Rato, F. Oliveira Pinheiro, M. Bernardes, L. Costa |
| 443 |
[GO] |
2022―Jun―28 |
POS1263 PRE-EXPOSURE PROPHYLAXIS FOR SARS-CoV-2 INFECTION WITH SUBCUTANEOUS CASIRIVIMAB/IMDEVIMAB IN PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES. |
F. Fagni, K. Schmidt, D. Bohr, L. Valor, F. Hartmann, K. Tascilar, K. Manger, B. Manger, A. Kleyer, D. Simon, G. Schett, T. Harrer |
| 444 |
[GO] |
2022―Jun―28 |
POS1215 IMMUNE CORRELATES AND CLINICAL COURSE OF PATIENTS WITH RHEUMATOID ARTHRITIS FOLLOWING VACCINATION WITH ANTI SARS-CoV-2 mRNA BASED VACCINES: RESULTS FROM A PROSPECTIVE, OBSERVATIONAL AND CONTROLLED STUDY |
K. Schmiedeberg, I. A. Abela, N. B. Pikor, N. Vuilleumier, M. Schwarzmueller, S. Epp, S. Pagano, S. Grabherr, A. B. Patterson, M. Nussberger, A. Trkola, B. Ludewig, J. Von Kempis, A. Rubbert-Roth |
| 445 |
[GO] |
2022―Jun―28 |
POS1217 ANTI-TNF THERAPY FOR IMMUNE MEDIATED INFLAMMATORY DISEASES MAY BE ASSOCIATED WITH LOWER ANTIBODY LEVELS AND VIRUS NEUTRALIZATION EFFICACY FOLLOWING SARS-CoV-2 mRNA VACCINATION |
N. Finkelstein, R. M. Dayam, J. Law, R. Goetgebuer, G. Chao, K. T. Abe, M. Sutton, J. M. Stempak, D. Pereira, D. Croitoru, L. Acheampong, S. Rizwan, K. Rymaszewski, R. Milgrom, D. Ganatra, N. V. Batista, M. Girard, I. Lau, R. Law, M. Cheung, B. Rathod, J. Kitaygorodsky, R. Samson, Q. Hu, N. Haroon, R. Inman, V. Piguet, M. Silverberg, A. C. Grigras, T. H. Watts, V. Chandran |
| 446 |
[GO] |
2022―Jun―28 |
POS1243 ACCELERATED WANING OF PROTECTIVE IMMUNITY AFTER SARS-CoV-2 mRNA VACCINATION IN PATIENTS TREATED WITH BIOLOGICAL AND TARGETED SYNTHETIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS |
S. Tobudic, E. Simader, T. Deimel, P. Mandl, H. Haslacher, T. Perkmann, L. Schneider, T. Nothnagl, H. Lechner-Radner, F. Winkler, H. Burgmann, K. Stiasny, G. Novacek, W. Reinisch, D. Aletaha, S. Winkler, S. Blüml |
| 447 |
[GO] |
2022―Jun―28 |
POS1237 SARS-CoV-2 mRNA VACCINE IMMUNOGENICITY IN CHRONIC INFLAMMATORY ARTHRITIS ON DMARD THERAPY |
N. Darwish, S. Jhaveri, U. Yoganathan, H. Bakillah, K. Chun, T. Wasser, J. Freeman |
| 448 |
[GO] |
2022―Jun―28 |
AB1119 GLUCOCORTICOIDS’ TREATMENT IMPAIRS THE MEDIUM-TERM IMMUNOGENIC RESPONSE TO SARS-CoV-2 mRNA VACCINES IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS. |
S. Garcia-Cirera, J. Calvet, A. Berenguer-Llergo, E. Pradenas, M. Llop Vilaltella, C. Galisteo, J. Blanco, J. Gratacos Masmitjà |
| 449 |
[GO] |
2022―Jun―28 |
AB1137 USE OF TOCILIZUMAB IN CRITICALLY ILL SARS-COV-2 PATIENTS CARE- PROGNOSTIC FACTORS OF TREATMENT EFFECTIVENESS AND TREATMENT RESULTS |
Z. Kardos, M. Szabó, Z. Baráth, Á. Miksi, Á. Kozma, G. A. József, Z. Szekanecz |
| 450 |
[GO] |
2022―Jun―28 |
AB1165 THE ROLE OF MOLECULAR MIMICRY IN SARS-CoV-2 RELATED AUTOIMMUNE RHEUMATIC DISEASES |
C. Liaskos, E. Patrikiou, L. Komorowski, C. Tsigalou, A. Tsirogianni, L. Sakkas, D. Bogdanos |
| 451 |
[GO] |
2022―Jun―28 |
AB1123 EFFICACY AND SAFETY OF SARS-CoV-2 THIRD VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO DID NOT RESPOND AFTER PRIMARY TWO-DOSE REGIMEN |
C. A. Isnardi, O. L. Cerda, E. E. Schneeberger, M. Landi, C. Calle Montoro, M. A. Alfaro, B. Roldan, A. B. Gómez Vara, P. Giorgis, R. A. Ezquer, M. G. Crespo Rocha, C. Reyes Gómez, M. D. L. A. Correa, M. Rosemffet, V. Carrizo Abarza, S. Catalan Pellet, M. Perandones, C. Reimundes, L. Cruces, L. Yesica, G. Turk, F. Quiroga, N. Laufer, R. Quintana, M. Delavega, P. Maid, G. Pons-Estel, G. Citera |
| 452 |
[GO] |
2022―Jun―28 |
AB1190 SOURCES OF INFORMATION ABOUT SARS-CoV-2 USED BY PATIENTS WITH CHRONIC INFLAMMATORY RHEUMATIC DISEASES (CIRD) |
I. Andreica, I. Roman, X. Baraliakos, U. Kiltz, J. Braun |
| 453 |
[GO] |
2022―Jun―28 |
AB1135 RESPONSE TO SARS-COV-2 VACCINATION IN SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASE DEPENDS ON IMMUNOSUPPRESSIVE REGIMEN: A MATCHED, PROSPECTIVE COHORT STUDY |
P. Mandl, S. Tobudic, H. Haslacher, D. Mrak, T. Nothnagl, T. Perkmann, H. Radner, J. Sautner, E. Simader, F. Winkler, H. Burgmann, D. Aletaha, S. Winkler, S. Blüml |
| 454 |
[GO] |
2022―Jun―28 |
AB1188 SARS-CoV-2 VACCINATION WILLINGNESS AND PREDICTORS IN PATIENTS WITH CHRONIC INFLAMMATORY RHEUMATIC DISEASES (CIRD) AND WITHOUT CIRD |
I. Andreica, I. Roman, X. Baraliakos, U. Kiltz, J. Braun |
| 455 |
[GO] |
2022―Jun―28 |
AB1163 ATTITUDES AND HESITANCY IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES TOWARDS SARS-CoV-2 VACCINATION: A SINGLE-CENTER STUDY FROM BULGARIA |
T. Georgiev, R. Moraliyska, S. Bogdanova-Petrova, G. Gerganov, P. Kabakchieva, S. Dimitrov, S. Hristova, T. Shivacheva |
| 456 |
[GO] |
2022―Jun―28 |
AB1169 IMMUNOMODULATORY EFFECTS OF SARS-CoV-2 VACCINATION: INCREASE OF REGULATORY T CELLS AFTER mRNA VACCINE |
F. La Gualana, F. Villani, G. Cusano, L. Gragnani, L. Stefanini, S. Santini, S. Basili, M. Casato, M. Fiorilli, M. Visentini |
| 457 |
[GO] |
2022―Jun―28 |
POS1196 SARS-CoV-2 VACCINE ACCEPTANCE AND ASSOCIATED PSYCHOLOGICAL FACTORS IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES |
H. Sugawara, H. Doi, T. Iwasaki, Y. Nakayama, Y. Nishida, Y. Gon, M. Kamakura, K. Ohbori, N. Sakane, N. Nakamura, T. Utsumi, A. Morinobu |
| 458 |
[GO] |
2022―Jun―28 |
AB1149 EVALUATION OF THE EFFICACY AND SAFETY OF THE SARS-CoV-2 VACCINE IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES TREATED WITH BIOLOGICAL THERAPY. |
J. Calvo Gutierrez, C. López-Medina, M. C. Ábalos-Aguilera, A. B. Pérez Jiménez, D. Ruíz-Vilchez, F. U. Pilar, R. Ortega Castro, A. Escudero Contreras, E. Collantes Estevez |
| 459 |
[GO] |
2022―Jun―28 |
POS1276 HUMORAL IMMUNE RESPONSE TO SARS-COV-2 VACCINE IN RITUXIMAB-TREATED PATIENTS |
E. Flores-Fernández, I. Vázquez-Gómez, C. Valera-Ribera, P. Andújar-Brazal, E. Valls-Pascual, J. M. Nogueira Coito, À. Martínez-Ferrer, D. Ybáñez-García, J. J. Alegre-Sancho |
| 460 |
[GO] |
2022―Jun―28 |
AB1192 SARS-COV-2 VACCINE IN SPONDYLOARTHRITIS PATIENTS: OVERALL MODERATE/HIGH IMMUNOGENICITY IMPAIRED BY IMMUNOSUPPRESSANTS AND BIOLOGICAL THERAPY |
C. Saad, M. Rodrigues Silva, P. Degrava Sampaio-Barros, J. Moraes, C. Goldenstein-Schainberg, N. Aikawa, E. Neves, S. Pasoto, T. Pedrosa, R. Kenji Aoyama, C. Scognamiglio Renner Araujo, C. Silva, A. C. Medeiros Ribeiro, E. Bonfa |
| 461 |
[GO] |
2022―Jun―28 |
POS1212 SARS-CoV-2 VACCINE SAFETY IN ADOLESCENTS WITH INFLAMMATORY RHEUMATIC AND MUSCULOSKELETAL DISEASES AND ADULTS WITH JUVENILE IDIOPATHIC ARTHRITIS |
S. Lawson-Tovey, A. Strangfeld, E. Mateus, L. Gossec, L. Carmona, P. Machado, B. Raffeiner, I. Bulina, D. Clemente, J. Zepa, A. M. Rodrigues, X. Mariette, K. Hyrich |
| 462 |
[GO] |
2022―Jun―28 |
POS1201 SAFETY OF SARS-COV-2 VACCINES IN PATIENTS WITH RHEUMATIC DISEASES: DATA FROM THE NATIONAL REGISTRY SAR-CoVAC FROM ARGENTINA |
M. Cosatti, M. E. D´ Angelo, I. E. Petkovic, N. Kogan, D. A. Pereira, Y. Tissera, M. V. Toledo, C. G. Alonso, L. Garcia, M. Severina, M. Rosemffet, A. Bertoli, M. Delavega, V. Cosentino, H. Maldonado Ficco, C. Calle Montoro, S. S. De la Vega Fernandez, G. Berbotto, A. Rollano Perasso, A. B. Gómez Vara, M. Landi, E. Velozo, M. E. Sattler, L. Perrotat, R. A. Ezquer, J. Flores Trejo, P. Farfan, R. Rojas Tessel, V. Carrizo Abarza, J. M. Bande, B. Hernandez, M. J. Papagno, L. A. Rodriguez, V. Martin Koller, F. Montoya, J. Kreimer, P. C. Luna, C. Echeverria, B. M. Virasoro, K. Roberts, C. A. Isnardi, E. E. Schneeberger, G. Pons-Estel, C. Pisoni |
| 463 |
[GO] |
2022―Jun―28 |
AB1146 SARS-Cov-2 VIRAL LOAD IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASE, A RETROSPECTIVE COMPARATIVE STUDY |
O. Alsaed, Y. A. Y. Alrimawi, R. Saleh, M. Chaponda, P. Coyle, K. Becetti, H. Ashour, E. Elsayed, M. Hamed, F. Alam, B. Awadh, M. Hammoudeh, S. Al Emadi |
| 464 |
[GO] |
2022―Jun―28 |
POS1178 PRESCRIBING RITUXIMAB IN PATIENTS WITH AUTO-IMMUNE DISEASES AND ACQUIRED HYPOGAMMAGLOBULINEMIA: DESCRIPTION OF THE RISK OF SEVERE INFECTION IN 121 PATIENTS BEFORE THE SARS-Cov2 ERA |
B. Xavier, M. Lafaurie, E. Treiner, O. Walter, G. Pugnet, G. Martin-Blondel, D. Biotti, J. Ciron, G. Moulis, A. Constantin, Y. Renaudineau, D. Chauveau, L. Sailler |
| 465 |
[GO] |
2022―Jun―28 |
AB1145 EVALUATION OF THE HUMORAL IMMUNE RESPONSE SECONDARY TO VACCINATION AGAINST SARS-CoV2 IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES |
P. M. Corbalán, M. Pera, G. V. Espasa, M. L. Leguizamón, A. L. Barbaglia, L. Gonzalez Lucero, H. R. Sueldo, M. C. Bertolaccini, R. N. Chehin, R. H. Tomas-Grau, D. Ploper, E. Vera Pinguitore, B. Socías, C. L. Ávila, S. I. Cazorla, C. Maldonado Galdeano, V. I. Bellomio |
| 466 |
[GO] |
2022―Jun―28 |
POS1191 IMMUNE RESPONSES TO MRNA VACCINES AGAINST SARS-COV2 IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY RHEUMATIC DISEASES |
C. Sieiro Santos, C. Moriano, E. Diez Alvarez, S. Calleja Antolín, I. González Fernández, C. Álvarez Castro, J. M. Garcia Ruiz de Morales |
| 467 |
[GO] |
2022―Jun―28 |
AB1170 IMPACT IN PRENATAL EVALUATION OF PREGNANT WOMEN WITH RHEUMATIC DISEASES BY THE SARS-COV2 PANDEMIC |
A. Y. Lujano Negrete, M. E. Corral Trujillo, C. M. Skinner Taylor, L. Pérez Barbosa, A. Aguilar-Leal, M. C. Rodriguez-Ruiz, L. G. Espinosa Banuelos, A. Cárdenas, D. Á. Galarza-Delgado |
| 468 |
[GO] |
2022―Jun―28 |
AB1130 A REDUCTION IN NEW REFERRALS FOR RHEUMATOID ARTHRITIS, OSTEOARTHRITIS AND CRYSTAL ARTHRITIS COMPARED TO GCA DURING COVID19 PANDEMIC |
M. Tormo-Ratera, M. Mirza, R. Luqmani |
| 469 |
[GO] |
2022―Jun―28 |
POS1496-HPR HARD TIMES: ADAPTING A FATIGUE MANAGEMENT PROGRAMME IN A PANDEMIC |
J. Dobson, D. Dockrell, K. Berg, H. Harris |
| 470 |
[GO] |
2022―Jun―28 |
POS1241 THE IMPACT OF TELEMEDICINE CONSULTATIONS FOR RHEUMATOID ARTHRITIS, GIANT CELL ARTERITIS, OSTEOARTHRITIS AND CRYSTAL ARTHRITIS DURING COVID19 PANDEMIC |
M. Tormo-Ratera, M. Mirza, R. Luqmani |
| 471 |
[GO] |
2022―Jun―28 |
AB1028 REGRESSIVE BONE MINERAL DENSITY TRENDS SEEN WITH DELAY IN FOLLOW UP OF DENOSUMAB TREATMENT DUE TO THE PANDEMIC INDUCED LOCKDOWN - A SINGLE CENTRE INDIAN EXPERIENCE. |
A. K. Aggarwal, N. Aggarwal, H. Sharma |
| 472 |
[GO] |
2022―Jun―28 |
AB1108 IMPACT OF THE FIRST WAVE OF THE COVID 19 PANDEMIC ON HEALTHCARE ACCESSIBILITY, DISEASE BEHAVIOUR, ANXIETY, AND PHYSICAL ACTIVITY IN RHEUMATIC DISEASE PATIENTS: AN ONLINE SURVEY AND POTENTIAL SOLUTIONS |
S. Yadav, R. Samant |
| 473 |
[GO] |
2022―Jun―28 |
POS0357-PARE EXPLORING THE IMPACT OF THE PANDEMIC ON ITALIAN RHEUMATIC DISEASE PATIENTS: A PATIENT ADVOCACY SURVEY |
A. Celano, D. Cafiero, S. Lopatriello, F. Tedone |
| 474 |
[GO] |
2022―Jun―28 |
AB1090 IMPACT OF THE COVID19 PANDEMIC ON THE SOCIAL BEHAVIOR OF PATIENTS WITH RHEUMATIC DISEASES |
L. Cano Garcia, S. Manrique Arija, M. Vera Rodríguez, R. Redondo, C. M. Romero-Barco, N. Mena-Vázquez |
| 475 |
[GO] |
2022―Jun―28 |
POS1544-HPR RHEUMATOID ARTHRITIS CONTROL USING SYNCHRONOUS TELEMEDICINE MODALITY IN THE PANDEMIC PERIOD |
L. J. Cajas Santana, D. Cajas |
| 476 |
[GO] |
2022―Jun―28 |
POS0358-PARE THE IRISH ‘WEAR RED’ FOR VASCULITIS CAMPAIGN - LAUNCHING AN ANNUAL AWARENESS CAMPAIGN IN A RESTRICTED PANDEMIC WORLD. |
S. Skeffington |
| 477 |
[GO] |
2022―Jun―28 |
POS1502-HPR A PHYSICAL EXERCISE PROGRAM FOR THE MANAGEMENT OF FATIGUE IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AT THE TIME OF PANDEMIC: A PILOT STUDY |
E. Elefante, C. Tani, V. Signorini, C. Stagnaro, L. Lunardi, D. Zucchi, F. Trentin, L. Carli, F. Ferro, M. Mosca |
| 478 |
[GO] |
2022―Jun―28 |
POS1503-HPR THE VALUE OF REMOTE CONSULTATIONS WITH A PHYSIOTHERAPIST, SPECIALISED IN AXIAL SPONDYLOARTHRITIS DURING THE COVID 19 PANDEMIC: EVALUATION OF A MEMBER-SUPPORT PROJECT WITH THE NATIONAL AXIAL SPONDYLOARTHRITIS SOCIETY. |
E. Clarke, J. Hamilton, S. Dickinson |
| 479 |
[GO] |
2022―Jun―28 |
POS1530-HPR RHEUMATIC MUSCULOSKELETAL DISEASES (RMDs) DURING THE FIRST WAVE OF THE COVID19 PANDEMIC: PATIENTS’ POINT OF VIEW ON THE ROLE OF TELEMEDICINE |
K. El Aoufy, M. R. Melis, M. Balzani, S. Guiducci, S. Bellando Randone, S. Bambi, L. Rasero, M. Matucci-Cerinic |
| 480 |
[GO] |
2022―Jun―28 |
POS1494-HPR INCIDENCE OF PSYCHIATRIC DISORDERS AND FIBROMYALGIA IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS DURING COVID 19 PANDEMIC: THE ROLE OF TELEMEDICINE. |
R. Foti, G. Amato, Y. Dal Bosco, C. Gagliano, A. Longo, R. Falsaperla, R. Foti, F. De Lucia, S. Speranza, E. Visalli |
| 481 |
[GO] |
2022―Jun―28 |
POS1249 EFFICACY AND SAFETY OF ChAdOx1 nCoV-19/AZD1222 AND mRNA-1273 VACCINES: A COMPARATIVE STUDY IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES |
Y. J. Chen, W. N. Huang, H. H. Chen, H. W. Chen, P. L. Cheng, J. P. Chen, C. T. Lin, K. T. Tang, W. T. Hung, T. Y. Hsieh, T. H. Hsiao, Y. M. Chen, Y. H. Chen |
| 482 |
[GO] |
2022―Jun―28 |
AB1101 PREVALENCE OF LONG COVID IN RHEUMATIC DISEASE PATIENTS: ANALYSIS OF SAR COVID REGISTRY |
C. A. Gonzalez Gomez, M. Cosatti, V. V. Castro Coello, M. Haye, Y. Tissera, A. A. Reyes, J. A. Albiero, S. Ornella, P. Alba, C. Gobbi, M. J. Gamba, I. E. Exeni, A. Cusa, J. Gallino Yanzi, V. I. Bellomio, G. Gomez, D. Zelaya, L. Takashima, L. Carlevaris, M. D. L. A. Correa, R. Rojas Tessel, M. García, N. German, A. L. Mercé, A. Bertoli, S. E. Aguero, M. E. Calvo, V. Martire, M. Mauri, M. L. Martin, E. Picco, D. Castrillon Bustamante, L. Ibañez Zurlo, M. N. Tamborenea, G. C. Subils, D. L. Vasquez, S. Soares de Souza, N. Herscovich, L. Raiti, V. Cosentino, F. Rodriguez, C. Ledesma, M. P. Diaz, M. L. Mamani Ortega, M. S. Castaño, G. Gómez, K. Roberts, R. Quintana, C. A. Isnardi, G. Pons-Estel, C. Pisoni |
| 483 |
[GO] |
2022―Jun―27 |
OP0253 COVID-19 ADMISSIONS AND MORTALITY IN PATIENTS WITH EARLY INFLAMMATORY ARTHRITIS: RESULTS FROM A NATIONAL COHORT |
M. Adas, M. Russell, E. Cook, E. Alveyn, S. Oyebanjo, P. Amlani-Hatcher, J. Ledingham, S. Norton, J. Galloway |
| 484 |
[GO] |
2022―Jun―27 |
OP0173 INCIDENCE OF COVID-19 INFECTION AND HOSPITALISATION ACCORDING TO VACCINATION STATUS AND DMARD TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS: A NATIONWIDE MATCHED COHORT STUDY FROM DENMARK |
R. Cordtz, S. Kristensen, R. Westermann, K. Duch, F. Pearce, J. Lindhardsen, C. Torp-Pedersen, M. P. Andersen, L. Dreyer |
| 485 |
[GO] |
2022―Jun―27 |
OP0249 CHARACTERISTICS ASSOCIATED WITH POOR COVID-19 OUTCOMES IN PEOPLE WITH PSORIASIS AND SPONDYLOARTHRITIS: DATA FROM THE COVID-19 PsoProtect AND GLOBAL RHEUMATOLOGY ALLIANCE PHYSICIAN-REPORTED REGISTRIES |
P. M. Machado, M. Schaefer, S. Mahil, N. Dand, M. Gianfrancesco, S. Lawson-Tovey, Z. Yiu, M. Yates, K. Hyrich, L. Gossec, L. Carmona, E. Mateus, D. Wiek, S. Bhana, M. Gore-Massy, R. Grainger, J. Hausmann, P. Sufka, E. Sirotich, Z. Wallace, T. Olofsson, C. Lomater, N. Romeo, D. Wendling, T. Pham, C. Miceli Richard, B. Fautrel, L. Silva, H. Santos, F. R. Martins, R. Hasseli, A. Pfeil, A. Regierer, C. Isnardi, E. Soriano, R. Quintana, F. Omura, F. Machado Ribeiro, M. Pinheiro, W. Bautista-Molano, D. Alpizar-Rodriguez, C. Saad, M. Dubreuil, N. Haroon, L. S. Gensler, J. Dau, L. Jacobsohn, J. Liew, A. Strangfeld, J. Barker, C. E. M. Griffiths, P. Robinson, J. Yazdany, C. Smith |
| 486 |
[GO] |
2022―Jun―27 |
OP0211-HPR EXPERIENCES DURING THE COVID-19 PANDEMIC AMONG PEOPLE WITH INFLAMMATORY ARTHRITIS. “REOPENING OF SOCIETY IS HARDER THAN LOCK-DOWN” - A QUALITATIVE INTERVIEW STUDY |
L. Lund, M. Løwe, O. Hendricks, K. Schreiber, B. Glintborg, R. Petersen, C. Plischke, W. Fick, J. Primdahl |
| 487 |
[GO] |
2022―Jun―27 |
OP0219 HIGH INCIDENCE OF MIS-C AND OTHER AUTOIMMUNE DISEASES AFTER SARS-COV-2 INFECTION COMPARED TO COVID-19 VACCINATION IN PEDIATRIC POPULATION FROM SOUTH CENTRAL EUROPE |
M. Bizjak, N. Emersic, M. Zajc Avramovič, T. Vesel Tajnšek, G. Markelj, S. Della Paolera, E. Conversano, V. Berce, N. Toplak, A. Taddio, T. Avcin |
| 488 |
[GO] |
2022―Jun―27 |
OP0179 CHARACTERISTICS AND OUTCOMES OF SARS-CoV-2 BREAKTHROUGH INFECTIONS AMONG DOUBLE AND TRIPLE VACCINATED PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES |
R. Hasseli, B. F. Hoyer, H. M. Lorenz, A. Pfeil, A. Regierer, J. Richter, T. Schmeiser, A. Strangfeld, A. Krause, R. Voll, H. Schulze-Koops, U. Müller-Ladner, C. Specker |
| 489 |
[GO] |
2022―Jun―27 |
OP0192 SEROLOGICAL RESPONSE AND SAFETY OF A THREE-DOSE SARS-CoV-2 VACCINATION STRATEGY IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPY |
I. Jyssum, A. T. Tveter, J. Sexton, I. E. Christensen, T. T. Tran, S. Mjaaland, D. J. Warren, T. K. Kvien, K. H. Bjørlykke, G. B. Kro, J. Jahnsen, L. A. Munthe, E. A. Haavardsholm, J. T. Vaage, G. Grodeland, F. Lund-Johansen, S. Aarrestad Provan, K. K. Jørgensen, G. L. Goll, S. W. Syversen |
| 490 |
[GO] |
2022―Jun―27 |
OP0176 THE PERSISTENCE OF ANTI-SPIKE ANTIBODIES FOLLOWING TWO SARS-CoV-2 VACCINES IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES USING IMMUNOSUPPRESSIVE THERAPY, COMPARED TO HEALTHY CONTROLS |
I. Egeland Christensen, I. Jyssum, A. T. Tveter, J. Sexton, T. T. Tran, S. Mjaaland, G. B. Kro, T. K. Kvien, D. Worren, J. Jahnsen, L. A. Munthe, E. Haavardsholm, J. T. Vaage, G. Grodeland, F. Lund-Johansen, K. K. Jørgensen, S. W. Syversen, G. L. Goll, S. Aarrestad Provan |
| 491 |
[GO] |
2022―Jun―27 |
OP0178 COVID-19 BREAKTHROUGH INFECTIONS IN VACCINATED PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES AND CONTROLS - DATA FROM TWO PROSPECTIVE COHORT STUDIES |
L. Boekel, E. Stalman, L. Wieske, F. Hooijberg, Y. Besten, M. Leeuw, S. Atiqi, L. Kummer, K. van Dam, M. Steenhuis, Z. van Kempen, J. Killestein, W. Lems, S. Tas, R. van Vollenhoven, M. Nurmohamed, M. Boers, M. van Ham, T. Rispens, T. Kuijpers, F. Eftimov, G. J. Wolbink |
| 492 |
[GO] |
2022―Jun―27 |
OP0254 FACTORS ASSOCIATED WITH THE SEVERITY OF COVID-19 INFECTION IN PATIENTS WITH SPONDYLOARTHRITIS: RESULTS OF THE FRENCH RMD COVID-19 COHORT |
L. Perrot, L. Boyer, R. M. Flipo, H. Marotte, E. Pertuiset, C. Miceli Richard, T. Thomas, R. Seror, P. Chazerain, R. Nicolas, C. Richez, T. Pham |
| 493 |
[GO] |
2022―Jun―27 |
OP0252 FACTORS ASSOCIATED WITH SEVERE COVID-19 OUTCOMES IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHY: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE PHYSICIAN-REPORTED REGISTRY |
S. A. Yeoh, M. Gianfrancesco, S. Lawson-Tovey, K. Hyrich, A. Strangfeld, L. Gossec, L. Carmona, E. Mateus, M. Schaefer, C. Richez, E. Hachulla, M. Holmqvist, C. A. Scirè, R. Hasseli, A. Jayatilleke, T. Hsu, K. D’Silva, V. Pimentel-Quiroz, M. Vasquez del Mercado, S. Katsuyuki Shinjo, E. Reis Neto, L. Rocha, A. C. D. O. E. S. Montandon, P. Jordan, E. Sirotich, J. Hausmann, J. Liew, L. Jacobsohn, M. Gore-Massy, P. Sufka, R. Grainger, S. Bhana, Z. Wallace, P. Robinson, J. Yazdany, P. Machado |
| 494 |
[GO] |
2022―Jun―27 |
OP0248 SEVERE COVID-19 OUTCOMES AMONG PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: A POPULATION-BASED STUDY |
S. Marozoff, Z. A. Fazal, J. Tan, N. Lu, A. Hoens, D. Lacaille, J. Kopec, H. Xie, J. M. Loree, J. Esdaile, J. A. Aviña-Zubieta |
| 495 |
[GO] |
2022―Jun―27 |
OP0251 IMPACT OF INTERSTITIAL LUNG DISEASE ON SEVERE COVID-19 OUTCOMES FOR PATIENTS WITH RHEUMATOID ARTHRITIS: A MULTICENTER STUDY |
E. Gilbert, G. Figueroa-Parra, M. Valenzuela-Almada, S. Vallejo, M. R. Neville, N. Patel, C. Cook, X. Fu, R. Hagi, G. McDermott, M. Di Iorio, L. Masto, K. Vanni, E. Kowalski, G. Qian, Z. Wallace, A. Duarte-Garcia, J. Sparks |
| 496 |
[GO] |
2022―Jun―27 |
OP0247 RISK FACTORS FOR SEVERE COVID-19 OUTCOMES: A STUDY OF IMMUNE-MEDIATED INFLAMMATORY DISEASES, THERAPIES AND COMORBIDITIES IN A LARGE US HEALTHCARE SYSTEM |
P. J. Mease, Q. Wei, M. Chiorean, L. Iles-Shih, J. Hadlock |
| 497 |
[GO] |
2022―Jun―27 |
OP0061 TIGHT CONTROL IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TARGETED THERAPIES ACROSS THE COVID-19 PANDEMIC ERA |
A. F. Luppino, G. Cincinelli, F. Ingegnoli, A. Orenti, E. G. Favalli, P. Boracchi, R. Caporali |
| 498 |
[GO] |
2022―Jun―27 |
OP0133 THE DECREASE OF MUSCLE MASS BY THE BEHAVIORAL RESTRICTION OF COVID-19 PANDEMIC IN PATIENTS WITH RHEUMATOID ARTHRITIS |
M. Tada, Y. Yamada, K. Mandai, Y. Matsumoto, N. Hidaka |
| 499 |
[GO] |
2022―Jun―27 |
OP0197 POST-TRAUMATIC STRESS DISORDER AND SYMPTOMS IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES DURING THE COVID-19 PANDEMIC: PRELIMINARY RESULTS FROM THE PERMAS STUDY |
G. Fulvio, V. Pedrinelli, G. Andreozzi, F. Trentin, S. Fantasia, S. Fonzetti, C. Fustini, M. Da Rio, G. Cappellato, C. Cigolini, D. Schilirò, M. Maffi, L. Scagnellato, A. Valevich, F. Fattorini, I. C. Navarro García, I. Palla, V. Lorenzoni, A. Gaglioti, C. Carmassi, C. Tani, G. Turchetti, L. Dell’Osso, M. Mosca |
| 500 |
[GO] |
2022―Jun―27 |
OP0175 TYPE OF mRNA COVID-19 VACCINE AND TREATMENT INFLUENCE ANTIBODY KINETICS IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES |
C. E. Raptis, D. O. Andrey, C. Polysopoulos, C. Berger, A. Ciurea, P. Lescuyer, T. Maletic, M. Riek, A. Scherer, I. von Loga, J. Safford, K. Lauper, B. Moeller, N. Vuilleumier, A. Finckh, A. Rubbert-Roth |
| 501 |
[GO] |
2022―Jun―27 |
OP0174 T-CELL RESPONSE AFTER COVID-19 VACCINE IS NOT IMPAIRED BY EARLY RITUXIMAB TREATMENT OR BELIMUMAB IN SYSTEMIC AUTOIMMUNE DISORDERS |
G. De Marchi, M. Fabris, R. Domenis, S. Guella, N. Cabas, F. Caponnetto, A. P. Beltrami, S. De Vita, F. Curcio, L. Quartuccio |
| 502 |
[GO] |
2022―Jun―27 |
OP0172 THE IMPACT OF IMMUNOMODULATING TREATMENT ON THE IMMUNOGENICITY OF COVID-19 VACCINES IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY RHEUMATIC DISEASES COMPARED TO HEALTHY CONTROLS. A SWEDISH NATIONWIDE STUDY (COVID19-REUMA) |
M. Frodlund, K. Chatzidionysiou, A. Södergren, E. Klingberg, A. Bengtsson, L. Klareskog, M. C. Kapetanovic |
| 503 |
[GO] |
2022―Jun―14 |
Oral antiviral treatment in patients with systemic rheumatic disease at risk for development of severe COVID-19: a case series |
George E Fragoulis, Christos Koutsianas, Kalliopi Fragiadaki, Ilias Mariolis, Stylianos Panopoulos, Christina Tsalapaki, Maria Pappa, Theodoros Dimitroulas, Maria G Tektonidou, Dimitrios Vassilopoulos, Petros P Sfikakis |
| 504 |
[GO] |
2022―Jun―10 |
Correction: Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study |
|
| 505 |
[GO] |
2022―Apr―13 |
BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study |
Amir Bieber, Iftach Sagy, Lena Novack, Shay Brikman, Ran Abuhasira, Snait Ayalon, Irina Novofastovski, Mahmoud Abu-Shakra, Reuven Mader |
| 506 |
[GO] |
2022―Apr―13 |
Humoral immune-response to a SARS-CoV-2-BNT162b2 booster in inflammatory arthritis patients who received an inactivated virus vaccine |
Josefina Durán, Paula Isabel Burgos, Nicole Le Corre, Cinthya Ruiz Tagle, Constanza Martinez-Valdebenito, Mauricio Castro, Valentina Metcalfe, Paula Niemann, M Elvira Balcells |
| 507 |
[GO] |
2022―Apr―08 |
Severely impaired humoral response against SARS-CoV-2 variants of concern following two doses of BNT162b2 vaccine in patients with systemic lupus erythematosus (SLE) |
Arthur Mageau, Valentine Marie Ferré, Tiphaine Goulenok, Charlotte Charpentier, Nicole Delory, Chrystel Francois, Nadhira Houhou-Fidouh, Thomas Papo, Diane Descamps, Karim Sacre |
| 508 |
[GO] |
2022―Apr―07 |
In the shadow of antibodies: how T cells defend against COVID-19 |
David S Pisetsky, Kevin L Winthrop |
| 509 |
[GO] |
2022―Mrz―25 |
Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases |
Lianne Kearsley-Fleet, Min-Lee Chang, Saskia Lawson-Tovey, Ruth Costello, Šárka Fingerhutová, Natálie Švestková, Alexandre Belot, Florence A Aeschlimann, Isabelle Melki, Isabelle Koné-Paut, Sascha Eulert, Tilmann Kallinich, Yackov Berkun, Yosef Uziel, Bernd Raffeiner, Filipa Oliveira Ramos, Daniel Clemente, Christina Dackhammar, Nico M Wulffraat, Helen Waite, Anja Strangfeld, Elsa F Mateus, Pedro M Machado, Marc Natter, Kimme L Hyrich |
| 510 |
[GO] |
2022―Mrz―18 |
Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort study |
Peter Mandl, Selma Tobudic, Helmut Haslacher, Thomas Karonitsch, Daniel Mrak, Thomas Nothnagl, Thomas Perkmann, Helga Radner, Judith Sautner, Elisabeth Simader, Florian Winkler, Heinz Burgmann, Daniel Aletaha, Stefan Winkler, Stephan Blüml |
| 511 |
[GO] |
2022―Mrz―14 |
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases |
Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Fredrik N Albach, Jens Klotsche, Veronika Scholz, Lara Maria Jeworowski, Tatjana Schwarz, Alexander ten Hagen, Jan Zernicke, Victor Max Corman, Christian Drosten, Gerd-Rüdiger Burmester, Robert Biesen |
| 512 |
[GO] |
2022―Mrz―11 |
Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination |
Jie Lu, Yuwei He, Robert Terkeltaub, Mingshu Sun, Zijing Ran, Xinmiao Xu, Can Wang, Xinde Li, Shuhui Hu, Xiaomei Xue, Fei Yan, Hui Zhang, Huiyong Yin, Yongyong Shi, Nicola Dalbeth, Changgui Li |
| 513 |
[GO] |
2022―Mrz―11 |
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases |
Nádia Emi Aikawa, Leonard de Vinci Kanda Kupa, Ana Cristina Medeiros-Ribeiro, Carla Goncalves Schahin Saad, Emily Figueiredo Neves Yuki, Sandra Gofinet Pasoto, Priscila Tagliaferro Rojo, Rosa Maria Rodrigues Pereira, Samuel Katsuyuki Shinjo, Percival Degrava Sampaio-Barros, Danieli Castro Oliveira Andrade, Ari Stiel Radu Halpern, Ricardo Fuller, Fernando Henrique Carlos Souza, Lissiane Karine Noronha Guedes, Ana Paula Luppino Assad, Julio Cesar Bertacini de Moraes, Michelle Remiao Ugolini Lopes, Victor Adriano de Oliveira Martins, Lorena Betancourt, Carolina Torres Ribeiro, Lucas Peixoto Sales, Isabela Maria Bertoglio, Virginia Lucia Nazario Bonoldi, Renata Lys Pinheiro Mello, Gustavo Guimaraes Moreira Balbi, Ana Marli Christovam Sartori, Leila Antonangelo, Clóvis Artur Silva, Eloisa Bonfa |
| 514 |
[GO] |
2022―Feb―23 |
Efficacy of COVID-19 vaccines in patients taking immunosuppressants |
Chen Shen, Malcolm Risk, Elena Schiopu, Salim S Hayek, Tiankai Xie, Lynn Holevinski, Cem Akin, Gary Freed, Lili Zhao |
| 515 |
[GO] |
2022―Feb―23 |
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update |
Robert B M Landewé, Féline P B Kroon, Alessia Alunno, Aurélie Najm, Johannes WJ Bijlsma, Gerd-Rüdiger R Burmester, Roberto Caporali, Bernard Combe, Richard Conway, Jeffrey R Curtis, Ori Elkayam, Laure Gossec, Marloes W Heijstek, Lukas Haupt, Annamaria Iagnocco, John D Isaacs, István Ábel Juhász, Suzi Makri, Xavier Mariette, Iain B McInnes, Puja Mehta, Ulf Mueller-Ladner, Hendrik Schulze-Koops, Josef S Smolen, Dieter Wiek, Kevin L Winthrop, Victoria Navarro-Compán, Pedro M Machado |
| 516 |
[GO] |
2022―Feb―22 |
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial |
Carlo Scognamiglio Renner Araujo, Ana Cristina Medeiros-Ribeiro, Carla G S Saad, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, Andrea Yukie Shimabuco, Matheus Santos Rodrigues Silva, Emily Figueiredo Neves Yuki, Sandra Gofinet Pasoto, Tatiana Pedrosa, Leonard de Vinci Kanda Kupa, Gioanna Zou, Rosa M R Pereira, Clóvis Artur Silva, Nádia Emi Aikawa, Eloisa Bonfa |
| 517 |
[GO] |
2022―Feb―16 |
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance |
Manuel Francisco Ugarte-Gil, Graciela S Alarcón, Zara Izadi, Ali Duarte-García, Cristina Reátegui-Sokolova, Ann Elaine Clarke, Leanna Wise, Guillermo J Pons-Estel, Maria Jose Santos, Sasha Bernatsky, Sandra Lúcia Euzébio Ribeiro, Samar Al Emadi, Jeffrey A Sparks, Tiffany Y -T Hsu, Naomi J Patel, Emily L Gilbert, Maria O Valenzuela-Almada, Andreas Jönsen, Gianpiero Landolfi, Micaela Fredi, Tiphaine Goulenok, Mathilde Devaux, Xavier Mariette, Viviane Queyrel, Vasco C Romão, Graca Sequeira, Rebecca Hasseli, Bimba Hoyer, Reinhard E Voll, Christof Specker, Roberto Baez, Vanessa Castro-Coello, Hernan Maldonado Ficco, Edgard Torres Reis Neto, Gilda Aparecida Aparecida Ferreira, Odirlei Andre André Monticielo, Emily Sirotich, Jean Liew, Jonathan Hausmann, Paul Sufka, Rebecca Grainger, Suleman Bhana, Wendy Costello, Zachary S Wallace, Lindsay Jacobsohn, Tiffany Taylor, Clairissa Ja, Anja Strangfeld, Elsa F Mateus, Kimme L Hyrich, Loreto Carmona, Saskia Lawson-Tovey, Lianne Kearsley-Fleet, Martin Schäfer, Pedro M Machado, Philip C Robinson, Milena Gianfrancesco, Jinoos Yazdany |
| 518 |
[GO] |
2022―Feb―15 |
Rheumatoid arthritis disease activity assessed by patient-reported outcomes and flow cytometry before and after an additional dose of COVID-19 vaccine |
Sara K Tedeschi, Jacklyn Stratton, Jack Elias Ellrodt, Mary Grace Whelan, Keigo Hayashi, Kazuki Yoshida, Lin Chen, Ifeoluwakiisi Adejoorin, Kathryne Elizabeth Marks, A. Helena Jonsson, Deepak A Rao, Daniel H Solomon |
| 519 |
[GO] |
2022―Feb―10 |
Neutralisation of circulating SARS-CoV-2 delta and omicron variants by convalescent plasma and SARS-CoV-2 hyperimmune intravenous human immunoglobulins for treatment of COVID-19 |
Fatema Tuz Zahra, Lorenza Bellusci, Gabrielle Grubbs, Hana Golding, Surender Khurana |
| 520 |
[GO] |
2022―Feb―08 |
Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort |
Sakir Ahmed, Pankti Mehta, Aby Paul, S Anu, Somy Cherian, Veena Shenoy, Kaveri K Nalianda, Sanjana Joseph, Anagha Poulose, Padmanabha Shenoy |
| 521 |
[GO] |
2022―Feb―08 |
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis |
Ana Cristina Medeiros-Ribeiro, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, Andrea Yukie Shimabuco, Henrique Carriço da Silva, Carla G S Saad, Emily Figueiredo Neves Yuki, Sandra Gofinet Pasoto, Carlo Scognamiglio Renner Araujo, Tatiane Lie Nakai, Clóvis Artur Silva, Tatiana Pedrosa, Léonard de Vinci Kanda Kupa, Matheus Santos Rodrigues Silva, Guilherme Guimarães Moreira Balbi, Esper Georges Kallas, Nádia Emi Aikawa, Eloisa Bonfa |
| 522 |
[GO] |
2022―Feb―04 |
EULAR 2021 updated viewpoints on SARS-CoV-2 vaccination in patients with RMDs: a guidance to answer patients’ questions |
Johannes WJ Bijlsma |
| 523 |
[GO] |
2022―Jan―27 |
Has the gout epidemic peaked in the UK? A nationwide cohort study using data from the Clinical Practice Research Datalink, from 1997 to across the COVID-19 pandemic in 2021 |
Abhishek Abhishek, Laila J Tata, Mamas Mamas, Anthony J Avery |
| 524 |
[GO] |
2022―Jan―17 |
Attenuated response to fourth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series |
Mayan Teles, Caoilfhionn M Connolly, Sarah Frey, Teresa Po-Yu Chiang, Jennifer J Alejo, Brian J Boyarsky, Ami A Shah, Jemima Albayda, Lisa Christopher-Stine, William A Werbel, Dorry L Segev, Julie J Paik |
| 525 |
[GO] |
2022―Jan―13 |
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial |
Michael Bonelli, Daniel Mrak, Selma Tobudic, Daniela Sieghart, Maximilian Koblischke, Peter Mandl, Barbara Kornek, Elisabeth Simader, Helga Radner, Thomas Perkmann, Helmuth Haslacher, Margareta Mayer, Philipp Hofer, Kurt Redlich, Emma Husar-Memmer, Ruth Fritsch-Stork, Renate Thalhammer, Karin Stiasny, Stefan Winkler, Josef S Smolen, Judith H Aberle, Markus Zeitlinger, Leonhard X Heinz, Daniel Aletaha |
| 526 |
[GO] |
2022―Jan―10 |
Third COVID-19 vaccine dose with BNT162b2 in patients with ANCA-associated vasculitis |
Claudius Speer, Maximilian Töllner, Louise Benning, Katrin Klein, Marie Bartenschlager, Christian Nusshag, Florian Kälble, Paula Reichel, Paul Schnitzler, Martin Zeier, Christian Morath, Wilhelm H Schmitt, Raoul Bergner, Ralf Bartenschlager, Matthias Schaier |
| 527 |
[GO] |
2021―Dez―31 |
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry |
Pedro M Machado, Saskia Lawson-Tovey, Anja Strangfeld, Elsa F Mateus, Kimme L Hyrich, Laure Gossec, Loreto Carmona, Ana Rodrigues, Bernd Raffeiner, Catia Duarte, Eric Hachulla, Eric Veillard, Eva Strakova, Gerd R Burmester, Gözde Kübra Yardımcı, Jose A Gomez-Puerta, Julija Zepa, Lianne Kearsley-Fleet, Ludovic Trefond, Maria Cunha, Marta Mosca, Martina Cornalba, Martin Soubrier, Nicolas Roux, Olivier Brocq, Patrick Durez, Richard Conway, Tiphaine Goulenok, Johannes WJ Bijlsma, Iain B McInnes, Xavier Mariette |
| 528 |
[GO] |
2021―Dez―10 |
Survival after COVID-19-associated organ failure among inpatients with systemic lupus erythematosus in France: a nationwide study |
Arthur Mageau, Thomas Papo, Stephane Ruckly, Andrey Strukov, Damien van Gysel, Karim Sacre, Jean-François Timsit |
| 529 |
[GO] |
2021―Dez―07 |
Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations |
Féline P B Kroon, Aurélie Najm, Alessia Alunno, Jan W Schoones, Robert B M Landewé, Pedro M Machado, Victoria Navarro-Compán |
| 530 |
[GO] |
2021―Nov―29 |
Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors |
Dimitra Dimopoulou, George Vartzelis, Foteini Dasoula, Maria Tsolia, Despoina Maritsi |
| 531 |
[GO] |
2021―Nov―29 |
Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis |
Elisabeth Simader, Selma Tobudic, Peter Mandl, Helmuth Haslacher, Thomas Perkmann, Thomas Nothnagl, Judith Sautner, Helga Radner, Florian Winkler, Heinz Burgmann, Daniel Mrak, Daniel Aletaha, Stefan Winkler, Stephan Blüml |
| 532 |
[GO] |
2021―Nov―26 |
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases |
Francesco Ursini, Piero Ruscitti, Vincenzo Raimondo, Rossella De Angelis, Fabio Cacciapaglia, Erika Pigatto, Domenico Olivo, Ilenia Di Cola, Felice Galluccio, Francesca Francioso, Rosario Foti, Antonio Tavoni, Salvatore D'Angelo, Corrado Campochiaro, Francesca Motta, Maria De Santis, Silvia Bilia, Caterina Bruno, Giacomo De Luca, Marcella Visentini, Jacopo Ciaffi, Luana Mancarella, Veronica Brusi, Martina D’Onghia, Giovanna Cuomo, Enrico Fusaro, Lorenzo Dagna, Serena Guiducci, Riccardo Meliconi, Florenzo Iannone, Annamaria Iagnocco, Roberto Giacomelli, Clodoveo Ferri |
| 533 |
[GO] |
2021―Nov―25 |
Safety and disease flare of autoimmune inflammatory rheumatic diseases: a large real-world survey on inactivated COVID-19 vaccines |
Yong Fan, Yan Geng, Yu Wang, Xuerong Deng, Guangtao Li, Juan Zhao, Lanlan Ji, Xiaohui Zhang, Zhibo Song, Haoze Zhang, Xiaoying Sun, Dai Gao, Wenhui Xie, Hong Huang, YanJie Hao, Zhuoli Zhang |
| 534 |
[GO] |
2021―Nov―24 |
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2 |
Marcella Visentini, Laura Gragnani, Stefano Angelo Santini, Teresa Urraro, Annalisa Villa, Monica Monti, Andrea Palladino, Luisa Petraccia, Francesca La Gualana, Serena Lorini, Silvia Marri, Francesco Madia, Lucia Stefanini, Stefania Basili, Massimo Fiorilli, Clodoveo Ferri, Anna Linda Zignego, Milvia Casato |
| 535 |
[GO] |
2021―Nov―24 |
Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease |
David Simon, Koray Tascilar, Filippo Fagni, Katja Schmidt, Gerhard Krönke, Arnd Kleyer, Andreas Ramming, Verena Schoenau, Daniela Bohr, Johannes Knitza, Thomas Harrer, Karin Manger, Bernhard Manger, Georg Schett |
| 536 |
[GO] |
2021―Nov―22 |
Response to: Correspondence on ‘Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients’ by Trahtemberg et al |
Marvin J Fritzler, Uriel Trahtemberg |
| 537 |
[GO] |
2021―Nov―22 |
Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19? |
Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Johan Askling |
| 538 |
[GO] |
2021―Nov―22 |
Correspondence on ‘Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients’ by Trahtemberg et al |
Yudong Liu |
| 539 |
[GO] |
2021―Nov―10 |
Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases |
Charalampos Papagoras, George E Fragoulis, Nikoleta Zioga, Theodora Simopoulou, Kleopatra Deftereou, Eleni Kalavri, Evangelia Zampeli, Nafsika Gerolymatou, Evangelia Kataxaki, Konstantinos Melissaropoulos, Stylianos Panopoulos, Kalliopi Fragiadaki, Gerasimos Evangelatos, Vasiliki-Kalliopi Bournia, Aikaterini Arida, Anastasios Karamanakos, Maria Pappa, Alexandros Panagiotopoulos, Christos Koutsianas, Georgia Mparouta, Theodoros Dimitroulas, Stamatis-Nick Liossis, Maria G Tektonidou, Evrydiki Kravvariti, Nikolaos Kougkas, Panagiotis Georgiou, Paraskevi Voulgari, Antonia Elezoglou, Dimitrios P Bogdanos, Dimitrios Vassilopoulos, Petros P Sfikakis |
| 540 |
[GO] |
2021―Okt―10 |
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 |
Alessia Alunno, Aurélie Najm, Pedro M Machado, Heidi Bertheussen, Gerd-Rüdiger R Burmester, Francesco Carubbi, Gabriele De Marco, Roberto Giacomelli, Olivier Hermine, John D Isaacs, Isabelle Koné-Paut, César Magro-Checa, Iain B McInnes, Pier Luigi Meroni, Luca Quartuccio, A V Ramanan, Manuel Ramos-Casals, Javier Rodríguez Carrio, Hendrik Schulze-Koops, Tanja A Stamm, Sander W Tas, Benjamin Terrier, Dennis G McGonagle, Xavier Mariette |
| 541 |
[GO] |
2021―Okt―05 |
BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus |
Quentin Moyon, Delphine Sterlin, Makoto Miyara, François Anna, Alexis Mathian, Raphael Lhote, Pascale Ghillani-Dalbin, Paul Breillat, Sasi Mudumba, Sophia de Alba, Fleur Cohen-aubart, Julien Haroche, Micheline Pha, Thi Huong Du Boutin, Hedi Chaieb, Pedro Macedo Flores, Pierre Charneau, Guy Gorochov, Zahir Amoura |
| 542 |
[GO] |
2021―Sep―23 |
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics |
Renaud Felten, Pierre-Marie Duret, Elodie Bauer, Nathanael Sedmak, Julien H Djossou, Massiva Bensalem, Marc Ardizzone, Marion Geoffroy, Angelique Fan, Marion Couderc, Jean Hugues Salmon, Laurent Messer, Rose-Marie Javier, Alain Meyer, Emmanuel Chatelus, Christelle Sordet, Luc Pijnenburg, Jérémy Fort, Marina Rinagel, Julia Walther, Cassandre Fabre, Laurent Arnaud, Jean Sibilia, Nicolas Meyer, Francis Berenbaum, isabelle Chary-Valckenaere, Martin Soubrier, Jérémie Sellam, Jacques-Eric Gottenberg |
| 543 |
[GO] |
2021―Sep―23 |
Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series |
Caoilfhionn M Connolly, Teresa Po-Yu Chiang, Brian J Boyarsky, Jake A Ruddy, Mayan Teles, Jennifer L Alejo, Allan Massie, William A Werbel, Ami A Shah, Lisa Christopher-Stine, Jacqueline Garonzik-Wang, Dorry L Segev, Julie J Paik |
| 544 |
[GO] |
2021―Sep―13 |
SARS-CoV-2 and the rheumatology patient: the last 12 months and a boost in the future |
Kevin L Winthrop, Richard J Whitley, Daniel Aletaha |
| 545 |
[GO] |
2021―Sep―07 |
Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series |
Caoilfhionn M Connolly, Mayan Teles, Sarah Frey, Brian J Boyarsky, Jennifer L Alejo, William A Werbel, Jemima Albayda, Lisa Christopher-Stine, Jacqueline Garonzik-Wang, Dorry L Segev, Julie J Paik |
| 546 |
[GO] |
2021―Sep―06 |
Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases |
Claire Cook, Naomi J Patel, Kristin M. D’Silva, Tiffany Y -T Hsu, Michael DiIorio, Lauren Prisco, Lily W Martin, Kathleen Vanni, Alessandra Zaccardelli, Derrick Todd, Jeffrey A Sparks, Zachary Scott Wallace |
| 547 |
[GO] |
2021―Sep―06 |
SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases |
Saskia Lawson-Tovey, Kimme L Hyrich, Laure Gossec, Anja Strangfeld, Loreto Carmona, Bernd Raffeiner, Gözde Kübra Yardımcı, Ludovic Trefond, Nicolas Roux, Ana Rodrigues, Charalampos Papagoras, Elsa F Mateus, Xavier Mariette, Pedro M Machado |
| 548 |
[GO] |
2021―Aug―24 |
Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases |
Teresa Po-Yu Chiang, Caoilfhionn M Connolly, Jake A Ruddy, Brian J Boyarsky, Jennifer L Alejo, William A Werbel, Allan Massie, Lisa Christopher-Stine, Jacqueline Garonzik-Wang, Dorry L Segev, Julie J Paik |
| 549 |
[GO] |
2021―Aug―23 |
Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance physician registry” by Sparks et al |
Elisa Gremese, Gianfranco Ferraccioli |
| 550 |
[GO] |
2021―Aug―23 |
Response to: Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis” by Sparks et al |
Zachary S Wallace, Jeffrey A Sparks, Philip C Robinson, Pedro M Machado, Jinoos Yazdany |
| 551 |
[GO] |
2021―Aug―13 |
Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance physician registry” by Sparks et al |
Ronald F van Vollenhoven, Sander W Tas, Michael T Nurmohamed |
| 552 |
[GO] |
2021―Aug―13 |
Response to: Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis” by Sparks et al |
Jeffrey A Sparks, Zachary S Wallace, Andrea M Seet, Philip C Robinson, Pedro M Machado, Jinoos Yazdany |
| 553 |
[GO] |
2021―Aug―06 |
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression |
Maria Prendecki, Candice Clarke, Helena Edwards, Stacey McIntyre, Paige Mortimer, Sarah Gleeson, Paul Martin, Tina Thomson, Paul Randell, Anand Shah, Aran Singanayagam, Liz Lightstone, Alison Cox, Peter Kelleher, Michelle Willicombe, Stephen P McAdoo |
| 554 |
[GO] |
2021―Aug―02 |
Antiphospholipid antibodies and COVID-19 thrombotic vasculopathy: one swallow does not make a summer |
Pier Luigi Meroni, Maria Orietta Borghi |
| 555 |
[GO] |
2021―Jul―20 |
Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System |
Maximilian Pistor, Andreas G F Hoepner, Yanan Lin, Simon Jung, Claudio L Bassetti, Andrew Chan, Anke Salmen, Robert Hoepner |
| 556 |
[GO] |
2021―Jul―20 |
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity |
Daniel Mrak, Selma Tobudic, Maximilian Koblischke, Marianne Graninger, Helga Radner, Daniela Sieghart, Philipp Hofer, Thomas Perkmann, Helmuth Haslacher, Renate Thalhammer, Stefan Winkler, Stephan Blüml, Karin Stiasny, Judith H Aberle, Josef S Smolen, Leonhard X Heinz, Daniel Aletaha, Michael Bonelli |
| 557 |
[GO] |
2021―Jul―16 |
Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report |
Basil Golding, Youri Lee, Hana Golding, Surender Khurana |
| 558 |
[GO] |
2021―Jul―02 |
Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey’ |
Fernando Montero, Isabel Castrejón, Julia Martínez-Barrio, Juan Carlos Nieto-González, Javier Rivera, José María Álvaro-Gracia, Juan Molina Collada |
| 559 |
[GO] |
2021―Jul―02 |
Response to ‘Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey’’ by Montero et al |
Alessandro Tomelleri, Lorenzo Dagna, Corrado Campochiaro |
| 560 |
[GO] |
2021―Jun―29 |
Unexpected impact of COVID-19 lockdown on spinal mobility and health perception in spondyloarthritis |
Sophie De Mits, Ann-Sophie De Craemer, Liselotte Deroo, Thomas Renson, Filip E Van den Bosch, Philippe Carron, Dirk Elewaut |
| 561 |
[GO] |
2021―Jun―25 |
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis |
Serena Bugatti, Ludovico De Stefano, Silvia Balduzzi, Maria Immacolata Greco, Terenzj Luvaro, Irene Cassaniti, Laura Bogliolo, Iolanda Mazzucchelli, Bernardo D’Onofrio, Michele di Lernia, Eleonora Mauric, Daniele Lilleri, Fausto Baldanti, Antonio Manzo, Carlomaurizio Montecucco |
| 562 |
[GO] |
2021―Jun―23 |
Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study’’ by Klopfenstein et al |
Robert BM Landewé, Sofia Ramiro, Rémy L M Mostard |
| 563 |
[GO] |
2021―Jun―23 |
Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’ |
Timothée Klopfenstein, Vincent Gendrin, Thierry Conrozier, Aurélie Gerazime, Marc Puyraveau, Souheil Zayet |
| 564 |
[GO] |
2021―Jun―22 |
Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City |
Medha Barbhaiya, Jonah M. Levine, Vivian P. Bykerk, Deanna Jannat-Khah, Lisa A. Mandl |
| 565 |
[GO] |
2021―Jun―18 |
Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2 |
Yolanda Braun-Moscovici, Marielle Kaplan, Maya Braun, Doron Markovits, Samy Giryes, Kohava Toledano, Yonit Tavor, Katya Dolnikov, Alexandra Balbir-Gurman |
| 566 |
[GO] |
2021―Jun―14 |
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study |
Victoria Furer, Tali Eviatar, Devy Zisman, Hagit Peleg, Daphna Paran, David Levartovsky, Michael Zisapel, Ofir Elalouf, Ilana Kaufman, Roni Meidan, Adi Broyde, Ari Polachek, Jonathan Wollman, Ira Litinsky, Katya Meridor, Hila Nochomovitz, Adi Silberman, Dana Rosenberg, Joy Feld, Amir Haddad, Tal Gazzit, Muna Elias, Nizar Higazi, Fadi Kharouf, Gabi Shefer, Orly Sharon, Sara Pel, Sharon Nevo, Ori Elkayam |
| 567 |
[GO] |
2021―Jun―07 |
Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals |
Oleg Melikhov, Tatiana Kruglova, Karine Lytkina, Georgy Melkonyan, Elena Prokhorovich, Gleb Putsman, Grigory Rodoman, Arkady Vertkin, Alena Zagrebneva, Justin Stebbing |
| 568 |
[GO] |
2021―Mai―28 |
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry |
Jeffrey A Sparks, Zachary S Wallace, Andrea M Seet, Milena A Gianfrancesco, Zara Izadi, Kimme L Hyrich, Anja Strangfeld, Laure Gossec, Loreto Carmona, Elsa F Mateus, Saskia Lawson-Tovey, Laura Trupin, Stephanie Rush, Patricia Katz, Gabriela Schmajuk, Lindsay Jacobsohn, Leanna Wise, Emily L Gilbert, Ali Duarte-García, Maria O Valenzuela-Almada, Guillermo J Pons-Estel, Carolina A Isnardi, Guillermo A Berbotto, Tiffany Y -T Hsu, Kristin M D’Silva, Naomi J Patel, Lianne Kearsley-Fleet, Martin Schäfer, Sandra Lúcia Euzébio Ribeiro, Samar Al Emadi, Liselotte Tidblad, Carlo Alberto Scirè, Bernd Raffeiner, Thierry Thomas, René-Marc Flipo, Jérôme Avouac, Raphaèle Seror, Miguel Bernardes, Maria Margarida Cunha, Rebecca Hasseli, Hendrik Schulze-Koops, Ulf Müller-Ladner, Christof Specker, Viviane Angelina de Souza, Licia Maria Henrique da Mota, Ana Paula Monteiro Gomides, Philippe Dieudé, Elena Nikiphorou, Vanessa L Kronzer, Namrata Singh, Manuel F Ugarte-Gil, Beth Wallace, Akpabio Akpabio, Ranjeny Thomas, Suleman Bhana, Wendy Costello, Rebecca Grainger, Jonathan S Hausmann, Jean W Liew, Emily Sirotich, Paul Sufka, Philip C Robinson, Pedro M Machado, Jinoos Yazdany |
| 569 |
[GO] |
2021―Mai―28 |
SARS-COV-2 vaccination after stem cell transplantation for scleroderma |
Doron Rimar, Gleb slobodin, Alona Paz, Israel Henig, Tsila Zuckerman |
| 570 |
[GO] |
2021―Mai―26 |
POS1464-HPR ASSESSMENT OF EMOTIONAL WELL-BEING IN RHEUMATIC PATIENTS DURING COVID-19 LOCKDOWN THROUGH A WEB-BASED SURVEY APPROACH |
C. Iannuccelli, B. Lucchino, C. Gioia, A. Gattamelata, F. Giardina, M. DI Franco, R. Priori, F. Conti |
| 571 |
[GO] |
2021―Mai―26 |
POS1468-HPR THE IMPACT OF COVID-19 ON RHEUMATOLOGY HEALTH CARE WORKERS AND THEIR SCIENTIFIC OUTPUT: HEAVY LIES THE CROWN ON FEMALE RHEUMATOLOGISTS |
C. Kirchler, M. R. Andrews, E. Mosor, K. Thaler, T. Stamm, R. Fritsch-Stork, C. Duftner |
| 572 |
[GO] |
2021―Mai―26 |
AB0690 HOW DID COVID-19 AFFECT PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES TREATED WITH DMARDs - EXPERIENCE FROM A ROMANIAN RHEUMATOLOGY HOSPITAL |
A. Trandafir, I. Saulescu, A. Balanescu, D. Opris-Belinski, V. Bojinca, F. Berghea, D. Mazilu, S. Daia-Iliescu, D. Predeteanu, A. Borangiu, L. Groseanu, M. M. Negru, C. L. Constantinescu, M. Abobului, V. Violeta, R. Ionescu |
| 573 |
[GO] |
2021―Mai―26 |
POS1466-HPR IMPACT OF COVID-19 PANDEMIC ON ADHERENCE BEHAVIOR OF LATIN-AMERICAN PATIENTS WITH RHEUMATIC DISEASES |
I. A. Moreno-Arquieta, G. G. Sánchez Mendieta, D. E. Flores Alvarado, J. A. Esquivel Valerio, D. Á. Galarza-Delgado |
| 574 |
[GO] |
2021―Mai―26 |
POS1463-HPR IMPACT OF COVID-19 PANDEMIC ON DISEASE ACTIVITY AND EMOTIONAL WELL-BEING AMONG RHEUMATOID ARTHRITIS PATIENTS: A TELEMEDICINE STUDY |
B. Lucchino, C. Iannuccelli, C. Gioia, G. Dolcini, M. DI Franco |
| 575 |
[GO] |
2021―Mai―26 |
AB0668 THE ONSET OF RHEUMATOID ARTHRITIS AFTER COVID-19 - COINCIDENCE OR CONNECTED? |
V. Derksen, T. Kissel, F. Lamers-Karnebeek, A. Van der Bijl, A. C. Venhuizen, T. Huizinga, R. Toes, A. H. E. Roukens, D. Van der Woude |
| 576 |
[GO] |
2021―Mai―26 |
AB0702 PITFALLS IN THE DIAGNOSIS OF COVID-19 - EXPERIENCES FROM A RHEUMATOLOGY OUTPATIENT CLINIC |
S. G. Werner, H. E. Langer, P. Höhenrieder, R. Chatelain |
| 577 |
[GO] |
2021―Mai―26 |
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease |
Rebecca H Haberman, Ramin Herati, David Simon, Marie Samanovic, Rebecca B Blank, Michael Tuen, Sergei Koralov, Raja Atreya, Koray Tascilar, Joseph Allen, Rochelle Castillo, Amber Cornelius, Paula Rackoff, Gary Solomon, Samrachana Adhikari, Natalie Azar, Pamela Rosenthal, Peter Izmirly, Jonathan Samuels, Brian Golden, Soumya M Reddy, Markus Neurath, Steven B Abramson, Georg Schett, Mark Mulligan, Jose U Scher |
| 578 |
[GO] |
2021―Mai―26 |
AB0694 COVID-19 İNFECTION IN PATIENTS WITH RHEUMATIC DISEASES: TWO CENTERS EXPERIENCE |
A. Şahin, M. A. Gedikli, M. E. Derin, B. Karakaş, B. Karataş, N. Çabuk Çelik, İ. Yalçin |
| 579 |
[GO] |
2021―Mai―26 |
POS1458-HPR DIGITAL RHEUMATOLOGY IN THE ERA OF COVID-19: RESULTS OF A NATIONAL PATIENT AND PHYSICIAN SURVEY |
A. Kernder, H. Morf, P. Klemm, D. Vossen, M. Meyer, I. Haase, J. Mucke, A. Kleyer, P. Sewerin, G. Bendzuck, S. Eis, J. Knitza, M. Krusche |
| 580 |
[GO] |
2021―Mai―26 |
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group |
Francesco Ursini, Piero Ruscitti, Salvatore D'Angelo, Fabio Cacciapaglia, Rossella De Angelis, Corrado Campochiaro, Francesco Caso, Maria De Santis, Ilenia Di Cola, Simone Parisi, Vincenzo Raimondo, Giuseppina Abignano, Luisa Costa, Jacopo Ciaffi, Lorenzo Dagna, Annamaria Iagnocco, Florenzo Iannone, Riccardo Meliconi, Roberto Giacomelli, Clodoveo Ferri |
| 581 |
[GO] |
2021―Mai―26 |
POS1491-HPR MENTAL HEALTH OUTCOMES AMONG HEALTH CARE WORKERS DURING THE CORONAVIRUS-19 PANDEMIC |
O. Hamdi, M. Sellami, S. Miladi, A. Fazaa, L. Souabni, K. Ouenniche, S. Kassab, S. Chekili, K. Ben Abdelghani, A. Laatar |
| 582 |
[GO] |
2021―Mai―26 |
POS1422 CORRELATES OF TESTING POSITIVE FOR SARS-COV-2 IN PATIENTS WITH RHEUMATIC AD MUSCULOSKELETAL DISEASES |
N. Singh, I. Huang, M. Singleton, A. Bays, J. Sabo, S. Chung, G. Gardner, J. Schaeffer, K. Wysham, J. Andrews, R. Patel, J. Simard, J. Liew |
| 583 |
[GO] |
2021―Mai―26 |
POS1496-HPR IS NUTRITIONAL FOLLOW-UP IN PATIENTS LIVING WITH RHEUMATOID ARTHRITIS BETTER WITH TELECONSULTATION? - EXPERIENCE BEFORE AND AFTER PANDEMIC |
I. Mozo, M. Marquez, O. Valencia |
| 584 |
[GO] |
2021―Mai―26 |
Challenges in the diagnosis of early rheumatoid arthritis in times of COVID-19 |
Bernardo D'Onofrio, Ludovico De Stefano, Bianca Lucia Palermo, Blerina Xoxi, Antonio Manzo, Carlomaurizio Montecucco, Serena Bugatti |
| 585 |
[GO] |
2021―Mai―26 |
AB0673 THE ROUTINE HEALTH CARE OF PATIENTS WITH RHEUMATIC DISEASES DURING THE PANDEMIC OF COVID-19 |
S. Mariem, M. Yasmine, S. Miladi, A. Fazaa, L. Souebni, K. Ouenniche, S. Kassab, S. Chekili, K. Ben Abdelghani, A. Laatar |
| 586 |
[GO] |
2021―Mai―26 |
AB0682 RHEUMATOLOGY TEACHING IN TIMES OF COVID-19 |
Y. Chang, J. Nicholls |
| 587 |
[GO] |
2021―Mai―26 |
AB0681 HOW COMMON IS COVID-19 IN CHILDREN, YOUNG PEOPLE AND ADULTS WITH RHEUMATIC DISEASES? RESULTS FROM THE INTERNATIONAL COVID-19 EUROPEAN PATIENT REGISTRY |
S. Shoop-Worrall, S. Verstappen, W. Costello, S. Angevare, Y. Uziel, C. Wouters, N. Wulffraat, R. Beesley |
| 588 |
[GO] |
2021―Mai―26 |
AB0674 RAPID ADOPTION OF TELEMEDICINE IN RHEUMATOLOGY TRAINING: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE TRAINEE SURVEY |
S. A. Yeoh, K. Young, M. Putman, E. Graef, F. Berenbaum, R. Conway, R. Grainger, A. Kilian, M. Konig, J. Liew, P. M. Machado, S. E. Sattui, J. Sparks, P. Sufka, M. Ugarte-Gil, L. Upton, Z. Wallace, J. Yazdany, A. Jayatilleke |
| 589 |
[GO] |
2021―Mai―26 |
AB0670 THE COURSE AND OUTCOMES OF COVID-19 IN PATIENTS WITH ANCA-ASSOCIATED SYSTEMIC VASCULITIS, RECEIVING ANTI-B CELL THERAPY WITH RITUXIMAB |
T. Beketova, V. Babak, M. Suprun |
| 590 |
[GO] |
2021―Mai―26 |
AB0695 PATTERN OF COVID-19 IN PATIENTS WITH RHEUMATIC DISEASES UNDERGOING BIOLOGICAL THERAPY: A COHORT EXPERIENCE |
C. Ancuta, C. Pomirleanu, G. Strugariu, L. Petrariu, E. Ancuta, C. Bran, R. Chirieac, C. Mihailov |
| 591 |
[GO] |
2021―Mai―26 |
AB0705 SHORT-TERM OUTCOMES OF COVID-19 IN PATIENTS WITH RHEUMATIC DISEASES WHO ARE TREATED BY BIOLOGICAL AND TARGETED SYNTHETIC DMARDS: OBSERVATIONAL SINGLE-CENTER STUDY |
E. Luchikhina, D. Karateev, O. Semenova, O. Matveychuk, T. Kuznetsova |
| 592 |
[GO] |
2021―Mai―26 |
AB0689 INCIDENCE AND SEVERITY OF COVID-19 IN PATIENTS WITH SPONDYLOARTHRITIS IN ARGENTINA: EXPERIENCE IN A COUNTRY WITH STRICT ISOLATION |
V. Martire, C. Airoldi, M. S. Gálvez Elkin, M. Machado Escobar, N. Callahuara, V. Duarte, J. Alcivar Navarrete, E. Buschiazzo, E. Saturansky, M. J. Gamba, P. Girard Bosch, D. Zelaya, R. Garcia Salinas, M. A. Medina, M. Cosatti, S. Scarafia, M. L. Acosta Felquer, V. Cosentino, F. Sommerfleck, R. Luis, G. P. Pendon, R. Águila Maldonado, S. Nasi, R. Nieto, L. Abbas, D. Vila, E. Kerzberg, M. Benegas |
| 593 |
[GO] |
2021―Mai―26 |
AB0658 FEAR OF COVID-19 IN POSTPARTUM WOMEN WITH RHEUMATIC DISEASE |
L. G. Espinosa Banuelos, M. E. Corral Trujillo, C. M. Skinner Taylor, L. Pérez Barbosa, R. A. Rodriguez Chavez, A. Y. Lujano Negrete, R. Moyeda Martinez, A. Cárdenas, D. Á. Galarza-Delgado |
| 594 |
[GO] |
2021―Mai―26 |
AB0653 COURSE OF COVID-19 INFECTION IN A SERIES OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
C. Cetin, N. Aliyeva, Y. Yalçinkaya, A. Gül, M. Inanc, B. Artim-Esen |
| 595 |
[GO] |
2021―Mai―26 |
AB0703 THE COURSE OF COVID-19 INFECTION IN PATIENTS WITH ARTHRITIS RECEIVING TARGETED DMARDS |
E. Koltsova, G. Lukina, E. Shmidt, K. Lytkina, E. Rozochkina, E. Zhilyaev |
| 596 |
[GO] |
2021―Mai―26 |
AB0688 SEVERITY OF COVID-19 INFECTION IN RHEUMATIC IMMUNE-MEDIATEDINFLAMMATORY DISEASES. STUDY IN A SINGLE UNIVERSITY HOSPITAL |
D. Martínez-López, D. Prieto-Peña, L. Sanchez-Bilbao, A. Herrero-Morant, C. Álvarez-Reguera, M. Trigueros-Vazquez, M. A. González-Gay, R. Blanco |
| 597 |
[GO] |
2021―Mai―26 |
AB0692 REACTIVE ARTHRITIS ASSOCIATED WITH COVID-19 INFECTION: A REVIEW |
F. Alkindi, K. Alseiari, K. Al Naqbi |
| 598 |
[GO] |
2021―Mai―26 |
AB0667 A PROSPECTIVE STUDY INTO COVID-19 LIKE SYMPTOMS IN PATIENTS WITH AND WITHOUT IMMUNE MEDIATED INFLAMMATORY DISEASES OR IMMUNOMODULATING DRUGS |
L. van Ouwerkerk, A. Van der Meulen, M. Ninaber, Y. K. O. Teng, T. Huizinga, C. Allaart |
| 599 |
[GO] |
2021―Mai―26 |
AB0655 RHEUMATOID ARTHRITIS ACTIVITY BEFORE AND AFTER COVID-19 LOCKDOWN PERIOD |
M. Jordhani, D. Ruci, F. Skana, E. Memlika |
| 600 |
[GO] |
2021―Mai―26 |
AB0872-HPR IMPACT OF COVID-19 ON A PHYSICAL ACTIVITY FEASIBILITY PILOT STUDY: THE PIPPRA EXPERIENCE |
L. Larkin, A. Moses, S. Gallagher, A. Fraser, B. A. Esbensen, J. Green, L. Glynn, N. Kennedy |
| 601 |
[GO] |
2021―Mai―26 |
AB0687 EFFECT OF COVID-19 ON PATIENTS ATTENDING AMBULATORY DEEP VENOUS THROMBOSIS OUT-PATIENT CLINIC: A RETROSPECTIVE, COHORT ANALYSIS[KI1] [KI1]101 CHARACTERS |
T. Hill, K. P. Iyengar, A. Nune |
| 602 |
[GO] |
2021―Mai―26 |
AB0685 IMPACT OF COVID-19 ON PATIENTS WITH RHEUMATIC DISEASES: EXPERIENCE OF THE DEPARTMENT OF RHEUMATOLOGY OF THE UNIVERSITY HOSPITAL OF IBN ROCHD OF CASABLANCA |
H. El Moutaouakil, Z. El Ouali, K. Nassar, S. Janani |
| 603 |
[GO] |
2021―Mai―26 |
AB0664 THE PSYCHOLOGICAL STATE OF THE PATIENTS WITH RHEUMATIC DISEASES AND HOSPITAL WORKERS DURING THE CORONAVIRUS DISEASE (COVID-19) OUTBREAK |
T. Lisitsyna, D. Veltishchev, A. Borisova, E. Nasonov, A. Lila |
| 604 |
[GO] |
2021―Mai―26 |
AB0651 CASE-REPORT: ORGANIZING PNEUMONIA IN A PREGNANT WOMAN WITH RHEUMATOID ARTHRITIS DURING COVID-19 PANDEMIC |
A. Cornillie, C. Grivegnee |
| 605 |
[GO] |
2021―Mai―26 |
AB0657 PERCEIVED STRESS AND FOOD INSECURITY IN PREGNANT AND POSTPARTUM WOMEN WITH RHEUMATIC DISEASES DURING THE COVID-19 PANDEMIC |
L. G. Espinosa Banuelos, P. R. Ancer Rodríguez, M. G. Herrera López, C. M. Skinner Taylor, L. Pérez Barbosa, R. Moyeda Martinez, R. A. Rodriguez Chavez, A. Y. Lujano Negrete, A. Cárdenas, D. Á. Galarza-Delgado |
| 606 |
[GO] |
2021―Mai―26 |
AB0868-HPR ADHERENCE TO DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATIC DISEASES DURING COVID-19 PANDEMIC |
I. A. Moreno-Arquieta, G. G. Sánchez Mendieta, D. E. Flores Alvarado, J. A. Esquivel Valerio, D. Á. Galarza-Delgado |
| 607 |
[GO] |
2021―Mai―26 |
AB0877-HPR EXERCISE COMPLIANCE AND DISEASE STATUS IN PATIENTS WITH RHEUMATIC DISEASES DURING COVID-19 PANDEMIC |
G. G. Pala, Z. Tuna, N. G. Tore, S. Bayram, F. Sarİ, M. A. Ozturk, D. Oskay |
| 608 |
[GO] |
2021―Mai―26 |
AB0903-HPR DURATION OF TELEPHONE CONSULTATIONS AMONGST RHEUMATOLOGY PRACTITIONERS IN A DISTRICT GENERAL HOSPITAL - ADAPTING TO REMOTE CONSULTATION IN A COVID-19 PANDEMIC |
L. Parker, F. Coldstream |
| 609 |
[GO] |
2021―Mai―26 |
AB0908-HPR SIGNED, SEALED, DELIVERED: PHARMACISTS ACHIEVING BETTER CARE CLOSER TO HOME IN RHEUMATOLOGY HIGH COST DRUG MANAGEMENT DURING THE COVID-19 PANDEMIC |
S. Gohil |
| 610 |
[GO] |
2021―Mai―26 |
AB0920-PARE WHAT WE LEARNED DURING COVID-19 PANDEMIC |
J. Grygielska |
| 611 |
[GO] |
2021―Mai―26 |
AB0677 GENDER DIFFERENCES ON THE IMPACT OF THE COVID-19 PANDEMIC AND LOCKDOWN IN PATIENTS WITH RHEUMATIC DISEASES. RESULTS FROM THE REUMAVID STUDY (PHASE 1) |
M. Garrido-Cumbrera, H. Marzo-Ortega, L. Christen, L. Carmona, J. Correa-Fernández, S. Sanz-Gómez, P. Plazuelo-Ramos, S. Makri, E. Mateus, S. Mingolla, K. Antonopoulou, L. Grange, C. Jacklin, D. Webb, S. Irwin, V. Navarro-Compán |
| 612 |
[GO] |
2021―Mai―26 |
AB0708 HIGH DRUG RETENTION RATES DESPITE B/TSDMARD INTERRUPTIONS IN COVID-19 PANDEMIC CHAOS |
S. Gulle, Y. Erez, A. Karakas, T. Yüce İnel, S. B. Kocaer, T. Demirci Yildirim, G. Can, İ. Sari, M. Birlik, F. Onen |
| 613 |
[GO] |
2021―Mai―26 |
AB0907-HPR UNEXPECTED DIFFERENCE IN ACCEPTANCE OF TELECONSULTATION BETWEEN PATIENTS WITH LUPUS AND RHEUMATOID ARTHRITIS WHO UNDERWENT TO A DEVELOPED AND IMPLEMENTED TELEMEDICINE INNOVATIVE PROGRAM AFTER THE DECLARATION OF QUARANTINE DUE TO THE COVID-19 PANDEMIC IN COLOMBIA |
S. M. Hernández-Zambrano, R. A. Castiblanco-Montañez, J. Chavez-Chavez, D. P. Rivera-Triana, A. Aza, L. Villarreal, M. Martinez, A. Rojas-Villarraga, P. Santos-Moreno |
| 614 |
[GO] |
2021―Mai―26 |
AB0500 IMPACT OF COVID-19 PANDEMIC IN OVERALL HEALTH AND FUNCTIONING IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE REUMAVID STUDY (PHASE 1) |
D. Benavent, M. Garrido-Cumbrera, C. Plasencia, L. Christen, H. Marzo-Ortega, J. Correa-Fernández, P. Plazuelo-Ramos, D. Webb, V. Navarro-Compán |
| 615 |
[GO] |
2021―Mai―26 |
AB0921-PARE PRACTICES AND BEHAVIORS DURING THE COVID-19 PANDEMIC IN PATIENTS WHO PARTIALLY ATTEND TO AN EDUCATIONAL PROGRAM ON RHEUMATOID ARTHRITIS. A CROSS-SECTIONAL SURVEY |
F. Rodriguez, D. Buitrago-Garcia, G. Sánchez, P. Santos-Moreno |
| 616 |
[GO] |
2021―Mai―26 |
AB0669 DEPRESSION AND ANXIETY MIGHT NOT BE INCREASED DURING COVID-19 PANDEMIC IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS |
E. Erpek, D. Solmaz, D. Bayraktar, G. Duran, G. Kabadayi, E. Durak Ediboglu, E. Otman Akat, G. Alp, H. Cinakli, İ. Kurut Aysin, S. Gucenmez, O. Bayindir, M. Ozmen, S. Akar |
| 617 |
[GO] |
2021―Mai―26 |
AB0676 FEARS AND HOPES DURING THE COVID-19 PANDEMIC IN PATIENTS WITH RHEUMATIC DISEASES. RESULTS FROM THE REUMAVID STUDY (PHASE 1) |
M. Garrido-Cumbrera, H. Marzo-Ortega, L. Christen, L. Carmona, J. Correa-Fernández, S. Sanz-Gómez, P. Plazuelo-Ramos, D. Webb, C. Jacklin, S. Irwin, L. Grange, S. Makri, E. Mateus, S. Mingolla, K. Antonopoulou, V. Navarro-Compán |
| 618 |
[GO] |
2021―Mai―26 |
AB0901-HPR SOCIAL AND PSYCHOLOGICAL IMPACT OF THE CONTAINEMENT DURING COVID-19 PANDEMIC ON PATIENTS WITH CHRONIC INFLAMMATORY RHEUMATIC DISEASES |
T. El Joumani, H. Rkain, T. Fatima Zahrae, H. Kenza, A. Radouan, N. Laila, S. Bahloul, E. A. Nada, T. Latifa, N. Hajjaj-Hassouni, F. Allali |
| 619 |
[GO] |
2021―Mai―26 |
AB0675 COUNTRY COMPARISON ON THE IMPACT OF THE COVID-19 PANDEMIC ON PATIENTS WITH RHEUMATIC DISEASES. RESULTS FROM THE REUMAVID STUDY (PHASE 1) |
M. Garrido-Cumbrera, H. Marzo-Ortega, L. Christen, L. Carmona, J. Correa-Fernández, S. Sanz-Gómez, E. Mateus, S. Makri, P. Plazuelo-Ramos, L. Grange, S. Mingolla, K. Antonopoulou, D. Webb, C. Jacklin, S. Irwin, V. Navarro-Compán |
| 620 |
[GO] |
2021―Mai―26 |
AB0661 EFFECT OF COVID-19 PANDEMIC ON SLEEP DISORDERS IN PATIENTS WITH INFLAMMATORY ARTHRITIS |
F. Ingegnoli, M. Buoli, C. Posio, R. DI Taranto, R. Caporali |
| 621 |
[GO] |
2021―Mai―26 |
AB0899-HPR THE IMPACT OF CORONAVIRUS (COVID-19) PANDEMIC ON THERAPEUTIC MAINTENANCE IN PATIENTS WITH CHRONIC INFLAMMATORY RHEUMATIC DISEASES |
T. El Joumani, H. Rkain, T. Fatima Zahrae, H. Kenza, A. Radouan, N. Laila, S. Bahloul, E. A. Nada, T. Latifa, N. Hajjaj-Hassouni, F. Allali |
| 622 |
[GO] |
2021―Mai―26 |
AB0665 SWITCHING INTRAVENOUS ABATACEPT AND TOCILIZUMAB TO SUBCUTANEOUS INJECTIONS DURING THE COVID-19 PANDEMIC: A FRENCH EXPERIENCE |
A. Combier, S. Wanono, L. Poiroux, C. Frantz, E. Descamps, O. Fogel, M. Boisson, X. Ayral, C. Bottois, Y. Allanore, J. Avouac |
| 623 |
[GO] |
2021―Mai―26 |
AB0910-HPR LEVELS OF DEPRESSION AND ANXIETY DURING COVID-19 PANDEMIC: AT WHAT DEGREE ARE HEALTH CARE WORKERS AFFECTED IN TUNISIA? |
K. Ben Abdelghani, O. Hamdi, S. Miladi, M. Sellami, K. Ouenniche, L. Souabni, S. Kassab, S. Chekili, A. Fazaa, A. Laatar |
| 624 |
[GO] |
2021―Mai―26 |
AB0902-HPR COVID-19 PANDEMIC: KNOWLEDGE, BELIEVES AND FEARS IN PATIENTS WITH CHRONIC INFLAMMATORY RHEUMATIC DISEASES IN A DEVELOPING COUNTRY |
T. El Joumani, H. Rkain, T. Fatima Zahrae, H. Kenza, A. Radouan, N. Laila, S. Bahloul, E. A. Nada, T. Latifa, N. Hajjaj-Hassouni, F. Allali |
| 625 |
[GO] |
2021―Mai―26 |
AB0707 RHEUMATOLOGY PATIENT CARE IN THE COVID-19 PANDEMIC: TELEMEDICINE, DELEGATION, PATIENT SATISFACTION AND VACCINATION BEHAVIOUR |
T. Thiele, S. Beider, H. Kühl, G. Miehlke, A. Cossmann, A. Holz, C. Happle, K. Hoeper, T. Witte, A. Jabonka, D. Ernst |
| 626 |
[GO] |
2021―Mai―26 |
AB0683 OSTEOARTHRITIS PAIN AND COVID-19 PANDEMIC: THE LOCKDOWN IMPACT |
F. Orsini, O. De Lucia, F. Ingegnoli, G. Cincinelli, G. Armentaro, R. DI Taranto, R. Caporali |
| 627 |
[GO] |
2021―Mai―26 |
AB0898-HPR WICH FACTORS ARE RELATED TO PAINFUL EXPERIENCE IN PATIENTS AFFECTED BY CHRONIC INFLAMMATORY RHEUMATIC DISEASE DURING THE COVID-19 PANDEMIC? |
T. El Joumani, H. Rkain, T. Fatima Zahrae, H. Kenza, R. Abouqal, N. Laila, S. Bahloul, E. A. Nada, T. Latifa, N. Hajjaj-Hassouni, F. Allali |
| 628 |
[GO] |
2021―Mai―26 |
AB0696 ANTI-PHOSPHOLIPID AUTOANTIBODIES IN COVID-19 PATIENTS |
M. Jordhani, D. Ruci, V. Ruci |
| 629 |
[GO] |
2021―Mai―26 |
AB0700 TOCILIZUMAB DID NOT REDUCE MORTALITY IN SEVERE COVID-19 PATIENTS BUT CAUSED THROMBOCYTOSIS |
Z. Öztürk, S. M. Türk, D. Karataş, Ü. Erkorkmaz, K. Özmen Süner, H. Dheir, E. Güçlü, E. Gönüllü, O. Karabay |
| 630 |
[GO] |
2021―Mai―26 |
AB0679 NAILFOLD VIDEOCAPILLAROSCOPY RESULTS IN COVID-19 PATIENTS RECOVERED FROM DIFFERENT DISEASE SEVERITY |
E. Gotelli, P. F. Bica, T. Aloe’, A. Sulli, M. Grosso, C. Pizzorni, F. Cattelan, S. Paolino, E. Barisione, V. Smith, M. Cutolo |
| 631 |
[GO] |
2021―Mai―26 |
AB0697 ANTI-SARS-COV-2 ANTIBODIES AND AUTOANTIBODIES IN COVID-19 PATIENTS SURVIVED AFTER ICU ADMISSION, 6 MONTHS LATER |
K. Bitzogli, E. Magira, L. Chatzis, E. Jahaj, H. Alexopoulos, M. Dalakas, A. Kotanidou, A. Tzioufas, P. Vlachoyiannopoulos |
| 632 |
[GO] |
2021―Mai―26 |
AB0706 ASSOCIATED RISK FACTORS AND OUTCOMES IN HOSPITALISED COVID-19 PATIENTS WITH BIOLOGICS AND JAK-INHIBITORS: A REPORT FROM A CENTER SPECIALISED IN IMMUNE-MEDIATED DISEASES |
A. M. Anzola Alfaro, L. R. Caballero Motta, J. C. Nieto González, L. Menchen Viso, O. Baniandrés, C. Lobo Rodríguez, I. Monteagudo, J. M. Alvaro Gracia, C. Gonzalez |
| 633 |
[GO] |
2021―Mai―26 |
AB0710 ANISOCYTOSIS INDEX AS AN EARLY PREDICATOR OF HOSPITAL MORTALITY IN PATIENTS WITH COVID-19 PNEUMONIA FROM A LEVEL III HOSPITAL. LIMA PERU |
J. Ravelo |
| 634 |
[GO] |
2021―Mai―26 |
AB0666 PROGNOSTIC VALUE OF SERUM KREBS VON DEN LUNGEN-6 GLYCOPROTEIN CIRCULATING LEVELS IN COVID-19 PNEUMONIA: A PROSPECTIVE COHORT STUDY |
D. Lobo Prat, I. Castellví, D. Castillo, S. Orozco, A. Mariscal, L. Martínez-Martínez, A. M. Millán Arciniegas, P. Moya, A. Laiz, C. Díaz-Torné, B. Magallares, S. P. Fernandez-Sanchez, S. Jeria Navarro, L. Sainz Comas, H. Codes, J. Casademont, P. Domingo, H. Corominas |
| 635 |
[GO] |
2021―Mai―26 |
AB0660 COVID-19 SHARES CLINICAL FEATURES WITH ANTI-MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 5 POSITIVE DERMATOMYOSITIS AND ADULT STILL’S DISEASE |
Y. Kondo, Y. Kaneko, H. Takei, H. Tamai, T. Takeuchi |
| 636 |
[GO] |
2021―Mai―26 |
AB0680 SARCOPENIA RATE IN COVID-19 SURVIVORS |
D. Levy, M. Giannini, W. Oulehri, M. Riou, C. Marcot, A. Meyer, B. Geny |
| 637 |
[GO] |
2021―Mai―26 |
AB0652 FERRITIN IS ASSOCIATED WITH THE SEVERITY OF LUNG INVOLVEMENT BUT NOT WITH WORSE PROGNOSIS IN PATIENTS WITH COVID-19: DATA FROM TWO ITALIAN COVID-19 UNITS |
F. Carubbi, A. Alunno, L. Salvati, C. Ferri, D. Grassi |
| 638 |
[GO] |
2021―Mai―26 |
AB0709 CHARACTERIZATION OF NAILFOLD CAPILLAROSCOPY IN COVID-19: A CASE CONTROL STUDY |
P. E. Bermudez Bermejo, R. Jimenez-Soto, A. Sanchez Rodríguez, A. Turrent, D. Mercado Velasco, I. Bravo-Lee, M. B. Colli-Cortés, E. Alvarez Hernandez, M. D. C. Amigo Castañeda |
| 639 |
[GO] |
2021―Mai―26 |
AB0704 TELEMEDICINE AT THE TIME OF COVID-19: THE EXPERIENCE WITH RA PATIENTS TREATED WITH JAK-INHIBITORS |
C. Garufi, F. R. Spinelli, S. Mancuso, F. Ceccarelli, F. Conti |
| 640 |
[GO] |
2021―Mai―26 |
AB0698 CORONAVIRUS 19 DISEASE VACCINE: PERCEPTIONS AND INTENTIONS OF TUNISIAN PATIENTS WITH RHEUMATOID ARTHRITIS |
K. Ben Abdelghani, H. Boussaa, S. Miladi, M. Sellami, L. Souabni, K. Ouenniche, S. Kassab, S. Chekili, A. Fazaa, A. Laatar |
| 641 |
[GO] |
2021―Mai―26 |
AB0693 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS DURING CORONAVIRUS 19 PANDEMIC: WHAT DO TUNISIAN RHEUMATOLOGISTS THINK? |
H. Ferjani, H. Boussaa, K. Maatallah, H. Khalfalli, D. Kaffel, W. Hamdi |
| 642 |
[GO] |
2021―Mai―26 |
AB0386 CORONAVIRUS INFECTION AND VASCULITIS: IDENTIFYING ASSOCIATIONS MINING THE BIOMEDICAL LITERATURE |
A. Rodriguez-Pla, R. Cartin-Ceba |
| 643 |
[GO] |
2021―Mai―26 |
AB0691 ANALYSIS OF SARS-COV-2 ANTIBODIES IN NON-COVID-19 PATIENTS: COMPARISON BETWEEN SYSTEMIC SCLEROSIS PATIENTS AND HEALTHY CONTROLS |
L. Giardullo, C. Rotondo, A. Corrado, N. Maruotti, R. Colia, A. Altomare, E. Sanpaolo, D. Cici, F. P. Cantatore |
| 644 |
[GO] |
2021―Mai―26 |
AB0671 NO EVIDENCE OF SARS-COV-2 IN THE KNEE JOINT: A CADAVER STUDY |
M. Grassi, V. Giorgi, M. Nebuloni, P. Zerbi, M. R. Gismondo, F. Salaffi, P. Sarzi-Puttini, S. G. Rimoldi, A. Manzotti |
| 645 |
[GO] |
2021―Mai―26 |
AB0739 MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2 INFECTION AND E.COLI SEPSIS: THE POTENTIAL ROLE OF PROCALCITONINE AS A RAPID DIAGNOSTIC BIOMARKER TO DISTINGUISH TWO DIFFERENT PHASES OF SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
M. Gilio, S. B. Morella, F. Picaro, C. Acierno, D. Palazzo, A. Erezanu, M. Frontuto, G. Mastroberti, G. De Stefano |
| 646 |
[GO] |
2021―Mai―26 |
AB0656 SARS-CoV-2 INFECTION IN PATIENTS WITH RHEUMATIC DISEASE: A TERTIARY SINGLE-CENTER EXPERIENCE |
A. Halbac, B. Balan, C. Tamas, M. M. Tamas, I. Felea, I. Filipescu, L. Damian, L. Muntean, S. P. Simon, S. Rednic |
| 647 |
[GO] |
2021―Mai―26 |
AB0662 IMPACT OF THE SARS-CoV-2 PANDEMIC IN A POPULATION OF PATIENTS FOLLOWED IN A RHEUMATOLOGY DEPARTMENT |
S. Lahrichi, K. Nassar, S. Janani |
| 648 |
[GO] |
2021―Mai―26 |
AB0663 COMPARING METHODS FOR DETERMINING ANTIBODIES TO SARS-CoV-2 USING A RAPID TEST AND ENZYME-LINKED IMMUNOSORBENT ASSAY |
G. Gridneva, E. Aronova, S. Glukhova, M. Cherkasova, B. Belov, K. Nurbaeva, E. Salyanova |
| 649 |
[GO] |
2021―Mai―26 |
AB0672 PSYCHOLOGIC STATE OF PATIENTS WITH RHEUMATIC DISEASES AFTER THE OUTBREAK OF SARS-COV2 |
M. Yasmine, S. Mariem, S. Miladi, A. Fazaa, L. Souebni, K. Ouenniche, S. Kassab, S. Chekili, K. Ben Abdelghani, A. Laatar |
| 650 |
[GO] |
2021―Mai―26 |
AB0654 TOCILIZUMAB IS PROTECTIVE AGAINST SARS-COV2 INFECTION OR NOT? |
F. Fayed, E. Abdelkarim |
| 651 |
[GO] |
2021―Mai―26 |
AB0699 RETROSPECTIVE ANALYSIS OF 52 SARS-COV2 POSITIVE PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASE: A SINGLE CENTER EXPERIENCE |
Y. Karabulut |
| 652 |
[GO] |
2021―Mai―26 |
AB0684 LESS THAN 20% OF PATIENTS WITH A CHRONIC INFLAMMATORY RHEUMATIC DISEASE CHANGED THEIR IMMUNOSUPPRESSIVE MEDICATION BECAUSE OF THE COVID 19 PANDEMIC |
I. Andreica, R. Jast, G. Rezniczek, U. Kiltz, D. Kiefer, B. Buehring, X. Baraliakos, J. Braun |
| 653 |
[GO] |
2021―Mai―26 |
AB0905-HPR TELEMEDICINE IN RHEUMATOLOGY AT TIME OF COVID PANDEMIC |
G. Cuomo, F. Masini, K. Gjeloshi, D. Lubrano, L. E. Adinolfi, C. Romano |
| 654 |
[GO] |
2021―Mai―26 |
AB0926-PARE IMPACT OF COVID 19 PANDEMIC ON TUNISIAN SPA PATIENTS: PSYCHOLOGICAL STATE AND TREATMENT ADHERENCE |
M. Rachdi, A. Feki, Z. Gassara, S. Ben Jemaa, M. Ghali, M. Ezzeddine, M. H. Kallel, H. Fourati, R. Akrout, S. Baklouti |
| 655 |
[GO] |
2021―Mai―26 |
AB0879-HPR MOTIVATION OF HEALTHCARE PROVIDERS DURING COVID19 PANDEMIC OUTBREAK |
C. Cobilinschi, A. Constantinescu, I. Draniceanu, A. Balanescu, V. Bojinca, C. L. Constantinescu, L. Groseanu, S. Daia-Iliescu, I. Saulescu, D. Mazilu, M. Duna, D. Opris-Belinski, R. Ionescu |
| 656 |
[GO] |
2021―Mai―25 |
POS0047 OUTCOMES IN INFLAMMATORY ARTHROPATHY PATIENTS HOSPITALIZED FOR COVID-19 |
T. Collins, V. Patel, A. Babajanians, S. Kubomoto |
| 657 |
[GO] |
2021―Mai―25 |
OP0288 MACHINE LEARNING ALGORITHMS TO PREDICT COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME IN PATIENTS WITH RHEUMATIC DISEASES: RESULTS FROM THE GLOBAL RHEUMATOLOGY ALLIANCE PROVIDER REGISTRY |
Z. Izadi, M. Gianfrancesco, K. Hyrich, A. Strangfeld, L. Gossec, L. Carmona, E. Mateus, S. Lawson-Tovey, L. Trupin, S. Rush, G. Schmajuk, L. Jacobsohn, P. Katz, S. Al Emadi, L. Wise, E. Gilbert, M. Valenzuela-Almada, A. Duarte-Garcia, J. Sparks, T. Hsu, K. D’silva, N. Serling-Boyd, S. Bhana, W. Costello, R. Grainger, J. Hausmann, J. Liew, E. Sirotich, P. Sufka, Z. Wallace, P. Machado, P. Robinson, J. Yazdany |
| 658 |
[GO] |
2021―Mai―25 |
OP0282 RITUXIMAB ASSOCIATED WITH SEVERE COVID-19 AMONG PATIENTS WITH INFLAMMATORY ARTHRITIDES: A 1-YEAR MULTICENTER STUDY IN 1116 SUCCESSIVE PATIENTS RECEIVING BIOLOGIC AGENTS |
R. Felten, P. M. Duret, E. Bauer, M. Ardizzone, H. J. Djossou, J. H. Salmon, C. Fabre, J. Walther, I. Chary Valckenaere, M. Geoffroy, L. Messer, F. Berenbaum, M. Soubrier, J. Sellam, J. E. Gottenberg |
| 659 |
[GO] |
2021―Mai―25 |
OP0314 DOCK8 MUTATIONS IN COVID-19 AND MIS-C CYTOKINE STORM SYNDROME |
R. Cron, M. Zhang, D. Absher, J. Bridges, A. Schnell, P. Bhatraju, A. Vagrecha, S. Lozinsky, S. Acharya, C. Levy, W. Chatham |
| 660 |
[GO] |
2021―Mai―25 |
OP0284 OUTCOME OF COVID-19 IN PATIENTS WITH RHEUMATIC AND INFLAMMATORY DISEASES TREATED WITH RITUXIMAB: DATA FROM DE FRENCH RMD COVID-19 COHORT |
J. Avouac, E. Drumez, E. Hachulla, R. Seror, S. Georgin-Lavialle, S. El Mahou, E. Pertuiset, T. Pham, H. Marotte, A. Servettaz, F. Domont, P. Chazerain, M. Devaux, P. Claudepierre, V. Langlois, A. Mekinian, A. Maria, B. Banneville, B. Fautrel, J. Pouchot, T. Thomas, R. M. Flipo, C. Richez |
| 661 |
[GO] |
2021―Mai―25 |
OP0324-PARE PATIENT INFORMATION IN TIMES OF CRISIS: LESSONS LEARNED FROM COVID-19 COMMUNICATION IN RHEUMATOLOGY |
M. M. Bakker, T. Luttikhuis, I. Jansen, J. Rademakers, M. De Wit, A. Boonen, P. Putrik |
| 662 |
[GO] |
2021―Mai―25 |
POS0053 RHEUMATOID ARTHRITIS AND THE RISK OF COVID-19 DIAGNOSIS, HOSPITALISATION AND DEATH: A POPULATION-BASED MULTI-STATE COHORT ANALYSIS INCLUDING 5,586,565 PEOPLE IN CATALONIA, SPAIN |
A. Vivekanantham, E. Burn, S. Fernandez-Bertolin, M. Aragon, T. Duarte-Salles, D. Prieto-Alhambra |
| 663 |
[GO] |
2021―Mai―25 |
OP0006 ASSOCIATIONS OF BASELINE USE OF BIOLOGIC OR TARGETED SYNTHETIC DMARDS WITH COVID-19 SEVERITY IN RHEUMATOID ARTHRITIS: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE |
J. Sparks, Z. Wallace, A. Seet, M. Gianfrancesco, Z. Izadi, K. Hyrich, A. Strangfeld, L. Gossec, L. Carmona, E. Mateus, S. Lawson-Tovey, L. Trupin, S. Rush, G. Schmajuk, P. Katz, L. Jacobsohn, S. Al Emadi, L. Wise, E. Gilbert, A. Duarte-Garcia, M. Valenzuela-Almada, T. Hsu, K. D’silva, N. Serling-Boyd, P. Dieudé, E. Nikiphorou, V. Kronzer, N. Singh, M. F. Ugarte-Gil, B. Wallace, A. Akpabio, R. Thomas, S. Bhana, W. Costello, R. Grainger, J. Hausmann, J. Liew, E. Sirotich, P. Sufka, P. Robinson, P. Machado, J. Yazdany |
| 664 |
[GO] |
2021―Mai―25 |
OP0286 CHARACTERISTICS ASSOCIATED WITH SEVERE COVID-19 OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE (COVID-19 GRA) |
M. F. Ugarte-Gil, G. S. Alarcon, A. Seet, Z. Izadi, C. Reategui Sokolova, A. E. Clarke, L. Wise, G. Pons-Estel, M. J. Santos, S. Bernatsky, L. Mathias, N. Lim, J. Sparks, Z. Wallace, K. Hyrich, A. Strangfeld, L. Gossec, L. Carmona, E. Mateus, S. Lawson-Tovey, L. Trupin, S. Rush, G. Schmajuk, P. Katz, L. Jacobsohn, S. Al Emadi, E. Gilbert, A. Duarte-Garcia, M. Valenzuela-Almada, T. Hsu, K. D’silva, N. Serling-Boyd, P. Dieudé, E. Nikiphorou, V. Kronzer, N. Singh, B. Wallace, A. Akpabio, R. Thomas, S. Bhana, W. Costello, R. Grainger, J. Hausmann, J. Liew, E. Sirotich, P. Sufka, P. Robinson, P. Machado, M. Gianfrancesco, J. Yazdany |
| 665 |
[GO] |
2021―Mai―25 |
POS0051 THE IMPACT OF COVID-19 ON RHEUMATOLOGY TRAINING: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE TRAINEE SURVEY |
K. Young, S. A. Yeoh, M. Putman, E. Graef, F. Berenbaum, R. Conway, R. Grainger, A. Kilian, M. Konig, J. Liew, P. M. Machado, S. E. Sattui, J. Sparks, P. Sufka, M. Ugarte-Gil, L. Upton, Z. Wallace, J. Yazdany, A. Jayatilleke |
| 666 |
[GO] |
2021―Mai―25 |
OP0082-PARE THE EFFECT COVID-19 HAS ON THE MENTAL HEALTH OF PEOPLE LIVING WITH RHEUMATIC DISEASES. FROM DATA TO INTERVENTIONS. |
S. Mingolla, A. Celano, M. Santopietro |
| 667 |
[GO] |
2021―Mai―25 |
OP0285 COVID-19 HOSPITALIZATIONS, ICU ADMISSION, AND DEATH AMONG PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES (IMID) - A POPULATION-BASED STUDY |
L. Eder, R. Croxford, A. Drucker, A. Mendel, K. Bindee, Z. Touma, R. Cook, S. Johnson, S. Bernatsky, N. Haroon, J. Widdifield |
| 668 |
[GO] |
2021―Mai―25 |
OP0283 DOES TNF-INHIBITION DECREASE THE RISK OF SEVERE COVID-19 IN RMD-PATIENTS? |
R. Hasseli, B. F. Hoyer, A. Krause, H. M. Lorenz, A. Pfeil, A. Regierer, J. Richter, T. Schmeiser, A. Strangfeld, H. Schulze-Koops, R. Voll, C. Specker, U. Müller-Ladner |
| 669 |
[GO] |
2021―Mai―25 |
POS0054 THE IMPACT AND OUTCOME OF COVID-19 ON SYSTEMIC SCLEROSIS PATIENTS FROM THE EUROPEAN SCLERODERMA TRIAL AND RESEARCH GROUP (EUSTAR) |
A. M. Hoffmann-Vold, C. Brunborg, F. Tirelli, P. Carreira, N. Del Papa, A. Mekinian, M. Vonk, A. Giollo, G. De Luca, M. De Santis, C. Campochiaro, C. Mihai, P. Airò, M. G. Lazzaroni, E. Zanatta, R. Foti, Y. Allanore, D. Furst, M. Matucci-Cerinic, A. Gabrielli, O. Distler |
| 670 |
[GO] |
2021―Mai―25 |
POS1258 MISSING THE WINDOW OF OPPORTUNITY: EARLY ARTHRITIS CLINICS IN TIMES OF COVID-19 |
B. D’onofrio, L. De Stefano, B. L. Palermo, B. Xoxi, A. Manzo, C. Montecucco, S. Bugatti |
| 671 |
[GO] |
2021―Mai―25 |
POS1257 HYPOGAMMAGLOBULINEMIA IS A SIGNIFICANT RISK FACTOR FOR MORTALITY IN PATIENTS WITH ANCA ASSOCIATED VASCULITIS AND COVID-19 |
B. Ince, M. Bektas, N. Koca, B. F. Agargun, S. Zarali, D. Y. Guzey, Y. Yalçinkaya, B. Artim-Esen, A. Gül, M. Inanc |
| 672 |
[GO] |
2021―Mai―25 |
POS1251 ROLE OF SYSTEMIC AUTOINMUNE CONDITIONS IN HOSPITAL ADMISSIONS RELATED TO COVID-19 |
I. Perez-Sancristobal, L. Lopez Pedraza, M. P. Álvarez Hernandez, J. I. Colomer, A. Madrid García, B. Fernandez, C. Martinez Prada, L. Rodriguez Rodriguez, A. Mucientes, L. León, L. Abasolo |
| 673 |
[GO] |
2021―Mai―25 |
OP0274-PARE EVALUATION OF PATIENT SATISFACTION FOR TELEHEALTH (PHONE AND VIDEO) IN RHEUMATOLOGY OUTPATIENTS DURING COVID-19 PANDEMIC |
Y. Oh, A. Hennessey, L. Young, D. Yates, C. Barrett |
| 674 |
[GO] |
2021―Mai―25 |
OP0264-HPR “I LITERALLY CONVINCED MYSELF I WAS GOING TO CATCH IT AND DIE”: LIVED EXPERIENCES OF THE COVID-19 PANDEMIC BY PEOPLE WITH RHEUMATIC DISEASES FROM FOUR EUROPEAN COUNTRIES |
R. J. O. Ferreira, C. Costa, A. Marques, A. J. Barata Cavaleiro, S. Makri, K. Parperis, S. Psarelis, R. Williams, G. E. Fragoulis, H. Lempp, E. Nikiphorou |
| 675 |
[GO] |
2021―Mai―25 |
POS0056 ANXIETY AND CONCERNS RELATED TO THE WORK SITUATION DURING THE COVID-19 PANDEMIC IN >5,000 PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASE FOLLOWED IN THE DANISH DANBIO REGISTRY, RESULTS FROM A NATIONWIDE QUESTIONNAIRE |
B. Glintborg, D. V. Jensen, S. Engel, L. Terslev, M. Pfeiffer Jensen, O. Hendricks, M. Østergaard, S. H. Rasmussen, T. Adelsten, A. Colic, K. Danebod, M. Kildemand, A. G. Loft, H. L. Munk, J. K. Pedersen, R. Østgård, C. M. Sørensen, N. Steen Krogh, J. Nørgaard Agerbo, C. Ziegler, M. L. Hetland |
| 676 |
[GO] |
2021―Mai―25 |
OP0265-HPR IMPACT OF COVID-19 PANDEMIC ON RHEUMATOLOGY PATIENTS IN NORTHERN IRELAND - A WEB BASED CROSS-SECTIONAL SURVEY |
P. McKee, A. Irvine, C. Riddell, E. Ball |
| 677 |
[GO] |
2021―Mai―25 |
POS0152-HPR REMOTE CLINICAL MANAGEMENT: INCORPORATING ELECTRONIC ASSESSMENT OF PATIENTS WITH RHEUMATIC DISEASES INTO STANDARD CLINICAL PATHWAYS DURING THE COVID-19 PANDEMIC: A PILOT STUDY |
T. Malley, J. Jackman, S. Manderson, L. Saldana Pena, E. Evans, J. Barrett, A. Soni, R. Luqmani |
| 678 |
[GO] |
2021―Mai―25 |
LB0001 MAVRILIMUMAB IMPROVES OUTCOMES IN PHASE 2 TRIAL IN NON-MECHANICALLY-VENTILATED PATIENTS WITH SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPERINFLAMMATION |
L. Pupim, T. S. Wang, K. Hudock, J. Denson, N. Fourie, L. Hercilla Vasquez, K. Luz, M. Madjid, K. Mcharry, J. F. Saraiva, E. Tobar, T. Zhou, M. Samant, J. Pirrello, F. Fang, J. F. Paolini, A. Pano, B. C. Trapnell |
| 679 |
[GO] |
2021―Mai―25 |
OP0281 EXCESS GIANT CELL ARTERITIS CASES ARE ASSOCIATED WITH PEAKS IN COVID-19 PREVALENCE |
B. Mulhearn, J. Ellis, S. Skeoch, J. Pauling, S. Tansley |
| 680 |
[GO] |
2021―Mai―25 |
POS1237 ALGORITHM IDENTIFYING CHRONIC INFLAMMATORY DISEASES TREATED BY BIOTHERAPY AND/OR TARGETED SYNTHETIC TREATMENTS IN OUTPATIENT CARE IN FRANCE: FEASIBILITY, PRELIMINARY RESULTS, AND IMPACT OF COVID-19 |
P. Richette, M. Allez, V. Descamps, L. Perra, S. Pilet, M. Maravic |
| 681 |
[GO] |
2021―Mai―25 |
POS1228 THE ROLE OF CHEST CT IN UNDERSTANDING INTERSTITIAL LUNG DISEASE (ILD): SYSTEMIC SCLEROSIS (SSc). VERSUS COVID-19 |
M. Orlandi, N. Landini, G. Sambataro, C. Nardi, C. Bruni, S. Bellando-Randone, C. Denton, F. Luppi, B. Ruaro, S. Tomassetti, E. Cavigli, F. Melchiorre, S. Palmucci, S. Guiducci, A. Moggi Pignone, Y. Allanore, A. Bartoloni, M. Confalonieri, G. Cortese, L. Dagna, F. De Cobelli, A. De Paulis, S. Harari, D. Khanna, M. Kuwana, V. Miele, G. Taliani, M. Hughes, C. Vanchieri, S. Colagrande, M. Matucci-Cerinic |
| 682 |
[GO] |
2021―Mai―25 |
POS0050 ARE PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES (IMID) MORE LIKELY TO RECEIVE COVID-19 TESTS AND TEST POSITIVE FOR SARS-COV-2? A MATCHED POPULATION-BASED STUDY |
L. Eder, R. Croxford, A. Drucker, A. Mendel, K. Bindee, Z. Touma, S. Johnson, R. Cook, S. Bernatsky, N. Haroon, J. Widdifield |
| 683 |
[GO] |
2021―Mai―25 |
LB0003 IMMUNOGENICITY AND SAFETY OF THE BNT162b2 mRNA COVID-19 VACCINE IN ADULT PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES AND GENERAL POPULATION: A MULTICENTER STUDY |
V. Furer, T. Eviatar, D. Zisman, H. Peleg, D. Paran, D. Levartovsky, M. Zisapel, O. Elalouf, I. Kaufman, R. Meidan, A. Broyde, A. Polachek, J. Wollman, I. Litinsky, K. Meridor, H. Nochomovitz, A. Silberman, D. Rosenberg, J. Feld, A. Haddad, T. Gazitt, M. Elias, N. Higazi, F. Kharouf, G. Shefer, O. Sharon, S. Pel, S. Nevo, O. Elkayam |
| 684 |
[GO] |
2021―Mai―25 |
OP0009-PARE SUCCESSFUL PATIENT EDUCATION ON COVID-19 VACCINE SAFETY IN A LARGE RHEUMATOLOGY COHORT USING INTERACTIVE MOBILE-PHONE VIDEO TECHNOLOGY: CONTEXT, RESULTS, AND NEXT STEPS |
L. Rajagopala, M. Ford, M. Jasim, D. Mulherin, S. Venkatachalam, T. Sheeran, J. Bateman |
| 685 |
[GO] |
2021―Mai―25 |
LB0002 COVID-19 VACCINE SAFETY IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASE |
P. M. Machado, S. Lawson-Tovey, K. Hyrich, L. Carmona, L. Gossec, E. Mateus, A. Strangfeld, B. Raffeiner, T. Goulenok, O. Brocq, M. Cornalba, J. A. Gómez-Puerta, E. Veillard, L. Trefond, J. E. Gottenberg, J. Henry, P. Durez, G. R. Burmester, M. Mosca, E. Hachulla, H. Bijlsma, I. McInnes, X. Mariette |
| 686 |
[GO] |
2021―Mai―25 |
POS1223 RAS GUANYL RELEASING PROTEIN 1 (RASGRP1) IN PERIPHERAL B CELLS LINKS RA TO COVID-19 |
S. Hannawi, F. Alqutami, M. Y. Hachim |
| 687 |
[GO] |
2021―Mai―25 |
OP0287 IMMUNOMODULATORY THERAPIES FOR SEVERE FORMS OF COVID-19: A SYSTEMATIC LITERATURE REVIEW TO INFORM EULAR POINTS TO CONSIDER |
A. Alunno, A. Najm, X. Mariette, J. Emmel, L. Mason, G. De Marco, D. Mcgonagle, P. Machado |
| 688 |
[GO] |
2021―Mai―25 |
POS1177 REVAMPING BIOLOGIC THERAPY DURING COVID-19 |
S. Ahmed Narikkoottungal, A. Siddiqui, A. Constantin, S. Farrow, K. Ahmed |
| 689 |
[GO] |
2021―Mai―25 |
POS0052 PATHOPHYSIOLOGY OF ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 INFECTION: A SYSTEMATIC LITERATURE REVIEW TO INFORM EULAR POINTS TO CONSIDER |
A. Najm, A. Alunno, X. Mariette, B. Terrier, G. De Marco, L. Mason, J. Emmel, D. Mcgonagle, P. M. Machado |
| 690 |
[GO] |
2021―Mai―25 |
OP0313 PRELIMINARY CRITERIA FOR MACROPHAGE ACTIVATION SYNDROME ASSOCIATED WITH CORONAVIRUS DISEASE-19 |
S. Amikishiyev, M. G. Gunver, M. Bektas, S. Aghamuradov, B. Ince, N. Koca, E. S. Torun, N. Aliyeva, S. Sari, C. Cetin, B. Ç. Yalçin Dulundu, R. Deniz, F. Kemik, B. F. Agargun, U. A. Gulseren, B. Besisik, O. Alkan, C. Bağriaçik, Y. B. Tor, Y. Catma, G. Durak, S. Mese, A. Agacfidan, M. Kose, M. Erelel, A. A. Çağatay, S. Ş. Yavuz, S. K. Besisik, F. Esen, A. Gül |
| 691 |
[GO] |
2021―Mai―25 |
POS1163 CHARACTERISTICS AND OUTCOMES IN A REAL-WORLD COHORT OF RHEUMATOID ARTHRITIS PATIENTS WITH COVID-19 |
Y. Ye, X. Yue, W. Krueger, L. Wegrzyn |
| 692 |
[GO] |
2021―Mai―25 |
POS0349 SEQUENCE COMPLEMENTARITY BETWEEN SARS-CoV-2 GENOME AND HUMAN NONCODING RNAS ASSOCIATED WITH IMMUNOLOGICAL DISORDERS: AN IN SILICO PIVOTAL STUDY |
R. Talotta, S. Bahrami, M. J. Laska |
| 693 |
[GO] |
2021―Mai―25 |
POS0049 SARS-COV-2 INFECTION IN CHILDREN WITH RHEUMATIC DISEASE: EXPERIENCE OF A TERTIARY REFERRAL CENTER |
B. Sözeri, F. Demir, S. Kalin, C. Hasbal Akkuş |
| 694 |
[GO] |
2021―Mai―25 |
POS0055 SARS-COV-2 OUTBREAK IN AUTOIMMUNE DISEASES: THE EURO-COVIMID STUDY |
D. Saadoun, M. Vieira, M. Vautier, X. Baraliakos, I. Andreica, J. A. P. Da Silva, M. Sousa, M. Luis, N. Khmelinskii, J. M. Alvaro-Gracia, I. Castrejon, J. C. Nieto González, C. A. Scirè, E. Silvagni, A. Bortoluzzi, H. Penn, S. Hamdulay, P. Machado, B. Fautrel, P. Cacoub, M. Resche-Rigon, L. Gossec |
| 695 |
[GO] |
2021―Mai―25 |
OP0075 EVALUATION OF A VIRTUAL REALITY TEACHING CONCEPT FOR MEDICAL STUDENTS DURING THE SARS-COV-2 PANDEMIC |
A. Pfeil, F. Marcus, T. Hoffmann, P. Klemm, P. Oelzner, U. Müller-Ladner, A. Hueber, U. Lange, G. Wolf, G. Schett, D. Simon, A. Kleyer |
| 696 |
[GO] |
2021―Mai―25 |
OP0323-PARE “CELEBRATING THE 50TH ANNIVERSARY OF OUR ORGANISATION IN TIMES OF PANDEMIC: HOW WE USED DIGITAL TOOLS TO OVERCOME CHALLENGES AND DIFFICULTIES AND CAME INTO CONTACT WITH MORE PARTICIPANTS AND VIEWERS THAN EVER ENVISAGED!” |
C. Elling-Audersch |
| 697 |
[GO] |
2021―Mai―25 |
POS1235 ASSESSMENT OF RISK FACTORS FOR HOSPITALIZATION OF AUTOIMMUNE AND RHEUMATIC DISEASE PATIENTS WITH COVID-19 - A SINGLE CENTRE OBSERVATIONAL STUDY |
J. M N, P. Dekate, S. Vontari, R. Dudam |
| 698 |
[GO] |
2021―Mai―25 |
POS1264 IMMUNE-MEDIATED DISEASES (IMID) AND CORONAVIRUS DISEASE 2019 (COVID-19): RESULTS FROM AN OBSERVATIONAL RETROSPECTIVE MULTICENTER STUDY |
R. Dos-Santos, C. Calviño, I. Bastón, R. Ferreiro, F. Montero, C. Gonzalez, I. Marín-Jiménez, M. Barreiro-de-Acosta, E. Perez-Pampín |
| 699 |
[GO] |
2021―Mai―25 |
POS1190 EXPECTATIONS AND POTENTIAL CONCERNS OF PATIENTS WITH AUTOIMMUNE AND RHEUMATIC DISEASES REGARDING VACCINATION AGAINST SARS-CoV-2 (COVID-19): THE WORLDWIDE ONLINE VAXICOV STUDY |
R. Felten, M. Dubois, M. F. Ugarte-Gil, J. Fort, L. Pijnenburg, A. Chaudier, L. Kawka, C. Costecalde, H. Bergier, E. Chatelus, R. M. Javier, C. Sordet, J. E. Gottenberg, J. Sibilia, Y. Fuentes-Silva, L. Arnaud |
| 700 |
[GO] |
2021―Mai―25 |
POS1172 COVID-19 ACROSS RHEUMATOLOGY: A BIBLIOMETRIC STUDY |
B. Doskaliuk, R. Yatsyshyn, I. Stoika, K. Fedorovych, O. Drogomeretska, O. Hotsaniuk, Y. Delva |
| 701 |
[GO] |
2021―Mai―25 |
POS1210 PREVALENCE OF COVID-19 AMONG PATIENTS WITH RHEUMATIC DISEASES: AN OBSERVATIONAL SURVEY DURING THE TWO WAVES IN ITALY |
S. Fasano, I. Pantano, D. Mauro, D. Capocotta, D. Iacono, E. Gaggiano, M. D. Pasquale, G. Rozza, C. DI Vico, A. Ruggiero, E. Tirri, F. Ciccia |
| 702 |
[GO] |
2021―Mai―25 |
POS1211 IDENTIFICATION OF COMMON FUNCTIONAL PATHWAYS IN PATIENTS WITH LUPUS AND COVID-19 BY TIME-SERIES ANALYSIS |
Y. LI, S. X. Zhang, J. Qiao, Q. Wang, S. Song, R. Zhao, Y. Zhang, T. Cheng, M. J. Chang, G. Y. Liu, J. Luo, P. F. He, X. LI |
| 703 |
[GO] |
2021―Mai―25 |
POS1168 SELF-REPORTED SARS-CoV2 TESTING AND COVID-19 DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS IN A SWISS OBSERVATIONAL COHORT |
E. Papagiannoulis, A. Ciurea, D. Dan, A. Finckh, B. Gilbert, I. Von Loga, C. Melong Pianta Taleng, A. Scherer, K. Lauper |
| 704 |
[GO] |
2021―Mai―25 |
POS1263 COVID-19 FROM THE PATIENTS’S PERSPECTIVE: PRELIMINARY RESULTS OF ONLINE SURVEY |
D. Karateev, P. Pchelnikova, E. Luchikhina, T. Boboshko |
| 705 |
[GO] |
2021―Mai―25 |
POS1162 PREDICTORS OF HOSPITALISATION IN PATIENTS WITH RHEUMATIC DISEASE AND COVID-19 IN IRELAND: DATA FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE PHYSICIAN-REPORTED REGISTRY |
R. Conway, E. Nikiphorou, C. Demetriou, C. Low, K. Leamy, J. Ryan, R. Kavanagh, A. Fraser, J. Carey, P. O’connell, R. Flood, R. Mullan, D. Kane, P. Robinson, J. Liew, R. Grainger, G. Mccarthy |
| 706 |
[GO] |
2021―Mai―25 |
POS1201 Incidence and outcome of COVID-19 in ANCA-associated vasculitis: impact of COVID-19 in patients undergoing rituximab for maintenance |
E. Treppo, M. Binutti, G. Del Frate, S. De Vita, L. Quartuccio |
| 707 |
[GO] |
2021―Mai―25 |
POS1181 CLINICAL COURSE OF COVID-19 IN CHILDREN WITH RHEUMATIC DISEASE UNDER BIOLOGIC THERAPY |
F. Demir, K. Ulu, Ş. Çağlayan, T. Coşkuner, B. Sözeri |
| 708 |
[GO] |
2021―Mai―25 |
POS1202 EXPERIENCE WITH COVID-19 IN GERMAN PAEDIATRIC RHEUMATOLOGY CENTRES |
A. Klein, D. Windschall, W. Emminger, R. Berendes, J. Kuemmerle-Deschner, R. Trauzeddel, C. Rietschel, A. Kühn, M. Hufnagel, M. Sailer-Hoeck, T. Hospach, M. Haller, S. Mrusek, C. Sengler, K. Minden, G. Horneff |
| 709 |
[GO] |
2021―Mai―25 |
POS1233 USE OF BARICITINIB AND TOCILIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19 IN HOSPITALIZED PATIENTS |
D. X. Xibille Friedmann, S. M. Carrillo Vazquez |
| 710 |
[GO] |
2021―Mai―25 |
POS1246 COVID-19 IN ITALIAN PATIENTS WITH RHEUMATIC AUTOIMMUNE SYSTEMIC DISEASES: RESULTS OF A NATIONWIDE SURVEY STUDY |
C. Ferri, D. Giuggioli, V. Raimondo, L. Dagna, V. Riccieri, E. Zanatta, S. Guiducci, A. Tavoni, R. Foti, G. Cuomo, R. De Angelis, F. Cozzi, G. Murdaca, I. Cavazzana, N. Romeo, V. Codullo, F. Ingegnoli, R. Pellegrini, G. Varcasia, A. Della Rossa, M. De Santis, G. Abignano, M. Colaci, M. Caminiti, M. L’andolina, E. Lubrano, A. Spinella, F. Lumetti, G. De Luca, S. Bellando Randone, E. Visalli, S. Bilia, F. Masini, G. Pellegrino, E. Pigatto, E. Generali, F. Franceschini, G. Pagano Mariano, S. Barsotti, G. Pettiti, G. Zanframundo, R. Brittelli, V. Aiello, D. Scorpiniti, T. Ferrari, R. Caminiti, C. Campochiaro, P. Gigliotti, R. Cecchetti, D. Olivo, F. Ursini, V. Brusi, R. Meliconi, F. Caso, R. Scarpa, S. D’angelo, F. Iannone, M. Matucci-Cerinic, A. Doria, M. Miccoli, S. R. Paparo, F. Ragusa, G. Elia, S. M. Ferrari, P. Fallahi, A. Antonelli |
| 711 |
[GO] |
2021―Mai―25 |
POS1242 FACTORS ASSOCIATED WITH MORTALITY IN PATIENTS WITH RHEUMATIC DISEASES AND COVID-19 IN MEXICO |
D. Alpizar-Rodriguez, F. Irazoque-Palazuelos, T. S. Rodriguez-Reyne, E. Zamora, D. X. Xibille Friedmann, A. Castillo Ortiz, M. U. Martínez-Martínez, B. E. Zazueta, S. Duran Barragan, M. Rull-Gabayet, M. Vázquez-Del Mercado Espinosa, J. F. Moctezuma-Ríos, A. Barragán-Garfías, E. Martin-Nares, D. Cervantes-Rosete, D. Vega-Morales, M. Aguiar Castellanos, G. Reyes, M. Macias, L. V. Maya-Piña, F. Cobos-Villanueva, J. E. Navarro-Zarza, A. Sanchez-Rodriguez, M. D. P. Cruz-Domínguez, X. Jimenez Jimenez, O. Marquez, A. Martínez, A. Vargas Guerrero, L. Andrade, C. F. Pacheco Tena |
| 712 |
[GO] |
2021―Mai―25 |
POS1193 CLINICAL FEATURES AND THE COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER |
A. Avanoglu Guler, T. Yüce İnel, H. Karadeniz, R. Bilici Salman, H. Satiş, H. Küçük, M. A. Ozturk, B. Goker, S. Haznedaroglu, İ. Sari, T. Kasifoglu, A. Tufan |
| 713 |
[GO] |
2021―Mai―25 |
POS1259 FAVOURABLE SHORT-TERM COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER USING BIOLOGIC AGENTS |
N. Aliyeva, B. Ç. Yalçin Dulundu, S. Amikishiyev, S. Aghamuradov, M. Bektaş, B. Ince, N. Koca, Y. Yalçinkaya, B. Artim-Esen, M. Inanc, A. Gül |
| 714 |
[GO] |
2021―Mai―25 |
POS1247 CLINICAL FEATURES AND OUTCOMES OF COVID-19 IN PATIENTS WITH IGG4-RELATED DISEASE. A COLLABORATIVE EUROPEAN MULTI-CENTRE STUDY |
G. A. Ramirez, M. Lanzillotta, M. Ebbo, A. Fernandez-Codina, G. Mancuso, F. Martínez-Valle, O. Orozco-Galvez, N. Schleinitz, L. Dagna, E. L. Culver, E. Della Torre |
| 715 |
[GO] |
2021―Mai―25 |
POS1227 IMPACT OF A PRE-EXISTING INTERSTITIAL LUNG DISEASE ON SEVERITY OF COVID-19 IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES |
P. A. Juge, E. Hachulla, C. Richez, E. Drumez, A. Duhamel, R. Borie, P. Dieudé |
| 716 |
[GO] |
2021―Mai―25 |
POS1252 COVID-19 IN PATIENTS WITH RHEUMATIC DISEASES ON CHRONIC USE OF HYDROXYCHLOROQUINE IN A LARGE BRAZILIAN COHORT - A 24-WEEK PROSPECTIVE STUDY |
G. Salviato Pileggi, G. Ferreira, A. P. Gomides, E. Reis Neto, M. Abreu, C. Albuquerque, N. Araújo, A. B. Bacchiega, D. Bianchi, B. Bica, E. Bonfa, E. Borba, D. Brito, A. Duarte, M. Peixoto Gu e Silva de Souza, K. Wagner Poti Gomes, A. Maria Kakehasi, R. Cavalheiro Do Espírito Santo, P. Realle, E. Klumb, C. C. Lanna, C. Marques, O. Monticielo, L. Mota, G. Munhoz, E. Paiva, H. Pereira, J. R. Provenza, S. Ribeiro, L. Rocha Jr, C. Sampaio, V. Sampaio, E. Sato, T. Laroca Skare, V. De Souza, V. Valim, M. Lacerda, R. Xavier, M. Pinheiro |
| 717 |
[GO] |
2021―Mai―25 |
POS1188 COVID-19 IN PATIENTS WITH RHEUMATIC DISEASES: COMPARISON OF DATA FROM THE ARGENTINE REGISTRY (SAR-COVID), WITH THE LATIN AMERICAN AND GLOBAL REGISTRY (GLOBAL RHEUMATOLOGY ALLIANCE) |
A. A. Reyes, G. Alle, R. Tanten, M. Scolnik, E. Soriano, G. Berbotto, M. Haye, M. J. Gamba, R. Nieto, M. García, V. Savio, L. Gonzalez Lucero, P. Alba, L. Takashima, F. Risueño, L. Casalla, N. Cucchiaro, A. Bertoli, S. Porta, C. Maldini, R. Gallo, C. Goizueta, E. Picco, R. Quintana, K. Roberts, C. A. Isnardi, G. Pons-Estel |
| 718 |
[GO] |
2021―Mai―25 |
POS1245 MORTALITY OF COVID-19 IN PATIENTS WITH RHEUMATIC DISEASES: COMPARISON TO THE GENERAL POPULATION IN MÉXICO |
M. U. Martínez-Martínez, F. Irazoque-Palazuelos, T. S. Rodriguez-Reyne, E. Zamora, A. Castillo Ortiz, B. E. Zazueta, S. Duran Barragan, M. Rull-Gabayet, J. F. Moctezuma-Ríos, X. Jimenez Jimenez, E. Martin-Nares, D. Cervantes-Rosete, D. Vega-Morales, D. X. Xibille Friedmann, A. Barragán-Garfías, E. Alvarez Hernandez, M. Vázquez-Del Mercado Espinosa, C. F. Pacheco Tena, D. Alpizar-Rodriguez |
| 719 |
[GO] |
2021―Mai―25 |
POS1266 COVID-19 IN PATIENTS WITH RHEUMATIC DISEASES: SURVEY-BASED ASSESSMENT OF THE RISK OF HOSPITALIZATION |
D. Karateev, P. Pchelnikova, E. Luchikhina, T. Boboshko |
| 720 |
[GO] |
2021―Mai―25 |
POS1226 THE COURSE OF CORONAVIRUS DISEASE 2019 (COVID-19) IN PATIENTS WITH SJOGREN’S SYNDROME TREATED WITH ANTI-CD20 MONOCLONAL ANTIBODY (RITUXIMAB) |
E. Sokol, A. Torgashina, B. Chalcev, J. Khvan, O. Golovina |
| 721 |
[GO] |
2021―Mai―25 |
POS1232 COVID-19 IN PATIENTS WITH SYSTEMIC SCLEROSIS: ONE RHEUMATOLOGY CENTER EXPERIENCE |
M. Starovoytova, O. Desinova, L. P. Ananyeva, O. Koneva, L. Garzanova, O. Ovsyannikova, R. Shayakhmetova, V. Babak, T. Beketova |
| 722 |
[GO] |
2021―Mai―25 |
POS1161 A CITIZEN SCIENCE APPROACH TO CAPTURE POOR MENTAL HEALTH RELATED TO COVID-19 IN RHEUMATIC PATIENTS AFTER CONFINEMENT DURING PANDEMIC IN ITALY |
F. Ingegnoli, M. Buoli, C. Posio, R. DI Taranto, A. Lo Muscio, E. Cumbo, S. Ostuzzi, R. Caporali |
| 723 |
[GO] |
2021―Mai―25 |
POS1254 INCIDENCE AND OUTCOME OF COVID-19 IN ROUTINE RHEUMATOLOGY CARE: DATA FROM A SINGLE OUTPATIENT CENTER IN GERMANY |
S. G. Werner, P. Höhenrieder, R. Chatelain, H. E. Langer |
| 724 |
[GO] |
2021―Mai―25 |
POS1184 AUTOIMMUNE SYSTEMIC DISEASES AND COVID-19 INFECTION |
S. Monov, R. Shumnalieva, D. Monova |
| 725 |
[GO] |
2021―Mai―25 |
POS1198 THE ROLE OF SOCS3 IN COLCHICINE ANTI-INFLAMMATORY EFFECT ON COVID-19 INFECTION |
M. Y. Hachim, F. Alqutami, S. Hannawi |
| 726 |
[GO] |
2021―Mai―25 |
POS1215 INFLUENCE OF CONFINEMENT CARRIED OUT BY PATIENTS WITH AUTOIMMUNE AND IMMUNE- MEDIATED INFLAMMATORY DISEASE WITH BIOLOGICAL TREATMENT ON COVID-19 INFECTION |
J. Font-Urgelles, S. Mínguez, B. Rodríguez-Diez, L. Creus-Vila, M. Esquius Rafat, X. Fusta Novell, J. Llao Guardia, E. Sainz Arnau, M. Lopez de Recalde-Martorell, A. Arnau Bartes, M. Sallés Lizarzaburu |
| 727 |
[GO] |
2021―Mai―25 |
POS1183 OUTCOMES OF COVID-19 INFECTION AMONG CHILDREN AND YOUNG PEOPLE WITH PRE-EXISTING RHEUMATIC AND MUSCULOSKELETAL DISEASES |
L. Kearsley-Fleet, S. Lawson-Tovey, R. E. Costello, A. Belot, F. Aeschlimann, I. Melki, I. Koné-Paut, D. Clemente, M. C. Pinedo Gago, N. Svestkova, N. Vinšová, M. Hamad Saied, Y. Berkun, N. Wulffraat, S. Eulert, C. A. Scirè, A. Strangfeld, E. Mateus, P. Machado, Y. Uziel, K. Hyrich |
| 728 |
[GO] |
2021―Mai―25 |
POS1230 OUTCOME FOLLOWING COVID-19 INFECTION IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS |
A. Antovic, B. Lövström, A. Hugelius, O. Borjesson, A. Bruchfeld, I. Gunnarsson |
| 729 |
[GO] |
2021―Mai―25 |
POS1231 COVID-19 INFECTION IN RHEUMATIC IMMUNE-MEDIATED INFLAMMATORY DISEASES. EPIDEMIOLOGICAL STUDY IN A SINGLE UNIVERSITY HOSPITAL |
D. Martínez-López, D. Prieto-Peña, L. Sanchez-Bilbao, A. Herrero-Morant, C. Álvarez-Reguera, M. Trigueros-Vazquez, M. A. González-Gay, R. Blanco |
| 730 |
[GO] |
2021―Mai―25 |
POS1234 IMPACT OF THE CHANGE IN ADMINISTRATION ROUTE OF TOCILIZUMAB AND ABATACEPT, DUE TO THE COVID-19 LOCKDOWN ON DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS |
L. Diebold, T. Wirth, V. Pradel, N. Balandraud, E. Fockens, C. Paris, S. Trijau, P. Lafforgue, T. Pham |
| 731 |
[GO] |
2021―Mai―25 |
POS1189 THE IMPACT OF TELEMEDICINE AND COVID-19 ON A TERTIARY RHEUMATOLOGY SERVICE: A RETROSPECTIVE AUDIT |
W. Zhu, T. De Silva, L. Eades, S. Morton, S. Ayoub, E. F. Morand, A. Antony |
| 732 |
[GO] |
2021―Mai―25 |
POS1236 IMPACT OF COVID-19 ON INITIATION AND RENEWAL OF BIOTHERAPIES AND TARGETED SYNTHETIC TREATMENTS |
P. Richette, M. Allez, V. Descamps, L. Perra, S. Pilet, M. Maravic |
| 733 |
[GO] |
2021―Mai―25 |
POS1205 THE IMPACT OF COVID-19 ON PATIENT MANAGEMENT AND PRESCRIBING STRATEGY ACROSS THE EU AND US: A REAL-WORLD SURVEY OF RHEUMATOLOGISTS, DERMATOLOGISTS, AND GASTROENTEROLOGISTS |
E. Holdsworth, R. Lukanova, M. Hughes, J. Hall, J. Austin, G. Taylor-Stokes, J. Piercy |
| 734 |
[GO] |
2021―Mai―25 |
POS1192 BEHAVIOR AND FEELINGS OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS DURING LOCKDOWN MEASURES FOR THE COVID-19 OUTBREAK |
G. De Marchi, D. Azzolina, E. Maresio, D. Colatutto, M. Binutti, M. Monte, S. Gallipoli, F. Zobec, A. Palese, M. Silano, S. De Vita, D. Gregori, L. Quartuccio |
| 735 |
[GO] |
2021―Mai―25 |
POS1222 FACTORS ASSOCIATED WITH USE OF TELEMEDICINE FOR FOLLOW-UP OF LUPUS NEPHRITIS IN THE COVID-19 OUTBREAK |
H. So, E. Chow, T. K. LI, I. T. Cheng, S. L. Lau, C. C. Szeto, L. S. Tam |
| 736 |
[GO] |
2021―Mai―25 |
POS1164 USE OF TELEMEDICINE FOR FOLLOW-UP OF SLE PATIENTS WITH NEPHRITIS IN THE COVID-19 OUTBREAK (“TeleSLE”): THE 6-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL |
H. So, E. Chow, T. K. LI, S. L. Lau, I. T. Cheng, C. C. Szeto, L. S. Tam |
| 737 |
[GO] |
2021―Mai―25 |
POS1207 REAL WORLD POPULATION-BASED ASSESSMENT OF COVID-19 OUTCOMES AMONG RHEUMATOID ARTHRITIS PATIENTS USING BIOLOGIC OR SYNTHETIC DMARDs |
L. Wegrzyn, K. Winthrop, S. Kim, Y. Ye, C. Huisingh, W. Krueger, A. Maniccia, R. Kilpatrick |
| 738 |
[GO] |
2021―Mai―25 |
POS1186 EFFECT OF SOCIO-ECONOMIC STATUS AND EDUCATIONAL LEVEL ON COVID-19 OUTCOMES IN PATIENTS WITH RHEUMATIC DISEASES FROM ARGENTINA: DATA FROM THE SAR-COVID REGISTRY |
L. Sorrentino, J. Rebak, F. Maldonado, V. V. Castro Coello, A. Brigante, A. Hamaui, D. Dubinsky, R. Baez, C. Pisoni, C. Gobbi, L. Carlevaris, R. Tanten, A. K. Cogo, M. Delavega, R. Perez Alamino, M. A. Lazaro, M. Pera, S. I. Pineda Vidal, M. E. Calvo, D. Guaglianone, C. G. Alonso, M. Guinsburg, C. Retamozo, C. Aeschlimann, R. Quintana, K. Roberts, C. A. Isnardi, G. Pons Estel |
| 739 |
[GO] |
2021―Mai―25 |
POS1166 UNDERSTANDING PRESCRIPTION BEHAVIOR ACROSS HEALTHCARE PROFESSIONALS IN TREATING KNEE OSTEOARTHRITIS BEFORE AND DURING THE 2020 COVID-19 PANDEMIC |
D. Baldock, E. Baynton, H. Hamdan |
| 740 |
[GO] |
2021―Mai―25 |
POS1173 A SHORT DELAY IN ARTHRITIS CARE IS ASSOCIATED WITH HIGHER DISEASE ACTIVITY - LESSONS FROM THE CORONAVIRUS DISEASE 19 (COVID-19) PANDEMIC |
A. Giollo, E. Bertoldo, C. Benini, O. Viapiana, L. Idolazzi, G. Adami, A. Fassio, D. Gatti, M. Rossini |
| 741 |
[GO] |
2021―Mai―25 |
POS1178 THE ROLE OF VIRTUAL TELEPHONE VISITS IN THE TIGHT CONTROL OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TARGETED THERAPIES DURING THE COVID-19 PANDEMIC |
F. Ingegnoli, G. Cincinelli, A. F. Luppino, E. Favalli, R. Caporali |
| 742 |
[GO] |
2021―Mai―25 |
POS1244 PRELIMINARY RESULTS OF LONG-TERM FOLLOW-UP OF THE HEALTH STATUS OF PATIENTS USING csDMARDs AND b/tsDMARDS FOR RHEUMATIC DISEASES DURING THE COVID-19 PANDEMIC |
F. Unlu Ozkan, K. Sari, I. Aktas |
| 743 |
[GO] |
2021―Mai―25 |
POS1265 CHALLENGES OF EGYPTIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS DURING COVID-19 PANDEMIC |
S. Tharwat, S. Zohdy |
| 744 |
[GO] |
2021―Mai―25 |
POS1243 TELEMEDICINE AND MANAGEMENT OF THE PATIENT AFFECTED BY GIANT CELL ARTERITIS DURING THE COVID-19 PANDEMIC - TELEMACOV |
S. Parisi, M. C. Ditto, A. Laganà, C. L. Peroni, E. Fusaro |
| 745 |
[GO] |
2021―Mai―25 |
POS1213 IMPACT OF THE COVID-19 PANDEMIC AND LOCKDOWN ON WELLBEING ON PATIENTS WITH RHEUMATIC DISEASES. RESULTS FROM THE REUMAVID STUDY (PHASE 1) |
M. Garrido-Cumbrera, H. Marzo-Ortega, L. Christen, L. Carmona, J. Correa-Fernández, S. Sanz-Gómez, P. Plazuelo-Ramos, L. Grange, D. Webb, S. Irwin, C. Jacklin, S. Makri, E. Mateus, S. Mingolla, K. Antonopoulou, V. Navarro-Compán |
| 746 |
[GO] |
2021―Mai―25 |
POS1175 ASSESSMENT OF THE COVID-19 PANDEMIC FROM THE PERSPECTIVE OF PEOPLE WITH RHEUMATIC MUSCULOSKELETAL DISEASES IN EUROPE. RESULTS FROM THE REUMAVID STUDY (PHASE 1) |
M. Garrido-Cumbrera, H. Marzo-Ortega, J. Correa-Fernández, S. Sanz-Gómez, L. Christen, V. Navarro-Compán |
| 747 |
[GO] |
2021―Mai―25 |
POS1170 SELF-PROTECTION STRATEGIES, HEALTH BEHAVIOR AND DISEASE ACTIVITY DURING THE FIRST WAVE, RE-OPENING AND SECOND WAVE OF THE COVID-19 PANDEMIC IN >7000 DANISH PATIENTS WITH INFLAMMATORY ARTHRITIS |
B. Glintborg, D. V. Jensen, S. Engel, L. Terslev, M. Pfeiffer Jensen, O. Hendricks, M. Østergaard, S. H. Rasmussen, T. Adelsten, K. Danebod, A. Colic, M. Kildemand, A. G. Loft, H. L. Munk, J. K. Pedersen, R. Østgård, C. M. Sørensen, N. Steen Krogh, J. Nørgaard Agerbo, C. Ziegler, M. L. Hetland |
| 748 |
[GO] |
2021―Mai―25 |
POS1249 MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN DURING THE COVID-19 PANDEMIC IN TURKEY: FIRST REPORT FROM THE EASTERN MEDITERRANEAN |
Y. Ozsurekci, S. Gürlevik, S. Kesici, U. Kaya Akca, P. D. Oygar, K. Aykac, D. Karacanoglu, O. Saritas Nakip, S. Ilbay, B. Katlan, A. B. Cengiz, Ö. Basaran, B. C. Cura Yayla, J. Karakaya, Y. Bilginer, B. Bayrakci, M. Ceyhan, S. Özen |
| 749 |
[GO] |
2021―Mai―25 |
POS1169 IMPACT OF THE COVID-19 PANDEMIC ON MORBIDITY AND MORTALITY AMONG SWEDISH PATIENTS WITH INFLAMMATORY JOINT DISEASES VERSUS THE GENERAL POPULATION |
H. Bower, T. Frisell, D. DI Giuseppe, B. Delcoigne, G. M. Alenius, E. Baecklund, K. Chatzidionysiou, N. Feltelius, H. Forsblad-D’elia, A. Kastbom, L. Klareskog, E. Lindqvist, U. Lindström, C. Turesson, C. Sjowall, J. Askling |
| 750 |
[GO] |
2021―Mai―25 |
POS1241 THE IMPACT OF THE COVID-19 PANDEMIC ON PHYSICAL FUNCTIONING AND MENTAL WELLBEING IN 824 PATIENTS WITH RHEUMATIC DISEASE OVER 8 MONTHS: PHYSICAL FUNCTIONING DECLINES |
N. Cleaton, S. Raizada, T. Sheeran, J. Bateman |
| 751 |
[GO] |
2021―Mai―25 |
POS1167 REVIEW OF THE IMPACT OF COVID-19 PANDEMIC ON RHEUMATOLOGY SERVICES AT A LARGE TERTIARY CARE CENTRE IN WALES, UK |
R. Asif, N. Elndari, A. Negi |
| 752 |
[GO] |
2021―Mai―25 |
POS1185 IMPACT OF LOCKDOWN DURING COVID-19 PANDEMIC ON THE ONSET OF POST-TRAUMATIC STRESS DISORDER (PTSD) IN SYSTEMIC SCLEROSIS PATIENTS: A CASE-CONTROL STUDY |
D. M. Reza Beigi, G. Pellegrino, A. Lorello, C. Angelelli, K. Stefanantoni, F. Conti, V. Riccieri |
| 753 |
[GO] |
2021―Mai―25 |
POS1171 THE COVID-19 PANDEMIC PROMPTS ISOLATION AND BEHAVIORAL CHANGES IN PATIENTS WITH CHRONIC RHEUMATIC DISEASES LEADING TO REDUCED PHYSICAL ACTIVITY, INCREASED PAIN, DISEASE ACTIVITY, AND LOW SEROPREVALENCE OF SARS-CoV2 ANTIBODIES |
C. Ammitzbøll, J. B. Andersen, S. R. Vils, C. M. Jørgensen, E. M. Hauge, C. Erikstrup, S. Mikkelsen, M. K. Thomsen, A. Troldborg |
| 754 |
[GO] |
2021―Mai―25 |
POS1182 MANAGEMENT OF DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS DURING THE COVID-19 PANDEMIC: EVIDENCE FROM THE ITALIAN EPICENTER |
F. Ingegnoli, A. F. Luppino, G. Cincinelli, E. Favalli, R. Caporali |
| 755 |
[GO] |
2021―Mai―25 |
POS1261 DISEASE ACTIVITY AND PAIN LEVELS ARE NOT INFLUENCED BY THE CURRENT COVID19 PANDEMIC IN PATIENTS WITH RHEUMATIC DISEASES IN GERMANY - DATA FROM THE GERMAN COVID-19 PATIENT SURVEY |
R. Hasseli, U. Müller-Ladner, T. Schmeiser, H. M. Lorenz, A. Krause, H. Schulze-Koops, A. Pfeil, A. Regierer, J. Richter, A. Strangfeld, R. Voll, C. Specker, B. F. Hoyer |
| 756 |
[GO] |
2021―Mai―25 |
POS1250 VITAMIN D DEFICIENCY IS MAINLY ASSOCIATED WITH SEVERE LUNG INVOLVEMENT, LONGER DISEASE DURATION AND RISK OF DEATH IN ELDERLY COVID-19 PATIENTS |
A. Sulli, E. Gotelli, A. Casabella, M. Grosso, C. Schenone, C. Pizzorni, S. Paolino, E. Alessandri, V. Smith, M. Cutolo |
| 757 |
[GO] |
2021―Mai―25 |
POS1224 RHEUMATIC MANIFESTATIONS IN COVID-19 PATIENTS - SINGLE-CENTER EXPERIENCE AMIDST THE PANDEMIC |
S. Bogdanova-Petrova, T. Georgiev, G. Gerganov, S. Hristova, S. Dimitrov, T. Shivacheva |
| 758 |
[GO] |
2021―Mai―25 |
POS1256 SINGLE DOSE TOCILIZUMAB PHARMACOKINETICS IN GLUCOCORTICOID PRE-TREATED COVID-19 PATIENTS DURING CYTOKINE STORM SYNDROME HYPERINFLAMMATORY EPISODE: LESS IS MORE |
N. Boone, S. Ramiro, D. J. Moes, R. Mostard, C. Magro Checa, C. Van Dongen, M. Gronenschild, E. Van Haren, J. Buijs, R. Peeters, D. Wong, R. B. M. Landewé |
| 759 |
[GO] |
2021―Mai―25 |
POS1214 THE DYNAMICS OF INFLAMMATORY MARKERS IN COVID-19 PATIENTS TREATED WITH LEVILIMAB |
N. Lomakin, B. Bakirov, G. Musaev, D. Protsenko, O. Moiseeva, E. Pasechnik, V. Popov, E. Smolyarchuk, I. Gordeev, M. Gilyarov, D. Fomina, V. Mazurov, M. Morozova, E. Dokukina, D. Bogdan, A. Lutskii, A. Zinkina-Orihan, I. Linkova, A. Seleznev |
| 760 |
[GO] |
2021―Mai―25 |
POS1209 SUCCESSFUL TREATMENT OF SEVERE COVID-19 PNEUMONIA AND CYTOKINE RELEASE WITH SIMULTANEOUS TOCILIZUMAB AND ANAKINRA WITH ONE-MONTH FOLLOW-UP |
H. Haibel, J. L. Vahldiek, S. Angermair, M. Schumann, B. Siegmund, D. Poddubnyy, T. Schneider |
| 761 |
[GO] |
2021―Mai―25 |
POS1176 THE IMPACT OF COVID-19 QUARANTINE ON MENTAL HEALTH OF PATIENTS WITH FIBROMYALGIA |
F. Ingegnoli, M. Buoli, C. Posio, R. DI Taranto, R. Caporali |
| 762 |
[GO] |
2021―Mai―25 |
POS1262 A COHORT STUDY OF COVID-19 RELATED MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN AND ADOLESCENTS FROM MULTIPLE TERTIARY CARE CENTRES IN SOUTH INDIA |
A. Tiwari, A. Rauf, S. Kesavan, M. Kappanayil, S. Sivadas, S. Balan, P. Chickermane |
| 763 |
[GO] |
2021―Mai―25 |
POS1197 IN DEPTH IDENTIFICATION OF RISK FACTORS FOR SEVERE COVID-19, REQUIRING HOSPITALIZATION, IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: RESULTS OF A DUTCH NESTED CASE CONTROL STUDY (PRELIMINARY RESULTS) |
M. Opdam, S. Benoy, L. M. Verhoef, S. Van Bijnen, F. Lamers-Karnebeek, R. A. M. Traksel, P. Vos, A. Den Broeder, J. Broen |
| 764 |
[GO] |
2021―Mai―25 |
POS1191 COVID-19 STRESS: DOES IT AUGMENT PAIN IN PEOPLE WITH FIBROMYALGIA AND MIGHT PSYCHOLOGICAL FLEXIBILITY PROTECT AGAINST THIS INFLUENCE? |
T. Koppert, J. W. G. Jacobs, M. Lumley, R. Geenen |
| 765 |
[GO] |
2021―Mai―25 |
POS1187 WILLINGNESS TO GET THE COVID-19 VACCINE AMONG PATIENTS WITH RHEUMATIC DISEASES, HEALTH WORKERS AND GENERAL POPULATION |
B. Yurttas, B. C. Poyraz, N. Süt, A. Ozdede, M. Oztas, Ö. F. Tabak, V. Hamuryudan, E. Seyahi |
| 766 |
[GO] |
2021―Mai―25 |
POS1268 COVID-19 VACCINE HESITANCY AMONG RHEUMATOLOGY PATIENTS RECEIVING INFLUENZA VACCINE |
V. Valerio, H. C. Shen, E. Field, E. G. Mcdonald, A. Turner, S. Bernatsky, M. Hudson, I. Colmegna |
| 767 |
[GO] |
2021―Mai―25 |
POS1248 SAFETY PROFILE OF PFIZER-BIONTECH COVID-19 VACCINE IN PATIENTS WITH RHEUMATIC DISEASES: PRELIMINARY ASSESSMENT |
G. Cuomo, M. Atteno, C. Naclerio, L. E. Adinolfi, C. Romano |
| 768 |
[GO] |
2021―Mai―25 |
POS1196 COVID-19 VACCINE WILLINGNESS IN RA? RESULTS FROM THE RA LOUVAIN BRUSSELS COHORT |
T. Sokolova, V. Pirson, T. Xavier, E. Curraj, L. Bricman, E. Sapart, S. De Montjoye, S. Dierckx, A. Avramovska, P. Durez |
| 769 |
[GO] |
2021―Mai―25 |
POS1220 PREGNANT AND POSTPARTUM WOMEN WITH AUTOIMMUNE RHEUMATIC DISEASES AND COVID-19: A CASE SERIES |
R. A. Rodriguez Chavez, C. M. Skinner Taylor, L. Pérez Barbosa, G. Figueroa-Parra, J. E. Compeán-Villegas, L. G. Espinosa Banuelos, R. Moyeda Martinez, A. Y. Lujano Negrete, A. Cárdenas, D. Á. Galarza-Delgado |
| 770 |
[GO] |
2021―Mai―25 |
POS1174 HYPERINFLAMMATION AND CLINICAL OUTCOMES FOR PATIENTS WITH SYSTEMIC RHEUMATIC DISEASES HOSPITALIZED FOR COVID-19: A COMPARATIVE COHORT STUDY |
T. Hsu, K. D’silva, N. Serling-Boyd, J. Wang, A. Mueller, X. Fu, L. Prisco, L. Martin, K. Vanni, A. Zaccardelli, C. Cook, H. Choi, Y. Zhang, E. Gravallese, Z. Wallace, J. Sparks |
| 771 |
[GO] |
2021―Mai―25 |
POS1238 ANTIPHOSPHOLIPID ANTIBODIES AND COVID-19: TREND OVER TIME |
S. Mancuso, S. Truglia, A. Capozzi, F. Pasquali, S. Recalchi, G. Riitano, F. R. Spinelli, M. Sorice, R. Misasi, C. Alessandri, C. M. Mastroianni, F. Conti |
| 772 |
[GO] |
2021―Mai―25 |
POS1314 JUVENILE IDIOPATHIC ARTHRITIS IN THE CONTEXT OF THE CORONAVIRUS DISEASE 19 PANDEMIC: IMPACT ON THE DECREASE IN TREATMENT AND THE RETURN TO SCHOOL |
B. Quéré, I. Lemelle, A. Lohse, P. Pillet, J. Molimard, O. Richer, C. Sordet, V. Despert, L. Rossi-Semerano, C. Borocco, I. Koné-Paut, E. Gervais, D. Guellec, V. Devauchelle-Pensec |
| 773 |
[GO] |
2021―Mai―25 |
POS1195 ASSESSING ANTIBODY STATUS FOR SARS-CoV-2 IN PEOPLE WITH CORONAVIRUS INFECTION: A TIME COURSE STUDY IN PEOPLE WITH AUTOIMMUNE CONDITIONS |
K. Biddle, S. Koushesh, A. Blundell, D. Clark, S. Krishna, N. Sofat |
| 774 |
[GO] |
2021―Mai―25 |
POS1206 SEROPREVALENCE OF SARS-CoV-2 ANTIBODIES IN AUTOIMMUNE INFLAMMATORY RHEUMATOLOGIC PATIENTS |
T. Eviatar, D. Levartovsky, V. Furer, A. Polachek, O. Elalouf, M. Zisapel, T. Halperin, D. Turner, D. Paran, S. Pel, S. Nevo, O. Elkayam |
| 775 |
[GO] |
2021―Mai―25 |
POS1212 SARS-CoV-2 INFECTION AMONG PATIENTS WITH BEHÇET’S SYNDROME |
I. Mattioli, A. Bettiol, M. L. Urban, E. Silvestri, D. Malandrino, A. Palermo, F. Fagni, D. Prisco, G. Emmi |
| 776 |
[GO] |
2021―Mai―25 |
POS1267 CLINICAL COURSE OF NEW SARS-COV-2 INFECTION IN CHILDREN WITH RHEUMATIC DISEASES: RETROSPECTIVE STUDY OF SINGLE PEDIATRIC RHEUMATOLOGY CENTER |
I. Nikishina, Z. Kolkhidova, V. Matkava, A. Shapovalenko, S. Arsenyeva, M. Kaleda, E. Fedorov, S. Salugina |
| 777 |
[GO] |
2021―Mai―25 |
POS1260 FACTORS ASSOCIATED WITH SEVERE SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES IN MADRID: RESULTS FROM REUMA-COVID SORCOM REGISTRY |
A. Boteanu, A. García Fernández, N. De la Torre, M. Pavia Pascual, O. Sanchez Pernaute, S. Recuero Diaz, S. Perez Esteban, G. Bonilla, L. Nuño, J. J. Sanmartin Martinez, C. Bonilla Gonzalez-Leganá, D. Clemente Garulo, L. Lojo Oliveira, J. M. Rodríguez Herredia, J. Bachiller-Corral |
| 778 |
[GO] |
2021―Mai―25 |
POS1208 EPIDEMIOLOGY AND OUTCOMES OF PATIENTS WITH RHEUMATIC DISEASES AND SARS-CoV-2 INFECTION: DATA FROM THE ARGENTINEAN SAR-COVID REGISTRY |
C. A. Isnardi, R. Quintana, K. Roberts, V. V. Castro Coello, A. A. Reyes, Y. Tissera, M. Cosatti, R. Rojas Tessel, J. Scafati, T. Barbich, M. S. Gálvez Elkin, G. F. Rodriguez Gil, S. Moyano, M. L. Werner, J. Rebak, J. Morbiducci, V. Martire, M. S. Castaño, C. Dieguez, G. C. Subils, G. Pons-Estel |
| 779 |
[GO] |
2021―Mai―25 |
POS1194 THE EFFECT OF SARS-COV-2 ON THE COURSE AND THE TREATMENT OF RHEUMATIC INFLAMMATORY DISEASES. EXPERIENCE FORM THE NORTHWESTERN GREECE |
E. Pelechas, E. Kaltsonoudis, M. Migos, P. Karagianni, A. Kavvadias, P. Voulgari, A. Drosos |
| 780 |
[GO] |
2021―Mai―25 |
POS1229 ANTI-MDA5 AND ANTISYNTHETASE ANTIBODIES SCREENING IN SEVERE SARS-COV-2 PNEUMONIA. BE AWARE OF FALSE POSITIVE RESULTS |
A. Gil-Vila, J. Perurena-Prieto, C. Nolla-Fontana, O. Orozco-Galvez, M. Miarons-Font, A. Guillén del Castillo, A. Pacheco-Reyes, E. Trallero-Araguás, M. Hernandez-Gonzalez, A. Selva-O’callaghan |
| 781 |
[GO] |
2021―Mai―25 |
POS1219 SARS-COV-2 VACCINE HESITANCY AMONG PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES: A MESSAGE FOR RHEUMATOLOGISTS |
R. Priori, G. Pellegrino, S. Colafrancesco, C. Alessandri, F. Ceccarelli, M. DI Franco, V. Riccieri, R. Scrivo, A. Sili Scavalli, F. R. Spinelli, F. Conti |
| 782 |
[GO] |
2021―Mai―25 |
POS1255 REACTOGENICITY OF SARS-COV-2 VACCINES IN PATIENTS WITH AUTOIMMUNE AND INFLAMMATORY DISEASE |
M. Yang, P. Katz, D. Paez, A. Carvidi, M. Matloubian, M. Nakamura, L. S. Gensler |
| 783 |
[GO] |
2021―Mai―25 |
POS1180 TREATMENT COMPLIANCE OF PATIENTS WITH RHEUMATOID ARTHRITIS DURING THE FIRST WAVE OF THE SARS-CoV-2/COVID-19 PANDEMIC IN PORTUGAL: RESULTS FROM THE COVID IN RA (COVIDRA) SURVEY |
F. Araujo, N. Gonçalves, A. F. Mourão |
| 784 |
[GO] |
2021―Mai―25 |
POS1204 LOW POSITIVITY RATE IN ANTIBODY SARS-COV2 TESTS IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH RITUXIMAB. A CASE CONTROL STUDY OF A HIGH IMPACT SARS-COV2 INFECTION AREA. |
A. García Fernández, P. Morán Álvarez, J. Bachiller-Corral, M. Vázquez Díaz |
| 785 |
[GO] |
2021―Mai―25 |
POS1218 SAFETY AND EFFICACY OF ANAKINRA IN SEVERE SARS-COV2 INFECTION (COVID19) AT A TERTIARY HOSPITAL |
O. Rusinovich, A. Mora, E. Muñez, L. Delgado Tellez de Cepeda, N. De la Torre, M. Pavía, J. Sanz, M. Espinosa, J. L. Andréu Sánchez, J. Campos Esteban |
| 786 |
[GO] |
2021―Mai―25 |
POS1199 CLINICAL MANIFESTATIONS OF SARS-CoV2 INFECTIONS IN CHILDREN AND ADOLESCENTS WITH RHEUMATIC AND MUSCULUSKELETAL DISEASES - SURVEY DATA FROM GERMANY |
C. Sengler, S. Eulert, M. Niewerth, T. Kallinich, H. Wittkowski, H. Girschick, J. P. Haas, G. Horneff, T. Hospach, J. Armann, J. B. Kuemmerle-Deschner, J. Brunner, M. Borte, R. Hühn, K. Minden, A. Klein |
| 787 |
[GO] |
2021―Mai―25 |
POS1216 SYMPTOM RATES, ATTITUDES AND MEDICATION ADHERENCE OF RHEUMATIC AND MUSCULOSKELETAL DISEASE PATIENTS DURING THE SARS-CoV2 PANDEMIC |
K. Murray, S. Quinn, M. Turk, A. O’rourke, E. Molloy, L. O’neill, A. B. Mongey, U. Fearon, D. Veale |
| 788 |
[GO] |
2021―Mai―25 |
POS1221 SARS-COV2 SEROLOGY SCREENING IN SPONDYLOARTHRITIS PATIENTS IN NORTH-EASTERN ITALY: A PILOT STUDY |
A. Ortolan, C. Cosma, M. Lorenzin, G. Cozzi, A. Doria, M. Plebani, R. Ramonda |
| 789 |
[GO] |
2021―Mai―25 |
POS1217 THE PATTERN OF COVID 19 PANDEMIC AMONG PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES (AIIRD) |
F. Kharouf, T. Eviatar, M. Braun, E. Pokroy-Shapira, M. Brodavka, N. Agmon-Levin, K. Toledano, S. Oren, M. Lidar, Y. Tavor, M. Amit Vazina, F. Sabbah, G. Breuer, A. Dagan, D. Zisman, D. Markovits, T. Reitblat, S. Giryes, D. Mevorach, D. Paran, O. Elkayam, A. Balbir-Gurman, Y. Braun-Moscovici |
| 790 |
[GO] |
2021―Mai―25 |
POS1203 EFFECT OF THE COVID19 PANDEMIC ON RHEUMATOLOGIST PRESCRIPTION BEHAVIOUR OF NEW ADVANCED THERAPY: DATA OF THE TARDIS-RA REGISTRY, A NATIONWIDE BELGIAN BIOLOGIC REGISTRY |
D. De Cock, P. Durez, V. Badot, R. Westhovens, P. Verschueren |
| 791 |
[GO] |
2021―Mai―24 |
High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases |
Jake A Ruddy, Caoilfhionn Marie Connolly, Brian J Boyarsky, William A Werbel, Lisa Christopher-Stine, Jacqueline Garonzik-Wang, Dorry L Segev, Julie J Paik |
| 792 |
[GO] |
2021―Mai―13 |
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Rosenbaum et al |
Kimme L Hyrich, Martin Schäfer, Anja Strangfeld, Loreto Carmona, Laure Gossec, Elsa F Mateus, Saskia Lawson-Tovey, Milena Gianfrancesco, Philip C Robinson, Jinoos Yazdany, Pedro M Machado |
| 793 |
[GO] |
2021―Mai―13 |
Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry’ |
James Todd Rosenbaum, Michael H Weisman, Cassie Shafer, Elin Aslanyan, Richard A Howard, Kimberly Ogle, Hedley Hamilton, John D Reveille, Kevin L Winthrop, Dongseok Choi |
| 794 |
[GO] |
2021―Mai―12 |
Correspondence on ‘Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab’ |
Desiree Tampe, Peter Korsten, Samy Hakroush, Martin Sebastian Winkler, Björn Tampe |
| 795 |
[GO] |
2021―Mai―12 |
Response to: ‘Correspondence on ‘Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab’’ by Tampe et al |
Marcia A Friedman, Kevin L Winthrop |
| 796 |
[GO] |
2021―Mai―06 |
Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation |
Marlou T H F Janssen, Sofia Ramiro, Robert B M Landewé, César Magro-Checa, Rémy L M Mostard |
| 797 |
[GO] |
2021―Mai―06 |
SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response |
Michael Markus Bonelli, Daniel Mrak, Thomas Perkmann, Helmuth Haslacher, Daniel Aletaha |
| 798 |
[GO] |
2021―Mai―06 |
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases |
David Simon, Koray Tascilar, Filippo Fagni, Gerhard Krönke, Arnd Kleyer, Christine Meder, Raja Atreya, Moritz Leppkes, Andreas E Kremer, Andreas Ramming, Milena L Pachowsky, Florian Schuch, Monika Ronneberger, Stefan Kleinert, Axel J Hueber, Karin Manger, Bernhard Manger, Carola Berking, Michael Sticherling, Markus F Neurath, Georg Schett |
| 799 |
[GO] |
2021―Apr―27 |
Response to: ‘Correspondence on ‘Onset of rheumatoid arthritis after COVID-19: coincidence or connected?’’ by Roongta et al |
Veerle F A M Derksen, Diane van der Woude |
| 800 |
[GO] |
2021―Apr―27 |
EULAR COVID-19 registry: lessons learnt and future considerations |
Saskia Lawson-Tovey, Anja Strangfeld, Kimme L Hyrich, Loreto Carmona, Diana Rodrigues, Laure Gossec, Elsa F Mateus, Pedro M Machado |
| 801 |
[GO] |
2021―Apr―27 |
Correspondence on ‘Onset of rheumatoid arthritis after COVID-19: coincidence or connected?’ |
Rashmi Roongta, Arghya Chattopadhyay, Alakendu Ghosh |
| 802 |
[GO] |
2021―Apr―27 |
Correspondence on ‘EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs’ |
Serena Bugatti, Silvia Balduzzi, Ludovico De Stefano, Antonio Manzo, Blerina Xoxi, Laura Bogliolo, Sara Monti, Paolo Delvino, Carlomaurizio Montecucco |
| 803 |
[GO] |
2021―Apr―27 |
Response to: ‘Correspondence on ‘EULAR December 2020 View points on SARS-CoV-2 vaccination in patients with RMDs’’ by Bugatti et al |
Johannes W J Bijlsma |
| 804 |
[GO] |
2021―Apr―26 |
Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients |
Uriel Trahtemberg, Robert Rottapel, Claudia C Dos Santos, Arthur S Slutsky, Andrew Baker, Marvin J Fritzler |
| 805 |
[GO] |
2021―Apr―26 |
Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’ |
Aimilios Kaklamanos, Panagiotis Karamichalos, Panayiotis G Vlachoyiannopoulos, Athanasios G Tzioufas |
| 806 |
[GO] |
2021―Apr―26 |
Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by Kaklamanos et al |
Sofia Ramiro, Rémy L M Mostard, Robert B M Landewé |
| 807 |
[GO] |
2021―Apr―13 |
Ensuring tight control in patients with rheumatoid arthritis treated with targeted therapies during the COVID-19 pandemic using a telehealth strategy |
Francesca Ingegnoli, Gilberto Cincinelli, Angela Flavia Luppino, Ennio Giulio Favalli, Annalisa Orenti, Patrizia Boracchi, Roberto Caporali |
| 808 |
[GO] |
2021―Apr―13 |
Prospective study into COVID-19-like symptoms in patients with and without immune-mediated inflammatory diseases or immunomodulating drugs |
Lotte van Ouwerkerk, Andrea E van der Meulen-de Jong, Maarten K Ninaber, Y K Onno Teng, Tom WJ Huizinga, Cornelia F Allaart |
| 809 |
[GO] |
2021―Apr―09 |
Correspondence on ‘Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study’ |
Liang En Wee, Edwin Philip Conceicao, Jing Yuan Tan, Julian Thumboo, Indumathi Venkatachalam |
| 810 |
[GO] |
2021―Mrz―23 |
Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases |
Brian J Boyarsky, Jake A Ruddy, Caoilfhionn M Connolly, Michael T Ou, William A Werbel, Jacqueline M Garonzik-Wang, Dorry L Segev, Julie J Paik |
| 811 |
[GO] |
2021―Mrz―19 |
Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases |
Caoilfhionn M Connolly, Jake A Ruddy, Brian J Boyarsky, Robin K Avery, William A Werbel, Dorry L Segev, Jacqueline Garonzik-Wang, Julie J Paik |
| 812 |
[GO] |
2021―Mrz―16 |
SARS-CoV-2 infection among inpatients with systemic lupus erythematosus in France: a nationwide epidemiological study |
Arthur Mageau, Geoffrey Aldebert, Damien Van Gysel, Thomas Papo, Jean-François Timsit, Karim Sacre |
| 813 |
[GO] |
2021―Mrz―10 |
Correspondence on ‘SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease’ |
Shanoj K C, Sakir Ahmed, Veena Shenoy, Aparna R Menon, Sanjo Saijan, Sageer AS Babu, Padmanabha Shenoy |
| 814 |
[GO] |
2021―Mrz―10 |
Response to: ‘Correspondence on ‘SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease’’ by Shanoj et al |
Kristin M D’Silva, Naomi Serling-Boyd, Tiffany Y-T Hsu, Jeffrey A Sparks, Zachary Scott Wallace |
| 815 |
[GO] |
2021―Mrz―05 |
Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab |
Marcia A Friedman, Kevin L Winthrop |
| 816 |
[GO] |
2021―Mrz―03 |
Rheumatology and COVID-19 at 1 year: facing the unknowns |
Leonard Calabrese, Kevin L Winthrop |
| 817 |
[GO] |
2021―Mrz―03 |
Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by Charles |
Josef S Smolen |
| 818 |
[GO] |
2021―Mrz―01 |
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Mulhearn et al |
Martin Schäfer, Anja Strangfeld, Kimme L Hyrich, Loreto Carmona, Milena Gianfrancesco, Saskia Lawson-Tovey, Elsa F Mateus, Laure Gossec, Philip C Robinson, Jinoos Yazdany, Pedro M Machado |
| 819 |
[GO] |
2021―Mrz―01 |
Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry’ |
Ben Mulhearn |
| 820 |
[GO] |
2021―Mrz―01 |
Onset of rheumatoid arthritis after COVID-19: coincidence or connected? |
Veerle F A M Derksen, Theresa Kissel, Femke B G Lamers-Karnebeek, Arie E van der Bijl, Annemarie C Venhuizen, Tom W J Huizinga, René E M Toes, Anna H E Roukens, Diane van der Woude |
| 821 |
[GO] |
2021―Feb―23 |
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study |
Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Gerd-Marie Ahlenius, Eva Baecklund, Katerina Chatzidionysiou, Nils Feltelius, Helena Forsblad-d'Elia, Alf Kastbom, Lars Klareskog, Elisabet Lindqvist, Ulf Lindström, Carl Turesson, Christopher Sjöwall, Johan Askling |
| 822 |
[GO] |
2021―Feb―23 |
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists |
Roberta Priori, Greta Pellegrino, Serena Colafrancesco, Cristiano Alessandri, Fulvia Ceccarelli, Manuela Di Franco, Valeria Riccieri, Rossana Scrivo, Antonio Sili Scavalli, Francesca Romana Spinelli, Fabrizio Conti |
| 823 |
[GO] |
2021―Feb―18 |
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’ by Arnaud and Devilliers |
Pedro M Machado, Martin Schäfer, Anja Strangfeld, Laure Gossec, Milena Gianfrancesco, Saskia Lawson-Tovey, Elsa F Mateus, Loreto Carmona, Kimme L Hyrich, Philip C Robinson, Jinoos Yazdany |
| 824 |
[GO] |
2021―Feb―18 |
Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry’ |
Laurent Arnaud, Hervé Devilliers |
| 825 |
[GO] |
2021―Feb―16 |
Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’ |
Maria De Santis, Antonio Voza, Victor Savevski, Salvatore Badalamenti, Maurizio Cecconi, Alberto Mantovani, Carlo Selmi |
| 826 |
[GO] |
2021―Feb―16 |
Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by De Santis et al |
Sofia Ramiro, Rémy L M Mostard, Robert B M Landewé |
| 827 |
[GO] |
2021―Feb―16 |
Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider |
Alessia Alunno, Aurélie Najm, Xavier Mariette, Gabriele De Marco, Jenny Emmel, Laura Mason, Dennis G McGonagle, Pedro M Machado |
| 828 |
[GO] |
2021―Feb―15 |
Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’ |
Pierre Charles |
| 829 |
[GO] |
2021―Feb―15 |
Response to: ’Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by Charles |
Sofia Ramiro, Rémy L M Mostard, Robert B M Landewé |
| 830 |
[GO] |
2021―Feb―10 |
EULAR December 2020 View points on SARS-CoV-2 vaccination in patients with RMDs |
Johannes WJ Bijlsma |
| 831 |
[GO] |
2021―Feb―07 |
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19 |
Alessia Alunno, Aurélie Najm, Pedro M Machado, Heidi Bertheussen, Gerd R Burmester, Francesco Carubbi, Gabriele De Marco, Roberto Giacomelli, Olivier Hermine, John D Isaacs, Isabelle Koné-Paut, César Magro-Checa, Iain McInnes, Pier Luigi Meroni, Luca Quartuccio, Athimalaipet V Ramanan, Manuel Ramos-Casals, Javier Rodríguez Carrio, Hendrik Schulze-Koops, Tanja A Stamm, Sander W Tas, Benjamin Terrier, Dennis G McGonagle, Xavier Mariette |
| 832 |
[GO] |
2021―Jan―29 |
PASTUL questionnaire: a tool for self-assessment of scleroderma skin during the COVID-19 pandemic |
Julia Spierings, Voon Ong, Christopher P Denton |
| 833 |
[GO] |
2021―Jan―28 |
Correspondence on ‘Anti-inflammatory therapy for COVID-19 infection: the case for colchicine’ |
Carlo Perricone, Elena Bartoloni, Giacomo Cafaro, Roberto Caporali, Roberto Gerli |
| 834 |
[GO] |
2021―Jan―28 |
Response to: ‘Correspondence on ‘Anti-inflammatory therapy for COVID-19 infection: the case for colchicine’’ by Perricone et al |
Binita Shah, Aaron Z Reyes, Kelly A Hu, Jacob Teperman, Theresa L Wampler Muskardin, Jean-Claude Tardif, Michael H Pillinger |
| 835 |
[GO] |
2021―Jan―28 |
Correspondence on ‘Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries’ |
Shamma Al Nokhatha, Neil MacEoin, Richard Conway |
| 836 |
[GO] |
2021―Jan―28 |
Response to: ‘Correspondence on ‘Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries’ by Nokhatha et al |
Christian Dejaco, Johannes WJ Bijlsma, Frank Buttgereit |
| 837 |
[GO] |
2021―Jan―28 |
Potential acceptance of COVID-19 vaccine in rheumatological patients: a monocentric comparative survey |
Corrado Campochiaro, Giorgia Trignani, Alessandro Tomelleri, Stefano Cascinu, Lorenzo Dagna |
| 838 |
[GO] |
2021―Jan―27 |
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry |
Anja Strangfeld, Martin Schäfer, Milena A Gianfrancesco, Saskia Lawson-Tovey, Jean W Liew, Lotta Ljung, Elsa F Mateus, Christophe Richez, Maria J Santos, Gabriela Schmajuk, Carlo A Scirè, Emily Sirotich, Jeffrey A Sparks, Paul Sufka, Thierry Thomas, Laura Trupin, Zachary S Wallace, Sarah Al-Adely, Javier Bachiller-Corral, Suleman Bhana, Patrice Cacoub, Loreto Carmona, Ruth Costello, Wendy Costello, Laure Gossec, Rebecca Grainger, Eric Hachulla, Rebecca Hasseli, Jonathan S Hausmann, Kimme L Hyrich, Zara Izadi, Lindsay Jacobsohn, Patricia Katz, Lianne Kearsley-Fleet, Philip C Robinson, Jinoos Yazdany, Pedro M Machado |
| 839 |
[GO] |
2021―Jan―27 |
Response to: ‘Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’’ by Lee |
Shintaro Akiyama, Shadi Hamdeh, Dejan Micic, Atsushi Sakuraba |
| 840 |
[GO] |
2021―Jan―27 |
Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’ |
Young Ho Lee |
| 841 |
[GO] |
2021―Jan―27 |
Correspondence on ‘Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome’ |
Tomoyuki Kawada |
| 842 |
[GO] |
2021―Jan―27 |
Response to: ‘Correspondence on ‘Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome’’ by Kawada |
Silvia Piantoni, Laura Andreoli, Enrico Colombo, Monia Mendeni, Maria Laura Ghirardelli, Antonio Brucato, Massimo Imazio, Roberto Furloni, Franco Franceschini, Paolo Airó, Mirko Scarsi |
| 843 |
[GO] |
2021―Jan―25 |
CO0004 OLDER AGE, CARDIOVASCULAR COMORBIDITY AND GLUCOCORTICOSTEROIDS ARE RISK FACTORS FOR COVID-19 HOSPITALISATION IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: FIRST RESULTS OF THE GERMAN COVID-19-IRD REGISTRY |
A. Regierer, R. Hasseli, B. Hoyer, A. Krause, H. M. Lorenz, A. Pfeil, J. Richter, T. Schmeiser, C. Specker, A. Strangfeld, R. Voll, H. Schulze-Koops, U. Müller-Ladner |
| 844 |
[GO] |
2021―Jan―25 |
CO0001 MAVRILIMUMAB IMPROVES OUTCOMES IN SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPER-INFLAMMATION |
G. De Luca, G. Cavalli, C. Campochiaro, E. Della Torre, P. Angelillo, A. Tomelleri, N. Boffini, S. Tentori, F. Mette, P. Rovere-Querini, A. Ruggeri, T. D’aliberti, P. Scarpelllini, G. Landoni, F. De Cobelli, J. F. Paolini, A. Zangrillo, M. Tresoldi, B. C. Trapnell, F. Ciceri, L. Dagna |
| 845 |
[GO] |
2021―Jan―25 |
CO0005 C-C CHEMOKINE RECEPTOR TYPE 5 AND ITS LIGANDS CCL4, 8 AND 11 CAN LINK COVID-19, RHEUMATOID ARTHRITIS AND HYDROXYCHLOROQUINE |
M. Y. Hachim, S. Hannawi |
| 846 |
[GO] |
2021―Jan―25 |
CO0002 LOSS OF SELF-TOLERANCE IN SARS-COV-2 INFECTION: IMMUNOLOGICAL ASSESSMENT OF A CONVALESCENT COHORT |
A. Paglionico, V. Varriano, B. Tolusso, S. Alivernini, L. Petricca, G. Natalello, L. Gigante, S. L. Bosello, A. M. Martone, F. Landi, E. Gremese |
| 847 |
[GO] |
2021―Jan―25 |
C00006 PSYCHOLOGICAL IMPACT OF COVID 19 PANDEMIC ON PATIENTS WITH RHEUMATOLOGICAL DISORDERS - A WEB BASED CROSS-SECTIONAL MULTICENTRE SURVEY |
Y. G C, Y. P. Singh, S. Prasad, N. Srinivasulu, S. Kumar, S. R, P. Chebbi, V. R. K. Jain, N. Jain, S. Kumar C R |
| 848 |
[GO] |
2021―Jan―21 |
Correspondence on ‘Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients’ |
Tanaz A Kermani |
| 849 |
[GO] |
2021―Jan―21 |
Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts |
Angel YS Wong, Brian MacKenna, Caroline E Morton, Anna Schultze, Alex J Walker, Krishnan Bhaskaran, Jeremy P Brown, Christopher T Rentsch, Elizabeth Williamson, Henry Drysdale, Richard Croker, Seb Bacon, William Hulme, Chris Bates, Helen J Curtis, Amir Mehrkar, David Evans, Peter Inglesby, Jonathan Cockburn, Helen I McDonald, Laurie Tomlinson, Rohini Mathur, Kevin Wing, Harriet Forbes, Rosalind M Eggo, John Parry, Frank Hester, Sam Harper, Stephen JW Evans, Liam Smeeth, Ian J Douglas, Ben Goldacre |
| 850 |
[GO] |
2021―Jan―15 |
Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’ |
Sarthak Gupta, Shuichiro Nakabo, Jun Chu, Sarfaraz Hasni, Mariana J Kaplan |
| 851 |
[GO] |
2021―Jan―15 |
Response to: ‘Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’’ by Yang et al |
Shintaro Akiyama, Shadi Hamdeh, Dejan Micic, Atsushi Sakuraba |
| 852 |
[GO] |
2021―Jan―15 |
Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’ |
Haiyan Yang, Jie Xu, Li Shi, Guangcai Duan, Yadong Wang |
| 853 |
[GO] |
2021―Jan―13 |
SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease |
Kristin M D’Silva, Naomi Serling-Boyd, Tiffany Y-T Hsu, Jeffrey A Sparks, Zachary S Wallace |
| 854 |
[GO] |
2021―Jan―07 |
Correspondence on ‘Preliminary predictive criteria for COVID-19 cytokine storm’ |
Desiree Tampe, Martin S Winkler, Peter Korsten, Samy Hakroush, Onnen Moerer, Björn Tampe |
| 855 |
[GO] |
2021―Jan―07 |
Response to: ‘Correspondence on ‘Preliminary predictive criteria for COVID-19 cytokine storm’’ by Tampe et al |
Roberto Caricchio, Marcello Gallucci, Chandra Dass, Xinyan Zhang, Stefania Gallucci, David Fleece, Michael Bromberg, Gerard J Criner |
| 856 |
[GO] |
2021―Jan―06 |
Correspondence on ‘Systemic sclerosis and the COVID-19 pandemic-World Scleroderma Foundation preliminary advice for patient management’ |
Elena Snarskaya, Kseniia Vasileva |
| 857 |
[GO] |
2021―Jan―06 |
Response to: ‘Correspondence on ‘Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management’’ by Snarskaya and Vasileva |
Cosimo Bruni, Marco Matucci-Cerinic |
| 858 |
[GO] |
2021―Jan―05 |
Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland |
Aron Hjalti Bjornsson, Gerdur Grondal, Mar Kristjansson, Thorunn Jonsdottir, Thorvardur Jon Love, Bjorn Gudbjornsson |
| 859 |
[GO] |
2020―Dez―22 |
Correspondence on ‘Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases’ |
Sibel Zehra Aydin, Elliot Hepworth, Peter Tugwell |
| 860 |
[GO] |
2020―Dez―22 |
Response to: ‘Correspondence on ‘Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases’’ by Aydin et al |
Dalifer Dayanira Freites Nuñez, Leticia Leon, Arkaitz Mucientes, Luis Rodriguez-Rodriguez, Judit Font Urgelles, Alfredo Madrid García, Jose Ignacio Colomer, Juan A Jover, Benjamín Fernandez-Gutierrez, Lydia Abasolo |
| 861 |
[GO] |
2020―Dez―18 |
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine |
Alexis Mathian, Matthieu Mahevas, Julien Rohmer, Mathilde Roumier, Fleur Cohen-Aubart, Blanca Amador-Borrero, Audrey Barrelet, Cecile Chauvet, Thibaud Chazal, Michel Delahousse, Mathilde Devaux, Romain Euvrard, Jehane Fadlallah, Nans Florens, Julien Haroche, Miguel Hié, Laurent Juillard, Raphael Lhote, Thibault Maillet, Gaelle Richard-Colmant, Jean Baptiste Palluy, Micheline Pha, Laurent Perard, Philippe Remy, Etienne Rivière, Damien Sène, Pascal Sève, Capucine Morélot-Panzini, Jean-François Viallard, Jean-Simon Virot, Neila Benameur, Noël Zahr, Hans Yssel, Bertrand Godeau, Zahir Amoura |
| 862 |
[GO] |
2020―Dez―18 |
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management |
Marco Matucci-Cerinic, Cosimo Bruni, Yannick Allanore, Massimo Clementi, Lorenzo Dagna, Nemanja S Damjanov, Amato de Paulis, Christopher P Denton, Oliver Distler, David Fox, Daniel E Furst, Dinesh Khanna, Thomas Krieg, Masataka Kuwana, Eun Bong Lee, Mengtao Li, Shiv Pillai, Yukai Wang, Xiaofeng Zeng, Gloria Taliani |
| 863 |
[GO] |
2020―Dez―18 |
Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic |
Hendrik Schulze-Koops, Christof Specker, Christof Iking-Konert, Julia Holle, Frank Moosig, Klaus Krueger |
| 864 |
[GO] |
2020―Dez―16 |
Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study’’ by Calvo-Aranda et al |
Sofia Ramiro, Rémy Mostard, Robert BM Landewé |
| 865 |
[GO] |
2020―Dez―16 |
Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’ |
Enrique Calvo-Aranda, Irene Cañamares-Orbis, Marta Novella-Navarro, Alvaro Martinez-Alcala, Maria del Carmen Ortega de la O, Ismael Escobar-Rodriguez, Fernando Manuel Sanchez-Aranda |
| 866 |
[GO] |
2020―Dez―08 |
Anti-inflammatory therapy for COVID-19 infection: the case for colchicine |
Aaron Z Reyes, Kelly A Hu, Jacob Teperman, Theresa L Wampler Muskardin, Jean-Claude Tardif, Binita Shah, Michael H Pillinger |
| 867 |
[GO] |
2020―Dez―02 |
Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients |
|
| 868 |
[GO] |
2020―Nov―30 |
Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic |
Naomi Serling-Boyd, Kristin M D’Silva, Tiffany YT Hsu, Rachel Wallwork, Xiaoqing Fu, Ellen M Gravallese, April M Jorge, Yuqing Zhang, Hyon Choi, Jeffrey A Sparks, Zachary S Wallace |
| 869 |
[GO] |
2020―Nov―25 |
Response to: ‘Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine by Mathian et al’ by Notz et al |
Alexis Mathian, Zahir Amoura |
| 870 |
[GO] |
2020―Nov―20 |
Response to: ‘Correspondence on ‘Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort’ by Pouletty et al ’ by Ventura et al |
Juliette Chommeloux, Marie Pouletty, Naim Ouldali, Mathieu Kerneis, Alexis Mathian, Raphaele Mestiri, Julien Rohmer, Guillaume Hekimian, Isabelle Melki |
| 871 |
[GO] |
2020―Nov―17 |
COVID-19 cytokine storm: what is in a name? |
Peter A Nigrovic |
| 872 |
[GO] |
2020―Nov―12 |
Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey’ |
Cloé Comarmond, Mathilde Leclercq, Gaëlle Leroux, Cindy Marques, Alexandre Le Joncour, Fanny Domont, Céline Hatte, Ségolène Toquet-Bo, Perrine Guillaume-Jugnot, Anne-Claire Desbois, Mathieu Vautier, Aude Rigolet, Yves Allenbach, Olivier Benveniste, David Saadoun, Patrice Cacoub |
| 873 |
[GO] |
2020―Nov―12 |
Response to: ‘Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey’ by Comarmond et al |
Alessandro Tomelleri, Silvia Sartorelli, Elena Marina Baldissera, Lorenzo Dagna, Corrado Campochiaro |
| 874 |
[GO] |
2020―Nov―11 |
Response to ‘Correspondence on ‘Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort’ by Ruyssen-Witrand et al |
Adrian Ciurea, Axel Finckh |
| 875 |
[GO] |
2020―Nov―11 |
Correspondence on ‘Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort’ |
Adeline Ruyssen-Witrand, Martin Soubrier, André Basch, Marie-Elise Truchetet, Raphaèle Seror |
| 876 |
[GO] |
2020―Nov―10 |
Response to ‘Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’’ by Shi et al |
Shintaro Akiyama, Shadi Hamdeh, Dejan Micic, Atsushi Sakuraba |
| 877 |
[GO] |
2020―Nov―10 |
Correspondence on ‘prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’ |
Jiyuan Shi, Ya Gao, Lili Zhang, Yang Zhao, Jianguo Xu, Jinhui Tian |
| 878 |
[GO] |
2020―Nov―06 |
Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries |
Christian Dejaco, Alessia Alunno, Johannes WJ Bijlsma, Annelies Boonen, Bernard Combe, Axel Finckh, Pedro M Machado, Ivan Padjen, Francisca Sivera, Tanja A Stamm, Frank Buttgereit |
| 879 |
[GO] |
2020―Nov―03 |
Response to ‘Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’’ by Gremese et al |
Shintaro Akiyama, Shadi Hamdeh, Dejan Micic, Atsushi Sakuraba |
| 880 |
[GO] |
2020―Nov―03 |
Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’ |
Elisa Gremese, Giovanni Brondani, Luca Apollonio, Gianfranco Ferraccioli |
| 881 |
[GO] |
2020―Nov―02 |
Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area |
Rim Bourguiba, Marion Delplanque, Caroline Vinit, Léa Savey, Gilles Grateau, Veronique Hentgen, Sophie Georgin-lavialle |
| 882 |
[GO] |
2020―Okt―30 |
Neither earlier nor late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study |
Sergey Moiseev, Sergey Avdeev, Ekaterina Tao, Michail Brovko, Nikolay Bulanov, Anastasiia Zykova, Larisa Akulkina, Irina Smirnova, Victor Fomin |
| 883 |
[GO] |
2020―Okt―30 |
Response to ‘Neither earlier not late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study’ by Moiseev et al |
Sofia Ramiro, Robert B M Landewé, Rémy Mostard |
| 884 |
[GO] |
2020―Okt―30 |
Correspondence to ‘Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases’ |
Hendrik Schulze-Koops, Alla Skapenko, Andreas Krause, Klaus Krueger, Hanns-Martin Lorenz, Philipp Sewerin, Christof Specker, Ulf G Wagner, Anna Voormann, Ulf Mueller-Ladner, Reinhard E Voll |
| 885 |
[GO] |
2020―Okt―30 |
Response to: ‘Correspondence on ‘Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases’’ by Schulze-Koops et al |
Dalifer Dayanira Freites Nuñez, Leticia Leon, Arkaitz Mucientes, Luis Rodriguez-Rodriguez, Judit Font Urgelles, Alfredo Madrid García, Jose Ignacio Colomer, Juan A Jover, Benjamín Fernandez-Gutierrez, Lydia Abasolo |
| 886 |
[GO] |
2020―Okt―14 |
COVID-19 in Italian patients with rheumatic autoimmune systemic diseases |
Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, Poupak Fallahi, Alessandro Antonelli |
| 887 |
[GO] |
2020―Okt―14 |
Trajectories of COVID-19 information in the Annals of the Rheumatic Diseases: the first months of the pandemic |
Kim Lauper, Johannes W J Bijlsma, Gerd R Burmester |
| 888 |
[GO] |
2020―Okt―13 |
Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis |
Shintaro Akiyama, Shadi Hamdeh, Dejan Micic, Atsushi Sakuraba |
| 889 |
[GO] |
2020―Okt―06 |
Response to ‘Correspondence on ‘Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID19): a multicentre cohort’’ by Mastrolia et al |
Charlotte Borocco, Marie Pouletty, Caroline Galeotti, Ulrich Meinzer, Albert Faye, Isabelle Koné-Paut, Naim Ouldali, Isabelle Melki |
| 890 |
[GO] |
2020―Okt―01 |
Correspondence on ‘Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis’ |
Florence Jeny, Raphael Lhote, Gwenael Lorillon, Nicolas Belhomme, Grégory Pugnet, Raphaël Borie, Aurélien Justet, Stephane Jouneau, Nathalie Freymond, Arsène Mekinian, Robin Dhote, Yacine Tandjaoui-Lambiotte, Nathalie Saindenberg, Pierre Gazengel, Baptiste Hervier, Julien Haroche, Alexis Mathian, Miguel Hié, Thibaud Chazal, Dov Taieb, Yurdagul Uzunhan, Jérôme Le Pavec, Isabella Annesi-Maesano, Emmanuel Bergot, Abdellatif Tazi, Zahir Amoura, Dominique Valeyre, Hilario Nunes, Fleur Cohen-Aubart |
| 891 |
[GO] |
2020―Okt―01 |
Response to: ‘Correspondence on ‘Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis’’ by Jeny et al |
Andrea Hermina Györfi, Georg Schett, Jörg H W Distler |
| 892 |
[GO] |
2020―Sep―28 |
Tackling osteoarthritis during COVID-19 pandemic |
Francisco Airton Castro da Rocha, Lucas da Ponte Melo, Francis Berenbaum |
| 893 |
[GO] |
2020―Sep―25 |
Response to: ‘Correspondence to ‘Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases’’ by Wu et al |
Jose L Pablos, María Galindo, Ricardo Blanco, José M Alvaro-Gracia |
| 894 |
[GO] |
2020―Sep―25 |
Correspondence to ‘Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases’ |
Bo-Yao Wu, Chi-Ho Chan, James Cheng-Chung Wei |
| 895 |
[GO] |
2020―Sep―25 |
Preliminary predictive criteria for COVID-19 cytokine storm |
Roberto Caricchio, Marcello Gallucci, Chandra Dass, Xinyan Zhang, Stefania Gallucci, David Fleece, Michael Bromberg, Gerard J Criner |
| 896 |
[GO] |
2020―Sep―25 |
Correspondence on ‘Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort’ by Pouletty et al |
Meredith J Ventura, Emmanuel Guajardo, Eva H Clark, Kalpana Bhairavarasu, Riyad Y Kherallah, Andrew R DiNardo, Xunyan Ye, Pedro A Piedra, Robert L Atmar, Sandeep K Agarwal |
| 897 |
[GO] |
2020―Sep―22 |
Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort |
Adrian Ciurea, Eleftherios Papagiannoulis, Kristina Bürki, Isabell von Loga, Raphael Micheroli, Burkhard Möller, Andrea Rubbert-Roth, Michael Andor, René Bräm, Angela Müller, Diana Dan, Diego Kyburz, Oliver Distler, Almut Scherer, Axel Finckh |
| 898 |
[GO] |
2020―Sep―22 |
Response to: ‘Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic’ by Lecler et al |
Sara Monti, Carlomaurizio Montecucco |
| 899 |
[GO] |
2020―Sep―21 |
Correspondence on ‘Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case-control study’ |
Martin Sebastian Winkler, Peter Korsten, Claudia Binder, Björn Tampe |
| 900 |
[GO] |
2020―Sep―21 |
Correspondence to ‘Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort’ |
Maria Vincenza Mastrolia, Rino Agostiniani, Chiara Azzari, Roberto Bernardini, Ugo Bottone, Giovanni Battista Calabri, Flavio Civitelli, Rita Consolini, Roberto Danieli, Rosalia Di Silvio, Susanna Falorni, Luigi Gagliardi, Salvatore Grosso, Marco Martini, Graziano Memmini, Diego Peroni, Marco Pezzati, Giovanni Suriano, Luca Tafi, Angelina Vaccaro, Pier Luigi Vasarri, Gabriele Simonini |
| 901 |
[GO] |
2020―Sep―15 |
Correspondence on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry’ by Gianfrancesco M et al. The impact of cardiovascular comorbidity on COVID-19 infection in a large cohort of rheumatoid arthritis patients |
Fabio Cacciapaglia, Andreina Manfredi, Gianluca Erre, Matteo Piga, Garifallia Sakellariou, ombretta viapiana, Elisa Gremese, Francesca Romana Spinelli, Fabiola Atzeni, Elena Bartoloni |
| 902 |
[GO] |
2020―Sep―15 |
Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): what does the future hold? |
Murugan Sudhakar, Pandiarajan Vignesh |
| 903 |
[GO] |
2020―Sep―09 |
Response to: ‘Correspondence on ‘Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences’ by Ruscitti et al’ by Chen et al |
Piero Ruscitti, Federico Bruno, Onorina Berardicurti, Chiara Acanfora, Viktoriya Pavlych, Pierpaolo Palumbo, Alessandro Conforti, Francesco Carubbi, Ilenia Di Cola, Paola Di Benedetto, Paola Cipriani, Davide Grassi, Carlo Masciocchi, Annamaria Iagnocco, Antonio Barile, Roberto Giacomelli |
| 904 |
[GO] |
2020―Sep―09 |
Correspondence on ‘Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences’ by Ruscitti et al |
Acer I-Hung Chen, Sheng-Chieh Lin, James Cheng-Chung Wei |
| 905 |
[GO] |
2020―Sep―07 |
Comment on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases |
Alessandro Giollo, Eugenia Bertoldo, Giovanni Adami, Adam J Cybulski, Angelo Fassio, Giovanni Orsolini, Luca Idolazzi, Davide Gatti, Ombretta viapiana, Maurizio Rossini |
| 906 |
[GO] |
2020―Sep―07 |
Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: ‘Comment on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases’ by Giollo et al |
Kimme L Hyrich, Milena Gianfrancesco, Pedro M Machado, Jinoos Yazdany, Philip C Robinson |
| 907 |
[GO] |
2020―Sep―07 |
Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic |
Alireza Khabbazi, Hadiseh Kavandi, Roghayeh Paribanaem, Raha Khabbazi, Aida Malek Mahdavi |
| 908 |
[GO] |
2020―Sep―07 |
Education and treatment adherence during the COVID-19 pandemic. Response to: ‘Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic’ by Khabbazi et al |
Rita Angélica Pineda-Sic, Griselda Serna-Peña, Jesus Alberto Cardenas-de la Garza, Sergio A Torres-Castillo, Dionicio Angel Galarza-Delgado, Diana Elsa Flores-Alvarado |
| 909 |
[GO] |
2020―Sep―07 |
Response to: ‘Implications of SARS-CoV-2 infection for patients with rheumatic disease’ by Lin et al |
Alexis Mathian, Zahir Amoura |
| 910 |
[GO] |
2020―Sep―03 |
Response to ‘Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic’ by Chuah et al |
Alexis Mathian, Zahir Amoura |
| 911 |
[GO] |
2020―Sep―01 |
Response to: ‘Correspondence on ‘Interleukin-6 blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study’ by Potere et al’ by Buckley |
Nicola Potere, Marcello Di Nisio, Donatella Cibelli, Rosa Scurti, Antonella Frattari, Ettore Porreca, Antonio Abbate, Giustino Parruti |
| 912 |
[GO] |
2020―Sep―01 |
Correspondence on ‘Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study’ by Potere et al |
Leo Buckley |
| 913 |
[GO] |
2020―Aug―28 |
Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’ by Mathian et al |
Quirin Notz, Patrick Meybohm, Peter Kranke, Dirk Weismann, Christopher Lotz, Marc Schmalzing |
| 914 |
[GO] |
2020―Aug―28 |
Comment on ‘Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19’ by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19: a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France |
Emilie Sbidian, Laetitia Penso, Philippe Herlemont, Jérémie Botton, Bérangère Baricault, Laura Semenzato, Jérome Drouin, Alain Weill, Rosemay Dray-Spira, Mahmoud Zureik |
| 915 |
[GO] |
2020―Aug―28 |
Systemic lupus erythematosus and COVID-19: what we know so far |
Giuseppe A. Ramirez, Luca Moroni, Emanuel Della-Torre, Maria Gerosa, Lorenzo Beretta, Enrica P. Bozzolo, Lorenzo Dagna |
| 916 |
[GO] |
2020―Aug―27 |
Colchicine treatment in community healthcare setting to prevent severe COVID-19 |
Emanuel Della-Torre, Giuseppe A Ramirez, Lorenzo Dagna, Moreno Tresoldi |
| 917 |
[GO] |
2020―Aug―27 |
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: ‘Colchicine treatment in community healthcare setting to prevent severe COVID-19’ by Della-Torre et al |
Silvia Piantoni, Enrico Colombo, Roberto Furloni, Laura Andreoli, Antonio Brucato, Massimo Imazio, Paolo Airó, Mirko Scarsi |
| 918 |
[GO] |
2020―Aug―19 |
Correspondence to: ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al |
Rachael Mary Flood, Richard Conway, Colm Kirby, Diana Gheta, David J Kane, Ronan H Mullan |
| 919 |
[GO] |
2020―Aug―19 |
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed ‘window of opportunity’ |
Alessandro Giollo, Riccardo Bixio, Davide Gatti, Ombretta Viapiana, Luca Idolazzi, Christian Dejaco, Maurizio Rossini |
| 920 |
[GO] |
2020―Aug―19 |
High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab |
Edoardo Conticini, Federico Franchi, David Bennett, Serafina Valente, Maria A Mazzei, Elena Bargagli, Luca Volterrani, Sabino Scolletta, Bruno Frediani |
| 921 |
[GO] |
2020―Aug―19 |
Response to: ‘High dosage of Methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to Tocilizumab’ by Conticini et al |
Sofia Ramiro, Rémy Mostard, Robert BM Landewé |
| 922 |
[GO] |
2020―Aug―19 |
Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: ‘Correspondence on: ‘Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study’ by Della-Torre et al’ by Cheng and Zhang |
Emanuel Della-Torre, Giovanni Landoni, Alberto Zangrillo, Lorenzo Dagna |
| 923 |
[GO] |
2020―Aug―19 |
Correspondence on: ‘Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study’ by Della-Torre et al |
Chao Cheng, Fangjie Zhang |
| 924 |
[GO] |
2020―Aug―18 |
Rheumatic diseases and COVID-19: a cohort of 17 patients under DMARDs. Response to: ‘Comment on: Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab’ by Messina et al |
Pierre-Marie Duret, Lionel Spielmann, Laurent Messer |
| 925 |
[GO] |
2020―Aug―18 |
Comment on: Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a patient with COVID-19 with psoriatic arthritis receiving ustekinumab |
Francesco Messina, Francesca Pampaloni, Stefano Piaserico |
| 926 |
[GO] |
2020―Aug―13 |
Implications of SARS-CoV-2 infection for patients with rheumatic disease |
Changsong Lin, Ziyu Wang, Jie Li, Xinyi Xia, Yun Liu, Qianghu Wang |
| 927 |
[GO] |
2020―Aug―12 |
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study |
Jose L Pablos, María Galindo, Loreto Carmona, Ana Lledó, Miriam Retuerto, Ricardo Blanco, Miguel A Gonzalez-Gay, David Martinez-Lopez, Isabel Castrejón, José M Alvaro-Gracia, David Fernández Fernández, Antonio Mera-Varela, Sara Manrique-Arija, Natalia Mena Vázquez, Antonio Fernandez-Nebro |
| 928 |
[GO] |
2020―Aug―12 |
COVID-19 and how evidence of a new disease evolves |
Féline P B Kroon, Ted R Mikuls, Robert BM Landewé |
| 929 |
[GO] |
2020―Aug―12 |
COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: ‘Correspondence on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience’ by Khan et al, ‘Comment on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry’ by Gianfrancesco M et al’ by Andreica et al and ‘COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs’ by Ansarin et al |
Milena Gianfrancesco, Kimme L Hyrich, Jinoos Yazdany, Pedro M Machado, Philip C Robinson |
| 930 |
[GO] |
2020―Aug―11 |
Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic |
Seow Lin Chuah, Cheng Lay Teh, Sharifah Aishah Wan Mohd Akbar, Yaw Kiet Cheong, Benjamin Sachdev Manjit Singh |
| 931 |
[GO] |
2020―Aug―11 |
Case of adult large vessel vasculitis after SARS-CoV-2 infection |
Ryohei Oda, Takeshi Inagaki, Masahiro Ishikane, Masatoshi Hotta, Akira Shimomura, Mitsuhiro Sato, Takato Nakamoto, Yutaro Akiyama, Kei Yamamoto, Ryogo Minamimoto, Hiroshi Kaneko, Norio Ohmagari |
| 932 |
[GO] |
2020―Aug―10 |
High oligoclonality of immunoglobulins in SARS-CoV2 positive patients |
Marie Kolopp-Sarda, Pierre Miossec |
| 933 |
[GO] |
2020―Aug―07 |
Impact of lockdown on rheumatology outpatient care in the age of COVID-19 |
Benjamin Sachdev Manjit Singh, Seow Lin Chuah, Yaw Kiet Cheong, Sharifah Aishah Wan, Cheng Lay Teh |
| 934 |
[GO] |
2020―Aug―07 |
Correspondence on ‘Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist’ by Graef et al |
Chien Hsien Lo, Yu-Hsun Wang, Chin Feng Tsai, Kuei Chuan Chan, Li Ching Li, Tse Hsien Lo, Chun Hung Su, James Cheng-Chung Wei |
| 935 |
[GO] |
2020―Aug―07 |
Mild COVID-19 in ANCA-associated vasculitis treated with rituximab |
Silvia Suárez-Díaz, Claudia Morán-Castaño, Rubén Coto-Hernández, Lourdes Mozo-Avellaneda, Carlos Suárez-Cuervo, Luis Caminal-Montero |
| 936 |
[GO] |
2020―Aug―07 |
Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases |
Dalifer D Freites Nuñez, Leticia Leon, Arkaitz Mucientes, Luis Rodriguez-Rodriguez, Judit Font Urgelles, Alfredo Madrid García, Jose I Colomer, Juan A Jover, Benjamín Fernandez-Gutierrez, Lydia Abasolo |
| 937 |
[GO] |
2020―Aug―07 |
Impact of the COVID-19 lockdown on the management and control of patients with GCA |
Roman Praliaud, Helene Greigert, Maxime Samson, Marianne Zeller, Mathieu Boulin, Philip Bielefeld, André Ramon, Yves Cottin, Bernard Bonnotte |
| 938 |
[GO] |
2020―Aug―07 |
Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic |
Augustin Lecler, Delphine Villeneuve, Catherine Vignal, Thomas Sené |
| 939 |
[GO] |
2020―Aug―07 |
Response to: ‘Correspondence on ‘Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist’ by Graef et al’ by Lo et al |
Ali Duarte-García, Elizabeth R Graef, Jean W Liew, Maximilian F Konig, Alfred Hyoungju Kim, Jeffrey A Sparks |
| 940 |
[GO] |
2020―Aug―07 |
No increased rate of SARS-CoV-2 infection for patients with inflammatory rheumatic diseases compared with the general population in the city of Hamburg (Germany) |
Peer Aries, Christof Iking-Konert |
| 941 |
[GO] |
2020―Aug―05 |
Exacerbation of immune thrombocytopaenia triggered by COVID-19 in patients with systemic lupus erythematosus |
Yasushi Kondo, Yuko Kaneko, Tatsuhiro Oshige, Hiroyuki Fukui, Shuntaro Saito, Mikio Okayama, Hirofumi Kamata, Makoto Ishii, Naoki Hasegawa, Koichi Fukunaga, Tsutomu Takeuchi |
| 942 |
[GO] |
2020―Aug―05 |
Response to: ‘Exacerbation of immune thrombocytopaenia triggered by COVID-19 in patients with systemic lupus erythematosus’ by Kondo et al |
Alexis Mathian, Zahir Amoura |
| 943 |
[GO] |
2020―Aug―05 |
COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs |
Khalil Ansarin, Ali Taghizadieh, Saeid Safiri, Aida Malek Mahdavi, Shirin Ranjbar, Soheil Teymouri, Masoud Ahangari Maleki, Alireza Khabbazi |
| 944 |
[GO] |
2020―Aug―05 |
Response to: ‘Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5 positive dermatomyositis associated rapidly progressive interstitial lung diseases: a challenge for the future’ by Wang et al |
Janine A Lamb, Spyridon Megremis, Hector Chinoy |
| 945 |
[GO] |
2020―Aug―05 |
Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future |
Yukai Wang, Guangzhou Du, Guohong Zhang, Marco Matucci-Cerinic, Daniel E Furst |
| 946 |
[GO] |
2020―Aug―05 |
Hydroxychloroquin ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis |
Mendel E Singer, David C Kaelber, Maria J Antonelli |
| 947 |
[GO] |
2020―Aug―05 |
Response to: ‘Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis’ by Singer et al |
Manuel Francisco Ugarte-Gil, Maximilian F Konig, Peter Korsten, Francis Berenbaum, Alfred Hyoungju Kim, Jeffrey A Sparks |
| 948 |
[GO] |
2020―Aug―05 |
Correspondence on: ‘Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort’ by Pouletty et al |
Rosa Pino, Ana Carolina Izurieta, María Ríos-Barnés, Sílvia Ricart, Mariona F De Sevilla, Laura Monfort, Cristian Launes, Iván Cano, Laura Lecina, Judith Sánchez Manubens, Juan Manuel Mosquera, Iolanda Jordan, Joan Sánchez de Toledo, Manuel Monsonís, Cristina Esteva, Carmen Muñoz-Almagro, Victòria Fumadó, Clàudia Fortuny, Juan José Garcia Garcia, Antoni Noguera-Julian, Jordi Anton |
| 949 |
[GO] |
2020―Aug―05 |
Response to: ‘Correspondence on ‘Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort’ by Pouletty et al’ by Pino et al |
Naim Ouldali, Marie Pouletty, Johanna Lokmer, Cherine Benzouid, Constance Beyler, Anna Deho, Ulrich Meinzer, Albert Faye, Isabelle Melki |
| 950 |
[GO] |
2020―Aug―04 |
To immunosuppress: whom, when and how? That is the question with COVID-19 |
Kevin L Winthrop, Xavier Mariette |
| 951 |
[GO] |
2020―Aug―04 |
Transient monoarthritis and psoriatic skin lesions following COVID-19 |
Ludovico De Stefano, Silvia Rossi, Carlomaurizio Montecucco, Serena Bugatti |
| 952 |
[GO] |
2020―Aug―04 |
Response to: ‘Presence of anti-phospholipid antibodies in COVID-19: a case series study’ by Amezcua-Guerra et al |
Alexis Mathian, Marc Pineton De Chambrun, Alain Combes, Zahir Amoura |
| 953 |
[GO] |
2020―Aug―04 |
Presence of antiphospholipid antibodies in COVID-19: case series study |
Luis M Amezcua-Guerra, Gustavo Rojas-Velasco, Malinalli Brianza-Padilla, Armando Vázquez-Rangel, Ricardo Márquez-Velasco, Francisco Baranda-Tovar, Rashidi Springall, Hector Gonzalez-Pacheco, Yaneli Juárez-Vicuña, Claudia Tavera-Alonso, Fausto Sanchez-Muñoz, Marisol Hernández-Salas |
| 954 |
[GO] |
2020―Aug―04 |
Treatment of patients with inflammatory rheumatic diseases with rituximab should be carefully considered during the SARS-CoV-2/COVID-19 pandemic. Response to: ‘Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al’ by Benucci et al |
Hendrik Schulze-Koops, Klaus Krueger, Inka Vallbracht Vallbracht, Rebecca Hasseli, Alla Skapenko |
| 955 |
[GO] |
2020―Jul―31 |
Rational use of tocilizumab in COVID-19 |
Siddharth Jain, Shefali Khanna Sharma |
| 956 |
[GO] |
2020―Jul―31 |
COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine |
Cheng Lay Teh, Yaw Kiet Cheong, Wan Rosmaiza Wan Musa, Sharifah Aishah Wan Mohd Akbar, Noraini Mat Husin, Suk Chyn Gun |
| 957 |
[GO] |
2020―Jul―31 |
More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia |
Gianfranco Ferraccioli |
| 958 |
[GO] |
2020―Jul―31 |
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: ‘More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia’ by Ferraccioli |
Emanuel Della-Torre, Corrado Campochiaro, Giulio Cavalli, Giacomo De Luca, Fabio Ciceri, Alberto Zangrillo, Lorenzo Dagna |
| 959 |
[GO] |
2020―Jul―31 |
Targeting IL-6 in COVID-19. Response to: ‘Rational use of tocilizumab in COVID-19’ by Jain and Sharma |
Pier Leopoldo Capecchi, Pietro Enea Lazzerini |
| 960 |
[GO] |
2020―Jul―31 |
Response to: ‘Rational use of tocilizumab in COVID-19’ by Jain and Sharma |
Nicola Potere, Marcello Di Nisio, Donatella Cibelli, Rosa Scurti, Antonella Frattari, Ettore Porreca, Antonio Abbate, Giustino Parruti |
| 961 |
[GO] |
2020―Jul―30 |
Correspondence on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience |
Asim Khan, Alice Cole, Naveen Bhadauria, Munzir El-Hassan, Daud Abdulla, Thomas Axon, Zozik Fattah, Jessica J Manson, Jeronimo Moreno-Cuesta, Dev Mukerjee |
| 962 |
[GO] |
2020―Jul―30 |
Comment on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry’ by Gianfrancesco M et al |
Ioana Andreica, David Kiefer, Guenther A Rezniczek, Robert Jast, Bjoern Buehring, Uta Kiltz, Xenofon Baraliakos, Juergen Braun |
| 963 |
[GO] |
2020―Jul―30 |
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome |
Mirko Scarsi, Silvia Piantoni, Enrico Colombo, Paolo Airó, Donata Richini, Marco Miclini, Valeria Bertasi, Marta Bianchi, Damiano Bottone, Patrizia Civelli, Maria-Sofia Cotelli, Ezio Damiolini, Gloria Galbassini, Diego Gatta, Maria-Laura Ghirardelli, Roberto Magri, Paola Malamani, Monia Mendeni, Stefano Molinari, Andrea Morotti, Luisa Salada, Marinella Turla, Angiola Vender, Angela Tincani, Antonio Brucato, Franco Franceschini, Roberto Furloni, Laura Andreoli |
| 964 |
[GO] |
2020―Jul―28 |
Improving telemedicine and in-person management of rheumatic and autoimmune diseases,during and after COVID-19 pandemic outbreak. Definite need for more Rheumatologists. Response to: ‘Can telerheumatology improve rheumatic and musculoskeletal disease service delivery in sub-Saharan Africa?’ by Akpabio et al |
Francesco Caso, Antonio del Puente, Nicolò Girolimetto, Marco Tasso, Corrado Caso, Raffaele Scarpa, Luisa Costa |
| 965 |
[GO] |
2020―Jul―24 |
Response to: ‘Comment on Ye et al ‘Presence of respiratory failure of COVID-19 infection in patients with rheumatism in Wuhan, China’’ by Chen et al |
Jixin Zhong, Cong Ye, Shaozhe Cai, Lingli Dong |
| 966 |
[GO] |
2020―Jul―24 |
Comment on Ye et al ‘Presence of respiratory failure of COVID-19 infection in rheumatism patients in Wuhan, China’ |
Xiao-Huan Chen, Chih-Jung Yeh, Han-You Mo, James Cheng Chung Wei |
| 967 |
[GO] |
2020―Jul―24 |
Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia |
Sharifah Aishah Wan, Cheng Lay Teh, Benjamin Sachdev Manjit Singh, Yaw Kiet Cheong, Seow Lin Chuah, Ahmad Tirmizi Jobli |
| 968 |
[GO] |
2020―Jul―24 |
Response to: ‘Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia’ by Wan et al |
Jixin Zhong, Lingli Dong |
| 969 |
[GO] |
2020―Jul―24 |
Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia? |
Emine Duran, Levent Kilic, Gamze Durhan, Ahmet Çağkan Inkaya, Gulay Sain Guven, Gul Karakaya, Orhan Macit Ariyurek, Omer Karadag |
| 970 |
[GO] |
2020―Jul―22 |
Response to: ‘Should patients starting biologics be screened for COVID-19?’ by Cardenas-de la Garza et al |
Robert B M Landewé, Hendrik Schulze-Koops |
| 971 |
[GO] |
2020―Jul―21 |
COVID-19 and Behçet’s disease: clinical case series |
Gerard Espinosa, Olga Araujo, Sergi Amaro, Marta Bodro, Pedro Juan Moreno, Reinaldo Moreno, Ainoa Ugarte, R Cervera |
| 972 |
[GO] |
2020―Jul―21 |
Comment on: ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al |
Samet Karahan, Ali Cetinkaya, Kaniye Aydin, Hatice Aslan Sirakaya |
| 973 |
[GO] |
2020―Jul―21 |
COVID-19 prevalence and the impact on quality of life from stringent social distancing in a single large UK rheumatology centre |
Natasha Cleaton, Sabrina Raizada, Nick Barkham, Srinivasan Venkatachalam, Tom Sheeran, Tochukwu Adizie, Hem Sapkota, Baldev Singh, James Bateman |
| 974 |
[GO] |
2020―Jul―21 |
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study |
Sofia Ramiro, Rémy L M Mostard, César Magro-Checa, Christel M P van Dongen, Tom Dormans, Jacqueline Buijs, Michiel Gronenschild, Martijn D de Kruif, Eric H J van Haren, Tom van Kraaij, Mathie P G Leers, Ralph Peeters, Dennis R Wong, Robert B M Landewé |
| 975 |
[GO] |
2020―Jul―21 |
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences |
Piero Ruscitti, Federico Bruno, Onorina Berardicurti, Chiara Acanfora, Viktoriya Pavlych, Pierpaolo Palumbo, Alessandro Conforti, Francesco Carubbi, Ilenia Di Cola, Paola Di Benedetto, Paola Cipriani, Davide Grassi, Carlo Masciocchi, Annamaria Iagnocco, Antonio Barile, Roberto Giacomelli |
| 976 |
[GO] |
2020―Jul―15 |
Repeated false-negative tests delayed diagnosis of COVID-19 in a case with granulomatosis with polyangiitis under maintenance therapy with rituximab and concomitant influenza pneumonia |
Samy Hakroush, Jonas Franz, Jörg Larsen, Peter Korsten, Martin Sebastian Winkler, Björn Tampe |
| 977 |
[GO] |
2020―Jul―15 |
Response to: ‘Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India’ by Goyal et al |
Alexis Mathian, Zahir Amoura |
| 978 |
[GO] |
2020―Jul―15 |
Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India |
Mohit Goyal, Pravin Patil, Himanshu Pathak, Sham Santhanam, Anshul Goel, Vishnu Sharma, Akshat Pandey, Nikhil Gupta, Rahul Jain, Shashank Akerkar, Parthajit Das, Rajkiran Dudam, Naval Mendiratta, Bimlesh Dhar Pandey, Mithun CB, Bharat K Singh, Sharath Kumar, Nilesh Nolkha, Shriyanka Jain, Somya Jain, Ashish Sharma, Durga Prasanna Misra |
| 979 |
[GO] |
2020―Jul―13 |
COVID-19 in patients with rheumatic diseases: what is the real mortality risk? |
Claudia Marques, Marcelo M Pinheiro, Edgard Torres Reis Neto, Andrea Tavares Dantas, Francinne Machado Ribeiro, Ana Karla G Melo |
| 980 |
[GO] |
2020―Jul―10 |
Rheumatic disease and COVID-19 |
Jean W Liew, Elizabeth R Graef |
| 981 |
[GO] |
2020―Jul―09 |
Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study |
Nicola Potere, Marcello Di Nisio, Donatella Cibelli, Rosa Scurti, Antonella Frattari, Ettore Porreca, Antonio Abbate, Giustino Parruti |
| 982 |
[GO] |
2020―Jul―09 |
Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest? |
Pedro Santos-Moreno, Diana Buitrago-Garcia, Laura Villarreal, Anggie Aza, Michael Cabrera, Wilberto Rivero, Adriana Rojas-Villarraga |
| 983 |
[GO] |
2020―Jul―09 |
Response to: ‘Emergency arising from patients’ fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?’ by Santos-Mareno et al |
Jean W Liew, Elizabeth R Graef, Jeffrey A Sparks, Alfred Hyoungju Kim |
| 984 |
[GO] |
2020―Jul―06 |
Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD |
Maurizio Benucci, Arianna Damiani, Gianfranco Giannasi, Francesca Li Gobbi, Luca Quartuccio, Valentina Grossi, Maria Infantino, Mariangela Manfredi |
| 985 |
[GO] |
2020―Jul―06 |
COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study |
Muserref Kasap Cuceoglu, Ezgi Deniz Batu, Yelda Bilginer, Seza Özen |
| 986 |
[GO] |
2020―Jul―06 |
Should patients starting biologics be screened for COVID-19? |
Jesus Alberto Cardenas-de la Garza, Rosa I Arvizu-Rivera, Dionicio Angel Galarza-Delgado |
| 987 |
[GO] |
2020―Jul―06 |
Comparative analysis of synovial inflammation after SARS-CoV-2 infection |
Stefano Alivernini, Antonella Cingolani, Marco Gessi, Annamaria Paglionico, Giuliana Pasciuto, Barbara Tolusso, Massimo Fantoni, Elisa Gremese |
| 988 |
[GO] |
2020―Jul―06 |
Response to: ‘Comparative analysis of synovial inflammation after SARS-CoV-2 infection’ by Alivernini et al |
María-del-Carmen López-González, Vega Jovani, Esperanza Merino, Paloma Vela, Mariano Andrés |
| 989 |
[GO] |
2020―Jul―03 |
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study |
Emanuel Della-Torre, Corrado Campochiaro, Giulio Cavalli, Giacomo De Luca, Angela Napolitano, Salvatore La Marca, Nicola Boffini, Valentina Da Prat, Gaetano Di Terlizzi, Marco Lanzillotta, Patrizia Rovere Querini, Annalisa Ruggeri, Giovanni Landoni, Moreno Tresoldi, Fabio Ciceri, ALberto Zangrillo, Francesco De Cobelli, Lorenzo Dagna |
| 990 |
[GO] |
2020―Jul―02 |
Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey |
Marlene Plüß, Gamal Chehab, Peter Korsten |
| 991 |
[GO] |
2020―Jul―02 |
Response to: ‘Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey’ by Plüß et al |
Alexis Mathian, Zahir Amoura |
| 992 |
[GO] |
2020―Jul―01 |
COVID-19 and the practice of rheumatology in Africa: big changes to services from the shockwave of a pandemic |
Richard Oluyinka Akintayo, Akpabio Akpabio, Asgar Kalla, Dzifa Dey, Angela Migowa, Hakeem Olaosebikan, Rachid Bahiri, Yasser El Miedany, Djohra Hadef, Wafa Hamdi, Omondi Oyoo, Samy Slimani, Abubakar Yerima, Yassmin Taha, Adewale Adebajo, Olufemi Adelowo, Mohammed Tikly, Imad Ghozlani, Kawther Ben Abdelghani, Nermeen Ahmed Fouad, Doaa Mosad, Dalia El Mikkawy, Mohamed Hassan Abu-Zaid, Rasha A Abdel-Magied |
| 993 |
[GO] |
2020―Jun―30 |
Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis |
Andrea Hermina Györfi, Markus Kopp, Matthias May, Marcel Vetter, Michael Uder, Andreas E Kremer, Georg Schett, Thomas Harrer, Jörg H W Distler |
| 994 |
[GO] |
2020―Jun―30 |
Response to: ‘Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis’ by Györfi et al |
Milena Gianfrancesco, Kimme L Hyrich, Jinoos Yazdany, Pedro M Machado, Philip C Robinson |
| 995 |
[GO] |
2020―Jun―30 |
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases |
Laura Nuño, Marta Novella Navarro, Gema Bonilla, Karen Franco-Gómez, Pilar Aguado, Diana Peiteado, Irene Monjo, Carolina Tornero, Alejandro Villalba, Maria-Eugenia Miranda-Carus, Eugenio De Miguel, Patricia Bogas, Ana Castilla-Plaza, Miguel Bernad-Pineda, Elena García-Lorenzo, Tamara Rodríguez-Araya, Alejandro Balsa |
| 996 |
[GO] |
2020―Jun―26 |
Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab |
Hendrik Schulze-Koops, Klaus Krueger, Inka Vallbracht, Rebecca Hasseli, Alla Skapenko |
| 997 |
[GO] |
2020―Jun―26 |
Clinical course and outcome of COVID-19 in patients with rheumatic diseases: are all biological disease-modifying antirheumatic drugs alike? Response to: ‘Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab’ by Schulze-Koops et al |
Sara Monti, Carlomaurizio Montecucco |
| 998 |
[GO] |
2020―Jun―26 |
Case of acute arthritis following SARS-CoV-2 infection |
Naoto Yokogawa, Naoto Minematsu, Harutaka Katano, Tadaki Suzuki |
| 999 |
[GO] |
2020―Jun―25 |
Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors |
Vega Jovani, Irene Calabuig, Maria Luisa Peral-Garrido, Ernesto Tovar-Sugrañes, María-del-Carmen López-González, Pilar Bernabeu, Agustín Martínez, Joaquim Esteve-Vives, Jose-Manuel León-Ramírez, Oscar Moreno-Perez, Vicente Boix, Joan Gil, Esperanza Merino, Paloma Vela, Mariano Andrés |
| 1000 |
[GO] |
2020―Jun―25 |
Response to: ‘Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors’ by Jovani et al |
Kristin M D’Silva, Naomi Serling-Boyd, Rachel Wallwork, Tiffany Hsu, Jeffrey A Sparks, Zachary S Wallace |
| 1001 |
[GO] |
2020―Jun―25 |
Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments |
Zoé Gendebien, Christian von Frenckell, Clio Ribbens, Béatrice André, Marie Thys, Marjorie Gangolf, Laurence Seidel, Michel G Malaise, Olivier Malaise |
| 1002 |
[GO] |
2020―Jun―25 |
Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic |
Pedro Santos-Moreno, Josefina Chavez-Chavez, Sandra Milena Hernández-Zambrano, Diana Patricia Rivera-Triana, Ruth Alexandra Castiblanco-Montañez, Anggie Aza, Diana Buitrago-Garcia, Laura Villarreal, Adriana Rojas-Villarraga |
| 1003 |
[GO] |
2020―Jun―25 |
Response to: ‘Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic’ by Santos-Moreno et al |
Emanuele Bozzalla Cassione, Giovanni Zanframundo, Alessandro Biglia, Veronica Codullo, Carlomaurizio Montecucco, Lorenzo Cavagna |
| 1004 |
[GO] |
2020―Jun―25 |
Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics |
Arielle Mendel, Sasha Bernatsky, Anca Askanase, Sang-Cheol Bae, Ann Elaine Clarke, Nathalie Costedoat-Chalumeau, Dafna D Gladman, Caroline Gordon, John Hanly, Søren Jacobsen, Ken Kalunian, Anselm Mak, Marta Mosca, Bernardo A Pons-Estel, Guillermo Ruiz-Irastorza, Murray Urowitz, Évelyne Vinet |
| 1005 |
[GO] |
2020―Jun―24 |
Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19 |
Panayiotis G Vlachoyiannopoulos, Eleni Magira, Haris Alexopoulos, Edison Jahaj, Katerina Theophilopoulou, Anastasia Kotanidou, Athanasios G Tzioufas |
| 1006 |
[GO] |
2020―Jun―24 |
Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak |
Ho So, Cheuk-Chun Szeto, Lai-Shan Tam |
| 1007 |
[GO] |
2020―Jun―24 |
Telemedicine holds many promises but needs to be developed to be accepted by patients as an alternative to a visit to the doctor. Response to: ‘Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak’ by So et al |
Hendrik Schulze-Koops, Christof Specker, Klaus Krueger |
| 1008 |
[GO] |
2020―Jun―23 |
Treatment adherence behaviours in rheumatic diseases during COVID-19 pandemic: a Latin American experience |
Rita Angélica Pineda-Sic, Dionicio Angel Galarza-Delgado, Griselda Serna-Peña, Sergio A Castillo-Torres, Diana Elsa Flores-Alvarado, Jorge A Esquivel-Valerio, Iván De Jesús Hernández-Galarza |
| 1009 |
[GO] |
2020―Jun―23 |
Actions required to assure continuous supply of anti-rheumatic medication during the SARS-CoV-2/COVID-19 pandemic. Response to: ‘Treatment adherence behaviours in rheumatic diseases during pandemic COVID-19: a Latin American experience’ by Pineda-Sic et al |
Hendrik Schulze-Koops, Klaus Krueger, Christof Specker |
| 1010 |
[GO] |
2020―Jun―22 |
Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: ‘Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?’ by Xie et al |
Carmen Magdalena Gamboa-Alonso, Gabriel Figueroa-Parra, Dionicio Angel Galarza-Delgado |
| 1011 |
[GO] |
2020―Jun―19 |
Challenges and opportunities in telerheumatology in the COVID-19 era. Response to: ‘Online management of rheumatoid arthritis during COVID-19 pandemic’ by Zhang et al |
Gabriel Figueroa-Parra, Carmen Magdalena Gamboa-Alonso, Dionicio Angel Galarza-Delgado |
| 1012 |
[GO] |
2020―Jun―19 |
Mounting data indicate that antimalarials do not prevent mild or severe COVID-19 in rheumatic patients. Response to: ‘The role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients’ by Favalli et al |
Vasco C Romão, Ana Rita Cruz-Machado, João Eurico Fonseca |
| 1013 |
[GO] |
2020―Jun―19 |
Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients |
Ennio Giulio Favalli, Orazio De Lucia, Martina Biggioggero, Nicoletta Del Papa, Roberto Caporali |
| 1014 |
[GO] |
2020―Jun―16 |
Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China ‘hot pot’ versus in US ‘hot pot’: similarity and difference |
Jun Zhao, Rongrong Pang, Jian Wu, Yanju Guo, Yang Yang, Libo Zhang, Xinyi Xia |
| 1015 |
[GO] |
2020―Jun―16 |
Response to: ‘COVID-19 in patients with rheumatological diseases treated with Anti-TNF’ by Brito et al and ‘Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China ‘hot pot’ versus in US ‘hot pot’: similarity and difference’ by Zhao et al |
Kristin M D’Silva, Naomi Serling-Boyd, Rachel Wallwork, Tiffany Hsu, Jeffrey A Sparks, Zachary Scott Wallace |
| 1016 |
[GO] |
2020―Jun―16 |
Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study |
Yao Huang, Zhe Chen, Yu Wang, Liang Han, Kai Qin, Wenya Huang, Ying Huang, Hui Wang, Pan Shen, Xin Ba, Weiji Lin, Hui Dong, Mingmin Zhang, Shenghao Tu |
| 1017 |
[GO] |
2020―Jun―16 |
COVID-19 in patients with rheumatological diseases treated with anti-TNF |
Carlos Antunes Brito, José Gerardo Paiva, Fernando Nunes Pimentel, Rosinete Santos Guimarães, Mariana Ribeiro Moreira |
| 1018 |
[GO] |
2020―Jun―12 |
Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases |
Jose L Pablos, Lydia Abasolo, Jose M Alvaro-Gracia, Francisco J Blanco, Ricardo Blanco, Isabel Castrejón, David Fernandez-Fernandez, Benjamín Fernandez-Gutierrez, María Galindo-Izquierdo, Miguel A Gonzalez-Gay, Sara Manrique-Arija, Natalia Mena Vázquez, Antonio Mera Varela, Miriam Retuerto, Alvaro Seijas-Lopez |
| 1019 |
[GO] |
2020―Jun―11 |
Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort |
Luisa Costa, Marco Tasso, Nadia Scotti, Erika Mostacciuolo, Nicolò Girolimetto, Francesca Foglia, Antonio del Puente, Raffaele Scarpa, Francesco Caso |
| 1020 |
[GO] |
2020―Jun―11 |
Response to: ‘Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort’ by Costa et al |
Latika Gupta, Durga Prasanna Misra, Vishwesh Agarwal, Suma Balan, Vikas Agarwal |
| 1021 |
[GO] |
2020―Jun―11 |
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort |
Marie Pouletty, Charlotte Borocco, Naim Ouldali, Marion Caseris, Romain Basmaci, Noémie Lachaume, Philippe Bensaid, Samia Pichard, Hanane Kouider, Guillaume Morelle, Irina Craiu, Corinne Pondarre, Anna Deho, Arielle Maroni, Mehdi Oualha, Zahir Amoura, Julien Haroche, Juliette Chommeloux, Fanny Bajolle, Constance Beyler, Stéphane Bonacorsi, Guislaine Carcelain, Isabelle Koné-Paut, Brigitte Bader-Meunier, Albert Faye, Ulrich Meinzer, Caroline Galeotti, Isabelle Melki |
| 1022 |
[GO] |
2020―Jun―10 |
Biologics, spondylitis and COVID-19 |
James Todd Rosenbaum, Hedley Hamilton, Dongseok Choi, Michael H Weisman, John D Reveille, Kevin L Winthrop |
| 1023 |
[GO] |
2020―Jun―08 |
Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak |
Jan Holubar, Moglie Le Quintrec, Hind Letaief, Jean Luc Faillie, Yves-Marie Pers, Christian Jorgensen |
| 1024 |
[GO] |
2020―Jun―08 |
Response to: ‘Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak’ by Holubar et al |
Alexis Mathian, Zahir Amoura |
| 1025 |
[GO] |
2020―Jun―05 |
Response to: ‘Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab’ by Avouac et al |
Philippe Guilpain, Clément Le Bihan, Vincent Foulongne, Patrice Taourel, Nathalie Pansu, Alexandre Thibault Jacques Maria, Boris Jung, Romaric Larcher, Kada Klouche, Vincent Le Moing |
| 1026 |
[GO] |
2020―Jun―05 |
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies |
Carlos Sanchez-Piedra, Cesar Diaz-Torne, Javier Manero, José M Pego-Reigosa, Íñigo Rúa-Figueroa, Miguel A Gonzalez-Gay, Juan Gomez-Reino, Jose M Alvaro-Gracia |
| 1027 |
[GO] |
2020―Jun―05 |
COVID-19 infection in a patient with FMF: does colchicine have a protective effect? |
Senol Kobak |
| 1028 |
[GO] |
2020―Jun―05 |
Telemedicine will not keep us apart in COVID-19 pandemic |
Simone Perniola, Stefano Alivernini, Valentina Varriano, Annamaria Paglionico, Giacomo Tanti, Pietro Rubortone, Lucia Lanzo, Fabrizio Melpignano, Carlo Tur, Enrico De Lorenzis, Giusy Peluso, Annunziata Capacci, Elisa Gremese |
| 1029 |
[GO] |
2020―Jun―05 |
Telemedicine: a useful tool but not the holy grail. Response to: ‘Telemedicine will not keep us apart in the COVID-19 pandemic’ by Perniola et al |
Emanuele Bozzalla Cassione, Giovanni Zanframundo, Alessandro Biglia, Veronica Codullo, Carlomaurizio Montecucco, Lorenzo Cavagna |
| 1030 |
[GO] |
2020―Jun―05 |
COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases |
Clementina López-Medina, Alejandro Escudero, Eduardo Collantes-Estevez |
| 1031 |
[GO] |
2020―Jun―05 |
Candidate rheumatologic treatments for COVID-19. Response to: ‘COVID-19 infection in a patient with FMF: does colchicine have a protective effect?’ by Kobak |
Sara Monti, Carlomaurizio Montecucco |
| 1032 |
[GO] |
2020―Jun―05 |
Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab |
Jérôme Avouac, Paolo Airó, Nicolas Carlier, Marco Matucci-Cerinic, Yannick Allanore |
| 1033 |
[GO] |
2020―Jun―05 |
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 |
Robert BM Landewé, Pedro M Machado, Féline Kroon, Hans WJ Bijlsma, Gerd R Burmester, Loreto Carmona, Bernard Combe, Massimo Galli, Laure Gossec, Annamaria Iagnocco, John D Isaacs, Xavier Mariette, Iain McInnes, Ulf Mueller-Ladner, Peter Openshaw, Josef S Smolen, Tanja A Stamm, Dieter Wiek, Hendrik Schulze-Koops |
| 1034 |
[GO] |
2020―Jun―05 |
Response to: ‘COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases’ by Lopez-Medina et al |
Emanuele Bozzalla Cassione, Giovanni Zanframundo, Alessandro Biglia, Veronica Codullo, Carlomaurizio Montecucco, Lorenzo Cavagna |
| 1035 |
[GO] |
2020―Jun―03 |
COVID-19 in rheumatology outpatient clinics: Dutch mirror image to Lombardy, Italy |
Sophie Benoy, Rene Traksel, Peter Verhaegh, Jasper Broen |
| 1036 |
[GO] |
2020―Mai―31 |
Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: ‘Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’ by Carbillon et al |
Maximilian F Konig, Milena Gianfrancesco, Jinoos Yazdany, Philip C Robinson |
| 1037 |
[GO] |
2020―Mai―31 |
Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine |
Lionel Carbillon, Amélie Benbara, Jeremy Boujenah |
| 1038 |
[GO] |
2020―Mai―31 |
Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic |
George E Fragoulis, Gerasimos Evangelatos, Aikaterini Arida, Vasiliki-Kalliopi Bournia, Kalliopi Fragiadaki, Anastasios Karamanakos, Evrydiki Kravvariti, Katerina Laskari, Stylianos Panopoulos, Maria Pappa, Maria G Tektonidou, Petros P Sfikakis |
| 1039 |
[GO] |
2020―Mai―31 |
No advice to discontinue antirheumatic therapy for non-medical reasons in light of SARS-CoV-2. Response to: ‘Treatment adherence of patients with sytemic rheumatic diseases in COVID-19 pandemic’ by Fragoulis et al |
Hendrik Schulze-Koops, Klaus Krueger, Christof Specker |
| 1040 |
[GO] |
2020―Mai―31 |
Patients with lupus with COVID-19: University of Michigan experience |
Beth Wallace, Laraine Washer, Wendy Marder, J Michelle Kahlenberg |
| 1041 |
[GO] |
2020―Mai―31 |
Response to: ‘Patients with lupus with COVID-19: University of Michigan experience’ by Wallace et al |
Alexis Mathian, Zahir Amoura |
| 1042 |
[GO] |
2020―Mai―29 |
Case series of acute arthritis during COVID-19 admission |
María-del-Carmen López-González, Maria Luisa Peral-Garrido, Irene Calabuig, Ernesto Tovar-Sugrañes, Vega Jovani, Pilar Bernabeu, Raquel García-Sevila, Jose-Manuel León-Ramírez, Oscar Moreno-Perez, Vicente Boix, Joan Gil, Esperanza Merino, Paloma Vela, Mariano Andrés |
| 1043 |
[GO] |
2020―Mai―29 |
Response to: ‘Case series of acute arthritis in COVID-19 admission’ by López-González et al |
Elizabeth R Graef, Jean W Liew, Alfred HJ Kim, Jeffrey A Sparks |
| 1044 |
[GO] |
2020―Mai―29 |
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry |
Milena Gianfrancesco, Kimme L Hyrich, Sarah Al-Adely, Loreto Carmona, Maria I Danila, Laure Gossec, Zara Izadi, Lindsay Jacobsohn, Patricia Katz, Saskia Lawson-Tovey, Elsa F Mateus, Stephanie Rush, Gabriela Schmajuk, Julia Simard, Anja Strangfeld, Laura Trupin, Katherine D Wysham, Suleman Bhana, Wendy Costello, Rebecca Grainger, Jonathan S Hausmann, Jean W Liew, Emily Sirotich, Paul Sufka, Zachary S Wallace, Jinoos Yazdany, Pedro M Machado, Philip C Robinson |
| 1045 |
[GO] |
2020―Mai―29 |
Correspondence regarding research letter to the editor by Mathian et al, ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’ |
Mandana Nikpour, Benjamin Teh, Ian P Wicks, Marc Pellegrini |
| 1046 |
[GO] |
2020―Mai―29 |
Response to: Correspondence regarding research letter to the editor by Mathian et al, ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’’ by Nikpour et al |
Alexis Mathian, Zahir Amoura |
| 1047 |
[GO] |
2020―Mai―28 |
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study |
Carlo Salvarani, Gianluigi Bajocchi, Pamela Mancuso, Elena Galli, Francesco Muratore, Luigi Boiardi, Mariagrazia Catanoso, Nicolò Pipitone, Giulia Cassone, Nicolò Girolimetto, Stefania Croci, Luca Cimino, Federeica Gradellini, Marina Beltrami, Vito Di Lernia, Giovammi Dolci, Marco Massari, Anna Maria Marata, Massimo Costantini, Paolo Giorgi Rossi |
| 1048 |
[GO] |
2020―Mai―26 |
Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’ |
Kristin M D’Silva, Naomi Serling-Boyd, Rachel Wallwork, Tiffany Hsu, Xiaoqing Fu, Ellen M Gravallese, Hyon K Choi, Jeffrey A Sparks, Zachary S Wallace |
| 1049 |
[GO] |
2020―Mai―25 |
Are patients with systemic lupus erythematosus at increased risk for COVID-19? |
Ennio Giulio Favalli, Maria Gerosa, Antonella Murgo, Roberto Caporali |
| 1050 |
[GO] |
2020―Mai―25 |
Response to: ‘Are patients with systemic lupus erythematosus at increased risk for COVID-19?’ by Favalli et al |
Alexis Mathian, Zahir Amoura |
| 1051 |
[GO] |
2020―Mai―24 |
Online management of rheumatoid arthritis during COVID-19 pandemic |
Yang Zhang, Jian Wang, Liang Zhao, Jun Xiao, Zhanjun Shi |
| 1052 |
[GO] |
2020―Mai―24 |
Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis |
Sara Monti, Paolo Delvino, Elisa Bellis, Alessandra Milanesi, Fabio Brandolino, Carlomaurizio Montecucco |
| 1053 |
[GO] |
2020―Mai―23 |
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine |
Emanuele Bozzalla Cassione, Giovanni Zanframundo, Alessandro Biglia, Veronica Codullo, Carlomaurizio Montecucco, Lorenzo Cavagna |
| 1054 |
[GO] |
2020―Mai―23 |
Response to ‘To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic’ by Parperis |
Francesca Romana Spinelli, Fulvia Ceccarelli, Manuela Di Franco, Fabrizio Conti |
| 1055 |
[GO] |
2020―Mai―23 |
The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: ‘Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India’ by Gupta et al and ‘Antirheumatic agents in covid-19: is IL-6 the right target?’ by Capeechi et al |
Sara Monti, Carlomaurizio Montecucco |
| 1056 |
[GO] |
2020―Mai―22 |
Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept |
Pierre-Marie Duret, Eden Sebbag, Auriane Mallick, Simon Gravier, Lionel Spielmann, Laurent Messer |
| 1057 |
[GO] |
2020―Mai―22 |
Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China |
Cong Ye, Shaozhe Cai, Guifen Shen, Hanxiong Guan, Liling Zhou, Yangyang Hu, Wei Tu, Yu Chen, Yikai Yu, Xuefen Wu, Yuxue Chen, Jixin Zhong, Lingli Dong |
| 1058 |
[GO] |
2020―Mai―22 |
Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis |
Spyridon Megremis, Thomas D J Walker, Xiaotong He, William E R Ollier, Hector Chinoy, Lynne Hampson, Ian Hampson, Janine A Lamb |
| 1059 |
[GO] |
2020―Mai―21 |
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19 |
Maximilian F Konig, Alfred HJ Kim, Marc H Scheetz, Elizabeth R Graef, Jean W Liew, Julia Simard, Pedro M Machado, Milena Gianfrancesco, Jinoos Yazdany, Daman Langguth, Philip C Robinson |
| 1060 |
[GO] |
2020―Mai―21 |
Response to ‘Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?’ by Moiseev et al |
Francesca Romana Spinelli, Fulvia Ceccarelli, Manuela Di Franco, Fabrizio Conti |
| 1061 |
[GO] |
2020―Mai―21 |
Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: ‘Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)’ by Giollo et al |
Sara Monti, Carlomaurizio Montecucco |
| 1062 |
[GO] |
2020―Mai―21 |
Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey |
Alessandro Tomelleri, Silvia Sartorelli, Corrado Campochiaro, Elena Marina Baldissera, Lorenzo Dagna |
| 1063 |
[GO] |
2020―Mai―20 |
Rheumatic diseases in intensive care unit patients with COVID-19 |
Sergey Moiseev, Sergey Avdeev, Michail Brovko, Andrey Yavorovskiy, Pavel I Novikov, Karina Umbetova, Larisa Akulkina, Natal'ya Tsareva, Victor Fomin |
| 1064 |
[GO] |
2020―Mai―20 |
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? |
Piero Ruscitti, Onorina Berardicurti, Antonio Barile, Paola Cipriani, Yehuda Shoenfeld, Annamaria Iagnocco, Roberto Giacomelli |
| 1065 |
[GO] |
2020―Mai―20 |
Hydroxychloroquine shortages during the COVID-19 pandemic |
Arielle Mendel, Sasha Bernatsky, J Carter Thorne, Diane Lacaille, Sindhu R Johnson, Évelyne Vinet |
| 1066 |
[GO] |
2020―Mai―20 |
Response to: ‘Hydroxychloroquine shortages during the COVID-19 pandemic’ by Mendel et al |
Iain McInnes |
| 1067 |
[GO] |
2020―Mai―20 |
Comorbidities and rheumatological diseases at the time of COVID-19. Response to: ‘Rheumatic diseases in intensive care unit patients with COVID-19’ by Moiseev et al |
Sara Monti, Carlomaurizio Montecucco |
| 1068 |
[GO] |
2020―Mai―18 |
Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation? |
Gian Luca Erre, Edoardo Sean Ferraccioli, Matteo Piga, Arduino Mangoni, Giuseppe Passiu, Elisa Gremese, Gianfranco Ferraccioli |
| 1069 |
[GO] |
2020―Mai―18 |
Response to: ‘Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?’ by Erre et al |
Elizabeth R Graef, Jean W Liew, Alfred HJ Kim, Jeffrey A Sparks |
| 1070 |
[GO] |
2020―Mai―15 |
Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: ‘COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs’ by Conticini et al |
Sara Monti, Carlomaurizio Montecucco |
| 1071 |
[GO] |
2020―Mai―15 |
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs |
Edoardo Conticini, Elena Bargagli, Marco Bardelli, Giuseppe Domenico Rana, Caterina Baldi, Paolo Cameli, Stefano Gentileschi, David Bennett, Paolo Falsetti, Nicola Lanzarone, Francesca Bellisai, Cristiana Barreca, Roberto D'Alessandro, Luca Cantarini, Bruno Frediani |
| 1072 |
[GO] |
2020―Mai―15 |
Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: ‘Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia’ by Guilpain et al |
Sara Monti, Carlomaurizio Montecucco |
| 1073 |
[GO] |
2020―Mai―13 |
Response to: ‘Patients with lupus are not protected from COVID-19: a comment’ by Sawalha, ‘No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit’ by Romão et al and ‘SLE patients are not immune to COVID-19: importance of sending the right message across’ by Goyal |
Beuy Joob, Viroj Wiwanitkit |
| 1074 |
[GO] |
2020―Mai―13 |
No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: response to the comment by Joob and Wiwanitkit |
Vasco C. Romão, Ana Rita Cruz-Machado, João Eurico Fonseca |
| 1075 |
[GO] |
2020―Mai―06 |
Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series |
Achille Aouba, Aurelie Baldolli, Loïk Geffray, Renaud Verdon, Emmanuel Bergot, Nicolas Martin-Silva, Aurélien Justet |
| 1076 |
[GO] |
2020―Apr―28 |
Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19 |
Haralampos M Moutsopoulos |
| 1077 |
[GO] |
2020―Apr―24 |
Patients with lupus are not protected from COVID-19 |
Amr H Sawalha |
| 1078 |
[GO] |
2020―Apr―23 |
Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: ‘Does hydroxychloroquine prevent the transmission of COVID-19?’ by Heldwein and Calado and ‘SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment’ by Joob and Wiwanitkit |
Sara Monti, Carlomaurizio Montecucco |
| 1079 |
[GO] |
2020―Apr―23 |
SLE patients are not immune to covid-19: importance of sending the right message across |
Mohit Goyal |
| 1080 |
[GO] |
2020―Apr―23 |
Myositis as a manifestation of SARS-CoV-2 |
Maxime Beydon, Kevin Chevalier, Omar Al Tabaa, Sabrina Hamroun, Anne-Sophie Delettre, Marion Thomas, Julia Herrou, Elodie Riviere, Xavier Mariette |
| 1081 |
[GO] |
2020―Apr―22 |
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) |
Alessandro Giollo, Giovanni Adami, Davide Gatti, Luca Idolazzi, Maurizio Rossini |
| 1082 |
[GO] |
2020―Apr―22 |
What is the true incidence of COVID-19 in patients with rheumatic diseases? |
Ennio Giulio Favalli, Francesca Ingegnoli, Rolando Cimaz, Roberto Caporali |
| 1083 |
[GO] |
2020―Apr―22 |
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic |
Konstantinos Parperis |
| 1084 |
[GO] |
2020―Apr―21 |
Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)? |
Sergey Moiseev, Sergey Avdeev, Michail Brovko, Pavel Novikov, Victor Fomin |
| 1085 |
[GO] |
2020―Apr―21 |
Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality? |
Wenhui Xie, Yu Wang, Zhuoli Zhang |
| 1086 |
[GO] |
2020―Apr―20 |
Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia |
Philippe Guilpain, Clément Le Bihan, Vincent Foulongne, Patrice Taourel, Nathalie Pansu, Alexandre Thibault Jacques MARIA, Boris Jung, Romaric Larcher, Kada Klouche, Vincent Le Moing |
| 1087 |
[GO] |
2020―Apr―16 |
COVID-19 and rheumatology: first steps towards a different future? |
Iain B McInnes |
| 1088 |
[GO] |
2020―Apr―16 |
Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India |
Latika Gupta, Durga Prasanna Misra, Vishwesh Agarwal, Suma Balan, Vikas Agarwal |
| 1089 |
[GO] |
2020―Apr―16 |
Antirheumatic agents in covid-19: is IL-6 the right target? |
Pier Leopoldo Capecchi, Pietro Enea Lazzerini, Luca Volterrani, Maria Antonietta Mazzei, Barbara Rossetti, Giacomo Zanelli, David Bennett, Elena Bargagli, Federico Franchi, Matteo Cameli, Serafina Valente, Luca Cantarini, Bruno Frediani |
| 1090 |
[GO] |
2020―Apr―15 |
Role of immunosuppressive therapy in rheumatic diseases concurrent with covid-19 |
Chenyang Lu, Shasha Li, Yi Liu |
| 1091 |
[GO] |
2020―Apr―15 |
Festina lente: hydroxychloroquine, covid-19 and the role of the rheumatologist |
Elizabeth R Graef, Jean W Liew, Michael S Putman, Julia F Simard, Emily Sirotich, Francis Berenbaum, Alí Duarte-García, Rebecca Grainger, Carly Harrison, Maximilian F Konig, Peter Korsten, Laurie Proulx, Dawn P Richards, Philip C Robinson, Sebastian E Sattui, Manuel Francisco Ugarte-Gil, Kristen J Young, Alfred HJ Kim, Jeffrey A Sparks |
| 1092 |
[GO] |
2020―Apr―15 |
SLE, hydroxychloroquine and no SLE patients with covid-19: a comment |
Beuy Joob, Viroj Wiwanitkit |
| 1093 |
[GO] |
2020―Apr―15 |
Does hydroxychloroquine prevent the transmission of covid-19? |
Flavio L Heldwein, Adriano Calado |
| 1094 |
[GO] |
2020―Apr―03 |
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD |
Carina Mihai, Rucsandra Dobrota, Maria Schröder, Alexandru Garaiman, Suzana Jordan, Mike Oliver Becker, Britta Maurer, Oliver Distler |
| 1095 |
[GO] |
2020―Apr―03 |
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies |
Sara Monti, Silvia Balduzzi, Paolo Delvino, Elisa Bellis, Verdiana Serena Quadrelli, Carlomaurizio Montecucco |
| 1096 |
[GO] |
2020―Apr―03 |
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic |
Francesca Romana Spinelli, Fulvia Ceccarelli, Manuela Di Franco, Fabrizio Conti |
| 1097 |
[GO] |
2020―Mrz―23 |
Are my patients with rheumatic diseases at higher risk of COVID-19? |
Gabriel Figueroa-Parra, Gloria Mayela Aguirre-Garcia, Carmen Magdalena Gamboa-Alonso, Adrian Camacho-Ortiz, Dionicio Angel Galarza-Delgado |
|
